0001493152-22-007862.txt : 20220328 0001493152-22-007862.hdr.sgml : 20220328 20220328145715 ACCESSION NUMBER: 0001493152-22-007862 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 116 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agape ATP Corp CENTRAL INDEX KEY: 0001713210 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 364838886 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-220144 FILM NUMBER: 22775090 BUSINESS ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 BUSINESS PHONE: (603) 27325716 MAIL ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 10-K 1 form10-k.htm
0001713210 false FY Yes Yes 0001713210 2021-01-01 2021-12-31 0001713210 2021-06-30 0001713210 2022-03-23 0001713210 2021-12-31 0001713210 2020-12-31 0001713210 2020-01-01 2020-12-31 0001713210 us-gaap:CommonStockMember 2019-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001713210 us-gaap:RetainedEarningsMember 2019-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2019-12-31 0001713210 2019-12-31 0001713210 us-gaap:CommonStockMember 2020-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001713210 us-gaap:RetainedEarningsMember 2020-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2020-12-31 0001713210 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001713210 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001713210 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001713210 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001713210 us-gaap:CommonStockMember 2021-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001713210 us-gaap:RetainedEarningsMember 2021-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2021-12-31 0001713210 AATP:AgapeATPInternationalHoldingLimitedMember 2021-12-31 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember 2020-05-07 2020-05-08 0001713210 AATP:SubsidiaryCompanyTwoMember 2020-05-08 0001713210 AATP:SubsidiaryCompanyFiveMember 2021-11-11 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember 2020-05-08 0001713210 AATP:SubsidiaryCompanyMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyOneMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyOneMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyTwoMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyTwoMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyThreeMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyFourMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyFourMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyFiveMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyFiveMember 2021-12-31 0001713210 AATP:HealthAndWellnessProductsMember 2021-01-01 2021-12-31 0001713210 AATP:HealthAndWellnessServicesMember 2021-01-01 2021-12-31 0001713210 AATP:HealthAndWellnessServicesMember 2020-01-01 2020-12-31 0001713210 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-12-31 0001713210 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0001713210 AATP:SocialSecurityOrganizationMember 2021-01-01 2021-12-31 0001713210 AATP:SocialSecurityOrganizationMember AATP:MYRCurrencyMember 2020-01-01 2020-12-31 0001713210 AATP:EmployeesProvidentFundMember 2021-01-01 2021-12-31 0001713210 AATP:EmploymentInsuranceSystemMember 2021-01-01 2021-12-31 0001713210 AATP:EmploymentInsuranceSystemMember AATP:MYRCurrencyMember 2021-01-01 2021-12-31 0001713210 AATP:HumanResourceDevelopmentFundMember 2021-01-01 2021-12-31 0001713210 us-gaap:ComputerEquipmentMember srt:MinimumMember 2021-01-01 2021-12-31 0001713210 us-gaap:ComputerEquipmentMember srt:MaximumMember 2021-01-01 2021-12-31 0001713210 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2021-01-01 2021-12-31 0001713210 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2021-01-01 2021-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001713210 us-gaap:VehiclesMember 2021-01-01 2021-12-31 0001713210 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-01 2021-12-31 0001713210 AATP:SurvivorSelectMember 2021-01-01 2021-12-31 0001713210 AATP:SurvivorSelectMember 2020-01-01 2020-12-31 0001713210 AATP:EnergizedMineralConcentrateMember 2021-01-01 2021-12-31 0001713210 AATP:EnergizedMineralConcentrateMember 2020-01-01 2020-12-31 0001713210 AATP:IonizedCalMagMember 2021-01-01 2021-12-31 0001713210 AATP:IonizedCalMagMember 2020-01-01 2020-12-31 0001713210 AATP:OmegaBlendMember 2021-01-01 2021-12-31 0001713210 AATP:OmegaBlendMember 2020-01-01 2020-12-31 0001713210 AATP:BetaMaxxMember 2021-01-01 2021-12-31 0001713210 AATP:BetaMaxxMember 2020-01-01 2020-12-31 0001713210 AATP:VegeFruitFiberMember 2021-01-01 2021-12-31 0001713210 AATP:VegeFruitFiberMember 2020-01-01 2020-12-31 0001713210 AATP:IronMember 2021-01-01 2021-12-31 0001713210 AATP:IronMember 2020-01-01 2020-12-31 0001713210 AATP:YoungFormulaMember 2021-01-01 2021-12-31 0001713210 AATP:YoungFormulaMember 2020-01-01 2020-12-31 0001713210 AATP:OrganicYouthCareCleansingBarMember 2021-01-01 2021-12-31 0001713210 AATP:OrganicYouthCareCleansingBarMember 2020-01-01 2020-12-31 0001713210 AATP:MitogizeMember 2021-01-01 2021-12-31 0001713210 AATP:MitogizeMember 2020-01-01 2020-12-31 0001713210 AATP:NoOneMEDMember 2021-01-01 2021-12-31 0001713210 AATP:NoOneMEDMember 2020-01-01 2020-12-31 0001713210 AATP:EnergetiqueMember 2021-01-01 2021-12-31 0001713210 AATP:EnergetiqueMember 2020-01-01 2020-12-31 0001713210 AATP:TrimPlusMember 2021-01-01 2021-12-31 0001713210 AATP:TrimPlusMember 2020-01-01 2020-12-31 0001713210 us-gaap:ProductMember 2021-01-01 2021-12-31 0001713210 us-gaap:ProductMember 2020-01-01 2020-12-31 0001713210 AATP:PeriodEndMYRMember 2021-12-31 0001713210 AATP:PeriodEndMYRMember 2020-12-31 0001713210 AATP:PeriodEndHKDMember 2021-12-31 0001713210 AATP:PeriodEndHKDMember 2020-12-31 0001713210 AATP:PeriodAverageMYRMember 2021-01-01 2021-12-31 0001713210 AATP:PeriodAverageMYRMember 2020-01-01 2020-12-31 0001713210 AATP:PeriodAverageHKDMember 2021-01-01 2021-12-31 0001713210 AATP:PeriodAverageHKDMember 2020-01-01 2020-12-31 0001713210 AATP:SubsidiaryCompanyThreeMember 2021-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2021-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2021-01-01 2021-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-01-01 2020-12-31 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-05-08 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-06-29 2020-07-02 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-01-01 2020-03-31 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-03-31 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-01-01 2020-12-31 0001713210 srt:MinimumMember 2021-12-31 0001713210 srt:MaximumMember 2021-12-31 0001713210 AATP:ComputerAndOfficeEquipmentMember 2021-12-31 0001713210 AATP:ComputerAndOfficeEquipmentMember 2020-12-31 0001713210 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001713210 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001713210 AATP:VehicleMember 2021-12-31 0001713210 AATP:VehicleMember 2020-12-31 0001713210 AATP:GreenproCapitalCorpMember 2018-05-17 0001713210 AATP:GreenproCapitalCorpMember 2018-07-30 0001713210 AATP:GreenproCapitalCorpMember 2018-10-16 0001713210 AATP:DSwissIncMember 2020-11-03 0001713210 AATP:DSwissIncMember 2020-12-09 0001713210 AATP:SEATechVenturesCorpMember 2021-09-27 0001713210 srt:DirectorMember 2021-12-31 0001713210 srt:MaximumMember 2019-03-10 0001713210 srt:MinimumMember 2019-03-10 0001713210 AATP:MrHowKokChoongMember 2021-12-31 0001713210 AATP:UnreservedSdnBhdMember 2020-03-03 0001713210 AATP:MrHowKokChoongMember 2019-12-31 0001713210 2020-01-01 2020-03-31 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 us-gaap:CommonStockMember AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2021-12-31 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2020-12-31 0001713210 AATP:PhoenixPlusCorpMember 2021-12-31 0001713210 AATP:PhoenixPlusCorpMember 2020-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2021-01-01 2021-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2021-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2020-12-31 0001713210 AATP:HostastaySdnBhdMember 2021-01-01 2021-12-31 0001713210 AATP:HostastaySdnBhdMember 2020-01-01 2020-12-31 0001713210 AATP:HostastaySdnBhdMember 2021-12-31 0001713210 AATP:HostastaySdnBhdMember 2020-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2021-01-01 2021-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2020-01-01 2020-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2021-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2020-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2021-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2020-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2021-01-01 2021-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-01-01 2020-12-31 0001713210 AATP:VettonsSdnBhdOneMember 2021-01-01 2021-12-31 0001713210 AATP:VettonsSdnBhdOneMember 2020-01-01 2020-12-31 0001713210 AATP:HostastaySdnBhdOneMember 2020-01-01 2020-12-31 0001713210 AATP:HowKokChoongMember srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001713210 AATP:DSYWellnessAndLongevityCenterSdnBhdMember srt:ChiefExecutiveOfficerMember 2020-01-01 2020-12-31 0001713210 AATP:DSYWellnessAndLongevityCenterSdnBhdMember srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001713210 AATP:DSYWellnessAndLongevityCenterSdnBhdMember 2020-01-01 2020-12-31 0001713210 AATP:DSYWellnessAndLongevityCenterSdnBhdMember 2021-01-01 2021-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember srt:ChiefExecutiveOfficerMember 2020-01-01 2020-12-31 0001713210 AATP:HowKokChoongMember 2021-01-01 2021-12-31 0001713210 AATP:HowKokChoongMember 2020-01-01 2020-12-31 0001713210 AATP:HostastaySdnBhdOneMember 2021-01-01 2021-12-31 0001713210 AATP:HostastaySdnBhdOneMember srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001713210 AATP:HostastaySdnBhdOneMember srt:ChiefExecutiveOfficerMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-05-01 2020-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2021-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2021-01-01 2021-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-06-29 2020-07-31 0001713210 AATP:ShareForfeitureAgreementsMember AATP:HowKokChoongTalentLimitedMember 2021-01-01 2021-12-31 0001713210 AATP:ShareForfeitureAgreementsMember AATP:HowKokChoongTalentLimitedMember AATP:ShareholdersMember 2021-01-01 2021-12-31 0001713210 AATP:ShareForfeitureAgreementsMember AATP:HKCHoldingsSdnBhdMember 2021-01-01 2021-12-31 0001713210 AATP:ShareForfeitureAgreementsMember 2021-01-01 2021-12-31 0001713210 country:MY 2021-01-01 2021-12-31 0001713210 country:MY 2020-01-01 2020-12-31 0001713210 country:HK 2021-01-01 2021-12-31 0001713210 country:HK 2020-01-01 2020-12-31 0001713210 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-12-31 0001713210 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001713210 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001713210 country:US 2021-12-31 0001713210 country:US 2020-12-31 0001713210 AATP:LabuanMember 2018-12-28 2019-01-02 0001713210 country:MY 2021-12-31 0001713210 country:MY 2020-12-31 0001713210 AATP:UnutilizedMember 2021-12-31 0001713210 AATP:UnutilizedMember 2020-12-31 0001713210 AATP:AATPHKMember 2021-01-01 2021-12-31 0001713210 AATP:AATPLBASLSEAWATPAndDSYMember 2021-01-01 2021-12-31 0001713210 AATP:AATPHKMember 2020-01-01 2020-12-31 0001713210 AATP:AATPLBASLSEAAndWATPMember 2020-01-01 2020-12-31 0001713210 AATP:NoCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:NoCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001713210 us-gaap:AccountsReceivableMember AATP:ECommerceCompanyMember us-gaap:CustomerConcentrationRiskMember AATP:VendorOneMember 2020-01-01 2020-12-31 0001713210 AATP:VendorOneMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:VendorTwoMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:VendorOneMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001713210 AATP:VendorTwoMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001713210 AATP:DSwissIncMember 2020-12-01 2020-12-31 0001713210 AATP:DSwissIncMember 2020-11-30 0001713210 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember AATP:VendorOneMember AATP:DSwissIncMember 2021-01-01 2021-12-31 0001713210 AATP:VendorOneMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember AATP:DSwissIncMember 2020-01-01 2020-12-31 0001713210 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember AATP:OneVendorMember 2021-01-01 2021-12-31 0001713210 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember AATP:OneSalesDistributorMember 2021-01-01 2021-12-31 0001713210 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember AATP:NoSalesDistributorMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-04-01 0001713210 2021-05-30 2021-05-31 0001713210 AATP:TrainingCenterMember 2021-05-30 2021-05-31 0001713210 2021-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2021-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2021-12-31 0001713210 AATP:COVIDNineteenImpactMember 2021-01-01 2021-12-31 0001713210 us-gaap:SubsequentEventMember AATP:MrHowKokChoongMember AATP:ShareForfeitureAgreementMember 2022-01-01 2022-01-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:MYR xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Fiscal Year Ended December 31, 2021

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____________________________

 

Commission File Number 333-220144

 

AGAPE ATP CORPORATION

(Exact name of registrant issuer as specified in its charter)

 

Nevada   36-4838886

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,

Taman Desa, 58100 Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

 

Registrant’s phone number, including area code

(60) 192230099

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act:

 

Common Stock, $0.0001 par value

(Title of Class)

 

The OTC Market – Pink Sheets

(Name of exchange on which registered)

 

Securities registered pursuant to Section 12(g) of the Securities Exchange Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files). YES ☒ NO ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-accelerated Filer ☒ Smaller reporting company ☒

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Emerging growth Company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

The aggregate market value of the Company’s common stock held by non-affiliates computed by reference to the closing bid price of the Company’s common stock, as of the last business day of the registrant’s most recently completed second fiscal quarter:

 

$914,950,575.

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at March 23, 2022
Common Stock, $0.0001 par value   75,452,012

 

 

 

 

 

 

AGAPE ATP CORPORATION

FORM 10-K

For the Fiscal Year Ended December 31, 2020

Index

 

    Page #
PART I    
     
Item 1. Business 4
Item 1A. Risk Factors 20
Item 1B. Unresolved Staff Comments 28
Item 2. Properties 28
Item 3. Legal Proceedings 28
Item 4. Mine Safety Disclosure 28
     
PART II    
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29
Item 6. Selected Financial Data 29
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 30
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 39
Item 8. Financial Statements and Supplementary Data 39
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 39
Item 9A. Controls and Procedures 39
Item 9B. Other Information 41
     
PART III    
     
Item 10. Directors, Executive Officers and Corporate Governance 42
Item 11. Executive Compensation 45
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 46
Item 13. Certain Relationships and Related Transactions, and Director Independence 47
Item 14. Principal Accounting Fees and Services 50
     
PART IV    
     
Item 15. Exhibits, Financial Statement Schedules 51
     
SIGNATURES 52

 

2

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. These risks and uncertainties include the following:

 

  ● The availability and adequacy of our cash flow to meet our requirements;
     
  ● Economic, competitive, demographic, business and other conditions in our local and regional markets;
     
  ● Changes or developments in laws, regulations or taxes in our industry;
     
  ● Actions taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory, judicial and other governmental authorities;
     
  ● Competition in our industry;
     
  ● The loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;
     
  ● Changes in our business strategy, capital improvements or development plans;
     
  ● The availability of additional capital to support capital improvements and development; and
     
  ● Other risks identified in this report and in our other filings with the Securities and Exchange Commission or the SEC.

 

This report should be read completely and with the understanding that actual future results may be materially different from what we expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Use of Defined Terms

 

Except as otherwise indicated by the context, references in this Report to:

 

  ● The “Company,” “we,” “us,” or “our,” “Agape” are references to Agape ATP Corporation, a Nevada corporation.
     
  ● “Common Stock” refers to the common stock, par value $0.0001, of the Company;
     
  ● “Malaysia” is Malaysia;
     
  ● “U.S. dollar,” “$” and “US$” refer to the legal currency of the United States;
     
  ● “RM” and “Ringgit” are to the legal currency of Malaysia;
     
  ● “Securities Act” refers to the Securities Act of 1933, as amended; and
     
  ● “Exchange Act” refers to the Securities Exchange Act of 1934, as amended.

 

3

 

 

PART I

 

ITEM 1. BUSINESS

 

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. (“ASL”), a company incorporated in Malaysia. .

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., a network marketing entity incorporated in Malaysia.

 

Agape Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.

 

On September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (“WATP”), a wholly owned subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.

 

On November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

The Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.

 

The accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3), and DSY Wellness.

 

4

 

 

Details of the Company’s subsidiaries:

 

    Subsidiary company name   Place and date of incorporation   Particulars of issued capital   Principal activities   Proportional of ownership interest and voting power held  
                       
1.   Agape ATP Corporation   Labuan,
March 6, 2017		   100 shares of ordinary share of US$1 each   Investment holding     100 % 
                         
2.   Agape ATP International Holding Limited   Hong Kong,
June 1, 2017		   1,000,000 shares of ordinary share of HK$1 each   Wholesaling of health and wellness products; and health solution advisory services     100 %
                         
3.   Agape Superior Living Sdn. Bhd.   Malaysia,
August 8, 2003		   9,590,598 shares of ordinary share of RM1 each   Health and wellness products and health solution advisory services via network marketing     99.99 % 
                         
4.   Agape S.E.A. Sdn. Bhd.   Malaysia,
March 4, 2004		   2 shares of ordinary share of RM1 each   VIE of Agape Superior Living Sdn. Bhd.     VIE  
                         
5.   Wellness ATP International Holdings Sdn, Bhd   Malaysia,
September 11, 2020		   100 shares of ordinary share of RM1 each   The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns     100 %
                         
6. DSY Wellness International Sdn Bhd.   Malaysia,
November 11, 2021		   1,000 shares of ordinary share of RM1 each   Provision of complementary health therapies     60 % 

 

 

5

 

 

Business Overview

 

Agape ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.

 

Via ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.

 

The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.

 

The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.

 

The Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various wellness programs.

 

To further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

6

 

 

Our Products

 

ATP1s Survivor Select

 

ATP1s Survivor Select contains various essential nutrients required by the human body to maintain the normal metabolism, which includes productions of biological energy (ATP). Effective production of ATP enhances both physical as well as mental health, and helps the body to build up resistance to diseases.

 

 

It helps to:

 

  ● Stimulate instant bio-energy production at the cellular level to ensure sufficient supply of bio energy for body cell.
  ● Promote better metabolism at the cellular level.
  ● Promote healthy and optimal growth of bones system, teeth structure and muscle tissue of children.
  ● Improve the digestion and nutrient absorption powers of body cell.
  ● Promote cell detoxification and repair capabilities in order to enhance cell self-healing ability.

 

ATP2 Energized Mineral Concentrate

 

The ATP2 is a nutritional supplement made from the finest plant substances and also is a proprietary formulation of a super-energized colloidal concentrate developed from a dibase solution. Its formula supports and enhances nutritional biochemical activities.

 

 

7

 

 

It helps to:

 

  ● Support and enhance nutritional biochemical activities (nutrient absorption and waste metabolism).
  ● Break down or oxidised toxins and waste material to promote cellular detoxification and improve blood circulation.
  ● Increase cellular respiration and energy production to reduce fatigue and maintain energy level.
  ● Increase oxygen level in body cells to create a high oxygen environment in the body, which possibly help to prevent the growth of harmful pathogens that contribute to diseases.
  ● Provide sufficient antioxidants that act as a superior scavenger of free radicals, to strengthen the body cells resistance against oxidative damages.

 

ATP3 Ionized Cal-Mag

 

ATP3 Ionized Cal-Mag is a specialized calcium and magnesium minerals supplement that is designed to transform into ionic form completely before entering the body. This is compatible to the cellular ion channel theory, that all cellular metabolisms are dependent on ionic transmission to achieve the highest absorption rate. This product was tested for its nanoparticle by the National Measurement Institute of Australian Government, with proven content of nanosized calcium and magnesium that has better absorption and bio-availability.

 

 

It helps to:

 

  ● Strengthen the bone system and promote better bone development.
  ● Strengthen the teeth structure and prevent teeth damages.
  ● Provide abundant of ionic calcium and magnesium to prevent chronic diseases through better blood circulation and acid-base regulation.
  ● Promote better relaxing of nervous system and regulations of neurotransmitters which helps to enhance sleep quality.
  ● Promote better relaxing of muscle to prevent muscle soreness and cramps.

 

8

 

 

ATP4 Omega Blend

 

ATP4 Omega Blend is a proprietary oil blend that is rich in undamaged polyunsaturated essential fatty acid, which is fully extracted from plant-based ingredients. It provides a bio-effective balance of both essential fatty acids, Omega 3 and Omega 6 which are the important structural components of cell membranes that cannot be synthesized by humans.

 

 

It helps to:

 

  ● Regulate cholesterol and triglycerides levels to promote better blood circulation.
  ● Regulate inflammation, the unifying component of many diseases, and enhance cell repairing activities.
  ● Regulate hormones production and functions in the body through supplies of the balanced ratio of Omega 3 and Omega 6.
  ● Promote healthy functioning of the brain through the maintenance of healthy impulse transmission in brain cells that is crucial for memory and learning ability.

 

ATP5 BetaMaxx

 

ATP5 BetaMaxx is derived from the cell wall of premium food-grade baker’s yeast and is a medical breakthrough result of more than 50 years of intensive research and studies by scientists and physicians. This product combines the immunostimulatory properties of perfectly molecularly structured beta 1-3, 1-6-D-glucan with other immunomodulating compounds that work in perfect synergy to make ATP5 a unique and effective natural product. It is a 100% natural immune enhancer, safe and does not cause any allergic reactions.

 

9

 

 

 

It helps to:

 

  ● Strengthen the function of immune cells to build up a better immune response of body for external and internal protections
  ● Promote better cell repairing and regulate inflammatory responses in wound healing.
  ● Enhance the function of immune cell against damages caused by radiation.
  ● Helps to normalize blood sugar levels.

 

AGN-Vege Fruit Fiber

 

AGN-Vege Fruit Fiber is the special nutrition-based formula for intestines and stomach. It consists of four most essential components for gastrointestinal health effects such as fiber, probiotic the “friendly bacteria”, prebiotic fructooligosaccharides (FOS) as well as digestive enzymes.

 

 

10

 

 

It helps to:

 

  ● Promote better bowel movement and prevent low-fiber diet-induced constipation.
  ● Maintain bowel health. FOS helps increase intestinal bifidobacteria and helps maintain a good intestinal environment.
  ● Slow the absorption of sugar and lipid into the bloodstream which helps improve blood sugar and cholesterol level.
  ● Induce better satiety, which results in reduced total food intake and helps in achieving an ideal weight management.

 

AGP1-Iron

 

AGP1-Iron is the purest and most advanced Colloidal Iron that is sourced from the remains of an ancient rainforest which contains the most active plant-based element from nature. The colloidal nanosized iron provides high zeta potential promotes better absorptivity and cellular iron uptake through the ion channel.

 

 

It helps to:

 

  ● Promote better hemoglobin production to improve iron deficiency anemia.
  ● Iron is a component of hemoglobin in red blood cell which carries oxygen to all part of the body. Therefore, it helps to improve blood circulation and prevent some oxygen deficiency symptoms through enhancement of oxygen delivery and nutrient circulation as well as toxins excretion.
  ● Iron is a factor in red blood cell formation. It promotes hemoglobin production hence is suitable especially for women and individual who experienced accidental bleedings.

 

YFA-Young Formula

 

YFA-Young Formula is a 100% natural unique formula, a combination of amino acid, vitamins, and minerals and is the best anti-aging and youthful maintenance supplement. It stimulates the pituitary gland to release endocrine hormones such as human growth hormone (HGH) to stimulate synergies thus achieving the efficacy of anti-ageing through the promotion of cells vitality and strengthening of organ function.

 

11

 

 

 

It helps to:

 

  ● Enhance the production of bio-energy ATP and metabolism, which aids in reducing body fat accumulation and promote strong muscles building.
  ● Stimulate the production of collagen to restore skin elasticity and reduce wrinkles.
  ● Reduce pigmentation and dark spots on face caused by hormonal imbalances.
  ● HGH builds and repairs tissues and thus has an effect on hair cells at the hair root to promote healthy hair growth.
  ● Enhance memory and cardiovascular function and prevent various chronic diseases due to HGH deficiency.

 

BEAUNIQUE Mito+

 

The BEAUNIQUE Mito+ is a strong antioxidant drink with great flavor and taste. The preeminence of BEAUNIQUE Mito+ is its ability to further protect and stimulate mitochondria (the powerhouse of cells) in cellular energy (ATP) production with the added advantage of less total sugars and calories. The formula comprises 11 Superfood including potent mangosteen skin extract. Backed by advanced scientific research and tested on 88 nutrigenomic profile, the formulation revealed enhanced antioxidant properties. 96.34% DPPH Radical Scavenging activity.

 

 

12

 

 

It Promotes:

 

  Cellular health
  ● Effective antioxidants to protect from cellular oxidative damages.
     
  Immune health
  ● Enhance adaptive immune response.
  ● Anti-inflammatory.
  ● Strengthen immunity against bacteria and viruses.
     
  Metabolic health
  ● Reduce risk of obesity.
  ● Reduce risk of vascular diseases.
  ● Reduce risk of Type II Diabetic.
     
  Brain health
  ● Reduce risk of neurodegenerative diseases.
     
  Skin health
  ● Systemic photoprotection.
  ● Reduce dark spot formation.
  ● Alleviates skin wrinkle and inflammation induced by UV-B irradiation.

 

ORYC-Organic Youth Care Cleansing Bar

 

ORYC-Organic Youth Care Cleansing Bar is a natural, organic cleansing soap for skin. It contains pure Australian-accredited natural and organic plant oils acting as a high quality and natural skin lubricant. It maintains the softness of the skin while promoting skin beauty and radiance.

 

 

13

 

 

It helps:

 

  ● With its biodynamic avocado oil and vanilla extract, remove impurities, leaving skin clear, fresh and clean.
  ● With its biodynamic, coconut, almond and olive oil, moisturize and texturize the skin to prevent skin drying.
  ● In acting as natural anti-bacterial and anti-inflammatory agents, reduce the risks of skin infections and allergies.

 

*References alluding to the efficacy and effects of our products are based on client testimonials.

 

Beauty Products

 

The Company’s ENERGETIQUE series aim to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of Energy Mask, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

ENERGY MASK SERIES

 

The Company’s Energetique Mask Series is formulated with triple action natural ingredients and advanced technologies. The innovative combination of award-winning patented liposome encapsulating the customized fast acting patented essence, produces micro-particle liposome which, combined with collagen peptide Tencel film, creates an effective formulation that benefits the skin at the cellular level.

 

There are three types of face masks in the Energetique Mask Series, each to suit a different skin requirement. They are: N°1 Med-Hydration; N°2 Med-Whitening; N°3 Med-Firming. Advanced genetic analysis and clinical trials conducted revealed the benefits and efficacies of the patented functional essence. The Energetique Mask Series has clinically shown deep penetration of liposomal essence into deep skin layers within 5 minutes of the application to deliver immediate, deep-reaching and long-lasting benefit of skin hydration, whitening, and firming.

 

N°1 Med-Hydration

 

Formulated with the patented Sea Grape (Caulerpa lentillifera) extract, the N°1 Med-Hydration enhances skin moisture and luminosity. This treatment effectively improves the moisture content of the inner skin layer and rejuvenate the skin barrier function to avoid moisture loss.

 

 

14

 

 

It helps:

 

  ● locking the skin moisture and nutrients, strengthening the skin barrier function and boosting the skin’s moisture level.
  ● to increase the skin’s natural moisturizing factor (PCA) and skin layer glycoprotein connectivity to maintain the skin’s moisture.
  ● to effectively retain water, provides moisturization, restores skin elasticity, and promotes the growth of fibroblasts for moisturization, removes dryness, regains skin’s elasticity and smoothness.
  ● immensely in delivering an instant boost of skin moisture content up to 45.7% in just 5 minutes of application and synergistically ensuring a profound and long-lasting skin moisturization and hydration.

 

N°2 Med-Whitening

 

Formulated with patented Peach Blossom Stem Cell Extract, the N°2 Med-Whitening has clinically shown its efficacy in inhibiting the melanin synthesis, down-regulating the melanin synthesis gene, boosting skin moisture level and protecting skin against UV radiation.

 

 

It helps:

 

  ● in suppressing melanin production and fight against UV radiation to protect skin cells and result in whitening effect.
  ● to stimulate interstitial hyperplasia cell and helps in increasing the moisturizing ceramide by 7.4 times in order to remove skin roughness and smoothing skin.
  ● to enhance the skin brightness up to 6.3% in just 5 minutes of application and synergistically rejuvenate a profound and long-lasting skin ability in anti-UV damage.

 

15

 

 

N°3 Med-Firming

 

Formulated with the patented Djulis (Chenopodium formosanum Koidz) Seed Extract, the native cereal plant in Taiwan and traditionally called “ruby of cereals.” The formulation is clinically proven to be effective in stimulation of collagen secretion and anti-advances glycation end-products (AGEs) reducing the glycation of skin collagen, provide protection and maintenance of the basal skin collagen production.

 

 

It helps:

 

  ● to suppress the skin collagen glycation process, reduces collagen loss, and enhancing collagen secretion.
  ● repairing the dead skin tissue, smooth wrinkles to restore the smoothness and health of the skin.
  ● preventing wrinkles formation and providing the essential skin moisture content.
  ● to boost skin elasticity by up to 14.4%. and improve sagging skin by 135 in just 5 minutes of application.

 

ÉNERGÉTIQUE Hyaluronic Acid (HA) Serum

 

Formulated with four functional hyaluronic acid and a unique peptide, this scientifically advanced and intensive quintuple action serum proven to deliver 5Rs dermal benefits. Filled in an innovative yet convenient and hygienics syringe packaging, this HA serum also ensure consumer-perceivable benefits for every skin type.

 

 

16

 

 

Benefits

 

  ● REBALANCE - Hydrate the skin surface by forming a protection layer and keep skin moisturized even after cleansing
  ● RECOVER – Repair the out-balanced lamellar layer to act as barrier to prevent skin moisture from evaporation
  ● REGENERATE - Promote the production of Type I pro-collagen and boost skin’s own production of Hyaluronic Acid up to 3 times
  ● REHYDRATE - Nano-sized particles with high capacity of water-holding allow deep penetration and bestows moisture from inside the skin. Long-lasting moisture retention up to 72 hours
  ● REMODELLING - Proven to increase skin firmness +200% (cheek, under-eye and neck). Enhance skin viscoelasticity to improves skin roughness

 

ÉNERGÉTIQUE Mousse Facial Cleanser

 

Formulated with the mildest surface-active agents available on the market, this facial cleanser was designed to deliver a distinct A to E cleansing benefits to consumers. The unique mousse like-foam delivers a comfortable and soft feeling of the skin during and after use without compromising the moisturizing level and viscoelastic properties of the skin.

 

 

Benefits

 

  A. All Skin Type
     
      a. Hypoallergenic
      b. Non-comedogenic
         
  B. Balance
     
      a. pH-balanced formula with buffer capacity at pH 5.5 of the skin.

 

17

 

 

Benefits

 

  C. Comfortable
     
      a. Mild to skin and eyes without irritating or drying your skin
      b. Comfortable and soft feeling – prolonged comfortable to skin before and after use. Accidental consuming would not be harmful to your body.
         
  D. Dense
     
      a. Mousse-like foam very fine porous foam and smooth skin-feel during use
         
  E. Effortlessly
     
      a. Easily remove light makeup, dirt and impurities.
      b. Easy to rinse with no residual.

 

Unique Characteristics via Nutrigenomic

 

The Company’s BEAUNIQUE product series focuses on the research of diet’s impact on modifying gene expressions to address genetic variations and deliver a personalized nutrigenomic solution for every individual.

 

Trim+:

 

Trim+ is the first product launched under this series, utilizes the advanced technology to extract the patented active ingredients in foods. Trim+ has scientifically proven to be effective in inhibiting the activities of carbohydrates digestive enzymes, which results in a reduction of the breakdown and absorption of sugars.

 

 

It helps to:

 

  ● Reduce total carbohydrates calories intake with the scientifically proven effect on weight management.
  ● Regulate blood sugar levels with scientifically proven efficacy.
  ● Improve cellular uptake of sugars for bioenergy ATP production.
  ● Maintain insulin hormone balance, helps prevent diabetes.
  ● Improve blood lipids composition, helps prevent cardiovascular disease.

 

Future Plans

 

As at the date of this report, the number of COVID-19 cases have hit over 447 million worldwide with approximately 6.0 million lives lost.

 

It has been approximately 2 years since the declaration of the COVID-19 pandemic, the lethargy brought about by the pandemic to the world populace, countries and governments is immense.

 

As of March 2022, Malaysia stands at position 26 as the country with the highest COVID-19 cases as recorded under the coronavirus statistics of the “worldometer”. Total COVID-19 cases in Malaysia hit approximately 3.6 million and associated fatality of 33, 228. These figures are huge relative to the small size economy of the country. We are witnessing the adverse impact on the purchasing power of consumers in Malaysia, where our products are mainly sold as a direct result of the prolonged pandemic. Revenue of ASL, our subsidiary that is principally involved in network marketing decreased significantly for the year ended December 31, 2021 as compared to the same period in 2020.

 

Our immediate plans will be: (i) to bring the operational activities of ASL to pre-pandemic levels, to record higher revenue and profits. As businesses continues to be digitized, we will further capitalize on the e-commerce trading platform provided by Vettons Sdn. Bhd. to perform e-marketing and e-trading of our products to members, as well as online e-recruitment of new members; and (ii) to activate WATP whose principal activity is in promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle. We will focus on developing customer centric programs, prioritizing high level engagements for a speedier and more tangible outcome.

 

On November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies. The establishment of DSY Wellness is a further expansion of our business into the health and wellness industry. The independent third party readily owns 33 proprietary formulas for treating non-communicable disease which he has agreed to bring into the company for joint commercialization. The independent third party also has existing clients receiving traditional complimentary medicine or “TCM” in Indonesia and Thailand.

 

While the COVID-19 pandemic subsists, we will concentrate our resources in developing our businesses in Malaysia where most of our activities are concentrated. DSY Wellness will expand its businesses in the state of Penang and Johor in the short term. At time opportune, when the pandemic has subsided or is over and restrictions on travelling between nations are uplifted, service centers will be set up in Indonesia and Thailand. Together with ASL and WATP, this has the potential for the development of wellness tourism. As the products and services offerings of the Company widens beyond the sale of health products via network marketing, any overseas expansion could generate multiplier effect to the Company’s income and profitability, which the Company will capitalize. It is the Company’s ultimate aim to partake in all the lucrative areas of the health and wellness ecosystem as far as possible, to carve a niche in the health and wellness industry.

 

18

 

 

Marketing

 

Leveraging on information technology, we will continue to build our brand image to create brand awareness to penetrate the marketplace and attract customers. For the Company’s network marketing business, we have a corporate website which introduces and promotes our products and services, enable e-trading and e-recruitment of members. Going forward, we will use our corporate website more extensively to market all our products and services. We will utilize marketing related search engines to attract potential clients to our website. In financial year 2020, we have also synched-up with Vettons Sdn. Bhd, an e-merchant to further our reach through e-commerce. On February 1, 2021, Mr. How Kok Choong, the CEO and director of the Company, was appointed as the non-executive Chairman of Vettons Sdn Bhd. Vettons Sdn. Bhd became our related party since then.

 

Additionally, we will explore other online methods to enhance brand awareness that are impactful for community building for our other ventures in the health and wellness industry such as referral programs, develop contents for guest publishing, social media contests, etc. We will be social focus in the selection of social networks for our social media marketing, and where appropriate infographics will be used and influence marketing will be employed.

 

With the incorporation of DSY Wellness, much cross-selling and up-selling will be deployed for a more comprehensive products and services offerings to our customers. As discussed above, the multiplier effect of a wide products and services offerings to the Company’s revenue stream and bottom line is huge.

 

Competition

 

The health and wellness industry, with a focus on health supplements in particular in Malaysia, where we operate, is rather competitive. Our focus is on the mature group of customers, i.e. adults ranging in age from 18-65 years old. We face competition from various retail health supplement providers, pharmacies, and Multi-Level Marketing Companies which supply health supplement products, such as Bio-Life Marketing Sdn Bhd, Elken Group, Usana Group, BMS Organics, NHF Group and their respective affiliates. These competitors are generating significant traffic to their marketing websites; and have established brand recognition and financial resources.

 

We believe that the principal competitive factors in our type of market include the quality of health supplements, the efficacies of the health supplements, strength and depth of relationships with clients, the ability to identify the changing needs and requirements of prospective clients, and the scope of services. Through utilizing our competitive strengths, we believe that we have a competitive edge over other competitors due to the breadth of our product offerings, one stop convenience, pricing, our services, our reputation and product safety. As discussed, the prolonged pandemic has eroded much of the purchasing power of the Malaysian community. The last year has seen consumers shifting to more affordable goods and services. As nations start to accept COVID-19 as endemic, we will target our resources to regain our operational activities to pre-pandemic level. Next, we will develop and enlarge our market share in the Malaysian market and potentially further into the overseas market.

 

The Company’s latest investment in TCM is comparatively a less competitive health and wellness segment, especially at a time when non-communicable disease is on the rise. The independent third party whom we joint venture with is an accredited practitioner in TCM in Malaysia.

 

Customers

 

Our customer base from our network marketing sales channel stood at 128,235 members as at December 31, 2021. We will rework our product-mix and pricing to help our distributors and members to strengthen and widen their sales network. We will also capitalize the existing customer base to build the wellness and wellbeing lifestyle community to enhance WATP’s business, and for our TCM products and services offerings.

 

19

 

 

Employees

 

The following table sets forth the number of employees by function as of the date of this annual report:

 

Function 

Number of

employees

 
     
Senior Management   3 
Business Development Department   3 
Corporate Affairs Department   3 
Finance Department   6 
Human Resources Department   4 
Operations Department   9 
Product Development Department   5 
Sales & Marketing Department   3 
Total   36 

 

Regulations

 

At present, our products are predominately sold in Malaysia. As the contents and combination of the main ingredients in our ATP Zeta Health Program and BEAUNIQUE series are categorized as health food rather than medicines or drugs, all of our products require authorization from the Food Safety and Quality Division of the Ministry of Health, Malaysia according to the Food Act 1983 (ACT 281) & Regulations in order to be sold in the country. Accordingly, we have obtained the appropriate authorizations from the Food Safety and Quality Division of the Ministry of Health, Malaysia for all products in our ATP Zeta Health Program and BEAUNIQUE series.

 

Our ÉNERGÉTIQUE series is regulated under the Control of Drugs and Cosmetics Regulations 1984, the Ministry of Health, Malaysia. We have also obtained the appropriate authorizations for distribution and sale of the products.

 

ITEM 1A. RISK FACTORS

 

We are exposed to concentration risk of heavy reliance on our major supplier for the supply of our products, and any shortage of, or delay in, the supply may significantly impact on our business and results of operation.

 

For the year ended December 31, 2021, we purchased $28,969 and $27,707 from two of our major suppliers, represented approximately 47.3% and 45.2%, respectively, of our total purchases. Our business, financial condition and operating results depend on the continuous supply of products from our major suppliers and our continuous supplier-customer relationships with them. Our heavy reliance on our major suppliers for the supply of our products will have significant impact on our business and results of operation in the event of any shortage of, or delay in the supply.

 

As is customary in distribution arrangements of this type, the distribution agreement with our major suppliers are terminable by either party by giving notice. There is no assurance that our major suppliers will not terminate the distribution agreement. In the event that they terminate the distribution agreements, we will have to source products from other suppliers and we may not be able to secure supply of products with quantity and quality required to support our business or at all. Such termination may therefore have a material adverse impact on our business, financial condition and operating results if we fail to engage any other suppliers before the termination.

 

There is no assurance that our major suppliers will continue to supply their products in the quantities and timeframes required by us to meet the needs of our customers or comply with their supply agreements with us. Our product supply may also be disrupted by potential labor disputes, strike action, natural disasters or other accidents, epidemic and pandemic affecting the supplier. If our major suppliers do not supply products to us in a timely manner or in sufficient quantities, our business, financial condition and operating results may be materially and adversely affected.

 

20

 

 

Furthermore, in the event of any delay in delivery of the products to us, our cash flow or working capital may be materially and adversely affected as a result of the corresponding delay in delivery of our products to our customers, and hence the delay in our receipt of payment from our customers.

 

Our major suppliers may change their existing sales or marketing strategy in respect of the products supplied to us by changing their export strategy, reducing its sales or production volume or changing its selling prices. Consequently, there are no assurances that our major suppliers will not appoint other dealers or distributors which may compete with us in the market where we operate. Furthermore, any significant increase in the selling prices of the products which we source from our suppliers will increase our costs and may adversely affect our profit margin if we are not able to pass the increased costs on to our customers.

 

There are no assurances that there will be no deterioration in our relationships with our major suppliers which could affect our ability to secure sufficient supply of products for our business. In the event that our major suppliers change their sales or marketing strategy or otherwise appoint other dealers or distributors who may compete with us, our business, financial condition and operating results may be materially and adversely affected.

 

We could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich our product offering or gain market acceptance of our new products could have a negative effect on our business.

 

The market we operate is subject to changes in consumer preference, perception and spending habits. Our performance depends significantly on factors which may affect the level and pattern of consumer spending in the market we operate. Such factors include consumer preference, consumer confidence, consumer income and consumer perception of the safety and quality of our products. Media coverage regarding the safety or quality of, or diet or health issues relating to, our products or the raw materials, ingredients or processes involved in their manufacturing, may damage consumer confidence in our products. A general decline in the consumption of our products could occur as a result of change in consumer preference, perception and spending habits at any time.

 

Any failure to adapt our product offering to respond to such changes may result in a decrease in our sales if such changes are related to certain of our products. Any changes in consumer preference could result in lower sales of our products, put pressure on pricing or lead to increased levels of selling and promotional expenses. In any event a decrease in customer demand on our products may also result in lower sales and slow down the consumption of our inventory to a low inventory turnover level. Any of these changes could result in a material adverse effect on our business, financial conditions or results of operations.

 

The success of our products depends on a number of factors including our ability to accurately anticipate changes in market demand and consumer preferences, our ability to differentiate the quality of our products from those of our competitors, and the effectiveness of our marketing and advertising campaigns for our products. We may not be successful in identifying trends in consumer preferences and developing products that respond to such trends in a timely manner. We also may not be able to effectively promote our products by our marketing and advertising campaigns and gain market acceptance. If our products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, we may not be able to fully recover our costs and expenses incurred in our operation, and our business prospects, financial condition or results of operations may be materially and adversely affected.

 

If we fail to maintain quality products and value, our sales are likely to be negatively affected.

 

Our success depends on the safety and quality of products that we obtain from our suppliers for our customers. Our future customers will identify our brand name with a certain level of quality and value. If we cannot meet this perceived value or level of quality, we may be negatively affected and our operating results may suffer. In addition, any failure on the part of our suppliers to maintain the quality of their products, will in turn substantially harm the results of our business operations, potentially forcing us to identify other suppliers or alter our business strategy significantly.

 

21

 

 

If we are unable to create brand influence, we may not be able to maintain current or attract new users and customers for our products.

 

Our operational and financial performance is highly dependent on the strength of our brand. We believe brand familiarity and preference will continue to have a significant role in winning customers as the decision to buy our products and services. In order to further expand our customer base, we may need to substantially increase our marketing expenditures to enhance brand awareness through various online and offline means. Moreover, negative coverage in the media of our company could threaten the perception of our brand, and we cannot assure you that we will be able to defuse negative press coverage about our company to the satisfaction of our investors, customers and suppliers. If we are unable to defuse negative press coverage about our company, our brand may suffer in the marketplace, our operational and financial performance may be negatively impacted and the price of our shares may decline.

 

Currently, we sell our products, with or without customization, under our brand name “ATP”, to domestic customers in Malaysia and to overseas customers. However, if our competitors initiate a lawsuit against us for infringing their trademark, we may be forced to adopt a new brand name for our products. As a result, we may incur additional marketing cost to raise awareness of such new brand name. We may also be ordered to pay a significant amount of damages, and our business, results of operations and financial condition could be materially and adversely affected.

 

We may incur losses resulting from product liability claims or product recalls.

 

We may incur losses resulting from product liability claims with respect to our products supplied by our supplier. We may face claims or liabilities which may arise if there exist any defects in quality of these products or any of these products are deemed or proven to be unsafe, defective or contaminated. In the event that the use or misuse of any product distributed by us results in personal injury or death, product liability and/or indemnity claims may be brought against us, in addition to our product recalls, and the relevant regulatory authorities in the market we operate may close down some of our related operations and take administrative actions against us. If we experience any business disruption and litigation, we may incur additional costs and have to divert our management’s attention and resources on such matters, which may adversely affect our business, financial condition and results of operations.

 

We operate in a heavily regulated industry.

 

Our business is principally regulated by various laws and regulations in the market we operate, such as in Malaysia the Food Act of 1983 (Act 281) and Regulations, Control of Drugs and Cosmetics Regulations 1984 mandate authorization from the Food Safety and Quality Division and National Pharmaceutical Regulatory Agency of the Ministry of Health for our Company’s products to be sold in the country. Various registrations, certificates and/or licenses for the conduct of our business are required under the above laws, which also contain provisions for requirements on the storage, labelling, advertising and importation of some of our products.

 

Based on our experience, some of the laws and regulations of the place where we operate our business are subject to amendments, uncertainty in interpretation and administrative actions from time to time. Therefore, we cannot assure you that, for the implementation of our business plans and the introduction of any new product, we will be able to obtain all the necessary registrations, certificates and/or licenses. Any failure to comply with the above laws and regulations may give rise to fines, administrative penalties and/or prosecution against us, which may adversely affect our reputation, financial condition or results of operation.

 

Our internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated to the public.

 

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. As defined in Exchange Act Rule 13a-15(f), internal control over financial reporting is a process designed by, or under the supervision of, the principal executive and principal financial officer and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: pertain to the maintenance of records in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and/or directors of the Company; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

 

22

 

 

In connection with the audit of our consolidated financial statements as of December 31, 2021, we and our independent registered public accounting firms identified six “material weaknesses”, and other control deficiencies including significant deficiencies in our internal control over financial reporting. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses identified related to the Company were: (i) insufficient full-time personnel with appropriate levels of accounting knowledge and experience to monitor the daily recording of transactions, address complex U.S. GAAP accounting issues and to prepare and review financial statements and related disclosures under U.S. GAAP; (ii) lack of a functional internal audit department or personnel that monitors the consistencies of the preventive internal control procedures and lack of adequate policies and procedures in internal audit function to ensure that the Company’s policies and procedures have been carried out as planned; (iii) lack of adequate segregation of duties and effective risk assessment, which in turn may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors; (iv) we lack of proper procedures developed for system change management policies. Change management policies and procedures have not been developed. Critical change management control processes and procedures, such as change request and approval, periodic status reporting, user testing and acceptance, post-implementation review, etc., were either not performed or formally documented; (v) we lack of the following internal control procedures in relation of Third-Party (Service Organization) Vendor Management – (a) service evaluation and qualification assessment of third-party vendors were not performed for the year ended December 31, 2021 and (b) Management was not able to provide evidence of their review of their service providers’ SOC 1 and SOC 2, or ISO 27001 certificate reports and therefore unable to provide evidence of their review of the physical security and environmental controls in place at IP Serverone cloud server (which the Company’s financial system is hosted on; (vi) we lack of the following internal control procedures in relation of User Account Management – (a) Evidence relating to the authorization of database administrator user accounts and access was not preserved for the MLM System during the year ended December 31, 2021 and (b) Evidence relating to periodic recertification of MLM and SQL Finance System end user are privileged accounts and related access rights were preserved during the year ended December 31, 2021; (vii) we lack of the following internal control procedures in relation of Audit Logs and Segregation of Duty (“SOD”) Management – (a) MLM-DB level system/audit logs were not preserved. Procedures for periodic review and analysis of application (“AP”), operating system (“OS”), and database (“DB”) level audit logs were not established and performed and (b) An SOD conflict was identified, where administrative rights to AP, OS and DB levels of the MLM system were assigned to the CTO and (viii) we lack of qualified person to be able to provide the tax provision for the U.S. income taxes in connection with the Subpart F and GILTI taxable income.

 

We have taken measures and plan to continue to take measures to remedy these material weaknesses. The measures that we have taken and are planning to take which includes, but not limited to, hired a chief financial officer who possesses U.S. GAAP and SEC reporting knowledge and hiring more qualified accounting personnel with U.S. GAAP experiences. We are also seeking a U.S. tax professional to assist in the preparation of the Subpart F and GILTI tax provisions. We also intend to form an internal audit function and have plans to hire internal auditors to strengthen our overall governance. All internal auditors will be independent of our operations and will report directly to the audit committee. The implementation of these measures may not fully address the material weaknesses in our internal control over financial reporting, and we cannot conclude that they have been fully remedied. Our failure to correct theses material weaknesses or our failure to discover and address any other material weaknesses could result in inaccuracies in our financial statements and could also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis.

 

23

 

 

As a public company, we will become subject to the Sarbanes-Oxley Act of 2002. Section 404 of the Sarbanes-Oxley Act, or SOX 404, will require that we include a report from management on the effectiveness of our internal control over financial reporting in our annual report on Form 10-K and in our quarterly report on Form 10-Q if we are qualified as an accelerated filer. Our management may conclude that our internal control over financial reporting is not effective. Moreover, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue a report that is qualified if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we become a public company, our reporting obligations may place a significant strain on our management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation.

 

During the course of documenting and testing our internal control procedures, in order to satisfy the requirements of SOX 404, we may identify other weaknesses and deficiencies in our internal control over financial reporting. In addition, if we fail to maintain the adequacy of our internal control over financial reporting, as these standards are modified, supplemented or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with SOX 404. If we fail to achieve and maintain an effective internal control environment, we could suffer material misstatements in our financial statements and fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial information. This could in turn limit our access to capital markets, harm our results of operations, and lead to a decline in the trading price of our shares. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions. We may also be required to restate our financial statements from prior periods.

 

Legal disputes or proceedings could expose us to liability, divert our management’s attention and negatively impact our reputation.

 

We may at times be involved in potential legal disputes or proceedings during the ordinary course of business operations relating to product or other types of liability, employees’ claims, labor disputes or contract disputes that could have a material and adverse effect on our reputation, operation and financial condition. If we become involved in material or protracted legal proceedings or other legal disputes in the future, the outcome of such proceedings could be uncertain and could result in settlements or outcomes which adversely affect our financial condition. In addition, any litigation or legal proceedings could incur substantial legal expenses as well as significant time and attention of our management, diverting their attention from our business and operations.

 

If we are unable to successfully develop and timely introduce new products or services or enhance existing products or services, our business, financial condition and results of operations may be materially and adversely affected.

 

We must continually source, develop and introduce new products and services as well as improve and enhance our existing products and services to maintain or increase our sales. The success of new or enhanced products or services may depend on a number of factors including, anticipating and effectively addressing user preferences and demand, the success of our sales and marketing efforts, effective forecasting and management of products and services demands, purchase commitments, and the quality of or defects in our products. The risk of not meeting our customers’ preferences and demands through our products and services may result in a shift in market shares, as customers instead choose products and services offered by our competitors. This may result in lower sales revenue, materially and adversely affecting our business, financial condition and results of operations.

 

24

 

 

Fluctuations in foreign currency exchange rates could have a material adverse effect on our financial results.

 

We earn revenues, pay expenses, own assets and incur liabilities in countries using currencies other than the U.S. dollar, including Australian Dollar, Malaysian Ringgit and the Hong Kong Dollar. Because our consolidated financial statements are presented in U.S. dollars, we must translate revenues, income and expenses, as well as assets and liabilities, into U.S. dollars at exchange rates in effect during or at the end of each reporting period. Therefore, increases or decreases in the value of the U.S. dollar against other currencies affect our net operating revenues, operating income and the value of balance sheet items denominated in foreign currencies. We cannot assure you that fluctuations in foreign currency exchange rates, particularly the strengthening of the U.S. dollar against major currencies would not materially affect our financial results.

 

Our business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result in a severe impediment to our business.

 

Our success is dependent upon the continued contributions made by our CEO and President, Mr. How Kok Choong. We rely on his expertise in business operations when we are developing our business. We have no “Key Man” insurance to cover the resulting losses in the event that any of our officer or directors should die or resign.

 

If Mr. How Kok Choong cannot serve the Company or is no longer willing to do so, the Company may not be able to find alternatives in a timely manner or at all. This would likely result in a severe damage to our business operations and would have an adverse material impact on our financial position and operating results. To continue as a viable operation, the Company may have to recruit and train replacement personnel at a higher cost. Additionally, if Mr. How Kok Choong joins our competitors or develops similar businesses that are in competition with our Company, our business may also be negatively impacted.

 

Our future success depends on our ability to attract and retain qualified long-term staff to fill management, technology, sales, marketing, and customer services positions. We have a great need for qualified talent, but we may not be successful in attracting, hiring, developing, and retaining the talent required for our success.

 

If we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively affected.

 

We have established and publicly announced certain long-term growth objectives. These objectives were based on, among other things, our evaluation of our growth prospects, which are generally driven by the sales potential of many product types, some of which are more profitable than others, and on an assessment of the potential price and product mix. There can be no assurance that we will realize the sales potential and the price and product mix necessary to achieve our long-term growth objectives.

 

We face risks related to health epidemics, severe weather conditions and other outbreaks.

 

In recent years, there have been outbreaks of epidemics in various countries, including Malaysia. Recently, there was an outbreak of a novel strain of coronavirus (COVID-19), which has spread rapidly to many parts of the world, including Malaysia. In March 2020, the World Health Organization declared the COVID-19 a pandemic. The epidemic has resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia for prolong periods.

 

25

 

 

Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:

 

● temporary closure of offices, travel restrictions, financial impact of our customers or suspension supplies may negatively affected, and could continue to negatively affect, the demand for our products;
   
● our customer may require additional time to pay us or fail to pay us at all, which could significantly increase the amount of accounts receivable and require us to record additional allowances for doubtful accounts. We may have to provide significant sales incentives to our sole customer during the outbreak, which may in turn materially adversely affect our financial condition and operating results;
   
● any disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations, including causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers, which may also lead to loss of our customers; and
   
● the global stock markets have experienced, and may continue to experience, significant decline from the COVID-19 outbreak and the marketable securities that we have invested in could be materially adversely affected, which may lead to significant impairment in the fair values of our investments and in turn materially adversely affect our financial condition and operating results.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the coronavirus cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year over year in the fiscal year 2022. We may have to record downward adjustments or impairment in the fair value of investments in the fiscal year 2022, if conditions have not been significantly improved and global stock markets have not recovered from recent declines.

 

In general, our business could be adversely affected by the effects of epidemics, including, but not limited to, the COVID-19, avian influenza, severe acute respiratory syndrome (SARS), the influenza A virus, Ebola virus, severe weather conditions such as flood or hazardous air pollution, or other outbreaks. In response to an epidemic, severe weather conditions, or other outbreaks, government and other organizations may adopt regulations and policies that could lead to severe disruption to our daily operations, including temporary closure of our offices and other facilities. These severe conditions may cause us and/or our partners to make internal adjustments, including but not limited to, temporarily closing down business, limiting business hours, and setting restrictions on travel and/or visits with clients and partners for a prolonged period of time. Various impact arising from a severe condition may cause business disruption, resulting in material, adverse impact to our financial condition and results of operations.

 

Risks Related to our Industry

 

Our business and reputation may be affected by product liability claims, litigation, customer complaints, product tampering, food safety issues, food-borne illnesses, health threats, quality control concerns or adverse publicity relating to our products. Product liability insurance of our supplier may not cover our liability sufficiently or at all.

 

Like other consumer product manufacturers, sale of our products involves an inherent risk of our products being found to be unfit for consumption or cause illness. Products may be rendered unfit for consumption due to raw materials or product contamination or degeneration, presence of microbials, illegal tampering of products by unauthorized third parties or other problems arising during the various stages of the procurement, production, transportation and storage processes. The occurrence of such problems may result in customer complaints, fines, penalties or adverse publicity causing serious damage to our reputation and brand, as well as product liability claims, other legal disputes and loss of revenues. Under certain circumstances, we may be required to recall our products. Even if a situation does not necessitate a product recall, we cannot assure you that product liability claims or other legal disputes will not be asserted against us as a result. Product liability insurance of our supplier may not cover our liability sufficiently or at all and will not cover liability that arises out of our default such as mishandling, poor storage condition and/or contamination of the products by us. As a result, a product liability or other judgment against us, or a product recall, could have a material adverse effect on our business, financial condition or results of operations.

 

26

 

 

Our business is susceptible to food-borne illnesses. We cannot assure you that we are able to effectively prevent all diseases or illnesses caused by our products or contamination of our products. Furthermore, our reliance on third-party product suppliers means that food-borne illness incidents could be caused by our suppliers outside of our control. New illnesses may develop in the future, or diseases with long incubation periods could arise that could give rise to claims or allegations on a retroactive basis. Reports in the media of instances of food-borne illnesses or health threats of our products or any of their major ingredients could adversely and significantly affect our sales, and have significant negative impact on our results of operations. This risk exists even if it were later determined that the illness or health threat in fact was not caused by our products.

 

In addition, adverse publicity about health and safety concerns, whether unfounded or not, may discourage consumers from buying our products. Even if a product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our products caused personal injury or illness could adversely affect our reputation and our corporate and brand image. If consumers were to lose confidence in our brand and reputation, we could suffer long-term or even permanent declines in our sales and results of operation. The amount of negative news, customers complaints and claims against us may also be very costly and may divert our management’s attention from our business operation.

 

Increased competition and capabilities in the marketplace could hurt our business.

 

The market where we operate is highly competitive. We compete with other companies that operate in multiple geographic areas, as well as numerous companies that are primarily regional or local in operation. Our ability to gain or maintain share of sales in the market where we operate or in various local markets may be limited as a result of actions by competitors. If we do not continue to strengthen our capabilities in marketing and innovation to maintain our brand loyalty and market share while we selectively expand into other product categories, our business could be negatively affected.

 

Risks Related to our Common Stock

 

The market price of our shares is likely to be highly volatile and subject to wide fluctuations in response to factors such as:

 

  ● variations in our actual and perceived operating results, especially during this time when the COVID-19 pandemic poses a threat;
     
  ● news regarding gains or losses of customers or suppliers by us or our competitors;
     
  ● news regarding gains or losses of key personnel by us or our competitors;
     
  ● announcements of competitive developments, acquisitions or strategic alliances in our industry by us or our competitors;
     
  ● changes in earnings estimates or buy/sell recommendations by financial analysts;
     
  ● potential litigation;
     
  ● the imposition of fines or penalties related to our activities in the market where we operate and failure to comply with applicable rules and regulations;
     
  ● general market conditions or other developments affecting us or our industry; and
     
  ● the operating and stock price performance of other companies, other industries and other events or factors beyond our control.

 

In addition, the securities markets have from time-to-time experienced significant price and volume fluctuations that are not related to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of the shares.

 

27

 

 

We may never be able to pay dividends and are unlikely to do so.

 

To date, we have not paid, nor do we intend to pay in the foreseeable future, dividends on our common stock, even if we become profitable. Earnings, if any, are expected to be used to advance our activities and for working capital and general corporate purposes, rather than to make distributions to stockholders. Since we are not in a financial position to pay dividends on our common stock and future dividends are not presently being contemplated, investors are advised that return on investment in our common stock is restricted to an appreciation in the share price. The potential or likelihood of an increase in share price is uncertain.

 

In addition, under Nevada law, we may only pay dividends subject to our ability to service our debts as they become due and provided that our assets will exceed our liabilities after the dividend. Our ability to pay dividends will therefore depend on our ability to generate sufficient profits.

 

Shareholders may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities.

 

Wherever possible, our board of directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe that the non-cash consideration will consist of shares of our common stock, warrants to purchase shares of our common stock or other securities. Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the authorized but unissued shares of common stock or warrants to purchase such shares of common stock. In addition, we may attempt to raise capital by selling shares of our common stock, possibly at a discount to market in the future. These actions will result in dilution of the ownership interests of existing shareholders and may further dilute common stock book value, and that dilution may be material. Such issuances may also serve to enhance existing management’s ability to maintain control of us, because the shares may be issued to parties or entities committed to supporting existing management.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 2. PROPERTIES

 

Business support services are rendered from:

 

Our principal executive office at

1705 – 1708, Level 17, Tower 2,

Faber Towers, Jalan Desa Bahagia,

Taman Desa, 58100 Kuala Lumpur, Malaysia.

Room 2708-9, 2F,

The Metropolis Tower,

10 Metropolis Drive, Hunghom,

Kowloon, Hong Kong.

 

ITEM 3. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. There are currently no pending legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

28

 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Our Common Stock is currently listed on the OTC Markets – Pink Sheets under the trading symbol “ATTP.” There is no active trading market in the Company’s securities.

 

Holders

 

As of December 31, 2021, we had 290,460,047 shares of our Common Stock par value, $0.0001 issued and outstanding. There were 1,220 record holders of our Common Stock.

 

Transfer Agent and Registrar

 

Our transfer agent is VStock Transfer, LLC, with an address at 18, Lafayette Place, Woodmere, New York 11598 and telephone number is +1 (212) 828-843.

 

Dividend Policy

 

Any future determination as to the declaration and payment of dividends on shares of our Common Stock will be made at the discretion of our board of directors out of funds legally available for such purpose. We are under no contractual obligations or restrictions to declare or pay dividends on our shares of Common Stock. In addition, we currently have no plans to pay such dividends. Our board of directors currently intends to retain all earnings for use in the business for the foreseeable future.

 

Equity Compensation Plan Information

 

Currently, there are no equity compensation plan in place.

 

Unregistered Sales of Equity Securities

 

None.

 

Purchases of Equity Securities by the Registrant and Affiliated Purchasers

 

We have not repurchased any shares of our common stock during the twelve months ended December 31, 2021.

 

ITEM 6. SELECTED FINANCIAL DATA

 

The following table sets forth selected financial data as of December 31, 2021 and 2020 and for the years ended December 31, 2021 and 2020. This selected financial data should be read in conjunction with the consolidated financial statements and related notes included in Item 15 of this Annual Report.

 

   Years Ended December 31, 
   2021   2020 
         
Revenue  $1,016,962   $3,452,621 
Net income (loss) attributable to Agape ATP Corporation  $(2,524,244)  $354,766 
Net income (loss) per share – (basic and diluted)  $(0.01)  $0.00 

 

29

 

 

   As of December 31, 
   2021   2020 
         
Total assets  $4,724,535    7,210,607 
Total liabilities  $1,312,841   $1,285,773 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the notes to those financial statements appearing elsewhere in this Report.

 

Certain statements in this Report constitute forward-looking statements. These forward-looking statements include statements, which involve risks and uncertainties, regarding, among other things, (a) our projected sales, profitability, and cash flows, (b) our growth strategy, (c) anticipated trends in our industry, (d) our future financing plans, and (e) our anticipated needs for, and use of, working capital. They are generally identifiable by use of the words “may,” “will,” “should,” “anticipate,” “estimate,” “plan,” “potential,” “project,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend,” or the negative of these words or other variations on these words or comparable terminology. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. You should not place undue reliance on these forward-looking statements.

 

The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

Overview

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. (“ASL”), a company incorporated in Malaysia. .

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., a network marketing entity incorporated in Malaysia.

 

Agape Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.

 

On September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (“WATP”), a wholly owned subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.

 

On November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

30

 

 

The Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.

 

Agape ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.

 

Via ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.

 

The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.

 

The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.

 

The Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various wellness programs.

 

To further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

Results of Operation

 

For the years ended December 31, 2021 and 2020

 

Revenue

 

We generated revenue of $1,016,962 for the year ended December 31, 2021 as compared to $3,452,621 for the year ended December 31, 2020, representing a significant decrease of $2,435,659 or approximately 70.5%. It is to be noted that as between the two fiscal years, ASL, with its large group of customers in an established network marketing sales channel that has been in established in Malaysia for the past 15 years, contributed revenue throughout the entire year ended December 31, 2021, whereas ASL’s revenue contribution to us only began from April 1, 2020 to December 31, 2020, after its acquisition on May 8, 2020. For the period from January 1, 2020 to March 31, 2020, we were only making sales to our related party on wholesale basis when ASL placed the purchase orders.

 

31

 

 

Despite a full year revenue contribution from ASL for the year ended December 31, 2021, the Company’s revenue decreased significantly due to the COVID-19 situation in Malaysia. From the date of declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO to the date of this report, Malaysia has been put through intermittent lockdowns of various degree of seriousness such as (1) full movement control orders (“MCO”), under which, quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (“RMCO”).

 

The lockdowns disrupted much of our operational activities, which led to the significant decrease in revenue for the year ended December 31, 2021 as compared to the same period in 2020. As of March 2022, Malaysia stands at position 26 as the country with the highest COVID-19 cases as recorded under the coronavirus statistics of the “worldometer”. Total COVID-19 cases of the country hit approximately 3.6 million and associated fatality of 33, 228. These figures are large relative to the small size economy of the country. The prolonged pandemic has adversely affected the purchasing power of consumers in Malaysia.

 

Cost of Revenue

 

Cost of revenue for the year ended December 31, 2021 amounted to $297,333 as compared to $775,855 for the year ended December 31, 2020, representing a significant decrease of $478,522 or approximately 61.7%.

 

The cost of revenue comprised of freight-in, cost of goods purchased, and packing materials. The significant decrease in cost of revenue for the year ended December 31, 2021 as compared to the same period in 2020, was in line with the significant decrease in our revenues. As explained in the above, much of our operational activities was disrupted as a result of the resurgence of COVID-19 infection and movement control orders imposed in Malaysia.

 

Gross Profit

 

Gross profit for the year ended December 31, 2021 amounted to $719,629 as compared to $2,676,766 for the year ended December 31, 2020. Gross margin for the year ended December 31, 2021 was approximately 70.8% as compared to approximately 77.5% for the year ended December 31, 2020.

 

In view of the significant drop in revenue, the Company offered promotional discounts to our customers with the aim to promote sales, which reduced the gross margin for the year ended December 31, 2021.

 

Operating Expenses

 

Our operating expenses consist of selling expenses, commission expenses, general and administrative expenses and provision for doubtful accounts.

 

Selling expenses

 

Selling expenses for the year ended December 31, 2021 amounted to $394,682 as compared to $376,582 for the year ended December 31, 2020, an increase of $18,100 or approximately 4.8%. The increase was mainly due to selling expenses incurred by ASL for the year ended December 31, 2021 for the entire year, whereas selling expenses for the corresponding period last year in connection to ASL’s network marketing activities only began from April 1, 2020 to December 31, 2020 after its acquisition. The Company incurred higher salaries and benefits expenses for the current year, as it represented a full year from January 1, 2021 to December 31, 2021, but lower other selling expenses, such as credit card processing fees, promotional expenses, events expenses, and travelling expenses from our sales team, as compared to the corresponding period last year for 9 months only from April 1, 2020 to December 31, 2020.

 

32

 

 

Commission expenses

 

Commission expenses were $316,267 and $830,659 for the years ended December 31, 2021 and 2020, respectively, representing a significant decrease of $514,392 or approximately 61.9%. The significant decrease in commission expenses was in line with the significant decrease in revenue.

 

General and administrative expenses

 

General and administrative expenses for the year ended December 31, 2021 amounted to $1,745,734, as compared to $1,627,660 for the year ended December 31, 2020, representing an increase of $118,074 or approximately 7.3%. The increase was mainly due to general and administrative expenses incurred by ASL for the year ended December 31, 2021 for the entire year, whereas general and administrative expenses for the corresponding period last year in connection to ASL’s network marketing activities only began from April 1, 2020 to December 31, 2020 after its acquisition. The Company incurred higher salaries and benefits expenses for the current year, as it represented a full year from January 1, 2021 to December 31, 2021, but lower other general and administrative expenses, such as professional expenses and office expenses, as compared to the corresponding period of last year for 9 months only from April 1, 2020 to December 31, 2020.

 

Other (Expenses) Income

 

For the year ended December 31, 2021, we recorded an amount of $529,045 as other expenses, net as compared to $674,482 other income, net for the year ended December 31, 2020, representing a change of $1,203,527, or approximately 178.4%, in other income. The net other expenses of $529,405 incurred during the year ended December 31, 2021 comprised of other expense of $42,753, unrealized holding loss on marketable securities of $505,231 and dividend income from marketable securities of $18,939. The net other income of $674,482 incurred during the year ended December 31, 2020 comprised of other income of $164,283, unrealized holding gain on marketable securities of $350,137 and dividend income from marketable securities of $160,062.

 

Provision for Income Taxes

 

We had a provision for income taxes of $137,067 and a provision for income taxes of $161,581 for the years ended December 31, 2021 and 2020, respectively. During the year ended December 31, 2021, we had provision for income taxes of $114,862 due to certain permanent items required for the income taxes provision in Malaysia jurisdiction after our Malaysia local tax audit and had provision for income taxes of $22,205 on U.S. GILTI taxes provision. On the other hand, during the year ended December 31, 2020, we generated taxable income in ASL that was subjected to a unified 24% income tax rate.

 

Net (Loss) Income

 

We incurred a net loss of $2,524,680 for the year ended December 31, 2021, from a net income of $354,766 for the year ended December 31, 2020, a change of $2,879,446, predominately due to reasons as discussed above.

 

Liquidity and Capital Resources

 

On March 11, 2020, the World Health Organization or WHO declared the corona virus or COVID-19 a pandemic. To help counter the transmission of COVID-19, the government of Malaysia initiated movement control orders (“MCO”), the first effective March 18, 2020. The MCO had resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia. The first MCO was extended three times, each for a two-weeks period, until May 12, 2020. On May 13, 2020, the MCO was eased to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia. The CMCO was further relaxed, and on June 8, 2020, Malaysia moved into the Recovery Movement Control Order (“RMCO”). Due to a resurgence of COVID-19, CMCO was reimposed in the state of Sabah, Selangor, Kuala Lumpur and Putrajaya effective October 14, 2020. On November 7, 2020, the CMCO was extended to a wider geographical area to include another six states in the country. Effectively, ten of thirteen states in Malaysia were placed under CMCO with the exceptions of Perlis, Pahang and Kelantan. On January 1, 2021, the Government of Malaysia extended the Recovery Movement Control Order (“RMCO”) through March 31, 2021. On January 12, 2021, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the country.

 

33

 

 

On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless, COVID-19 cases in the country continue to rise. On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country is administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunization Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily since beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot.

 

Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:

 

  ● temporary closure of offices, travel restrictions, disruption or suspension of supplies, our customers may be negatively impacted financially resulting in which the demand for our products may be adversely affected;
  ● we may have to provide significant sales incentives to our customers during the outbreak, which may in turn materially adversely affect our financial condition and operating results; and
  ● any disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations, including causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers, which may also lead to loss of our customers.

 

Although some of the countries from which our products are sourced are experiencing lockdowns, industries involve in the provision of food especially health products and pharmaceuticals are normally exempted. We may experience slight delay in products delivery lead time but barring unforeseen circumstances, the setback should be temporary.

 

We are currently operating primarily in Malaysia and anticipate expanding into the Asian markets in the future, with a particular focus, at least initially, on expanding into Thailand, Indonesia and Taiwan. We will explore expansion via e-commerce. When the pandemic has subsided or is over and restrictions on travelling between nations are uplifted, we will set up offices in the countries in which we operate to better service our customers.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year over year in 2022.

 

As of December 31, 2021, we had working capital of $2,599,281 consisting of cash in bank of $554,864 and time deposits of $1,975,347 as compared to working capital of $4,645,729 consisting of cash in bank of $1,112,147 and time deposits of $2,391,182 as of December 31, 2020. The company had a net loss 2,524,680 for the year end December 31, 2021 and accumulated deficit of $3,258,687 as of December 31, 2021 as compared to net income of $354,766 for the year ended December 31, 2021 and accumulated deficit of $734,443 as of December 31, 2020. In assessing our liquidity and going concern, management is projecting that the company’s revenue will revert to pre-pandemic level, generating sufficient cash therefrom to cover our operating expenses.

 

34

 

 

If we are unable to generate sufficient cash flow within the normal operating cycle of a twelve-month period to pay for its future payment obligations, we may have to consider supplementing our available sources of funds through the following sources:

 

  ● other available sources of financing from Malaysia banks and other financial institutions; and
     
  ● financial support from our related parties and shareholders.

 

Based on the above initiatives, management is of the opinion that the company shall have sufficient funds to meet its working capital requirements and debt obligations as they become due in the foreseeable future from the date of issuance of this Form 10-K. However, there is no assurance that management will be successful in its plans.

 

The following summarizes the key components of our cash flows for the years ended December 31, 2021 and 2020:

 

   For the years ended December 31, 
   2021   2020 
         
Net cash used in operating activities  $(845,842)  $(557,951)
Net cash (used in) provided by investing activities   (3,959)   1,276,200 
Net cash used in financing activities   (19,061)   (22,091)
Effect of exchange rate on cash and cash equivalents   (50,890)   76,985 
Net change in cash and cash equivalents  $(919,752)  $773,143 

 

Operating activities

 

Net cash used in operating activities for the year ended December 31, 2021 was $845,842 and were mainly comprised of the net loss of $2,524,680, dividend income from marketable securities of $18,939, the increase in prepayments and deposits of $128,363, and the payment of operating lease liabilities of $138,143. The net cash used in operating activities was mainly offset by the non-cash depreciation and amortization expense of $77,758, amortization of operating right-of-use assets of $139,451, the unrealized holding loss on marketable securities of $505,231, the non-cash deferred tax expense of $10,127, inventories write-down of $36,241, provision for doubtful accounts of $121,514, the decrease of accounts receivables of $167,566, the decrease in inventories of $192,713, the refund in prepaid taxes of $430,062, the increase in customer deposits of $52,981, the increase in income tax payables of $3,988, and the increase in other payables and accrued liabilities of $226,651.

 

Net cash used in operating activities for the year ended December 31, 2020 was $557,951 and were mainly comprised of the non-cash income on unrealized holding gain on marketable securities of $350,137 and dividend income from marketable securities of $160,062, the increase of accounts receivables of $165,149, the decrease of customer deposits of $1,421,886 and the payment of operating lease liabilities of $105,009. The net cash used in operating activities was mainly offset by the net income of $354,766, the non-cash depreciation and amortization expense of $56,912, amortization of operating right-of-use assets of $106,561, deferred tax provision of $178,329, the decrease in inventories of $78,674, the decrease in prepaid taxes of $184,985, the decrease in prepayments and deposits, including related party of $352,577, and the increase in other payables and accrued liabilities of $336,709.

 

Investing activities

 

Net cash used in investing activities for the year ended December 31, 2021 was $3,959, the amount entirely for the purchase of equipment.

 

35

 

 

Net cash provided by investing activities for the year ended December 31, 2020 was $1,276,200, which were in respect of cash and cash equivalents acquired through acquisition of ASL of $1,210,818, partial proceeds collected from the sale of our non-marketable securities of $70,173 and proceeds from sale of investment in marketable securities of $121, offset by purchase of equipment and intangible assets of $4,912.

 

Financing activities

 

Net cash used in financing activities for the year ended December 31, 2021 was $19,061, mainly comprised of payment of deferred offering cost of $15,210 and advances to related parties of $3,851.

 

Net cash used in financing activities for the year ended December 31, 2020 was $22,091 which were mainly comprised of payment of deferred offering cost of $249,525 offset by repayments from related parties of $227,434.

 

Credit Facilities

 

We do not have any credit facilities or other access to bank credit.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2021, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

Critical Accounting Polices

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 

Revenue recognition

 

The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

 

The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

36

 

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues.

 

Sales of Health and Wellness services

 

- Performance obligations satisfied at a point in time

 

The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person. The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp.

 

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  ● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

37

 

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

In October 2020, the FASB issued ASU 2020-08, “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs”. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

38

 

 

In October 2020, the FASB issued ASU 2020-10, “Codification Improvements”. The amendments in this Update represent changes to clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Foreign exchange risk. Substantially most of our revenues are denominated in the U.S. dollar while most of our expenses are denominated in Malaysian Ringgit and Hong Kong Dollar. We do not believe that we currently have any significant direct foreign exchange risk and have not hedged exposures denominated in foreign currencies or any other derivative financial instruments. Although in general, our exposure to foreign exchange risks should be limited, the value of an investment in our Common Stock may be affected by the foreign exchange rate between U.S. dollar and Malaysian Ringgit; and U.S. dollar and Hong Kong Dollar because the value of our business is effectively denominated in Malaysian Ringgit and Hong Kong Dollar, while the Common Stock is traded in U.S. dollars.

 

Credit risk. Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The financial statements required by this item are located in PART IV of this Annual Report.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Disclosures Control and Procedures

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

 

  ● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;

 

39

 

 

  ● Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
     
  ● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

As of December 31, 2021, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on such evaluation, the Company’s management concluded that, during the period covered by this Report, internal controls and procedures over financial reporting were not effective. This was due to deficiencies that existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

 

Identified Material Weakness

 

A material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

 

Management identified the following material weakness during its assessment of internal controls over financial reporting as of December 31, 2021,:

 

(i) insufficient full-time personnel with appropriate levels of accounting knowledge and experience to monitor the daily recording of transactions, address complex U.S. GAAP accounting issues and to prepare and review financial statements and related disclosures under U.S. GAAP; (ii) lack of a functional internal audit department or personnel that monitors the consistencies of the preventive internal control procedures and lack of adequate policies and procedures in internal audit function to ensure that the Company’s policies and procedures have been carried out as planned; (iii) lack of adequate segregation of duties and effective risk assessment, which in turn may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors; (iv) we lack of proper procedures developed for system change management policies. Change management policies and procedures have not been developed. Critical change management control processes and procedures, such as change request and approval, periodic status reporting, user testing and acceptance, post-implementation review, etc., were either not performed or formally documented; (v) we lack of the following internal control procedures in relation of Third-Party (Service Organization) Vendor Management – (a) service evaluation and qualification assessment of third-party vendors were not performed for the year ended December 31, 2021 and (b) Management was not able to provide evidence of their review of their service providers’ SOC 1 and SOC 2, or ISO 27001 certificate reports and therefore unable to provide evidence of their review of the physical security and environmental controls in place at IP Serverone cloud server (which the Company’s financial system is hosted on; (vi) we lack of the following internal control procedures in relation of User Account Management – (a) Evidence relating to the authorization of database administrator user accounts and access was not preserved for the MLM System during the year ended December 31, 2021 and (b) Evidence relating to periodic recertification of MLM and SQL Finance System end user are privileged accounts and related access rights were preserved during the year ended December 31, 2021; (vii) we lack of the following internal control procedures in relation of Audit Logs and Segregation of Duty (“SOD”) Management – (a) MLM-DB level system/audit logs were not preserved. Procedures for periodic review and analysis of application (“AP”), operating system (“OS”), and database (“DB”) level audit logs were not established and performed and (b) An SOD conflict was identified, where administrative rights to AP, OS and DB levels of the MLM system were assigned to the CTO and (viii) we lack of qualified person to be able to provide the tax provision for the U.S. income taxes in connection with the Subpart F and GILTI taxable income.

 

40

 

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2021 based on criteria established in Internal Control—Integrated Framework issued by COSO.

 

Management’s Remediation Initiatives

 

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we will prepare written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines, to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity and debt transactions.

 

To further strengthen the Company’s internal controls, we plan to initiate the following measures going forward:

 

1. We intend to establish an internal audit function with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal control.
   
2. Once we hire additional employees, we intend to initiate a comprehensive training program and development plan to provide ongoing company-wide trainings regarding internal control and requirements of U.S. GAAP financial statements and related disclosures, with particular emphasis on our accounting staff.
   
3. We are seeking a U.S. tax professional to assist in the preparation of the Subpart F and GILTI tax provisions.

 

We anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2022.

 

Changes in internal controls over financial reporting

 

There were no significant changes in our internal controls over financial reporting that occurred during the period covered by this Report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:

 

This annual report does not include an attestation report of the Company’s registered independent public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report on Form 10-K.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

41

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Our executive officer’s and director’s and their respective ages as of the date hereof are as follows:

 

NAME   AGE   POSITION
How Kok Choong   58   Chief Executive Officer, President, Secretary, Treasurer, Director
Mohd Shaharuddin Bin Abdullah   66   Director
Andrew Lee Kam Fan   60   Chief Financial Officer

 

Set forth below is a brief description of the background and business experience of our executive officer and director for the past five years.

 

How Kok Choong - President, Chief Executive Officer, Secretary, Treasurer, Director

 

Mr. How is primarily responsible for overall development and business strategies, financial, administrative and human resources affairs of the Company. Mr. How has more than 20 years of experience in the senior management roles in the health and wellness industry. From 1987 to 2016, Mr. How was with the San Hin Group of Companies and his last position held was the group chief executive officer for the group. Since August 2003, Mr. How began to work for AGAPE Superior Living International Group as the global president, and continues to hold this position. Further, since September 2009, Mr. How has been serving as president for TH3 Holdings Sdn Bhd, company specialized in IT, academics, online education, mobile Apps, e-Commerce and digital marketing. Mr. How obtained a master’s degree and a doctorate degree in Business Administrative from Newport University, USA in December 1997 and December 2000, respectively. In Malaysia, Mr. How Kok Choong was recognized by the Junior Chamber Malaysia (JCM) as an Outstanding Young Malaysian 2003, and was awarded the title of Justice of Peace of Malaysia since 2005. Mr. How Kok Choong received the Outstanding Asian Community Contribution Award in 2011, Malaysia Top Team 50 Enterprise Award in 2011 and 2016, The Contributor Award (Medical and Health Research) in 2012, “Man of The Year” in Worldwide Excellence Award in 2015, “Man of The Year” in McMillan Global Award in 2016, The Distinguished Asia Pacific Outstanding Entrepreneur Lifetime Achievement Award in 2019, World Outstanding Chinese Entrepreneur Lifetime Award in 2019 and Certified Professional Trainer of The International Professional Managers Association in 2019.

 

Mohd Shaharuddin Bin Abdullah- Director

 

Mohd Shaharuddin Bin Abdullah, was appointed as an executive director of the Board on January 12, 2021. Prior to joining the Company, Mr. Shaharuddin has approximately 24 years of banking industry background and approximately 8 years of accounting and finance related experience. From October 2013 to October 2016, Mr. Shaharuddin served as the assistant director and the head of consumer credit management at Kuwait Finance House (M) Berhad. From April 2010 to October 2012, Mr. Shaharuddin served as the associate director head of special projects at Danajamin Nasional Berhad, and was later seconded to head the corporate debt restructuring committee, a unit incorporated by Bank Negara Malaysia. From January 2006 to April 2010, Mr. Shaharuddin served as the first vice president and the head of the corporate loans and special assets management division at AffinBank Berhad. From January 2002 to December 2005, Mr. Shaharuddin served as an assistant general manager of operations department at Pengurusan Danaharta Nasional Berhad. From January 1984 to December 2001, Mr. Shaharuddin served as the internal auditor, a branch manager, a regional manager at Interfinance Berhad, which was merged with RHB Bank Bhd. in 2000 and Mr. Abdullah served as the head of monitoring and collection division post-merger. From January 1980 to December 1983, Mr. Shaharuddin served as an investment officer and subsequently an assistant project accountant at Permodalan Bumiputra Sabah Berhad. From October 1976 to December 1979, Mr. Shaharuddin served as an executive officer at Bank Negara Malaysia. Mr. Shaharuddin has been an associate member of the Asian Institute of Chartered Bankers since April 1998. Mr. Shaharuddin received his diploma in accountancy at Universiti Teknoloji Mara in 1976, his diploma in banking and finance and Certified Credit Professional I from the Asian Institute of Chartered Bankers in 1992 and 2001, respectively, and his master’s degree in business administration from MBA-USA (Off Campus) in 2002.

 

42

 

 

Andrew Lee Kam Fan

 

Lee Kam Fan, Andrew, age 59, was appointed as the chief financial officer of the Company on January 12, 2021. Prior to joining the Company, Mr. Lee has approximately 38 years of accounting and finance related experience. Since July 2014, Mr. Lee has been the proprietor of Andrew Lee & Company. Since June 2010, Mr. Lee served as an adjunct lecturer of the HKICPA Processional Examinations Preparatory Programme at HKU Space. From January 2011 to October 2015, Mr. Lee served as the managing director at ANSA CPA Limited. From September 2010 to October 2012, Mr. Lee served as an independent non-executive director at Sunrise (China) Technology Group Limited (currently referred to as KOALA Financial Group Limited (Hong Kong stock code: 08226)). From March 2006 to April 2017, Mr. Lee was in cooperation with Friedman LLP to oversee financial statements are prepared in accordance with U.S. GAAP. From October 2000 to December 2010, Mr. Lee served as an audit manager and subsequently a partner at Clodick & Company. From April 1998 to September 2000, Mr. Lee served as a director at Nitwell Business Services Limited. From August 1994 to April 1998, Mr. Lee was an assistant audit manager at Cheng, Kwok & Chang. From July 1990 to July 1994, Mr. Lee served as an accountant at K.C. Manufacturing Company. From April 1989 to July 1990, Mr. Lee served as an accountant at Haldane, Midgley & Booth. From January 1987 to April 1989, Mr. Lee served as an audit senior at RSM Nelson Wheeler. From October 1985 to December 1986, Mr. Lee served as an audit assistant at Andrew Ma & Company. From April 1983 to September 1985, Mr. Lee served as an audit Clerk at Anthony Y.T. Tse & Company. Mr. Lee is an associate member of the Institute of Chartered Accountants in England and Wales since April 2019, a certified public accountant (practicing) of the Hong Kong Institute of Certified Public Accountants since May 2010, a fellow member of the Association of International Accountants since December 2006, and an associate member and certified tax advisor of the Tax Institute of Hong Kong since July 2010. Mr. Lee received his bachelor’s degree in business administration at the Open University of Hong Kong in June 2004 and his master’s degree in professional accounting from the Hong Kong Polytechnic University in November 2010.

 

Corporate Governance

 

The Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the “SEC”) and in other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations. The Company has not formally adopted a written code of business conduct and ethics that governs the Company’s employees, officers and Directors as the Company is not required to do so.

 

In lieu of an Audit Committee, the Company’s Board of Directors, is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company’s financial statements and other services provided by the Company’s independent public accountants. The Board of Directors and the Chief Executive Officer of the Company review the Company’s internal accounting controls, practices and policies with advice from third party consultants.

 

Committees of the Board

 

Our Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does our Company have a written nominating, compensation or audit committee charter.

 

Audit Committee Financial Expert

 

Our Board of Directors has determined that we do not have a board member that qualifies as an “audit committee financial expert” as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as “independent” as the term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(14) of the FINRA Rules.

 

In order to maintain good corporate governance and in view of the Company’s planned expansion, the Company plans to establish a full board comprising the nominating, compensation, and audit committees during the year.

 

43

 

 

Involvement in Certain Legal Proceedings

 

Our Directors and our Executive officers have not been involved in any of the following events during the past ten years:

 

1. Bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
   
2. Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
   
3. Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his/her involvement in any type of business, securities or banking activities; or
   
4. Being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
   
5. Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

 

6. Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;
   
7. Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:
   
  (i) Any Federal or State securities or commodities law or regulation; or
  (ii) Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or
  (iii) Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;
   
8. Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Code of Ethics

 

We have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or Directors expand in the future, we may take actions to adopt a formal Code of Ethics.

 

44

 

 

Shareholder Proposals

 

Our Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for Directors. The Board of Directors believes that, given the stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. Our Company does not currently have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.

 

A shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President, at the address appearing on the first page of this Information Statement.

 

ITEM 11. EXECUTIVE COMPENSATION

 

Mr. How Kok Choong, the Chief Executive Officer, President, Secretary, Treasurer, Director of the Group received $275,210 and $203,431 as total salaries for the year ended December 31, 2021, and 2020 respectively. Mr. How Kok Choong had not received any (i) Stock compensation; (ii) Option awards, (iii) Non-equity incentive plan compensation, (iv) Non-qualified deferred compensation earnings and (v) Any other compensations.

 

Mr. Mohd Shaharuddin Bin Abdullah was appointed and entered into an employment agreement with the Company on January 12, 2021 and the employment agreement will take effect on the listing of our stock on NASDAQ Capital Market / New York Stock Exchange.

 

Mr. Andrew Lee Kam Fan was appointed and entered into an employment agreement with the Company on January 12, 2021. For the financial year ended December 31, 2021, Mr. Andrew Lee Kam Fan received $46,988 as total salary.

 

Summary of Compensation

 

Stock Option Grants

 

We have not granted any stock options to our executive officers since our incorporation.

 

Employment Agreements

 

Save except for Mr. Mohd Shaharuddin Bin Abdullah and Mr. Andrew Lee Kam Fan, we do not have an employment or consulting agreement with any officers or Directors.

 

Compensation Discussion and Analysis

 

Director Compensation

 

As the Chief Executive Officer, President, Secretary, Treasurer, Director of the Group, Mr. How Kok Choong is paid a monthly salary of $22,934 (RM 95,000). His salary shall accrue on a day-to-day basis, payable in arrears on the last day of each calendar month, provided that if his employment is terminated prior to the end of a calendar month, his compensation for the month shall be pro-rated to reflect his period of service up to the date of termination.

 

As executive director of the Company, Mr. Mohd Shaharuddin Bin Abdullah will be paid a monthly salary of $3,000. He is also entitled to receive a stock-based compensation of $60,000 per annum. His compensation, i.e., salary and stock-based compensation shall accrue on a day-to-day basis, payable in arrears on the last day of each calendar month, provided that if his employment is terminated prior to the end of a calendar month, his compensation for the month shall be pro-rated to reflect his period of service up to the date of termination.

 

45

 

 

As Chief Financial Officer of the Company, Mr. Andrew Lee Kam Fan is paid a monthly salary of $3,870. His salary shall accrue on a day-to-day basis, payable in arrears on the last day of each calendar month, provided that if his employment is terminated prior to the end of a calendar month, his compensation for the month shall be pro-rated to reflect his period of service up to the date of termination.

 

Executive Compensation Philosophy

 

Our Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors reserves the right to pay our executive or any future executives a salary, and/or issue them shares of common stock in consideration for services rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive officer’s performance. This package may also include long-term stock-based compensation to certain executives, which is intended to align the performance of our executives with our long-term business strategies. Additionally, while our Board of Directors has not granted any performance base stock options to date, the Board of Directors reserves the right to grant such options in the future, if the Board in its sole determination believes such grants would be in the best interests of the Company.

 

Incentive Bonus

 

The Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion, if the Board of Directors believes such bonuses are in the Company’s best interest, after analyzing our current business objectives and growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result of the actions and ability of such executives.

 

Long-term, Stock Based Compensation

 

In order to attract, retain and motivate executive talent necessary to support the Company’s long-term business strategy we may award our executive and any future executives with long-term, stock-based compensation in the future, at the sole discretion of our Board of Directors, which we do not currently have any immediate plans to award.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

As of December 31, 2021, the Company has 290,460,047 shares of common stock issued and outstanding, which number of issued and outstanding shares of common stock have been used throughout this report.

 

Name and Address of
Beneficial Owner		  Shares of Common Stock Beneficially Owned   Common Stock Voting Percentage Beneficially Owned   Voting
Shares of Preferred Stock		   Preferred Stock Voting Percentage Beneficially Owned   Total
Voting Percentage Beneficially Owned		 
Executive Officers and Directors                         
How Kok Choong, President, Chief Executive Officer, Secretary, Treasurer and Director; collectively this includes HKC Holdings Sdn. Bhd.*   243,216,637    83.73%   -    -    83.73%
Mohd Shaharuddin Bin Abdullah   -    -    -    -    - 
Andrew Lee Kam Fan   -    -    -    -    - 

 

46

 

 

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person’s actual voting power at any particular date.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE

 

On June 1, 2016, Mr. How Kok Choong was appointed as CEO, President, Secretary, Treasurer and a member of our Board of Directors. Additionally, on June 1, 2016, the Company issued 100,000 shares of restricted common stock, each with a par value of $0.0001 per share, to Mr. How Kok Choong for initial working capital of $10.

 

On April 5, 2017, the Company acquired Agape ATP Corporation, a company incorporated in Labuan, Malaysia.

 

On April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to Mr. How Kok Choong and HKC Holdings Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.

 

On July 1, 2020, the Company issued 176,547 shares of restricted common stock to Mr. How Kok Choong, with a par value of $0.0001 per share, for total consideration payable by shares by the Company for the acquisition of 99.99% of the equity interest in ASL from Mr. How.

 

Vettons Sdn Bhd (“Vettons”) is an e-commerce company through which ASL conducts some of its distribution activities to its members. On February 1, 2021, Mr. How Kok Choong, our CEO and director, was appointed as the non-executive Chairman of Vettons. As of December 31, 2020, the Company has accounts receivable of $172,757 from Vettons, representing 100% of our accounts receivable.

 

In December 2021, there were share forfeiture agreements (the “Share Forfeiture Agreements”) between the Company and (i) HKC Talent Limited; (ii) various shareholders of the Company (the “Forfeiting Shareholders”), pursuant to which: (i) HKC Talent Limited had agreed to forfeiture of 41,750,000 shares of common stock of the Company, and

 

(ii) the Forfeiting Shareholders had agreed to forfeiture, in aggregate, 44,242,000 shares of common stock of the Company. Included in (ii) is 11,242,000 shares forfeited from HKC Holdings Sdn. Bhd, a company in which Mr. How Kok Choong, the CEO and director of the Company, is a shareholder. As a result, the outstanding shares was reduced by 85,992,000 shares of common stock.

 

A share forfeiture agreement (the “Share Forfeiture Agreement”) dated January 20, 2022, between the Company and Mr. How Kok Choong, the CEO and director of the Company, pursuant to which Mr. How Kok Choong agreed to forfeit 215,008,035 shares of common stock of the Company.

 

*HKC Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our CEO and Director. As such, HKC Holdings Sdn Bhd is regarded a related party.

 

With regards to all of the above transactions we claim an exemption from registration afforded by Section 4a(2) and/or Regulation S of the Securities Act of 1933, as amended (“Regulation S”) due to the fact that all sales of stock were made to non-U.S. persons (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing.

 

Related Party Transactions

 

The Company’s related party list and relationship are as follows:

 

Related parties   Relationships
     
Agape S.E.A. Sdn Bhd   VIE of Agape Superior Living Sdn Bhd, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of Agape S.E.A. Sdn Bhd
     
Agape Superior Living Pty Ltd   Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd

 

47

 

 

Related parties   Relationships
     
Agape ATP (Asia) Limited   Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.
     
Hostastay Sdn. Bhd.   Mr. How Kok Choong, the CEO and director of the Company is also a director of Hostastay Sdn. Bhd.
   
Redboy Picture Sdn Bhd   Mr. How Kok Choong, the CEO and director of the Company is also a director of Redboy Picture Sdn Bhd.
     
Vettons Sdn Bhd   Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.

 

Related party balances as of December 31, 2021 and 2020 are as per table below:

 

Amount due from related parties

 

      As of December 31, 
Name of Related Party  Nature  2021   2020 
            
Agape ATP (Asia) Limited (“AATP Asia”)  Expenses paid for AATP Asia  $2,214   $2,227 
              
Hostastay Sdn. Bhd. (“Hostastay”)  Sublease rent due from Hostastay   4,790    996 
              
TH3 Technology Sdn Bhd  Expenses paid for TH3 Technology   -    12 
Total     $7,004   $3,235 

 

Amount due to a Related Party

 

      As of December 31, 
Name of Related Party  Nature  2021   2020 
            
Agape Superior Living Pty Ltd  ATP Label Printing Fees  $-   $455 
Total     $-   $455 

 

48

 

 

Related party transactions for years ended December 31, 2021 and 2020, are as per table below:

 

Related party transactions

 

Revenue

 

      For the years ended December 31, 
Name of Related Party  Nature  2021   2020 
            
Agape Superior Living Pty Ltd (“ASLPL”)  Sales of products  $-   $18,060 
Vettons Sdn Bhd*  Sales of products made through its platform   6,625    - 
Total     $6,625   $18,060 

 

* During the year ended December 31, 2021, we had sales of $6,625 through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, our CEO and director, is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.

 

Purchase

 

         For the years ended December 31, 
Name of Related Party  Relationship  Nature  2021   2020 
               
DSY Wellness & Longevity Center Sdn Bhd  Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd.  Purchase  $718   $- 
Total        $718   $- 

 

Commission expense

 

      For the years ended December 31, 
Name of Related Party  Nature  2021   2020 
            
Mr. How Kok Choong*  Commission expense  $12,758   $10,740 
Total     $12,758   $10,740 

 

* Mr. How Kok Choong is the CEO and director of the Company.

 

Other income

 

      For the years ended December 31, 
Name of Related Party  Nature  2021   2020 
            
Hostastay Sdn. Bhd.  Sublease rental income due from Hostastay  $4,345   $2,881 
Total     $4,345   $2,881 

 

Review, Approval and Ratification of Related Party Transactions

 

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. Until formal policies and procedures are put in place, our Directors will continue to approve any related party transaction.

 

49

 

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Friedman LLP is our independent auditor and tax accountant for the year ended December 31, 2021 and 2020.

 

Below is the aggregate amount of fees billed for professional services rendered by our principal accountants with respect to our last two fiscal years.

 

   For the years ended December 31, 
   2021   2020 
         
Audit fees  $395,000   $245,000 
Tax fees  16,500   28,000 
Total  $411,500   $273,000 

 

The category of “Audit fees” includes fees for our annual audit, quarterly reviews and services rendered in connection with regulatory filings with the SEC, such as the issuance of comfort letters and consents.

 

The category of “Tax fees” includes professional services rendered by our principal accountant for tax compliance, tax advice, and tax planning.

 

All of the professional services rendered by principal accountants for the audit of our annual financial statements that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved by our board of directors.

 

50

 

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) Financial Statements

 

The following are filed as part of this report:

 

Financial Statements

 

The following financial statements of AGAPE ATP Corporation. and Report of Independent Registered Public Accounting Firm are presented in the “F” pages of this Report:

 

  Page
   
Index F-1
   
Reports of Independent Registered Public Accounting Firm F-2
   
Consolidated Financial Statements  
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations and Comprehensive Income (Loss) F-4
   
Consolidated Statements of Changes in Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 – F-34

 

(b) Exhibits

 

The following exhibits are filed or “furnished” herewith:

 

3.1 Articles of Incorporation**
   
3.2 Bylaws**
   
31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial officer*
   
32.1 Section 1350 Certification of principal executive officer and principal financial officer*

 

101.INS Inline XBRL Instance Document*
101.SCH Inline XBRL Taxonomy Extension Schema Document*
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)*

 

* Filed herewith.

 

** As filed in the Registrant’s Registration Statement on Form S-1 Amendment No.2 (File No. 333-220144) on October 26, 2017.

 

51

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AGAPE ATP CORPORATION.
  (Name of Registrant)
     
Date: March 28, 2022    
     
  By: /s/ How Kok Choong
    HOW KOK CHOONG
  Title: Chief Executive Officer, President, Secretary, Treasurer, Director
    Principal Executive Officer

 

Date: March 28, 2022 By: /s/ Andrew Lee Kam Fan
    LEE KAM FAN
  Title: Chief Financial Officer

 

52

 

 

INDEX TO FINANCIAL STATEMENTS

 

  Page
Financial Statements  
   
Report of Independent Registered Public Accounting Firm (PCAOB Name: Friedman LLP and PCAOB ID: 711) F-2
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations and Comprehensive Income (Loss) F-4
   
Consolidated Statements of Changes in Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 - F-34

 

F-1

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Agape ATP Corporation

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Agape ATP Corporation (the “Company”) as of December 31, 2021 and 2020, and the related consolidated statements of operations and comprehensive income (loss), changes in stockholders’ equity and cash flows for the years ended December 31, 2021 and 2020, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years ended December 31, 2021 and 2020, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Friedman LLP

 

We have served as the Company’s auditor since 2019

 

New York, New York

March 28, 2022

 

 

F-2

 

 

AGAPE ATP CORPORATION

CONSOLIDATED BALANCE SHEETS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

       
   As of December 31, 
   2021   2020 
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)  $2,597,848   $3,517,600 
Accounts receivable   -    172,757 
Amount due from related parties   7,004    3,235 
Inventories   375,535    589,814 
Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)   636,218    1,104,495 
Prepayments and deposits   295,517    296,370 
Total Current Assets   3,912,122    5,684,271 
           
OTHER ASSETS          
Property and equipment, net   215,799    298,309 
Intangible assets, net   3,660    5,826 
Operating right-of-use assets   237,718    394,141 
Investment in marketable securities   89,001    577,035 
Investment in non-marketable securities   1,500    1,500 
Deferred offering costs   264,735    249,525 
Total other assets   812,413    1,526,336 
           
TOTAL ASSETS  $4,724,535   $7,210,607 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts payable  $13,715   $- 
Customer deposits   279,689    236,134 
Operating lease liabilities   157,094    154,276 
Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.)   858,355    647,677 
Income tax payable   3,988    - 
Amount due to a related party   -    455 
Total Current Liabilities   1,312,841    1,038,542 
           
NON-CURRENT LIABILITIES          
Operating lease liabilities  $83,484   $241,488 
Deferred tax liabilities   15,574    5,743 
Total Non-current Liabilities   99,058    247,231 
           
TOTAL LIABILITIES  $1,411,899   $1,285,773 
           
STOCKHOLDERS’ EQUITY          
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding   -    - 
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively.   29,046    37,645 
Additional paid in capital   6,449,215    6,440,616 
Accumulated deficit   (3,258,687)   (734,443)
Accumulated other comprehensive income   93,398    181,016 
TOTAL AGAPE CORPORATION STOCKHOLDERS’ EQUITY   3,312,972    5,924,834 
           
NON-CONTROLLING INTERESTS   (336)   - 
           
TOTAL EQUITY   3,312,636    5,924,834 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $4,724,535   $7,210,607 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

       
   For the years ended December 31, 
   2021   2020 
         
REVENUE  $1,016,962   $3,434,561 
REVENUE – RELATED PARTY   -    18,060 
TOTAL REVENUE   1,016,962    3,452,621 
           
COST OF REVENUE   (297,333)   (775,855)
           
GROSS PROFIT   719,629    2,676,766 
           
SELLING   (394,682)   (376,582)
COMMISSION   (316,267)   (830,659)
GENERAL AND ADMINISTRATIVE   (1,745,734)   (1,627,660)
PROVISION FOR DOUBTFUL ACCOUNTS   (121,514)   - 
TOTAL OPERATING EXPENSES   (2,578,197)   (2,834,901)
           
LOSS FROM OPERATIONS   (1,858,568)   (158,135)
           
OTHER (EXPENSES) INCOME          
Other (Expenses) Income, net   (42,753)   164,283 
Unrealized holding (loss) gain on marketable securities   (505,231)   350,137 
Dividend income from marketable securities   18,939    160,062 
TOTAL OTHER (EXPENSES) INCOME, NET   (529,045)   674,482 
           
(LOSS) INCOME BEFORE INCOME TAXES   (2,387,613)   516,347 
           
PROVISION FOR INCOME TAXES   (137,067)   (161,581)
           
NET (LOSS) INCOME   (2,524,680)   354,766 
           
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS   436    - 
           
NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION  $(2,524,244)  $354,766 
           
NET (LOSS) INCOME  $(2,524,680)  $354,766 
           
OTHER COMPREHENSIVE (LOSS) INCOME          
Foreign currency translation adjustment   (87,615)   171,231 
           
TOTAL COMPREHENSIVE (LOSS) INCOME   (2,612,295)   525,997 
           
Less: Comprehensive loss attributable to non-controlling interests   (433)   - 
           
COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION  $(2,611,862)  $525,997 
           
(LOSS) EARNINGS PER SHARE          
Basic and diluted  $(0.01)   $0.00  
           
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING          
Basic and diluted   376,216,452    376,387,778 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

     

Number of shares

                                        
      COMMON STOCK                                        
     

Number of shares

       Par value          


ADDITIONAL PAID IN CAPITAL

       ACCUMULATED
DEFICIT		      

ACCUMULATED

OTHER

COMPREHENSIVE

INCOME

     

NON-

CONTROLLING INTERESTS

       TOTAL
STOCKHOLDERS’
EQUITY
Balance as of December 31, 2019     376,275,500     $ 37,628         $ 5,293,082     $ (1,089,209 )   $ 9,785     $ -      $ 4,251,286
Net income     -       -           -       354,766       -       -       354,766
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd     176,547       17           1,147,534       -       -       -       1,147,551
Foreign currency translation adjustment     -       -           -       -       171,231       -       171,231
Balance as of December 31, 2020     376,452,047       37,645           6,440,616       (734,443 )     181,016       -       5,924,834
Forfeiture of common stock     (85,992,000 )     (8,599 )         8,599       -       -       -       -
Contributions from non-controlling interest shareholders     -       -           -       -       -       97       97
Net loss     -       -            -       (2,524,244 )     -       (436 )     (2,524,680)
Foreign currency translation adjustment     -       -           -       -       (87,618 )     3       (87,615)
Balance as of December 31, 2021     290,460,047     $ 29,046         $ 6,449,215     $ (3,258,687 )   $ 93,398     $ (336 )   $ 3,312,636

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Currency expressed in United States Dollars (“US$”)

 

       
   For the years ended December 31, 
   2021   2020 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net (loss) income  $(2,524,680)  $354,766 
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Depreciation   75,797    55,407 
Amortization   1,961    1,505 
Amortization of operating right-of-use assets   139,451    106,561 
Unrealized holding loss (gain) on marketable securities   505,231    (350,137)
Dividend income from marketable securities   (18,939)   (160,062)
Deferred tax expense   10,127    178,329 
Inventory write-down   36,241    - 
Provision for doubtful accounts   121,514    - 
Changes in operating assets and liabilities:          
Accounts receivables   167,566    (165,149)
Amount due from a related party   -    (2,417)
Inventories   192,713    78,674 
Prepaid taxes   430,062    184,985 
Prepayments and deposits   (128,363)   352,577 
Accounts payable   -    (2,804)
Customer deposits   52,981    (1,421,886)
Other payables and accrued liabilities   226,651    336,709 
Operating lease liabilities   (138,143)   (105,009)
Income tax payables   3,988    - 
Net cash used in operating activities   (845,842)   (557,951)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of equipment   (3,959)   (4,734)
Purchase of intangible assets   -    (178)
Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd   -    1,210,818 
Proceeds from sale of marketable securities   -    121 
Proceeds from sale of non-marketable securities to a related party   -    70,173 
Net cash (used in) provided by investing activities   (3,959)   1,276,200 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Deferred offering costs   (15,210)   (249,525)
(Advances to) Repayments from related parties   (3,851)   227,434 
Net cash used in financing activities   (19,061)   (22,091)
           
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS   (50,890)   76,985 
           
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS   (919,752)   773,143 
           
CASH AND CASH EQUIVALENTS, beginning of year   3,517,600    2,744,457 
           
CASH AND CASH EQUIVALENTS, end of year  $2,597,848   $3,517,600 
           
SUPPLEMENTAL CASH FLOWS INFORMATION          
Income taxes paid  $326,838   $288,929 
Interest paid  $-   $- 
           
SUPPLEMENTAL NON-CASH FLOWS INFORMATION          
Changes in right-of-use assets and lease liabilities due to lease modifications  $3,250   $- 
Initial recognition of right-of-use assets and lease liabilities  $-   $483,343 
Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL  $-   $656,495 
Issuance of common stock in exchange for acquisition payment of ASL  $-   $1,147,551 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. (“ASL”), a company incorporated in Malaysia. .

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., a network marketing entity incorporated in Malaysia.

 

Agape Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.

 

On September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (“WATP”), a wholly owned subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.

 

On November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

The Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.

The accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3), and DSY Wellness.

 

Details of the Company’s subsidiaries:

 

    Subsidiary company name  Place and date of incorporation  Particulars of issued capital  Principal activities  Proportional of ownership interest and voting power held 
                  
1.   Agape ATP Corporation  Labuan,
March 6, 2017		  100 shares of ordinary share of US$1 each  Investment holding   100%
                   
2.   Agape ATP International Holding Limited  Hong Kong,
June 1, 2017		  1,000,000 shares of ordinary share of HK$1 each  Wholesaling of health and wellness products; and health solution advisory services   100%
                   
3.   Agape Superior Living Sdn. Bhd.  Malaysia,
August 8, 2003		  9,590,598 shares of ordinary share of RM1 each  Health and wellness products and health solution advisory services via network marketing   99.99%
                   
4.   Agape S.E.A. Sdn. Bhd.  Malaysia,
March 4, 2004		  2 shares of ordinary share of RM1 each  VIE of Agape Superior Living Sdn. Bhd.   VIE 
                   
5.   Wellness ATP International Holdings Sdn, Bhd  Malaysia,
September 11, 2020		  100 shares of ordinary share of RM1 each  The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns   100%
                   
6.   DSY Wellness International Sdn Bhd.  Malaysia,
November 11, 2021		  1,000 shares of ordinary share of RM1 each  Provision of complementary health therapies   60%

 

F-7

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

1. ORGANIZATION AND BUSINESS BACKGROUND (CONT’D)

 

Business Overview

 

Agape ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.

 

Via ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.

 

The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.

 

The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.

 

The Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various wellness programs.

 

To further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

F-8

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

 

The consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.

 

Principles of consolidation

 

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

 

F-9

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, no allowance of doubtful accounts was recorded.

 

Inventories

 

Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. For the years ended December 31, 2021, and 2020, the company recorded $36,241 and $0 write-downs for inventory.

 

Prepaid taxes

 

Prepaid taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax.

 

Prepayments and deposits

 

Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, there was $121,514 and $0 allowance for the doubtful accounts recorded.

 

F-10

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

    Useful Life
     
Computer and office equipment   5-7 years
Furniture & fixtures  

6-7 years

Leasehold improvements   Lease Term
Vehicle   5 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.

 

Intangible assets, net

 

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

Classification   Useful Life
     
Computer software   5 years

 

Impairment for long-lived assets

 

Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and 2020, no impairment of long-lived assets was recognized.

 

Deferred offering costs

 

Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.

 

Investment in marketable equity securities

 

The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s unaudited condensed consolidated statements of operations and comprehensive loss in the caption of “unrealized holding gain loss on marketable securities” in each reporting period.

 

F-11

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Investment in non-marketable equity securities

 

The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

 

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

 

Customer deposits

 

Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.

 

Revenue recognition

 

The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

F-12

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $15,209 and $170,431 as forfeited coupon income.

 

As of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $183,816 which it is expected to fulfill within 12 months from December 31, 2021.

 

Sales of Health and Wellness services

 

- Performance obligations satisfied at a point in time

 

The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person.

 

The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp. For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $7,543 and $0, respectively.

 

F-13

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Disaggregated information of revenues by products and services are as follows:

 

       
   For the years ended December 31, 
   2021   2020 
         
Survivor Select  $83,904   $149,897 
Energized Mineral Concentrate   52,047    81,481 
Ionized Cal-Mag   39,527    908,964 
Omega Blend   222,718    495,567 
BetaMaxx   208,043    156,550 
Vege Fruit Fiber   65,757    1,755 
Iron   28,114    133,389 
Young Formula   52,425    653,631 
Organic Youth Care Cleansing Bar   5,137    43,127 
Mitogize   183,800    162,801 
No. 1 MED   15,331    46,713 
Energetique   25,574    253,396 
Trim+   27,042    365,350 
Total revenues – products   1,009,419    3,452,621 
Health and Wellness services   7,543    - 
Total revenues  $1,016,962   $3,452,621 

 

Cost of revenue

 

Cost of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue amounted to $297,333 (including inventory write-downs of $36,241) and $775,855 for the years ended December 31, 2021 and 2020, respectively.

 

Shipping and handling

 

Shipping and handling charges amounted to $11,054 and $9,315 for the years ended December 31, 2021 and 2020, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.

 

Advertising costs

 

Advertising costs amounted to $20,218 and $14,339 for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as incurred and included in selling expenses.

 

Commission expenses

 

Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent

 

F-14

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $316,267 and $830,659 for the years ended December 31, 2021 and 2020, respectively.

 

Defined contribution plan

 

The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $99,488 and $75,802 for the years ended December 31, 2021 and 2020, respectively.

 

The related contribution plans include:

 

  - Social Security Organization (“SOSCO”) – 1.75% based on employee’s monthly salary capped of RM 4,000;
  - Employees Provident Fund (“EPF”) – 12% based on employee’s monthly salary;
  - Employment Insurance System (“EIS”) – 0.2% based on employee’s monthly salary capped of RM 4,000;
  - Human Resource Development Fund (“HRDF”) – 1% based on employee’s monthly salary

 

Income taxes

 

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. $395 and $0 penalties and interest incurred related to underpayment of income tax for the years ended December 31, 2021 and 2020, respectively.

 

F-15

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Comprehensive income (loss)

 

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

 

Non-controlling interest

 

Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company.

 

Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2021 and 2020, there were no dilutive shares.

 

Foreign currencies translation and transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statements of operations and comprehensive income (loss).

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.

 

F-16

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

   As of December 31, 
   2021   2020 
         
Period-end MYR : US$1 exchange rate   4.18    4.02 
Period-end HKD : US$1 exchange rate   7.80    7.75 

 

   For the years ended December 31, 
   2021   2020 
         
Period-average MYR : US$1 exchange rate   4.14    4.20 
Period-average HKD : US$1 exchange rate   7.77    7.76 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  ● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

 

F-17

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Leases

 

The Company adopts ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company’s leases include one or more options to renew, which is typically at the Company’s sole discretion. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications result in re-measurement of the right of use (“ROU”) assets and lease liabilities. Operating ROU assets and lease liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.

 

Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information.

 

F-18

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

In October 2020, the FASB issued ASU 2020-08, “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs”. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

In October 2020, the FASB issued ASU 2020-10, “Codification Improvements”. The amendments in this Update represent changes to clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

F-19

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

3. VARIABLE INTEREST ENTITY (“VIE”)

 

SEA is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided majority of ASL’s purchases. Its equity at risk was insufficient to finance its activities and 100% of its business is transacted with ASL. Therefore, it was considered to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:

 

  a. The power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and
  b. The obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

 

Accordingly, the accounts of SEA is consolidated in the accompanying financial statements.

 

The carrying amount of the VIE’s assets and liabilities were as follows:

         
   As of December 31, 
   2021   2020 
         
Current assets  $18,850   $48,717 
Current liabilities   (51,272)   (53,573)
Net deficit  $(32,422)  $(4,856)

 

         
   As of December 31, 
   2021   2020 
         
Current assets:          
Cash  $17,493   $37,387 
Prepaid taxes   1,357    11,330 
Total current assets  $18,850   $48,717 
           
Current liabilities:          
Accounts payable – intercompany  $49,724   $51,669 
Other payables and accrued liabilities   1,548    1,904 
Total current liabilities  $51,272   $53,573 
           
Net deficit  $(32,422)  $(4,856)

 

The summarized operating results of the VIE’s are as follows:

 

         
   For the years ended December 31, 
   2021   2020 
         
Operating revenues  $-   $346,907 
Gross profit  $-   $4,442 
Loss from operations  $(21,966)  $(10,752)
Net loss  $(27,966)  $(24,014)

 

F-20

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

4. BUSINESS COMBINATION

 

On May 8, 2020, the Company entered into a Share Exchange Agreement (“SPA”) with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $1,804,046, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $656,495 as of March 31, 2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue 176,547 shares of the Company’s common stock, par value $0.0001, representing approximately 0.0469% of the total issued and outstanding shares in the Company after the issuance of the Shares, which is valued at $1,147,551 based on the closing price of $6.50 of the Company as quoted on the OTC Market on March 31, 2020. As of December 31, 2020, the Company has issued all 176,547 shares of the Company’s common stock.

 

The Company’s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020 as ASL was under the common control of Mr. How.

 

The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.

   Carry Value 
ASSETS     
Current assets     
Cash  $1,206,493 
Other receivables   33,210 
Other receivables - related parties   219,121 
Inventories   616,880 
Prepaid taxes   1,206,821 
Prepayments and other assets   318,267 
Total current assets   3,600,792 
      
Other assets     
Property and equipment, net   325,648 
Intangible assets, net   6,686 
Deferred taxes asset, net   172,250 
Total other assets   504,584 
      
Total assets  $4,105,376 
      
LIABILITIES AND SHAREHOLDERS’ EQUITY     
Current liabilities     
Accounts payable - related party  $491,628 
Customer deposits   1,600,606 
Other payables and accrued liabilities   209,096 
Total current liabilities   2,301,330 
      
Total liabilities  $2,301,330 
      
Total net assets acquired  $1,804,046 

 

F-21

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

4. BUSINESS COMBINATION (CONT’D)

 

The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2020. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2020. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.

 

 

   For the year ended December 31, 2020 
     
Revenue  $4,693,873 
Cost of revenue   (875,708)
Gross profit   3,818,165 
Total operating expenses   (3,839,184)
 Loss from operations   (21,019)
Other income (expense), net   267,633 
Income before income taxes   246,614 
Provision for income taxes   (212,414)
Net income  $34,200 
Net income per common share - basic and diluted  $0.00 
Weighted average number of common shares outstanding - basic and diluted   376,452,047 

 

5. CASH AND CASH EQUIVALENTS

 

As of December 31, 2021 and 2020 the Company had $2,597,848 and $3,517,600, respectively, of cash and cash equivalents, which consists of $554,864 and $1,112,147, respectively, of cash in banks and $1,975,347 and $2,391,182, respectively, of time deposits placed with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between 1.10% to 1.25% per annum.

 

6. ACCOUNTS RECEIVABLE

           
   As of December 31, 
   2021   2020 
Accounts receivable  $-   $172,757 
Allowance for doubtful accounts   -    - 
Total  $-   $172,757 

 

F-22

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

7. INVENTORIES

 

Inventories consist of the following:

         
   As of December 31, 
   2021   2020 
Finished goods  $375,535   $589,814 

 

For the years ended December 31, 2021 and 2020, the Company recognized $36,241 and $0 inventory write-down, respectively.

 

8. PREPAYMENTS AND DEPOSITS

           
   As of December 31, 
   2021   2020 
Receivables from sales distributors  $115,379   $35,302 
Deposits to suppliers   301,233    261,068 
Subtotal   416,612    296,370 
Less: Provision for doubtful accounts   (121,095)   - 
Total  $295,517   $296,370 

 

Movements of allowance for doubtful accounts are as follows:

 SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS

         
   For the years ended December 31, 
   2021   2020 
Beginning balance  $-   $- 
Addition   121,514    - 
Write off   -    - 
Exchange rate effect   (419)   - 
Ending balance  $121,095   $- 

 

9. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consist of the following:

 

       
   As of December 31, 
   2021   2020 
Computer and office equipment  $82,298   $81,437 
Furniture & fixtures   122,185    126,966 
Leasehold improvements   202,570    210,496 
Vehicle   98,702    102,564 
Subtotal   505,755    521,463 
Less: accumulated depreciation   (289,956)   (223,154)
Total  $215,799   $298,309 

 

Depreciation expense for the years ended December 31, 2021 and 2020 amounted to $75,797 and $55,407, respectively.

 

F-23

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

10. INTANGIBLE ASSETS, NET

 

Intangible assets, net, consist of the following:

 

       
   As of December 31, 
   2021   2020 
Computer software  $34,453   $35,801 
Less: accumulated amortization   (30,793)   (29,975)
Total  $3,660   $5,826 

 

Amortization expense for the years ended December 31, 2021 and 2020 amounted to $1,961 and $1,505, respectively.

 

11. INVESTMENT IN MARKETABLE SECURITIES

 

  (i) On May 17, 2018, the Company purchased 83,333 shares of common stock in Greenpro Capital Corp. for $500,000 at a purchase price of $6 per share.
     
  (ii) On July 30, 2018, the Company disposed 20 shares of common stock in Greenpro Capital Corp. for $125 at a purchase price of $6.2613 per share.
     
  (iii) On October 16, 2018, the Company purchased 33,333 shares of common stock in Greenpro Capital Corp. for $1,000 at a purchase price of $0.03 per share.
     
  (iv) On November 3, 2020, the Company received dividend of 6,667 shares of common stock in DSwiss, Inc. for $76,671 at fair value of $11.50 per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.’s shares
     
  (v) On December 9, 2020, the Company received dividend of 16,663 shares of common stock in DSwiss, Inc. for $83,315 at fair value of $5 per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.’s shares.
     
  (vi) On September 27, 2021, the Company received dividend of 11,665 shares of common stock in SEATech Ventures Corp. for $18,874 at fair value of $1.62 per share from Greenpro Capital Corp as a dividend income since Greenpro Capital Corp previously owned these shares.

 

   2021   2020 
   As of December 31, 
   2021   2020 
Cost of investment  $577,035   $66,484 
Dividend income from Greenpro Capital Corp.   18,939    160,062 
Unrealized holding (loss) gain   (505,231)   350,137 
Exchange rate effect   (1,742)   352 
Investment in marketable securities  $89,001   $577,035 

 

F-24

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

12. INVESTMENT IN NON-MARKETABLE SECURITIES

 

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (RM 3,500,000), which approximated 20% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019, Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately 20.0% to approximately 17.86%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.

 

Unreserved Sdn Bhd was incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.

 

On March 3, 2020, the Company agreed to sell the 17.86% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value of $730,637 to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $70,173, and had an amount due from director of $660,464 at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in a transaction which the Company had acquired the CEO’s ownership interest of Agape Superior Living Sdn. Bhd.

 

On April 3, 2019, the Company purchased a 5% of stock or 15,000,000 shares of common stock in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

 

   As of December 31, 
Unreserved Sdn Bhd  2021   2020 
Investment in non-marketable securities  $-   $730,637 
Less: Sale of investment in non-marketable securities   -    (730,637)
Investment in non-marketable securities   -    - 

 

Phoenix Plus Corporation          
Cost of investment   1,500    1,500 
           
Total investment in non-marketable securities  $1,500   $1,500 

 

13. OTHER PAYABLES AND ACCRUED LIABILITIES

 

   2021   2020 
   As of December 31, 
   2021   2020 
Professional fees  $436,541   $297,636 
Promotion expenses   36,024    37,433 
Payroll   22,669    23,976 
Commission   219,721    224,711 
Others   143,400    63,921 
           
Total  $858,355   $647,677 

 

F-25

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

14. RELATED PARTY BALANCES AND TRANSACTIONS

 

Related party balances

 

Amount due from related parties

 

Name of Related        As of December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape ATP (Asia) Limited (“AATP Asia”)  Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia  Expenses paid for AATP Asia  $2,214   $2,227 

Hostastay Sdn. Bhd.

“Hostastay” 

  Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay  Sublease rent due from Hostastay   4,790    996 

TH3 Technology Sdn Bhd

“TH3 Technology”

  Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology  Expenses paid for TH3 Technology   -    12 
Total        $7,004   $3,235 

 

Amount due to a Related Party

 

Name of Related        As of December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape Superior Living Pty Ltd “ASLPL”  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  ATP Label Printing Fees   $-   $455 
Total        $-   $455 

 

F-26

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

14. RELATED PARTY BALANCES AND TRANSACTIONS (CONT’D)

 

Related party transactions

 

Revenue

 

Name of Related        For the years ended December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  Sales of products  $-   $18,060 
Vettons Sdn Bhd*  Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021  Sales of products made through its platform   6,625    - 
Total        $6,625   $18,060 

 

* During the year ended December 31, 2021, the Company had sales of $6,625 through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.

 

Purchase

 

         For the years ended December 31, 
Name of Related Party  Relationship  Nature  2021   2020 
               
DSY Wellness & Longevity Center Sdn Bhd  Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd.  Purchase  $718   $- 
Total        $718   $- 

 

Commission expense

 

        For the years ended December 31,  
Name of Related Party  Relationship  Nature  2021   2020 
               
Mr. How Kok Choong  Mr. How Kok Choong, the CEO and director of the Company.  Commission expense  $12,758   $10,740 
Total        $12,758   $10,740 

 

Other income

 

Name of Related Party           For the years ended December 31,  
  Relationship   Nature   2021     2020  
                     
Hostastay Sdn. Bhd.   Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay   Sublease rental income due from Hostastay   $ 4,345     $ 2,881  
Total           $ 4,345     $ 2,881  

 

F-27

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

15. STOCKHOLDERS’ EQUITY

 

Preferred stock

 

As of December 31, 2021 and 2020, there were 200,000,000 preferred stocks authorized but none were issued and outstanding.

 

Common stock

 

As of December 31, 2021 and 2020, there were 1,000,000,000 common stocks authorized, 290,460,047 and 376,452,047 shares issued and outstanding, respectively.

 

In May 2020, the Company issued 162,694 shares of the Company’s common stock in connection with the acquisition of ASL as part of the acquisition payment.

 

In June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased by $90,043, which required the issuance of an additional 13,853 shares of the Company’s common stock to fully satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The 13,853 additional shares were issued in July 2020.

 

In December 2021, there were share forfeiture agreements (the “Share Forfeiture Agreements”) between the Company and (i) HKC Talent Limited; (ii) various shareholders of the Company (the “Forfeiting Shareholders”), pursuant to which: (i) HKC Talent Limited had agreed to forfeiture of 41,750,000 shares of common stock of the Company, and (ii) the Forfeiting Shareholders had agreed to forfeiture, in aggregate, 44,242,000 shares of common stock of the Company. Included in (ii) is 11,242,000 shares forfeited from HKC Holdings Sdn. Bhd, a company in which Mr. How Kok Choong, the CEO and director of the Company, is a shareholder. As a result, the outstanding shares was reduced by 85,992,000 shares of common stock.

 

There were no stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2021 and 2020.

 

16. NON-CONTROLLING INTEREST

 

The Company’s non-controlling interest consists of the following:

 

 

   2021   2020 
   As of December 31, 
   2021   2020 
DSY Wellness:      
Paid-in capital  $97   $- 
Accumulated deficit   (436)   - 
Accumulated other comprehensive income   3    - 
 Non Controlling interest Gross   (336)   - 
ASL   -          - 
Total  $(336)  $- 

 

F-28

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

17. INCOME TAXES

 

The United States and foreign components of (loss) income before income taxes were comprised of the following:

         
   For the years ended December 31, 
   2021   2020 
Tax jurisdictions from:          
Local – United States  $(706,659)  $(735,159)
Foreign – Malaysia   (1,064,314)   1,070,806 
Foreign – Hong Kong   (616,640)   180,700 
(Loss) income before income tax  $(2,387,613)  $516,347 

 

The (provision for) benefit of income taxes consisted of the following:

         
   For the years ended December 31, 
   2021   2020 
Current:        
- Local  $(22,205)  $- 
- Foreign   (104,735)   16,748 
           
Deferred:          
- Local   -    - 
- Foreign   (10,127)   (178,329)
           
Provision for income taxes  $(137,067)  $(161,581)

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a corporate tax rate of 21% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart F income (“Subpart F”) tax, which is a tax primarily on passive income from controlled foreign corporations with a tax rate of 35%. In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax, which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are applied.

 

For the years ended December 31, 2021 and 2020, the Company’s foreign subsidiaries did not generate any income that are subject to Subpart F tax and GILTI tax.

 

F-29

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

17. INCOME TAXES (CONT’D)

 

For the year ended December 31, 2021, the Company re-visited its fiscal 2020 U.S. income taxes and determined its stock dividend from Greenpro Capital Corp as a result of its Spin-off of DSwiss Inc.’s shares in 2020 were subject to Subpart F and GILTI taxes. As a result, the Company incurred additional income taxes expenses of $22,205, including interest and penalty of $395, for the year ended December 31, 2021, after utilizing its estimated cumulative net operating losses (“NOL”) of $312,608 as of December 31, 2020. As a result, the Company’s deferred tax assets of estimated NOL of $65,648 were fully utilized and reduced to $0.

 

As of December 31, 2021 and 2020, the operations in the United States of America incurred approximately $729,000 and $0, respectively, of cumulative net operating losses (“NOL”) which can be carried forward to offset future taxable income or Subpart F and GILTI taxes. These balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately $153,000 and $0, respectively.

 

Malaysia

 

Changes to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies incorporated in Labuan to satisfy the “substantial activity requirements” to qualify for the preferential tax rate of 3% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the “substantial activity requirements” was issued. As Agape ATP Corporation did not maintain a permanent establishment in Labuan, and therefore did not satisfy the said requirements, the company was subjected to tax at 24% on its net audited profit. On June 11, 2021, Agape ATP Corporation made an irrevocable election to be taxed under the Malaysian Income Tax Act 1967 as the elected tax regime is more tax efficient to the entity compare to LBATA.

 

Agape Superior Living Sdn Bhd, Agape S.E.A Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of Malaysia and the income taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia, enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate.

 

As of December 31, 2021 and 2020, the operations in the Malaysia incurred approximately $946,000 and $261,000, respectively, of cumulative net operating losses (“NOL”) which can be carried forward to offset future taxable income. Approximately $685,000 and $261,000 of the net operating loss carry forwards will expire in 2028 and 2027, respectively, if unutilized. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately $217,000 and $0, respectively.

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.

 

F-30

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

17. INCOME TAXES (CONT’D)

 

The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:

         
   For the years ended December 31, 
   2021   2020 
U.S. statutory rate   21.0%   21.0%
Valuation allowance   (17.0)%   (4.0)%
Differential tax rate in Malaysia   3.0%   3.0%
Permanent difference   (12.7)%(1)   11.3%(2)
Effective tax rate   (5.7)%   31.3%

 

  (1) The amount comprised:
 
    - 6.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and
    - 6.7% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.
       
  (2) The amount comprised:
 
    - 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;
    -

0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and

    - 1.3% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

         
   As of December 31, 
   2021   2020 
Deferred tax assets:          
Net operating loss carry forwards in U.S.  $153,061   $- 
Net operating loss carry forwards in Malaysia   227,106    62,678 
Less: valuation allowance   (380,167)   -
Deferred tax liabilities:          
Depreciation   (15,574)   (68,421)
Deferred tax liabilities, net  $(15,574)  $(5,743)

 

Uncertain tax positions

 

The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the years ended December 31, 2020 and 2020.

 

F-31

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

18. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the years ended December 31, 2021 and 2020, no customer accounted for 10% or more of the Company’s total revenues.

 

There are no accounts receivable balance as of December 31, 2021. As of December 31, 2020, receivables from a third-party e-commerce company accounted for approximately 100.0% of the total balance of accounts receivable.

 

(b) Major vendors

 

For the year ended December 31, 2021, two vendors accounted for approximately 47.3% and 45.2% of the Company’s total purchases, respectively. For the year ended December 31, 2020, two vendors accounted for approximately 74.1% and 25.9% of the Company’s total purchases. In November and December 2020, the Company received dividend of 23,330 shares of common stock of DSwiss, Inc., represents approximately 0.01% ownership that the Company accounted for as investment in marketable securities (See Note 11). DSwiss, Inc.’s wholly owned subsidiary is the vendor that accounted for the Company’s total purchases of approximately 47.3% and 74.1% for the years ended December 31, 2021 and 2020, respectively.

 

As of December 31, 2021, one vendor accounted for 100% of the total balance of accounts payable. There are no accounts payable balance as of December 31, 2020.

 

(c) Commission Expenses to Sales Distributors and Stockists

 

For the year ended December 31, 2021, one sales distributor accounted for 17.9% of the Company’s total commission expense.

 

For the year ended December 31, 2020, no sales distributor accounted for 10.0% of the Company’s total commission expense.

 

(d) Credit risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December 31, 2021 and 2020, $554,864 and $1,112,147 were deposited with financial institutions, respectively, $295,761 and $563,788 of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.

 

F-32

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

18. CONCENTRATIONS OF RISKS (CONT’D)

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

19. COMMITMENTS AND CONTINGENCIES

 

Lease commitments

 

On April 1, 2020, the Company adopted ASC 842 for ASL’s office space lease and sales and training center as the lease commencement date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $490,000, with a corresponding right-of-use (“ROU”) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an effective interest rate of 5.5%, which was determined using the Company’s estimated incremental borrowing rate.

 

On May 31, 2021, the Company entered into two separate two-year leases extension with the modified lease expiring May 31, 2023 for its office space and expiring August 31, 2023 for its training center. The lease modification required the Company to re-measure the ROU assets and lease liabilities based on the modified leases. The Company recognized a reduction of $3,250 in ROU assets and lease liabilities upon lease modifications based on the present value of the future minimum rental payments of the lease, using an effective interest rate of 5.5%, which was determined using the Company’s estimated incremental borrowing rate.

 

As of December 31, 2021, the weighted remaining term of the lease is approximately 1.64 years.

 

The five-year maturity of the Company’s operating lease liabilities is as follow:

Twelve Months Ending December 31,  Operating lease liabilities 
     
2022  $166,426 
2023   84,915 
Thereafter   - 
Total lease payments   251,341 
Less: interest   (10,763)
Present value of lease liabilities  $240,578 

 

Rent expense for the years ended December 31, 2021 and 2020 was $179,562 and $156,716, respectively.

 

Contingencies

 

Legal

 

From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.

 

F-33

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

19. COMMITMENTS AND CONTINGENCIES (CONT’D)

 

COVID-19

 

Since the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO, Malaysia has been put through various stages of lockdowns such as (1) full movement control orders (“MCO”), under which, quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (“RMCO”). On January 12, 2021, due to a resurgence of COVID-19 cases, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the country. February 2021 marked a significant month for Malaysia as all frontline staff of the country, which comprised those in healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defense sectors were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless, COVID-19 cases in the country continue to rise. On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot.

 

Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:

 

  ● temporary closure of offices, travel restrictions, financial impact of the Company’s customers or suspension supplies may be negatively affected, and could continue to negatively affect the demand for the Company’s product;
  ● the Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely affect its financial condition and operating results; and
  ● any disruption of the Company’s supply chain, logistics providers or customers could adversely impact its business and results of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery to its customers, which may also lead to loss of its customers.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that the Company’s total revenues will grow or remain at the similar level year over year in 2021 and 2022.

 

20. SUBSEQUENT EVENTS

 

Forfeiture of Common Stock

 

A share forfeiture agreement (the “Share Forfeiture Agreement”) dated January 20, 2022, between the Company and Mr. How Kok Choong, the CEO and director of the Company, pursuant to which Mr. How Kok Choong agreed to forfeit 215,008,035 shares of common stock of the Company.

 

F-34

 

 EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, HOW KOK CHOONG, certify that:

 

1. I have reviewed this annual report on Form 10-K of Agape ATP Corporation (the “Company”) for the year ended December 31, 2021;

 

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2022 By: /s/ How Kok Choong
    HOW KOK CHOONG
   

Chief Executive Officer,

President, Director, Secretary, Treasurer

    (Principal Executive Officer and Principal Financial Officer)

 

 

 

 

EXHIBIT 31.2

 

CERTIFICATION

 

I, ANDREW LEE KAM FAN, certify that:

 

1. I have reviewed this annual report on Form 10-K of Agape ATP Corporation (the “Company”) for the year ended December 31, 2021;

 

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2022 By: /s/ Andrew Lee Kam Fan
    LEE KAM FAN
    Chief Financial Officer,

 

 

 EX-32.1 3 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Agape ATP Corporation (the “Company”) on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: March 28, 2022 By: /s/ How Kok Choong
    HOW KOK CHOONG
   

Chief Executive Officer,

President, Director, Secretary, Treasurer

    (Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Agape ATP Corporation (the “Company”) on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: March 28, 2022 By: /s/ Andrew Lee Kam Fan
    LEE KAM FAN
    Chief Financial Officer

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 GRAPHIC 4 image_001.jpg begin 644 image_001.jpg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end GRAPHIC 5 image_002.jpg begin 644 image_002.jpg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end GRAPHIC 6 image_003.jpg begin 644 image_003.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#WXGD4M(1R M*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ QGK3=B_W M1^5.HH ,#THP/2BB@ HHHH 3'U_.@@'U_.EHH 0*!Z_G2T44 %%%% "$$]R/ MI0 1_$3]<4M% !^-%%% !1110 AZK]:6BB@ HHHH **** "BBB@ HHJK>:C: MV"YN)0K$9"#EC^% %JBN7N?%E.2?P'3\ZRIM7U&<_/=R#V0[?Y M4 =W))'$NZ1U1?5C@55DU;3XURUY"1_LMN_E7 DECDG)]310!VS>(M,49$Y; MV$;?U%5_^$IL<_ZJX/\ P$?XUR5%(9U#^+(1_J[61O\ >8#_ !J/_A+?^G'_ M ,B__6KFQ1B@#I/^$M/_ #X_^1?_ *U)_P ):?\ GR_\B_\ UJYS%&* .D_X M2W_IR_\ (O\ ]:I$\5PD_O+61?\ =8'_ KE\4E '7CQ38DC,-I]"C?X5Q%% 'H4=]:3$+'H1R* M8'HM%<9!XDOXC^\9)A_MKC^6*V+3Q-:3$+.C0-ZGYE_,<_I0(VZ*:DB2H'C= M70]&4Y!IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <]KGB$V M4IL[4 SX^:0]$_#N:Y@EI&+NS.[I.:J'E3]179V- M]'?VXD3Y6'#(>JFN/AM&ZL*V=(#V]V@S\KY!'X47 Z&BBBF(**** "BBB@ H MHHH **:?]8OT/]*=0 4444 %%%% !110>!0!YG;N0*N*J/\ 7KQ_GZ_I5&'J M*N0\8/T_G2&2^1VX_P __J/Y4&VSVIT;$X&>,=/P7_$U80[GVD<$_P V/^%( M"F;5NU--O(/X:TTP^W/\0'ZDDTY0&7([@'\S@4 9!B<=5--*MZ5N;%R<]/F_ M(4[R0>"HSP/Q- &#M/I1BM[[.A'W1CG]*/LL?=!VH P<4;:WQ9Q$_<'7'2E% MG%C_ %8Z9Z4 <_CVI<'TKH19Q9^XO7%.%K'V1: .()#T1ORKHA H_A M%.$0]!0!SZV4S?P'\:F73)#]X@5N; *-HH RX]-0?>YJTEJB]% JW@4&@"$1 M*OX5+:_\?T/U/\J:W?\ SWIUK_Q_Q?4_R-,#;HHHIB"BBB@ HHHH **** #' M.:*** "BBB@ HHHH *9,VV&1O12?TI]5]0;9IMT_]V%S^AH \YBSD5-<;1VX_FM3I]Z,_[O\FI M21#_ %7_ '^1J2/[J_[J?SID7'E_5?_ $$T^,_*O^ZG\Z )/X#_ +K_ ,ZE M'W_^!C^51?P'_=;^=2C_ %G_ ,?RH 3L_X :DYW'ZK48_U8_W#3_XC_O#^ M5 #@>GU:ES\O_ 12#M_P*E_A_P" B@!W?\?Z4#I^%'?_ (%0.GX4 +WHHHH M*6BB@!.](?\ /Z4X=:;_ )_E0 T]/RI]I_Q_Q?4_R-,)Z?A2VA_XF,(]S_(T M ;E%%%4(**** "BBB@ HHHH **** "BBB@ HHHH *AO(FGLIX4QNDC91GU(Q M4U% 'EQ1X6*LI!!P1W!JU#,&/4''7]*ZS5]#MKG?=+(MO)U9FX5OKZ?6N2:& M'SF D5R.-Z$C/\C28R]&P)7'J/YBI8V^6/UX_P#0352.-UQAPP]&&"?Q'^%6 M%+K]Z-N.I7D?X_I2N,LH>5_WA_Z#4D?1/^ 566XB4CK$9&%P> MF/TH$/S\G_ 3_.I5.7_[:?TJ,#YM+M;'0]!0 O?\:!T_"EVM MGH>M 4XZ=J #O2T;32[3[4 )10< ?UH 8[@#WHL S:I"0"0,D^PP1_,BA(O-F\J(!I",G)Z#U/YULV MUJEK'M7EC]YO6F@)Z***8@HHHH **** "BBB@!/XS]!2TG>EH **** "BBH+ MR\@L;=I[A]J#\R?0>] $]8&I^*;:TS':@7$O]X'Y!^/?\/SK#U77;G4F:-"8 MK;/W >6^I_I66(LT#L/O-2N]1EWW$K,.RC@#Z"F(,T"#FI5C([4K@.C>1>C' MZ&K<=RX^\F?<&HHT]JLI&3)>)WW+]14BM:N0Q$6>Q( -1K$#VJ3[.I'(! MI 3B*(\@M^#G_&I/*STED7Z8_P *JBS0]JE6V(Z.X^C4 6%A8?\ +5C]0*?L M?M(H^J__ %ZKB"0=)7_$U*L4V/\ 6'\J )-DO_/1/^^#_C2^7+_STC_[X/\ MC3?+F_YZ'\A2B.;/^L/Y"@!X23NZ?]\G_&G%&(QOQ[@?XTP12]Y#^E/\ECU= MOSH !$0.97/X#_"CRTSDEC_P(T" =V8_C0+=,DX_.@!N(%8D*F[N>II?.7'R M@GZ"GB%1T%+L [4 0&1ST7'UJ)PYZFK1'%1N*8&9/)-;.);>1D<=QW']:T++ MQ"#A+U-I_P">B#C\14$L>ZJCP"G<1UZ.LB!T8,IY!!R#2UR-I=3Z?)F(YC)R MT9Z'_ ^]=+9WL5]%OC.".&0]5IB+-%%% !1110 4444 )_$?I2T44 %%%% $ M-W=165K)<3$A$&3CJ?05Y_J&HSZI=&64X4<(@Z*/\]ZT/$>K?;KG[)"0;>%N M2/XFZ9^@YK(1:3&AR)4ZI34%3J*0P$8/:I%B'I2J*E6@!%B]JF6.E4U(*0 J M<5*%I%(J04 *HJ04T4\4 .%2+TI@-/5R* '4@ZFG;\]A0'&3P* 4[FCS,=A M09#0 N":,4WS,]Z0O[T .I#32]-+T .-1,107-1LQH 8YS4+#-3$9II%,"LR M TR-Y;6830MAQ^1'H:LE:C9* .ALKV.]@\Q.&'#(>JFK-FQTJ613B1OD3ZG_ 9 M/X5HURGC"XS);6P)X!D8=O0?R- ',H*L(*B05804ADJ+4RK3%%3**0QRBG@4 M**D I %/% %. H <*>*:!3L4 .!IP--%.% #@QIVXTRE% #PQH#')IM+@YS M0 _=1N-,Q3J %R:,TE% !FD)I<48H :*-M28I,4 1%:8RU.13 M"*8%5TK3T2YRCVK=4^9/IW_7^=466F6TOV:^BDS@;L-GT/!IH1U%%%%,0444 M4 (#DD>AQ2TU1@M[G^E.H *X7Q-*TFN2*>D:JH^F,_S)KNJ\\UF3S=:NV])" MOY* % IP%(* M<* % I0**<* $ IV* *I%2U1TAB^E0$^A'Y$BKU42%%%% !1110 5YQJ7_(7O/^N[_P#H1KT> MO-M1;.L7H])W'ZT#0Q:G2H4J9:0RPAJ=:K+4ZFD!.M2K4*FI%-("44X4P4\4 M /%.%-%.% #Q3@*:*>M #@M2!::#3MU,!0HI=HI-U+NXH =M%&T4@:G;J $V MT;:7-&: &[:,4M(: $(I*6FYH *;2DTA- "&F&G&F,: (WJI.>#5E^E59_NF M@#H-(0QZ5;@]UW?F<_UJ[573'$FDV;CHT"'_ ,=%6JHD**** "BD!R/QI: " MO)=:U&&S\>:A8RL%6=E=&/3<5&1^->M5\]_%7CQC>>H"'_QT4TKC1W*5,M>9 M:!X^:TV6NK!I(QPMPO+*/]H=_KU^M>BV-]:ZA L]I/'-$>C(V?P^M*46MQEU M:F6H5J9:D"9:D4U&M2+0!(#4@-1"I!0 \4\&F"G"@"0&G TP4X4 2 T[=48I M10 _-+FF4HH ?FES3:* '[J7-,HH =NHS3:* %I#124 &:::6D- #3333C4; MLJ*68@ #))[4 ,:N:\4:Y%I=H(5<&ZN/DC0'D#NWX5B>*/BCIFFA[;272_O. MF]3F)/JP^]]!^8K@]&DOO$&NBYNY7FD)W2.W8>@]/852B]QI'TII2[-(LDQC M;!&/_'15NHX$\NWC3^ZH'Z5)00%%%% "*,#\32T@Z?C2T %?/GQ6'_%8WOT3 M_P!!%?0=?/WQ5Y\7WWL$_P#0151W&CS.;K26FI7NEW GL;F6"0$9*-P<=B.A M'L:6?K5-^AKI2NC1'?Z1\5KRW*QZK:)<)P#+#\C@=R1T)^FVNXTKX@^'-251 M_:"6TA&XI=?N\?\ C\I/T)KP(TTFH=&+V#E1]4Q2I*BNCJRL,@J<@BK"U\K MV>HWNG.SV-Y<6S/PS0RE"WUP>:Z>Q^)WBBR(W7D=TBKM"3PJ1^)7#'\36;H2 MZ!R,^A!4@KQJR^--U'$BWVC12R9^:2&8H,>RD-_.NAM/C'X=FE2.>"_MP>LC MQ*5'_?+$_I4.G)=">5GHXIPKD[7XD>$KJ7RX]9B!]98WC'YLH%:T'BGP_<.$ MAUS39'_NI=(3^6:AIH5F;(IPJ-'5D#*A'0T\,/6@!XI::#3@10 HI:3-* M"* %I:;GWI3:C\=+&%T%AHMS.IZF>98B/P4/FN5U'XV>)+I94M(+*S5C\CK&7D0?5C MM/\ WS5>SEV'R,^@B16)K'BW0=!WKJ6JVT$B %HMVZ3!Z'8N6_2OFO4O&?B/ M5RXO=9O)%D7:\:R;(V'NBX7]*QX()[J98;>&265ONI&I8GZ 52I/J/D[GM6N M?&ZSB#Q:)I\EP_($UR=B9[$*.6'U*FO--=\::]XD8C4+Y_()XMXODC'.>@ZX M]3DU:TOX>:YJ&UYHELHC@[IC\V/]TSC^*8?*#[+T M_/-.T8B]U' Z!X7U#67618S#:]YG'!_W?6O4-.TZVT>U$-NG ^\QZL?>M-D6 M- H XJ$#>X'8FDW<5[GK]%%%00%%%% !THHHH *\ ^*@_P"*PU#_ '(__05K MW^O OB@N?&6HC_IFG_H JH[C1Y=-U-56JU-U-56KIB:H@;BFYR< 4YQ4^EB8 MZM9"V95G,Z"(L. ^X8S[9Q57&5C1BO1]9U_PV-1ELM5TH7K8..#4>T[H.;N<]-X M.U%0QCDMY,'A Q#'\QC]:H7'AS6+<*7L)&W=!$1(?_'2:]+GMIK7;)(TVO6#7=M%.WK+&&_G3Y^X^<\/\ 8@5#^8 -,3P=X?8[FTX'V\Z0#]&HYHOH/G1Y^/%? MB/\ ZO_ V7_XJGKXO\2(.->U/\;MS_6O0V\&>'G'&F!/]V>4_S8U#_P * M]T20@C[2OL)/\11S0ZH?/$X=?&WB=>FNW_XSL:&\:^)G/.O:A^$[#^M=N/AI MHSG_ %]Z/HZ__$U,GPQT0'F>];ZR+_\ $TN:GV#G@>??\)9XC)S_ ,)!JOX7 ML@_K0?%7B$\-KVJ,/]J\D/\ 6O34^'GAVWB+26TLV!G]Y,P_]!(KE]%TC1]7 MNKLC2H5M5F*0%9I@Q4'J.7N9GG<]6E8L3^)J,M@ M8%>Q6WAG0[>[=(M+@*J!_K5\S)_X%FK$^E:9$?-BTVQBD4@J\=NB$8]P*2JQ MZ(MRMT/%8D>:0)$K.YZ*HR?RK5A\-:[<2)&FDWH+\@O"R+_WTP _6O3'OY'O M[:*1V<%]H#'.#77!?E%$JKCT$YM'BL7PX\174FR2""V _BFF!'_CFZM:R^$L MI"-?:HJG/S1P19X]F)'_ *#7J1% '%8NI)F;DV6F0'\Q3&>K4445)( M4444 Z44#H** "O!OB7\WC>^&.-B#_QQ:]YKPCXE<>-[[_0/FSTXXYJ ^!-,:1[:+Q J7ENOF3A ME!"J.^,C;V[FJ.K>!=>BMVNVN8;V*-201,2P3&<_,,?D37/=/1/0B_2YUL,@ M_L;Q$N0?)MO/1& (1P'(8>^4!_X"*BS@D9SBJS,P$J*[HLH"R!6P' .<$=#Z M$]<<9QQ3U?'.?TIJ-B!E[=K9QQREP!YJJ?IW_3^5::," ]6$JM&<]ZL1US,V,_Q/?G3_#UY<+)L M=8FV'T;&%_\ 'B*YWP?9"VTVV0CG&Y@?7_\ 74_Q!F8Z5;V:D'[1<)&R]]O+ M']56K6F@0V$C*,%8CCVXK6.E-ON)*\TB[9@.)9AT=RPS^51WC?NV]QC.:G@7 MR[9!G/'7UJOV#7JT;K(BLIR&&01WIU>@IBGD\4G6G4F*R,V'>FN^*$_$L?\5K?'_9C_\ 0%JH[C1Y;J(VW3^_ M-9[&M755Q.#ZK62W>NF.QHB,U)97+6=];W2C+0RK(!ZE2#_2HR:[31]&T#4/ M#$5Q/'.]TC%;A[4EGC&XX)3GC&.@/\ZT^VFXM-AWK'<=% Z9;!QCMTK) MV>B?WDZ="\9/,^<@KN^;#=1FJM_J*6<)(8>9C@'M[FK4QQ*3TR:SI]/2XN8I M,G"MEPWY,F\,G NSC(&S_ -FJ.+5=6O+AA:LWT6PGLQ/O:,EPN- MI)Z9Z\>],TK3[ZP-TXC0RF(^7D@@MV!]JTE4I\TYZ/:QSQI5>2G3U6][%>2R MUK5)8TGC9MG 9@JA<]>G7I7=64(M[2* $D1H%R>I '_UJS;-KDRSB=8UC5ML M1 P6&3SU/;:,<<@]B -.$\>O-<=:NZB4;62.VCAXTFY7;;[EV)L]ZMQ^]4H3 MGIWJVC "N9FQQ'B^43^)M-MQG=%&\I Z$$A1_P"@M6S$/^)7(H')9%_ MS^E M@Q5 M2X'R9YY_*K;8.>G'I56X&%+8[=,UG%FL=6>?^*XV8,P.=I&/;_)KT?PK?#4? M#MG/N!8(%8>A%<5X@LWFMV; &!NRQ R/;U_"K?PZU**W:XTIIC(^XM&%&%/& M>,X.>O;M6E17AB$4APHW,0![T?.>/E0>O4U%(J(-Q.3ZLV/\ &FVR>8Y<]*L.:!/L0/@<#BJLAJ>0 MU5D-- B%^N:O:&"=;L@/^>RG\CFL]C6OX93?X@M!Z,3^2DTV4>F4445! 444 M4 %%%% !7A7Q,'_%97OTC_\ 0%KW6O"?B6?^*TOA_LQ_^BUJH[C6YYMJP^16 M^HK$:M[5ES:@CLU8#'BNB&QJAAJ6TO+FPN5N+6=X9EZ,I_3W'M0+:5XQ(B%E M]J[CPSK>GQZ!!IXN;2TOXV;+7D)*,"6/4,,=1U/;I3E*RVN-NQC-J6C>(5QJ M\?\ 9]^?^7VW3*.>>73U]Q^8%5KS3==T"U+P74ITZ3I<64Y,+]N=I]\<_K78 MWNH^+[*/>FE:==PD A[5'<'_ (#NS^E<[>?$'69;6XL);.QA5T:-U$3AER,' MJW!Y]*S3;V6A*N;$F6PQZXK/D@D\_P R*0J68%AG Q5\ME!SU J/;QQ6L96V M(E%25F5X_MHX692!W;_/]:OK(P;@'&>_:J^"HS4L39/-353GL[>@1AR[,O6M MS)YA C/3D\U;^TG;]QAD9 ((].,?C52V8"4#UJ^P*D8[]/>L/9S7VOR*:'1W ML>U=RL )D?-M.>!GMGVS_.N MZD@#$G'%AZ?;W*7-K'/&?D=0PS565C-+L7\:Y7PG MK+?8S8S'#K]T'^]W'X]?SKK[.([3*W4]*Y9P<)69C%Z*\&^)G_ "/-\/\ 8C_] 6JCN-' Z@-]K(/;-AXKEY 58J>H.* MWB:(V-,_X]1]35B6"*88DC5OF36XFB:F]G#=I;":*6,2 PMD MJ",\@X.?89I-V8[E'3;;4;>[CBT6[N(978D1*XV,0"?NM\IX'>M$>([Z\MA# MJ>E6.J*4(C<@(ZY'WN01GZ8J+3[Q=,UBVGGBEW1%BT.-LF"K#[K8]>]5[/*+ M'NZA0.:6["R;-4Q2* 2C<@>'K(+L$ERP&=W/7WSC^56#KY>+-G;*H/7 Z>]9:Z!$5^67\2N:U['36$ M)3S0V1W7%)\HRJ]Y?7 RSA0>W^>*EAC+C]Y([;NV<#]*G_LN8'[T9QZD_P"% M2Q:=,#C(M/FN-#O(D= 7BQ\Q..M1=%E(@4X[<#UKT6RC_T _[P-TM&2SV,PR>]:5Y)Z(F*U*[# J"1 <],UI?9>0-_Z4?8T/ M))-8JR-5)(Q_+XK/OK8;"V.E=7]DA'.WGWJ":.,8Q&N?I5QG8F3YG8\W9)[6 M[$UO')G<"S*I.WGK7IFF79OM/CE,?E/C#QY^Z?3Z>GMBLVX@#1E2.H[U3L;U M]/N-CY*]"!W7U^HS5U/?C?J1UT.E:,'J:9M5.@J5661 ZD%2,@CO36Q7.!$Y MXJ.G2''-1@^M #6K3\*(/^$@B_V5<_IC^M9C5M>$4!UQF[B%OYB@9W=%%%2( M***@\^@">BBB@ KP7XF?\CY>_P"Y'_Z M>]5X)\3!_Q7EX1V2/\ ]%K3CN-' M#R^GQO.TCDD$YV]*OOUYK+U*]DAVK%@9_BK9.QIL7$5(DPH"J/2I;>_G MLGW6D\L)SD^6V 3ZD=#^(K*L#)+"269CDY)-7?)&QB[$#!R1VJK*VHKMFY%X MON98_LVH6MGJ,?=)%"L3[\$?^.U,\GAJ]B=S;7NG3XSNB!=2<= HW #_ ("* MUI-1A76)M$;3;66RBC(AA*9W,$WXP>/7M[U0B'A_4+*YG2&[L9H8_,=86W_+ MD#*@Y&T9&>!@>U97716$26EFABC9CNRH.*THXT4850,U2M6/V>+/78N?RJZK M<"M&V%AKJ!P*1>,\U)(,CCK4/0^]- 6HFX/?C!JW;2B*4 \ GM6T4]QP:4'!YY-9^1)9B;O4&J\V$@[$8I M\;<>WI4=]EK)QV(/\C0MQ$.F9" GT[FMV(_(H-86G'A0?;I6RA*["#QFBKH. M*NRQCM2@''/!IV.:7%9B(WP%)JE@R29["K%PW&VF(FQ/>J0]D5[A&'0UN253FCR*TB["15TK4?LY\J;B(GN?N'_ UOY!Z5S4MMM8NHYQ@CUJ MUIU^8 (I6S#_ L?X?8^U*<;ZH;1JR=:CZU(YW#(/%,'6H)(FSFM[P>#_;DA M["W;_P!"6L)AS70>#P?[7F]/LY_]"6DP.VHHHJ0"JWD&K-1YH DHHHH *\)^ M)@"^,;]O]F/_ -%K7NU>!_%>0IXPN@._EY_[]K3CN-' RODX%9NIPDPK(>QQ MBM0+QDU7OT\RTD [#/Y5N6C(MKZ2U&T ,F>AKH)$$6C6>I321B*\9D$9ZK@D M?B./;J*Y4UT[1-JG@"$P@M+ID[>8HY.QN=WY_P C3D4RQ:ZA,NH)J*W'GS(R MMN8CG VX) [KQFNDTRY\-V$LE_#+=%C&RBR:/(7/\(&.?3[Q'OZ>5*[HV59E M/J#BNO\ UJNNZM<6=X\I46K,C+(RE6#* >",]>]3*-E<31T5F&ALX8W;+I& MJL?4@5<1SQS69:S^=;12XQO16Q]1FKL;U5@+H.:B=<#IUI8W!'O4I *DT"*V M<#UJ:-LJ?>HI% !YJ-),'D_ABKW&:NF7?DW8B;&UN*UI%*L3VKEI'*D.OW@< M@@UTUC6[B7^+)]JI('JP<=:A< U!+J"@_*A/U-4I;V= M^A"_05HHL:BR\ZJ%)8@ =S63K+]/;VKI[2XCNH%EB8,K=Q7(R6@#96M?1E,4#>62OS\CM4SB MMT*45T-Q^M;_ (/!_M.X/80X_45S8EW'##!KJ_!H!GO#Z*@_//\ A6+(.MHH MHJ1!2;12T4 %%%% !7S[\6SM\9W)_P"N?_H"U]!5\]?%[CQE<^XC_P#1:U4= MQHY ]*AD4,A!Z$5)G,:GVIA-:FB.8==KE3U!(-:&B:W<:%??:(0'C8;98F^[ M(OI]?>JU^FR\D]SD5;;PSJZV,5XEG)+;RH'5HOFX/J!R*MVMJ,Z/^SO!VOYG MM[\Z7.W+0R$*@/MGC\C^%:,%UH'@C2[F33[Z.^U*=-JLK*^#VZ?=&>>>M>:L M"K$,"".H-)4\C>E] Y?,]#LY +:$#@!% _*KJ/TYK%M)?]'B /\ /Y5HQ2^ M]:6$:D;\U;0Y%943]JOPR+;RQU)$GD5H)"% M;(''O7,-E6Q36Y6J<4U81Z_J%[G5BC.*M=FY;W+9=6,S@[5]?;I_GZ5 M&TC"3:I(W D_05:V^4 V &;EOK_^JL(JSL7/17[CW8D55D)QS4K/D5$Y]:T, MXH@P:8RU*1CDTUN.:99'CJ*;MP,8J8#ZTH7/K1<=R#8#6C91;8>G4YJJL18@ M+R36I$FQ%7T%1-D28FW%=9X)'S7Y_P"N?_LUOB__P CE<_2/_T!:^A:^>OC!_R.-S](_P#T M!:J.XT<6AW0K]*0TV Y@%.-:FB,C5TQ(C^H(IVF>(=6TLJEG>2*F>(V^9?R/ M3\*GU2/?9EO[I!K#!(.0<5:2:U':YZ9K_B'2;6ZCT_6]*COKE8QY\T2!=I(S M\N3GH?45EOHW@_5+*6]L;^YL0A >-U+B//3(Y./?.*4P6'CFW@E%W'::W&@C MD23[LV.A'_UNGITK4\->#;C0+VYO-7N+3[&;=XY%5B593UW9 XXK+1+?4G9' M,6S264L"7 P&56&>000#6E9BYDE\I&MIXT;#RK<@%1[A@I)QZ#\*NS6Z7&BV M3"":62-(S&T<1D*_+GY@HZ<<_6L.SNH#,(TNHEBS$AA:,B5MC$JH[')."W!] MNU:,CS0,2+W!KRJM30M8ET:_6523"QQ(GJ*)PNKK"M8.-M2G:2LNA8#YI'.3 M3A!*TGRHV#R#4R6,C$;B /UJKHRV*V.])M]JTUL$ ^9B?I4J6\2?=05/,@NC M+2"1^BD^]6([(X^<@?2M# I*ER)N0K"D:\#GUIRKFGD9H45+8AC\5U7@I + M>\<=V4'\ ?\ &N0NYEAB9V./ZUU_@0E](N)#U:<_^@BD]@.IHHHJ1"-]QOI2 MT$9&** "BBB@ KYZ^+__ ".-U](__0%KZ%KYZ^+X_P"*QN?=8S_XX*J.XT<) M:G]VP]ZFQ5:S;YG%6C6IHB*:/S8'0_Q*17-*I+A>Y.*ZG&:YR[3RKR11QSD5 M41H[A="\+0:K#H,WVV2_8*&G1@%5B,_YX-3(XCC>3J% M)'?C.*ZK0FL?$.LZ?J9NEM]5@*BXA?I/@8#*?7';_P#75W1_#%WI?BN\US4) M(H+.)YI%8N#N#9Y]A@U%[;BN+ICG^SK/_KDG7Z"J(@N)$M; WSV\4.3!!<1% M)"!_"K9VL,<;@,X)J:QN5,%OP%0HI7(X (XING0AKU#&E@GERAI$EN#.T8'= M!LR&'/5C^%-C:,".62WF:&=2DBG!!]:U(+C..:T=5TR/4DSD)<+]R3U]C7,A MIK.9Q*23QVKUC1=FCV5C972_/ MY>]]W\+-SS^%8UE;5%4YV1+86$TL8,F8U]^I_"MFWMH;=AL3YNN3RM5)M1CSY<)#.>]0F&<@R/N&>YZT[=P*UY,]U<)&!C'./2O2/ M!$8CT20#_GN<_P#?*UP%O %);N>37HGA!=NCR?\ 78_R6E+L!T%%%%0(**** M "BBB@ KY[^+QSXRNO9(_P#T 5]"5\^_%_'_ F5Q_USCS_WR*<=QH\YM#BX M(]15XUFP-MNU]^*T^U;%H08K'U:/%Q&X_BP.M0:K8S_V2EZ8CY!DVH^0< MD9!&.HZ'\J:>I1TOB?PY9:G.8M-"1:M# LS0@!1.A]/]KBN5T33;[Q%J7]DS MWT\6Q&8+*68*1VVD\4S6/$=U?:S;ZC'&UI<01J@VMGD$\]/?I7<^$M1TO7M7 M34F MM8CB*31KPLXX^8>_%3K&.HM4M3*@DCM]+M&ER0(T "J6)) Y--M; M4&. 0BQ6*&4#S_+9)U"GYE8;>6(R#DX.<_3N /X:$[E)W+P=3[BJE_8Q7\.V7 MAE'R2 &XL+62*9< X(8=&&>U8 M4W/4>AKSJ>U> EE.Y/7T^M'.XLQE!QU6Q=.YY-5I8=K9 MR*P]4WOH+9MLDJ@CL.:QMU8P MU&:49MX,+CEY.!^54+R\0QE[JZ,@'2.,X!_*CD;$E=FA?:W;P@@/N/HO-<_< M:S/M9&H:JD3':@+]E["L*74+B5LM+CV'%:J"1O&EW/8]"TN&*T2[ MF"EW4,,]!6KD8_RK@DZYKT+PR,:% ?4L?_ !XTF2S7 MHHHJ1!137Z?B/YTZ@ HHHH *^?/B^,>,KGWCC/\ XZ*^@Z^??C ?^*QG]HH_ M_013CN-'F(.VX4_[5:_UK%EX;-;"-NC5O45L6APHD#26[0EW\LY.S<=N<8SC MIFD'6G$'8VWKCB@HG3QI9W:B#7M%@N=HVF6,8<#VSW^A%2II_@G5#NLM3N-, MG/W4F.%7\3_\56CK6K>&]'N(+!]"ANH7A60S!5R0>X.,D^^:S19>!M6&;>^N M-,F(X27E0?/D=_E%8:ZNVHW-O9R68?S)-B M7YS#'(N1RNX9+?[(STX-;&BLD>@Z>-X_U" 'U^45CP7>LPW+V]Q:W=XSM 0T MMN&A#B0[V5@,!=N",G(-22B6^L9;(GS!F//#CI_]:L]HL'17)$!JZ77+@KITTMT8S2>L42PSC'6MC2W$M]!&3PS@'Z9K MG9(6B/4&M3PY&)]=M(VR=SX_0UO"O):,YY(]?N+N&WM;>%G4';YA&?7I^E4O MM\3CY0\G;A369=WOG7::F$ MD"?:6'R[CU^IK-NI!:V\DS=$4GZUQ?VJ2:X:9V)=CDT^3F+1UVHW-Y')B5VV M'H%X%8-WJ!P6!R!PHJ_I)U'5%>VM[=KG:O(R!M!]S5FQ\&/JFH7-O+=+;"V( M$@V[B2>>.?2I2:C$,S0F80R>4#@R;3MS]:])N?#/A MK2+^TT]G:XOYIH\)*2/?*DA5-W0# KL]2A?S!(6RO0#TKRSP]XDOK*" MWL+8*L?F$L>I;->LWC[K",MU.#^E8U+J5V8U4^:[,U*]#\.?\@&V_P"!?^A& MO/4ZUZ'X<_Y -M_P+_T(UFS-FI1112$!YHH-% !1110 5\__ !BQ_P )A)_U MQ3^5?0%?/_QD&/%[^\*']*<=QH\JF^\:U;5MUJA]L5E3=:T-.?-KCT.*WZ%H MMBG$$J0#R1@4BTXG"EL9P,T%&M<+X6U.PM[:^^T:?)$-L#CI46E>(Y8M)L MX(X'NZIH? M]F3K=;)8\2ZC<6+W!_LQ)F4_P,,D?3%>GS:=H$%I(5LI+Y@.5 +Y_ M$\?K4-N;X +IVDVE@G]^0 MC_=7'\S5)*Q4926S/*9H+Y2/,M9(MPRI=2N?S MJ,QS M8]]SSI+>)B [GON.*Z#PK8;=<2?(4Q1NR\=]I _G4E[H%Y:OB2#>!_%'S_] M>K6@1O%*F#GS'*X/;"G_ !JK*P>"2(G//O3HY67 K2=,U;CN!ZU0$17W%2*,&K4@5T-U^YQI)7/WG _K_2N73!/O6OX MB9AIT>?^>H_D:Y^*4C%:1E9%W/3_ 2O]G>'[F_9&+33JB[1DD @?S)JMXGM MY+7Q[I"P8)FO_$J:M9H86B4!-^">,\X_&NE^')^U:I? MZK>S!IF 7PF**/!P>I-=]J4H++ M$IX6G7VM6ULA2-PTAZ =JR1=^;\S#D]ZR;E)W9E*3D[LL*:]&T)-FB6@]4S^ M9)KS-IXXXFD<[449.:].T-Q)H.GR#H]NC?FH-0R&7Z***0@HHHH **** "O! M_C-;O_PD7VC'R>4BG\J]XKS7Q[IT6IZG/;2CAX5P?0^M-:#1\YS'FK>E-S(G MXU)KFDW.CWS6]PA'=6[,/452L9U@N,N<*1C-;K5%HVQFG\,",Y[&HT99!N4@ M@UJ6%UI\4!@O].$REBPFC.)![=LC\:38R^UG_P )#$MQ:R1_;UC"W$#G'F8& M R_A_D56\(>%M;TGQ']JN8?L]DJN)2TBD.I!P, GO@_A5E-(T^\8-I6KJLHY M6*Y^1P?8\'\@:S]>TCQCY1B#W=Q:E<.L4V\-^'WB/J*F_0/(ZC3[RPAT^%8< M,H7""-C0VDEVEO;PZ+/)%-N0Y:*=?FS[[L?7M6EIDD=AH.F-)$? MWJQ1'MM+8&3^)I9M*GMHK:W>^M4TR*X1XV>$^;&=XPJL#CD\9QW[TM$27]3M M+Z: B29Q&2 ZP* P'J,\YJ72=,A2U0R1,7YYE.YCSU.>_>K>L\Z1<\KCRVR& M!P1COCFH-%);28)!D\?,2K#)SU&><'K0F!H31K';N5 ''2N=2PO1?O7_!/E M^M.75;DC3PT>#<)&93Y;$;F7H,<#GU]OP5^\-W"!LX].<9^M M4-+4A,FHO#YKV]N\Q)79N=?+8(QY)PI&[:-PRO)],U2@M[R_O'GABB=X$D"$ M+P[;%8#[W4L67KQBM$2E0&!(;.01VJWH\LDMYYDCEMS-@DYXQ3=R[:7'Q:1- MYEV)F< 3'RB<$%,#&,<^O6H9=$F)W1X?'9371L:KNO.0<'U%0),YE[*:(X:- MA_O#%1-$1R5KJUN)4&&PX]#2,UE,?WMNH/J!3NP<3SWQ&N+&(_\ 33^AKGH\ M=Q7IVN:7I=U:1JTFSY^,-['UK /A.V;F*[./< U<9$9HN/\ :JU(:NNASPL23S&< M_2M*QLY8S\I* ]E.,UH#39(?O3Q>E:B$0QF M21PJ*,DL>E8E]XBL=*0^)+[6I/+),<&?EB3O]?6LF[DN MQT]_KKZSJ,=C99,)<+D?QG_"OHK1HC!H>GPGK';1K^2@5XU\/_!DEA&NJZC' MMF8?NHF'*CU/O7MEF,65N/\ IFO\JQD[O0SD34445)(AZCZTM(>HI: "BBB@ M K@?%0QXA8^L2?UKOJX+Q7_R,!_ZXK_6@:.=U31;/6[,V]W$&!^ZPZJ?4&O) MO$?@G4M$9I8T:YM.OF(.5'^T.U>U)4X4,,$9![&G&;B4F?,\4\L#YC<@BM*W MUHCB://^TM>O:Y\.M'UG=+$AL[D_QQ#@GW7I_*O.M8^&VO:86>&$7L(_B@^] M_P!\]?RS6RG&6Y2L0P7EK<+M613G^$]:MRZGJ6F6C2Z?>2Q%.=@;:=;Q6\EK#-#$ MH5<$JV![\C]*Z"V^(FG2*%N;6XB/?;A@/Y?RK-P:(LSKK\RW-C)%;F/>PQ^\ MSM/Y$$?6I-*B-M81QONW>>>,UST7BS1)"/+U!1GM(I7'XD5JVNL6 M5P,0WD$A/99 3_.IY6%B_?PDVLABZXZ>M3GGG///6KL4DRP)7>*%U5<2D8RX^5<9#'\.W6I[&^ M%GB1H\HBN<[NI"EL>PZ\^Q]LYQF1%/EQ*I.3U)Y(QD#.!]!Q[5IZ3Y;WJ"2% M6+H48\\C'IT[=>M#+DGRG0R79B,:L@+.@;Y22.64<9 _O5GS:L\<<9>$++YV MR6,Y^1I],'K6HZPRNCR1QNZ?=+*"5^GY#\A2".% 0D,* _W$"YSU MZ#V'Y5F8BE0:8R9.:<\B(-SLJCU)Q5&;7M'@!\S4[0$=0)03^0IC3*7B"$-: M1\?Q_P!#7.B%@>,_@:O:UXPT62!4AG>9@V2$C(_GBN8G\6H"1!:$^AD;'Z"M M(QT-8RT-]%D_O/\ ]]4]P(UWS2!%'5G; KC9_$FI3#"R+$#VC7^IYK*FGFN' MW32O(WJS9I\HFSM+KQ)IUH"$9IW](QQ^=8-[XHO[K*Q,+>,]DZ_G2:-X1UW7 MF']GZ;-(A_Y:L-J#_@1XKT[P]\%88BLVO7GFGK]GM\A?Q8\G\,?6HE*,3-ON M>4:5H^I:]>BWL+:2XF8\D=![D]J]K\'?#*UT+9>ZF4NKXU6VT^UBMXA_"BXS]?4U9:L95&R'+L5I.%XKIX!MMXAZ(!^E@J$0Q:***8A#U'UI:** "BBB@ KA/%HQX@7W@4_JU=W7'>,[7;=6EX < M,IA8]@1R/SRWY4 C"3I5E*K1]JLI2*)DJ91FHD%3+2&4[_0],U9-E_8P7 Q@ M%T!(^AZBN0U+X0Z'=;FLIKBR<] &WH/P//ZUZ M2"FI-;!=GB-_\'-:@+&RN M[6Z0= V8V/XB3+C_ ,>4T_;1ZH.:)XFNO:JN,7TQ^K9_G22:YJ,N M"]R21WVK_A7LS?!/02/DO]27ZNA_]DJ!O@AIA^[JUV/JBFJ]K I2B>/G6=0( MP;@X_P!U?\*E3Q#JT3ATO75AT(4WF1C_V2M"V^$7A. 8DM;BX]Y)V'_H.*7M8"YH'SP69VRQ+'U)HQ M7TY:_#OPG9G,6B6S?]==TG_H1-;-GHNEZ>G6EN?6&%4_D*7MUT0>T70^7 M+/P]K.H@&STJ\G4_Q1P,1^>,5TNG_"7Q7?,/-M8;-#SNN)A_);.?RKM=(^'?AC1MK0:9%+*!_K;C]XWU MYX!^@%=525FYR>[(NIZ;+;' Q-7J* /,(]RLR.I61&*NI[$<$5:2N@\2:)).YU&S3=*!B:(#F0#N/4CT[C MZ8/.0NKJ"I!!I,I,M+4RU"IJ9>E("5:D%,6I%H >*D%,%/% #A3Q313A0 H% M.%(*=2 44HI!3J %I:2EH 6BBEH **** "BEHH 2DI:* &TAI332:8##435* MQJ)4>>411C+-^@]: +FDP;I7G(X7Y5^O?_/O6O4<,2P0K$GW5'YU)5$A1110 M F>0*6FD?.#['^E.H **** "BBB@ KG-9\.F69KS3PJRMDR0] Y]1Z']#[/X=OQHL! -\T@BB4LY_3W-;%E M9K:1GG=(WWF_H*DM[:*UCV1+CU)ZGZU-5"N%%%% @HHHH **** "BBB@ HHH MH **** "BBB@"C>:197K,\D(64_\M4^5NF.3W_'-94WAVXC.;:X21<_=E&T@ M?4<$_@*Z.B@#CI+>[MO]?;2H,9) W*!]1D"B.96&001[&NQJ&:TMKAMTT$;M MC&YE&0/K18=SFEDJ57K5?1+-@ GF1X[J^?YYJ%M$^;]W$W_?LTK 39HW5"!.3C M[/-_W[-/^SWA&1 WY@?UIV ?N%)O%"V-Z_6-4_WW_P ,T]-*N67]Y/&A_P!D M%O\ "BPKD9D%1M,!U-7DTB($&2:5\=5R #_7]:M165M"04A7(.0QY(_$\T6" MYCIYT_\ J8G<>N,#\SQ5J/2Y7YGE"C^ZG)_,UJT4PN0PVL-O_JXP#_>ZG\ZF MHHH$%%%% !1110 4444 %%&><44 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 )_$3[4M)_$?I2T %%%% !S2'=V('U%%% -WK!AD4M%% !1110 4444 % C%%% !1110 4444 %%%% !1110 4444 %%%% !WS1110!_]D! end GRAPHIC 7 image_004.jpg begin 644 image_004.jpg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end GRAPHIC 8 image_005.jpg begin 644 image_005.jpg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image_006.jpg begin 644 image_006.jpg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end GRAPHIC 10 image_007.jpg begin 644 image_007.jpg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end GRAPHIC 11 image_008.jpg begin 644 image_008.jpg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

*=,E"[I9(F8XP\9X^I&16G;ZA9W+E(;N&1@,E M4D!('TKS)&YZ\=:.7#<3P MJ.TS(IS]21FM%B8]49O#RZ,]3#4X-7GD?C+50!F* MU<#KD$$_K5M/'C[@&TWCN1/S^6VK5>#ZDNC-=#NMU.#<5Q__ GFGKC=;76? M]E5_J:N1>,]'= SS/$?[K1G(_+(JO:0?4ATYKH=,#2@U@V_BO1KC[MZJGN'5 ME_F*N+K6FMC&H6O/K,O^-/FCW%ROL:F:D52W>L^+4+24XCNH7Q_=D!JVDA_A M(/XU0BUY:@?>I-B_WJB+/WQ^8I,M_DT 3;5'\5 "Y^]4//?^= .>X_.@"P%3 M^_1B,?QG\J@Y]1^8I?\ @2_]]"@";]WGJ:6Z?[T@%1IJ^FN/DU&V;_=E!I70[,U"JCM0=H]* MQ9O$&E0G#7F3Z+&S?R%0R^)]+B3U)YF*Y MW_A*K0KE;>?/^UM']:J_\):YD(6Q7;V)EY_+']:AUJ:ZEJC4?0ZSSAZ4F\GH M*XQ_%.HF8JJVZH1P!&[;!/0*HQ^0S4/$P12PTSMRS=SBJ MUSJ%I:X^T7<,6>!O<#/YUY]+[(M M85]6>@W'BG28-P-P7([(I.?H>E8USX]B5,V]A*QS@B5@N/RS7(.QD_F: MN8 %:1PZZLB5?^5'"V'@)LAKZX'^Y$/ZUTUEH.GZM49I1#S)6B()8VW,['IG%!(.<57CDRB MQ(O%" ]0HHHH **** "BBB@ HHHH M**** "N;\?#/@G4OHA_\B+725S_C="_@W4@.T8;\F!_I0QK<\!^O6C;DT'K2 MC@UY]3<]& Y1],T-^1I1]:1NE<[-D1G_ #WJ0+F \=#FF=^.?:IH &B88[^E M5!7=B9NR*K#YJD4<=J8P ;! IX^[631:8IY.,4T#WI2/:C QD4K#N*"!Z4T\ MYS3QQP2?I2%?\^M $8.&R#@U,L\F.&XZQC.JHRM:YRSR$G)QFEMW,\\<07EV"C)] M3732:/HDT_D)*X2X=W6:/:IQ_>&:IT9K6Y* MJPEH0'0;V)20J..VUO\ &H#I5]&"6M7Q[8/\J[-33P>U:^RB<_MI' 36LZ#+ M6\BC_:0BF,/E 8<]_6O1..^*AA>WNO,50K;&*,".A'^?UH]CV'[?NCS^)0O4 M8J:( 2@9.#P:[LZ?929+6L#'OE 32?V18'G[+&#ZJ,5/L7W&JZ['$SPJDIP0 M<'%/1-R8/IP,UV#Z'ITF2T)YY/SG_&A?#]@J@+&R@#'WSFE[*17MX'&&)0Y! M1<^OK5C+0\1DJ?\ 9-=2?#ED?XI1]&'^%*?#MHW DF'&,AA_A1[*8>V@ $?:9>^?WAKICX5M&/^NGQ]5_PI3X5M& S/.#ZY7_ I^ MSF+VM/\ I')"[O, ?:9?IO/2E:>24?O"S >I)KJQX4LP3B:?'U'^%.'A2QSN M,DY^I'^%'LYA[6".5MXD)'"@=1@58[X!X]CQ74IX;L5P,.V.Y;_"I!X>TX?\ MLS_WV>:GV4BO;P.85@L9 ZD=?6G0YW;N <\XKJ!X?T[;M\@XQT\QO\:L1Z59 M1\+ OZT_82[B^L1['* !GY[?K4NP%N@X[UU:V%HK;A;1 ^NP5.(HEZ(H^@Q3 M6'\Q?65V.3,4DBC9&S'V!Q4D%E=/RMN__ EQ_.NJ [4X52PZZLEXE]$[((;2VMU"PPH@_V5 J? ]**2K1GN!I,T44P M"D/2@T&@!*0T$@4S=D\4 5IH9.L3X]B:S+B21GQ)]Y:UIYBB[5&7/05F30,' MW6 MB!-]W OK(H_6FF!Z91110(**** "BBB@ HHHH **** "LGQ0GF>%=5'I:R-^ M2D_TK6K,\1_\BQJW_7G-_P"@&@$?.G![XI5/K2-PQ I5KSZFYZ-/8>,8S36. M13@.],DR:YV;#!C\:M6O^K//?UJKGM5JU_U?'')JZ>Y$]B"< 2D^M(/2IKH8 M*M^E1#I45%9EQ=T!X-'8=Q0<>U"X-0,#UI3Q1TY%6+"&WGNREU,88]A(?('. M1Z\>M.,>9V!RY5=DFCWBV&II+)_JV!1B.< G.?TJYJD$%G>PZE!*KQR2"3"\ M\@Y/-2?\(VLH+VM\CIVRN?U!_I5:7PYJ$9)2..0?[#X_GBNCDJ*/+:YASP4L$AC'16C+*/H1_C2RZY>WDL,$VQ5\U2RJI&>1US5.4%>33N^@E&>D4U M9=3KEIP/O48Y%.S6ESE'2SI# \LKA$12S,>@ YKD/#>MQS>)M2B$F8KAR\1/ M?;Q^H&?PK6\131_V<8'F$*SG:[YQB/\ B_3CZD5YK=:@D6MRW&D,R*)"48C& MWUX_'IZ=:]3!4%4A)/=H\[%UG"<6NAZV=?:EX5N+?3VU1[Z.Y1@)"<%2VX]35GJT5]/,K;;-XR.GG.H!_[Y M+&G)<7['YH+4#MB=C_[)7FS>#]N@^*(DRL=RBC^[<+_1 MJ7U2B_AJ+^OF/ZU5ZTW_ %\CTH/?EA\EMM[_ #D_TK+<^(/^$E0(;<:7M!9B M"3D9R.W//TX'?BN6\*>)+R+5(K*]FDGAF;9F4DLC=N3S[5Z0#FN;$4I8>7+) M)W.G#U8UX\RN2 Y'/ZT%\<9I@;WILC[>?SKB6Y&",561BR]<_A M4J_,U0I7*<;$N[K3MWYFH#)\V#V[TNZCG#E)P<>GXTX'/M4 ;GO2[@>AJE,7 M*3@C/6EX)!J$-S3MU5S"Y2;(HR*B#4X-D<528K$@(-+FF9I<^].XK#LT<4T& MES3N(6BDHQ3 "<>E':@E1WS1O&.!3$&*7 YII>*4&N"IN>A#8>,XY]:8YX_K3ZC?KQ7.S9#?PJW;#]TO?OBJF> MI':KL(PBX["KIDS8LR[XSCMS5-3TS5]N1BJ)7#$'L:55=0IOH!I >:4C\Z;R M#TK(L>WW?QI 6UG2>%]KKD>O![5KQ^)[I?\ 6P1./]G(/]:VI\MM6TS*IS7T M2:(XO$]\N 1#(!URIR?UJ6?Q!]N1;E:7C+1X;/3[*2UB6.*']UM7L#R/ MUS^=;WA?1?[&TE8W ^TR_O)F_P!H]OH.E7-'(_4"NW MZVHUX\ND8Z?YG+]6+K^/4Y;6PD$,<+;2VP$L1UZ]O\ "LP^*/$&T$W4F"./ MW*<_^.U#* WBYPZY5KWD=B"_\J[S4/$]CI%^+:\BFC7Y?WVU2@W!R.^?X&'2 ML:M2EAX07LT[HUI0JXB-U@B?S6D8'YB.1@]SFO4 V M%QVZ54L;J.]L(+N(,(YXUD4,.0",C/YU*9,#ODUY6,QCKRNU:QZ6%PJHQLG> MY*7XXI&<'(SG%5VE/ID4A+,^<$?C7FRK':H#@Y4@ #'_ -:K23@ DD?G55% M!WD\=!BB%A+)AEV\UFIR37F-Q3)/.W$M^&,TX3#@XIWE1L"%(^4=J0Q@]N]- M\_<+Q S DC!'TIPEX^O6D\H#!I1&.N.?6J3F+W1PE Z9)IXD!J,)SGO3A&> M.:M.0FHDN\ TX28'%0$!2"[JOU--\Z/G8)'/J!@5HILAI%L/P*>I8]JHB>E-)I2:8:=PL(:C8TYJ83Q3N!&W6I=//_$WLO\ KO'_ .A"H6-3:=SJ M]E_UW3_T(5:)9Z31115""BBB@ HHHH **** "BBB@ J"^3S=/N8_[T3+^8-3 MTV0;HG7U!% 'S&W#&E!Q37!WGZ^M*N/2N"IN>A3V).QXJ)\9)[5+FHFR2![U MA;4VZ#1S^=:"#@=#5?8"RX'?FK"UK&-C)NY(.152X7$A//-6@0/K]:BN5^4, M1S2FKH<79E4_2FXP:=3><^]G- !SG% $MI]G-[%]JW>3@A MB,^G'2MO^Q=-NB?LU]ANPW!L?AUK"@ADN;E(85!D?IDX ^M:Y\,7>P?O(">X MY']*WI)M?#/*N8G'JP*_XUJ75G%:>'E@F;>8L%6[[L]JQ1 MI6KV@*Q+(%'_ #REX_+-4KE;\HOVD7.T$8,N[C\ZMR4$_<:$E*37O'9EQ'&7 M)P ,DUAVOB"VNX8A=VY#O)C;MR$Y7:2#S_$OXUM@!EP0"",8JI=Z3:WLD3R1 MC,;!AA1SC&,G&>PZ5K3E#:9R5%/[(D7B#3)&VK<@_P"U@A1SCDXP.:N)?6[I M&Z.'61MJD>H[?SK./AO3C-O,1";0OEAR%/N1W_&K4.E006D=M%F.%&SM4#G] M/UZT5>3E_=[DQ]I?WK%\%' QM.1G-*?+7+G ')S6:^E@E0)#MQC) )'88/8 M^]!TW D(EQN# ?+Z^O/.*Y75FNAIKV+K6%E)*)GMH3*#D.4&<^N:6:VM)VWS M6\4C<>Q7>&*ASR!NZ_F/RIHM;PD[?+&UG92 M'/RB[:AR]3QW+#CKCUH6.75 M Z#-$R2$_*JJ/?FD)+'YG8^P.*SQ31YLFW<"0,XS3^NKH@]BS0"(#D+S M3N,50$S =FG(%4JM@Y;EI7SUJ0-5%7YJPDGTKIIU+FKS7GVA;B*>86S %"A*@>Q_'UIUM:V\ M>H6\K( H<_0<'^M;%Q?-%.84@5@!R6;']*Z(1]QINQC.7OII7.;CUS48V&9] MZ@=&4'_Z]27&OW-S9/!-%%\W\29&.?3FMEGL9CF?3QD]6"J?UZU2OK'239R& MV5UE ^4?-R<^]2U-)VF-.',KQ-A.@],5(#BF(C #@XJ18W/0?G0DS%V%!X%* M*>D)[X%.*QIRS=*;BR>9$!;;3?GD.%&<4Y[VT0XRIQ33J:YQ$F<\#BL_9\W4 MKFMT+$5L_?@58$*@#N!C:A]VS_ "I(D:8C3CH/\::^WLV0>QZYQ4)E(QM+ GODCBO* MG6E?4[(TU;0?,GE.3L4./XLY_6I&:YGQ+(5&!A2._P"%57D8J, 8ZY[59AP\ M#NQP "<'O6<6YR<5U-&K*X*CX')..I_^M4TT2^2KD_,.",U1%ZJ_Q<9X J-K MLS/CG&> *E-),I4Y-ED.<@9X[@U*H8+R.,5%&H"C>:=Y_R%<#GO3=H\L$8)/3V MJ)V*MA@,YY%5=H5DR=9,'MFKD%X=P1L%:S@KLVX*?H.:E2WG;HA_&MJ M*(G"+6IHM-ESC&*0-D4VWMY4&6VU<6('JWY5W0A4GJU8Y9.,=$5AGZ4JL0W6 MKZPI@ @GZT>3&>-HKLC0DNIFZJ(48D9I^?>I/*7&!36C(Z=*ZDFC)R3$!ZT$ M\4T'BCG\*:8K"YH-)GTI":=Q 3FF9Q2D\4TGBG<+#33#3F-1L>*=P&'BM+P[ MSX@M![M_Z":S#U/-:?AOGQ%:_P# _P#T!JTB2ST&BBBM" HHHH **** "BBB M@ HHHH **** /F:\4K>3+QPY'ZU%U^M7M=3RM>U"/'W+B1?R8U1'7@UPU=SO MIO0">#THC.-S9I'QZXIJY$9]SUK*.YI+8"?>K=NQ,:\U2S5JT.0P]Z4'J.2T M+:DU(,^HJ->E2+VZUH05;M.0PZ]ZJMG!-:=PF^$^HZ5FGIUXK&:U+B]!]L?] M)CQ_>'%;Z= 25;)_E6*]XI8E(E##HQZBF![RXC M:-9)F1N"NXD?K5PIHTZ>X/[U]H)YYS4J7,PMTG/DF)B,H MH(*@G'7/]*TTZ ^M9\RELBW&42E#I$"*-Q9L#!S5I+*.,_( /H*L 9I>@QFA MQ74GF9 ]N-N0V/;%9[6LAX+C\JT6RS8!IFTXKDK4H3Z&\)M&>+20 C?:E]4I]$5[>1S[6%R7)!0#WYJ.;2[T@ 21X'J3_ (5TGD@=J:R\5/U*!I'% M2.=;2[@C.8QGW_3I4EEHLH8L[IA> !DUMF XSG%68X]H Q51P<&]45+%S2L MC(.D3.3F? (_NT^/2'C^].6![8K79!C(/-.7!ZUHL%170P>)J/J9JV<2FDTK'(IA.>!3N%A":8?KS2L:8:86&GJ:T_ M#7_(PVO_ /_ - :LLUJ^&>?$-M]'_\ 036L")'H-%%%:F84444 %%%% !11 M10 4444 %%%% 'SKXH_Y&K5O7[;-_P"AFLH<5J>*?^1KU;_K\F_]#-90/-<5 M;<[J6R$32]3Q6&R-MV)C)J>V.),>M0<9I\1Q(O-*.XVM#37GN?I M3UQZ_E4:YP*D!^F:V,B0 $8(XIL=M$C;MN3ZFHY+A(QR]<[ KRW"8RHI)]"&"XG%PLJ$LZG(!&1710:K<%!Y]K'C'.'Z_A5.*!=\<48"EVVY Z?Y MQ6E)'86>$>'S9",G(W']:M-O5:(B26BDKLB_XEDQ)ELFC;KD+U_[YI9TLXX7 M:&X9'521$Q'/X$9J3_B72<;6A;UY4?X4V>V>V&2=\1Z/Z?6E*[5]&$;)VU1K M)]T?2GCKP*CB^Z/3%.;=@;3@YYXZBJ.:VI0AC:=TG,=HSYR< Y'X^M:RUD*8 M3,"'LW.>XVG/MUK8'3%33-*O0?T%1.V#BE+ 'GI4)/?FE4EI8B,23=A?YT@? MIM-0N^T?_7J/S=ISFL'(V4"X5R-V>M- YIB3JW>IE*=0:M),'="JG<&NB+N8-6%J&;J#4HIDX^05;V!;D'6F^M%)FH-1&IAIQIA-%P&Y)Z9IA MIQII--,5AA^M;/A89U^(^B,?TK&/7K6]X07.M,?[L+']16]/*1CQ7JWK]LE_\ 0S603CI70>-X_)\8 MZHN.LQ;\^?ZUSI..:XZNYW4MD,<\]>].'2HSRU2(AD/; [U@U,Q(3@'O5+[2 MUP-Q[]JM6]HTA!;A>U:J*2NS-MMV0D:M*W&2?45/-IP:+=(>1S@&M"")(TPH M _6I& 9"#@^M1.;>B&HV,946/ 48QZ50 X.*Y5>]C=VL7H=4,4T3NF0K9X].];T\?VAEN[8B5'4 @'GZBL'5K&.P MF18B2K#/)]ZBL+B^@D9K,.0,;E"[A^(K:,G%N$]3)Q4DIP-MG53M8%3CHPQ6 MA:1EM,F252(R"%#<87%8Z>)Y@H#VR,WH:]=7D#1J%B0CD+U-6ITXZ MIW)<9RTM8ZZW)-O&3U*BIL9(J"T;=:PL3DE ?TIUQ)+'"SPQ^8X_ASBKZ',U M[UBK;R% $:YMU.?N%<=^@YK74<E2L5L*CZ]"H+H,]'F(>K" MM]#&S'$#I3"=O%+O0=&IC2IT)R?I4NPTF/QP,U$^",5 U^BOM*G<#CFJ=SJA MC? C&#T)KGJ8BG%;FT*,V]$:J_=&*& /&<5F6]])+&#\H./2FS7$NW[QS[5+ MQ,.6Z*]A*]F:3,H[TPSQKQO%9AYQR3D=31C*GCFL)8F71%^Q75FHK*_*D?A1 M65!(T-M/-,0?**>:[H['-+*:U9&PC4S/44XTPT --,)R*<.=0Q_P!,O_1:UR'4 M]JY*OQ'92^$<$)&?4U:C4(N!34&% IS.J*6; Q46L6V,N;E;>/J-W85ARRO, MQ+$DT^YN&GF)/3/%36UN,!WZ^E)NR+2+FEVX*Y<#(Z UM*,8Y'Y5F6K!)1SU M%:8/3%)2YD)JS)1CTYJ4#MGBH5.>*E!YS2 S[R/:^>Q]J;9'%_;'_IJM6KY- MT>X8R*STD,4J.N R,&&:R>DKFBUB;OB,$7,##^[4OA?EKL?[O]:CC\1JX"W5 MJK#V/]#5ZSU;2D+>6! 6QN&S'_UJZ4X.KSJ1S/F5/D:.;NSB\G'^VW\ZK,?E M(]JZB32-.OI7E@O!N M7>-L RN.,U+;9TVJ!E!^;UQ7-B%:#-L-K-7.;75S#-E@"IX(%37MLE[;> M9%G!&0>]4I]/$Q/DN0>P-0VTE]I$C%P)+<_>&[ ^HKS4D]F>YR1^*#U,FX\Z MVD*DG'8U:TJ_?[?$I_/H*V9%M-9MV> Y/=2/F%<]-:/870;DKG&1VK9-- M6>YUPG&HG&2LSJ;370TQ:5Q%'T')+-_@*VXM:BF4"-\)Z UY3UJ5+J2 M/[CFJ49Q^%F<\OA/5'JPN]R_>KB8_$UU8W3!B)$W$.A)YY[5FPZ[=1@ OD8K M-D5*57L:XV- MW1@48@^QK>TW1);HK-=DI'GA>YK.<+:ME/!T:-Y2>AZ'HE]]OTY)=NT_4'/Y M5H, >^#6%I*1V>R&(A%Z;?6M\N".17?AYJ<->A\]B(J-1\NPT$KP>E*W(_I2 M85CP:3R@.Y6Q\P.:V%8E%) Y%9>WYA6HH MPJCT%:86-FS.MLBQ'R!3CTID?*T\FO06QQ/<0&HYS^[J3.*@N#P!3;T"*U(> ME(3FDSP:*4FF'FF@$Z&NB\%_P#( M9F_Z]S_Z$M#?$H?\5QJ!_ZY?^BUKDX_F<#-=?\ $Y=OC2[/]Y(S_P"."N3A M7(R:YJB]XZZ;]TF' ]*H:C.57RP>O6KS-L4D]!6%.YFG/N:@T0^UA\Q]QSM% M:. ./3VJ.%!$F /K4ASGVKFG*[-TK(?&Q5U.>_-:J'C(/-8X-:MNVZ)33@R9 M(LKZ_K4HXS42=,5*O%6R D4-$P]1TK%D^5CDUNCD5D7L9CG;@\\U$T5%D -/ M[<5%'EI$3IN(&?3-;3^'KU!N0QR ^AP:B,)2V13G%;LRCT[U,MU<)&46>0+C M&W<UD'T&?Y5 5/.0-?Y5>CYK/TT_\ M2VV';RU_E5J=U2TE:!*M,GM/7.BQS?P'^__GTK M!FG1Q@(H'M3%NG48!X%;*#L;^QNK]1NH64EI<%64X['%5BC#J.*Z&VOX;NW$ M%^AD Z2 Y*_XTDNB7D<#36C)

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end GRAPHIC 12 image_009.jpg begin 644 image_009.jpg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end GRAPHIC 13 image_010.jpg begin 644 image_010.jpg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end GRAPHIC 14 image_011.jpg begin 644 image_011.jpg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end GRAPHIC 15 image_012.jpg begin 644 image_012.jpg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�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end GRAPHIC 16 image_013.jpg begin 644 image_013.jpg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end GRAPHIC 17 image_014.jpg begin 644 image_014.jpg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image_015.jpg begin 644 image_015.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(UOQ1HWAP0 M_P!K7R6WG9\L,"2V.O K('Q.\('IK"'_ +9/_A7F7[1)9;S0BI(_=3?S6O%E MGEP/WC#\:>@M3ZW_ .%F>$?^@NO_ 'Z?_"C_ (69X2_Z"R_]^G_PKY+$TO\ MST;\Z=YT@_Y:-^=&@:GUE_PLSPE_T%A_WZ?_ H_X69X2_Z"R_\ ?I_\*^3Q M+)W=OSJ19'/_ "T:G9"U/JO_ (6;X1_Z"P_[\O\ X4G_ L_P?\ ]!=?^_3_ M .%?+(9C_$?SIX)/&XG\:+(+L^J+;XC^%+N>.&'5D9Y&"J#&XR3P.2*ZJOD? MP^,ZQ9#G_7I_Z$*^N*)*P)W"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH \$_:*_X_-"_ZY3?S6O$P<@5[7^T7_P ?>A?](H01@5]"_&GPOJWB+3[._L(O.;3TD$L*_?93@Y [XQT MKYX'H>#0!,*>#WJ-3SUIX]Z0#U(SR:D%1@T\>HIB)UJ534*YQUJ5.*8CH/"& M#XELA_TU3^8KZS[U\F^#^?$UE_UU7^=?65$N@1W84445)04444 %%%% !111 M0 4444 %%%% !6?-/Q]!ZU7AC"( * )E'Y" MGJ/XC2*,\?G3F(%,94N8W+?*H8>]/@A9V#2?P]/2IE^8Y_*FW4P@A('4T"*E M[WIF24L>F:\I^ M+&MZ?JEU_8#!Y%T^(WDYB<*=^0JID@]F)/X4F-:GB()[XJ9&['@UH :./^7. M]_\ I?_ (BASI7E,([2[#X^4M<*0#]-E%PL5C%(F-R%E=)H][HD<5T=5M?.N' VDCL%QQZ?6L@SV?R_:+:>1 H6,I($X'U4^M:-) M*YRTJLYS<'&UOZT*BY'-3H>*2! MHQ\\H<,&)'91Z5%SIY33\&G_ (JFR'_35?YU]95\F^"Q_P 519_]=5_F*^LJ M148EW'!J22,KRA_ TR%!(Y9A@B@" M<$(FX]!6/=SM/+@'BK6H7.!L%4HD/WCU- '/^-/$\'@[PS-?D*URW[NVB)^^ MY_H.IKYOTRYFO;C6KJX/X3WZ4""X0[Q% M*I4;LA3P/6@9L2:?F !WHN2XINY3[5K:;_ ,@7 M5/\ >@_FU9A@F'6*0C5 M\>:+XDUO09Q+INI7$!!R5#DJWU4\&O7?"OQJ@N"EIXFMEA)X^UPKE/\ @2]1 M]13 ]Q7FD)K*L]0BN+6.YL+F.ZM7&49'W CV-78[E)@=IPPZJ>HH&2,9)EN?6KVGP;Y#(1\B\+[FL^,%B>3SZ5T,4 M:Q1JBC H \%_:-&;G0_^N4W\UKR'0?N:IU_X\CQ_P #2O7_ -HS_CZT/G'[ MJ;^:UY!H/W-4//\ QY-_Z&E)[#CN;+>*KPW<]PL$*F?'FI@E6P"!QGMG/U%$ M7BFZB:9DMH,S0K"Q.>BC (YX..]8@CD*AA&Y!Z$*>:LV7DPS'[98RSJ<84$J M1S_]8T#-%O$\[K= VEOFZ5A*PR"265L]>.4&/J:C@\27=OMV11$K#'#ELGY5 MW>_4[C3!+IK&)ETN M[MV4>Y-?(FIZA?\ B[7[S5+R5!+,Q=VD;:D:]%7/8= *[7XQ>.&\3^(!H^GR M%].L7*C8(H& MY5NJM]".#3 *LV=]<6BE$8/"WWH9!N1OJ/ZCFKUC:VNI7ZK;VDF67 MS)\K2 M9 &&ZA>+]8\*7?G:9?!OQ TGQIL@ M1_L6JJ,F!FY/NA_B'MUKY[UC0[W3+R>&:)5,<8E(5]PV$XR#W&3BLB.>2VE2 M:&1HY4.Y'0X*GU!IH&K;GV8VHM WV:[ 24_=A]JJR.9'XKQWP9\5SK M'E:-XD=/M!PD-TW D] _HWOWKUC2A-+,(#ELCY'/7'O]*8C MYK5ID4:Q1JBC@#%/I >!_M&?\?.A_P#7*;^:5Y#H#1E[^)YHHFFM"B&5PH)W M*<9/'8UZ[^T;G[3H>/\ GE-_-*\)S]*'L"=F=?;2ZC:0I%#J>GK&@("_:8SP M3D_K1%)J$2JB:CIP50 !]HC[$D?S/YUR(QGWJ5<=Z6I5T=3"FH0JJQWVG@*H M4#[0AP VX?D>:D#:KR1J%@,EB<7$?\7WOSKF$X],5*/>G87,NQTQGUEA@ZE8 M'Y63_7Q]" #^@%00VOV'1K]);BV9Y7BV+%,')P6ST^M8RU*O7CK3L+F.B\&_ M\C39?]=5_F*^M:^2/!I_XJBRZ?ZU?YBOK>G+H3'=A1114E!1110 4444 %>: M_&'QS_PB_A_^SK*4#5+]2B8ZQ1]&?^@KNMY/ M%?(FMZS=^,O$]UJM^Y17)=NRR7#21DQI@*L8/ 4=![UK0:C:WQ2+4P$R1OF M"Y) & !Z>YI%:/0R[6)I;A5382"#A^A^M6XY)[._7[-YEK>PMN5.F&_V345W MILLT+2QXWA@,87@]>AQD9QW-0RZG'=V?EW4;-.@PDB]_3/^- ;%S4-9FU M"ZD_M:20F8;9'C4*PQTR.X]N,U@ZA;26C+EEDA?F.5#E7'M_AU%-N+B20+YC MLQ4;1D]!4FFS',L,PW61&Z93_#Z,OHW8>O3I3M85[F>>37UO\&VU2Z\ 6=YK M"-Y[DK#(Y^:2$?=8_7GZ@ U\_?##P-)XX\4I!*K#3+7$MV_JN>$!]6_EFOL" M&*."%(8D5(XU"HBC 4#@ 4"'T444 >!?M&Y^U:'C_GE-_-*\'.0<\?A7O'[1 MO_'SH?\ URF_FM>$&@!RG-/4XJ+CTJ11CF@"PI..0*D4^M1(:E%,1.I]ZE4^ ME5UQT J=*8CH?!V?^$ILNG^M3^8KZX%?(W@X_P#%467_ %V7^8KZY%$N@1W" MBBBI*"BBB@ HHKSOXM^.AX1\.FUM)!_:M^"D('6-.C/_ $'O]* /,?C7X[&M MZO\ V!I\N;"Q?]\RGB68?T7I]RL?N_1N/>JLNUK MAXKT-:7BG)=@07%LKV[-((GQOCS@D YX]*ORP0:O$9[4 M;+DD[HU7"CCY5_( 9ZDD^E5;VXF^S>3>6X,HP(YL8XP...O&/SK)\YXI \;% M6!X(IA>PDD4IDV!"S;MO'.2>F*N1V<]W=6^BZ?&9[F60*5CY\R0\ #V'^)I\ MEZT=E#*45)F0K$!V'=S[GH/Q]!7M_P !? 'V>W_X2[4H?WLH*6",/NIT:3ZG MH/;/K0)GI?P_\&V_@GPM!ID>UKEOWEU*!_K)".?P'0>PKJJ**!!1110!X%^T M=_Q\Z'_URF_FE>#$\]#7N_[1Y_TK0O\ KE-_-:\&)R?:@0X*++@_P"N3^8K MZ]%?'?A%_P#BI['_ *[)_P"A"OL,42V01%HHHJ2@HHH- %+5M4M-%TJYU*^E M$=M;1F1V/H.P]STKX]\6^)KKQ=XDNM7NB1YAVPQYXBC'W5'^>N:]:^*'B?\ MX2;7AXDLW9/HO?WKE(/AF-:L9+RSF%FY/[J-QE)/7N2!V_" MES)%Q@Y;'G"*34XX%7=3T/4-"NS;:C;/#)_"3RKCU4]#6?(V!3(:MN,D?/%6 M(M25H5M;^,W%LO"'.)(O]QO3_9/'TJDQJ-VH"YK.[6=ON)6^TQS@.!@H?0CJ MK<=._8UEK!;R74KJ[M9Q?,S$8+#LH]R>*CM[V:TF+PL,,-KHPRKCT([BISOU M.YM[#3;1U,L@"0*VXO(W'_UAZ"@=T=1\.O!T_P 0?&"Q3*5T^#$MVZ\!4'1! M]<8'MDU]?0016MO'!!&L<4:A$11@*H& !7+?#OP7!X(\*P:>H1KR3][=R@?? MD/;Z#H*ZV@04444 %%%% 'S_ /M(?\?6@_\ 7*;^:5X.37N_[21Q=Z#_ -M>U^&O'&E>(;>.R\PZ;> MC 6)C\K8[*W?Z<&N'\4?"?6M!#W-B#J5B.2T2_O$'^TO?ZBN)11N"E@G."3_ M U,HIEPJ.)]&ZI%:3Z<;77+>.>!SMW%<@SV.>F*\I\5_#6YL ][HC->6 M@Y,/61![?WA^M+H?C_4M$CCM]45M1TIN%D/+H/J>OT->B:=?VFH69OM$NEFB M?[R$YVGDG(Z[NU1K$Z/=J(^=F.,@\$=0:@=J]K\3>$-+\3B2:VVV6JJ,L0/E M<_[0[^F17CFJ:9>:1?/:7T)CF7\01Z@]Q6D9)G/.FXE.O>O@'X"W,?%^HQ=, MQV",/P:3^@_&O+_A[X,G\;^*H-.4,MG'^\NY0/N1CM]3T%?9%G9V]A9PVEK$ ML5O"@CC11@*H& *9!/1110 4444 %%%% 'S[^TE_Q^:#_P!\? MM)_\?F@?]([#_KXC_\ 0A7VS0Q(****DHBN8?M%N\62NX=1 MVKC[VYETJX\N\&%_A<]&'L:[6JU[8V^H6S6]U$LD;#H1T^E,#'TNXM[IPRRK M],UQGCKX<:-XHEDN;1%T_4/^>T:_+(?]M>_U'-:NI^';W12;BP9IK8')4#YE M_#O]:98ZXLJA9>OK0,^<]9T76O!]\;74;G]169I^N7VC:B; MS39C V>4'*D>A'<5]3ZEI]CKEB]I?6\=S;R#E'&?Q'H?>O!/'?PSN?#Q>^TL MO=:=G+*>9(?KZCWHL%VCH]&^(.F:M;/)),=-I_I7&>(Y?[3=F MEB,MW<.$@122VXG@#CIVKBP2""#@CD$5[O\ _P;<:O=IXMUE2\-MF.P5Q]Y M^\GX=![_ $J.2S-'5I[5Y&VD:?N<_9$/!QC M( Z=.?FXKTO]HJ_GL;[0?(8*7BFR<9[K7B)\0:@2Q,B'=U^0O])N7N](MIY$N"H:0$G&!VSQ76'X>^$P,_V)8GZ _P"->$:5\1/$6C6[ MP6=S$L;OO(:(,<_Y%7U^+7BYF %U;Y)Q_P >ZUFX2N;*I322L>U?\*\\) _\ M@:P^NT_XT@^'WA+_ * UCU_NGU^M>61^./'DBEA>6 8J=RH.02#U^E5+_XE M>-=-F$5Q=6FXC(*0JPZXZ_A1R2'[6GV_ ]:G\!>%(XW*Z)9'"DY"D=OK7C8T MJP)Q]E7#'C!/'/\ "<_-0?BQXL92#=V^",?\>ZUSHU[4.?WJG/7*CUS51C); MD3J0>R.RT33;--9L62W 831\A2<_/W&>*^LA7Q;H.MWLFO:>C2#;]HC& N/X MQ_C7VF*O4Q;3V"BBB@04444 !KE]<\*B[F:[L66*8CYHR,*Y]?8UU%% 'F9% M]I\IBDC:.1?X6Z'Z&H9+HWCX<8[%37IEQ:PW41CFC5U/8BN>U#PC'*RR6CA' M'9_\:=QGCFI_!^'Q!XDM)-*=;6&:3=>QXX1.[+[GICWKZ T[3[;2M.M["SB6 M*VMXQ'&B] HJMH^E+IMN0Q#3/R[#] /:M.DQ!1110 4444 %%%% !1110!\\ M_M+?\?WA[_KE/_-*\&KZB^-7P^U[QK-I$VBQ0R_95D25))0A&[:01GZ5Y3_P MHCQW_P! ^U_\"TH \SI:]*_X41X[_P"@?:_^!24O_"B/'?\ T#[7_P "T_QH M \UR3W-+D^M>D_\ "B/'?_0/M?\ P*2C_A1/CS_H'VO_ (%)3 \W!I0:]'_X M43X\_P"@?:_^!24O_"BO'G_0/MO_ +2@1Q?A\X\0:?_ -?,?_H0K[FKY:T? MX(^-[;6;*:>SM8XHYT=W^TJ< ,">!7U+0P"BBBD,**** "BBB@ HHHH **** K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$! end GRAPHIC 19 image_016.jpg begin 644 image_016.jpg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end GRAPHIC 20 report_001.jpg begin 644 report_001.jpg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report_002.jpg begin 644 report_002.jpg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end EX-101.SCH 22 aatp-20211231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - VARIABLE INTEREST ENTITY (“VIE”) link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CASH AND CASH EQUIVALENTS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - PREPAYMENTS AND DEPOSITS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - INTANGIBLE ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - NON-CONTROLLING INTEREST link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - CONCENTRATIONS OF RISKS link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - VARIABLE INTEREST ENTITY (“VIE”) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - BUSINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - VARIABLE INTEREST ENTITY (“VIE”) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - INVENTORIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 23 aatp-20211231_cal.xml XBRL CALCULATION FILE EX-101.DEF 24 aatp-20211231_def.xml XBRL DEFINITION FILE EX-101.LAB 25 aatp-20211231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Noncontrolling Interest [Member] Consolidated Entities [Axis] Agape ATP International Holding Limited [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Share Exchange Agreement [Member] Title of Individual [Axis] Mr.How Kok Choong [Member] Subsidiary Company Two [Member] Subsidiary Company Five [Member] Subsidiary Company [Member] Subsidiary Company One [Member] Subsidiary Company Three [Member] Subsidiary Company Four [Member] Product and Service [Axis] Health and Wellness Products [Member] Health And Wellness Services [Member] Shipping and Handling [Member] Legal Entity [Axis] Social Security Organization [Member] Award Type [Axis] MYR Currency [Member] Employees Provident Fund [Member] Employment Insurance System [Member] Human Resource Development Fund [Member] Long-Lived Tangible Asset [Axis] Computer Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Vehicles [Member] Finite-Lived Intangible Assets by Major Class [Axis] Computer Software, Intangible Asset [Member] Survivor Select [Member] Energized Mineral Concentrate [Member] Ionized Cal-Mag [Member] Omega Blend [Member] Beta Maxx [Member] Vege Fruit Fiber [Member] Iron [Member] Young Formula [Member] Organic Youth Care Cleansing Bar [Member] Mitogize [Member] No. 1 MED [Member] Energetique [Member] Trim Plus [Member] Product [Member] Variable Rate [Axis] Period-end MYR [Member] Period-end HKD [Member] Period-average MYR [Member] Period-average HKD [Member] Trading Activity [Axis] Variable Income Interest Rate [Member] Related Party [Axis] Agape Superior Living Sdn Bhd [Member] Computer And Office Equipment [Member] Vehicle [Member] Greenpro Capital Corp. [Member] DSwiss Inc [Member] SEATech Ventures Corp [Member] Director [Member] Unreserved Sdn Bhd [Member] Phoenix Plus Corporation [Member] Directors of Unreserved Investments [Member] Agape ATP Asia Limited [Member] Hostastay Sdn Bhd [Member] TH3 Technology Sdn Bhd [Member] Agape Superior Living Pty Ltd [Member] Agape Superior Living Pty Ltd ASLPL [Member] Vettons Sdn Bhd One [Member] Hostastay Sdn. Bhd [Member] How Kok Choong [Member] Chief Executive Officer [Member] DSY Wellness & Longevity Center Sdn Bhd [Member] Business Acquisition [Axis] ASL [Member] Share Forfeiture Agreements [Member] How Kok Choong Talent Limited [Member] Shareholders [Member] HKC Holdings Sdn Bhd [Member] Geographical [Axis] MALAYSIA HONG KONG Income Tax Authority [Axis] State and Local Jurisdiction [Member] Foreign Tax Authority [Member] Domestic Tax Authority [Member] UNITED STATES Labuan [Member] Scenario [Axis] Unutilized [Member] AATP HK [Member] AATP LB, ASL, SEA, WATP, and DSY [Member] AATP LB, ASL, SEA and WATP [Member] Customer [Axis] No Customer [Member] Concentration Risk Benchmark [Axis] Revenue from Contract with Customer Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Accounts Receivable [Member] E-commerce [Member] Vendor One [Member] Cost of Goods and Service Benchmark [Member] Supplier Concentration Risk [Member] Vendor Two [Member] Accounts Payable [Member] One Vendor [Member] One Sales Distributor [Member] No Sales Distributor [Member] Training Center [Member] Unusual Risk or Uncertainty, Nature [Axis] COVID-19 Impact [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Share Forfeiture Agreement [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Firm ID Auditor Location Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.) Accounts receivable Amount due from related parties Inventories Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.) Prepayments and deposits Total Current Assets OTHER ASSETS Property and equipment, net Intangible assets, net Operating right-of-use assets Investment in marketable securities Investment in non-marketable securities Deferred offering costs Total other assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable Customer deposits Operating lease liabilities Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.) Income tax payable Amount due to a related party Total Current Liabilities NON-CURRENT LIABILITIES Operating lease liabilities Deferred tax liabilities Total Non-current Liabilities TOTAL LIABILITIES STOCKHOLDERS’ EQUITY Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively. Additional paid in capital Accumulated deficit Accumulated other comprehensive income TOTAL AGAPE CORPORATION STOCKHOLDERS’ EQUITY NON-CONTROLLING INTERESTS TOTAL EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY VIE consolidated amount of cash and cash equivalents VIE consolidated amount of prepaid taxes VIE consolidated amount of other payables and accrued liabilities Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE REVENUE – RELATED PARTY TOTAL REVENUE COST OF REVENUE GROSS PROFIT SELLING COMMISSION GENERAL AND ADMINISTRATIVE PROVISION FOR DOUBTFUL ACCOUNTS TOTAL OPERATING EXPENSES LOSS FROM OPERATIONS OTHER (EXPENSES) INCOME Other (Expenses) Income, net Unrealized holding (loss) gain on marketable securities Dividend income from marketable securities TOTAL OTHER (EXPENSES) INCOME, NET (LOSS) INCOME BEFORE INCOME TAXES PROVISION FOR INCOME TAXES NET (LOSS) INCOME NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION NET (LOSS) INCOME OTHER COMPREHENSIVE (LOSS) INCOME Foreign currency translation adjustment TOTAL COMPREHENSIVE (LOSS) INCOME Less: Comprehensive loss attributable to non-controlling interests COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION (LOSS) EARNINGS PER SHARE Basic and diluted WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING Basic and diluted Statement [Table] Statement [Line Items] Beginning balance, value Shares, Outstanding, Beginning Balance Net income (loss) Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd Stock Issued During Period, Shares, New Issues Foreign currency translation adjustment Forfeiture of common stock Shares Issued, Shares, Share-based Payment Arrangement, Forfeited Contributions from non-controlling interest shareholders Ending balance, value Shares, Outstanding, Ending Balance Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net (loss) income Adjustments to reconcile net (loss) income to net cash used in operating activities: Depreciation Amortization Amortization of operating right-of-use assets Unrealized holding loss (gain) on marketable securities Dividend income from marketable securities Deferred tax expense Inventory write-down Provision for doubtful accounts Changes in operating assets and liabilities: Accounts receivables Amount due from a related party Inventories Prepaid taxes Prepayments and deposits Accounts payable Customer deposits Other payables and accrued liabilities Operating lease liabilities Income tax payables Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of equipment Purchase of intangible assets Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd Proceeds from sale of marketable securities Proceeds from sale of non-marketable securities to a related party Net cash (used in) provided by investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Deferred offering costs (Advances to) Repayments from related parties Net cash used in financing activities EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of year CASH AND CASH EQUIVALENTS, end of year SUPPLEMENTAL CASH FLOWS INFORMATION Income taxes paid Interest paid SUPPLEMENTAL NON-CASH FLOWS INFORMATION Changes in right-of-use assets and lease liabilities due to lease modifications Initial recognition of right-of-use assets and lease liabilities Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL Issuance of common stock in exchange for acquisition payment of ASL Accounting Policies [Abstract] ORGANIZATION AND BUSINESS BACKGROUND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] VARIABLE INTEREST ENTITY (“VIE”) Business Combination and Asset Acquisition [Abstract] BUSINESS COMBINATION Cash and Cash Equivalents [Abstract] CASH AND CASH EQUIVALENTS Receivables [Abstract] ACCOUNTS RECEIVABLE Inventory Disclosure [Abstract] INVENTORIES Prepayments And Deposits PREPAYMENTS AND DEPOSITS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS, NET Investment In Marketable Securities INVESTMENT IN MARKETABLE SECURITIES Investment In Non-marketable Securities INVESTMENT IN NON-MARKETABLE SECURITIES Other Liabilities Disclosure [Abstract] OTHER PAYABLES AND ACCRUED LIABILITIES Related Party Transactions [Abstract] RELATED PARTY BALANCES AND TRANSACTIONS Equity [Abstract] STOCKHOLDERS’ EQUITY Noncontrolling Interest [Abstract] NON-CONTROLLING INTEREST Income Tax Disclosure [Abstract] INCOME TAXES Risks and Uncertainties [Abstract] CONCENTRATIONS OF RISKS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation Principles of consolidation Use of estimates Cash and cash equivalents Accounts receivable Inventories Prepaid taxes Prepayments and deposits Property and equipment, net Intangible assets, net Impairment for long-lived assets Deferred offering costs Investment in marketable equity securities Investment in non-marketable equity securities Customer deposits Revenue recognition Cost of revenue Shipping and handling Advertising costs Commission expenses Defined contribution plan Income taxes Comprehensive income (loss) Non-controlling interest Earnings (loss) per share Foreign currencies translation and transaction Related parties Fair value of financial instruments Leases Recent accounting pronouncements SCHEDULE OF SUBSIDIARIES AND ASSOCIATES SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES SCHEDULE OF VARIABLE INTEREST ENTITY SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF PRO FORMA BUSINESS COMBINATION SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY SCHEDULE OF INVENTORIES SCHEDULE OF PREPAID EXPENSES AND DEPOSITS SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS SCHEDULE OF PROPERTY AND EQUIPMENT, NET SCHEDULE OF INTANGIBLE ASSETS, NET SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES SCHEDULE OF RELATED PARTIES SCHEDULE OF NON CONTROLLING INTEREST SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX SCHEDULE OF PROVISION FOR INCOME TAX SCHEDULE OF EFFECTIVE INCOME TAX RATE SCHEDULE OF DEFERRED TAX ASSETS SCHEDULE OF LEASE COMMITMENTS Subsidiary company name Place and date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held Ownership interest percentage Stock issued during period acquisitions, shares Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated Useful Life of Property and Equipment Estimated Useful Lives of Property and Equipment Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Estimated useful lives of intangible assets Schedule of Product Information [Table] Product Information [Line Items] Total revenues Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Foreign Currency Exchange Rate, Translation Foreign currency exchange rate period average Accounts receivable, allowance for credit loss Inventories write-down Allowance for doubtful accounts Impairment of long-lived assets Forfeited coupon income Revenue from sales Cost of revenue Selling expenses Advertising costs Commission expenses Defined contribution plan expense Salary percentage Monthly salary Income tax examination, likelihood of unfavorable settlement Income tax examination, penalties and interest expense Noncontrolling interest, description Potentially dilutive securities outstanding Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table] Trading Activity, Gains and Losses, Net [Line Items] Total current assets Current liabilities Net deficit Cash Prepaid taxes Accounts payable – intercompany Other payables and accrued liabilities Total current liabilities Operating revenues Gross profit Loss from operations Net loss Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Cash Other receivables Other receivables - related parties Inventories Prepaid taxes Prepayments and other assets Total current assets Property and equipment, net Intangible assets, net Deferred taxes asset, net Total other assets Total assets Accounts payable - related party Customer deposits Other payables and accrued liabilities Total current liabilities Total liabilities Total net assets acquired Revenue Cost of revenue Gross profit Total operating expenses  Loss from operations Other income (expense), net Income before income taxes Provision for income taxes Net income Net income per common share - basic and diluted Weighted average number of common shares outstanding - basic and diluted Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Ordinary shares no par value Purchase consideration value Loan payable Common stock par value Percentage of common stock issued and outstanding Stock issued during period, value, acquisitions Purchased price per shares Issuance of common stock shares Cash and cash equivalents Cash in bank Time deposits Percentage of Interest rate for time deposits Accounts receivable Allowance for doubtful accounts Total Finished goods Schedule Of Prepaid Expenses And Deposits Receivables from sales distributors Deposits to suppliers Subtotal Less: Provision for doubtful accounts Total Schedule Of Changes In Allowance For Doubtful Accounts Beginning balance Addition Write off Exchange rate effect Ending balance Subtotal Less: accumulated depreciation Total Computer software Less: accumulated amortization Total Amortization expense Schedule Of Investment In Marketable Securities Cost of investment Dividend income from Greenpro Capital Corp. Unrealized holding (loss) gain Exchange rate effect Investment in marketable securities Investment in securities, shares Investment amount Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] Investment in non-marketable securities Less: Sale of investment in non-marketable securities Investment in non-marketable securities Total investment in non-marketable securities Equity interest percentage Ordinary shares authorized Proceeds from investments Amount due from director Shares purchased during period Shares Issued, Price Per Share Professional fees Promotion expenses Payroll Commission Others Total Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Relationship Nature Amount due from related parties Amount due from related parties Revenue Purchase Commission expense Other income Schedule of Restructuring and Related Costs [Table] Restructuring Cost and Reserve [Line Items] Common stock, shares authorized Business combination, recognized identifiable assets acquired and liabilities assumed, assets Shares Issued, Shares, Share-based Payment Arrangement, Forfeited Paid-in capital Accumulated deficit Accumulated other comprehensive income  Non Controlling interest Gross ASL Total Local – United States Foreign (Loss) income before income tax - Local - Foreign - Local - Foreign Provision for income taxes U.S. statutory rate Valuation allowance Differential tax rate in Malaysia Permanent difference Effective tax rate Tax percentage Net operating loss carry forwards Less: valuation allowance Depreciation Deferred tax liabilities, net Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Tax percentage Tax rate description Income tax expense benefit Income tax examination penalties and interest expense Net operating loss carryforward Deferred tax assets operating loss carryforwards Cumulative net operating losses Deferred tax valuation allowance Tax percentage Income tax examination, description Concentration Risk [Table] Concentration Risk [Line Items] Concentrations of risk percentage [custom:DividendShareForCommonStock] Deposits Deposit for insurance 2022 2023 Thereafter Total lease payments Less: interest Present value of lease liabilities Operating lease liability Operating lease effective interest rate Lease expiration term Reduction in ROU assets and liabilities Operating lease, weighted average remaining lease term Operating lease, rent expenses COVID-19 impact description Subsequent Event [Table] Subsequent Event [Line Items] Company share forfeiture Investment in non-marketable securities. VIE consolidated amount of cash and cash equivalents. VIE consolidated amount of Prepaid taxes . VIE consolidated amount of other payables and accrued liabilities. The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. Increase decrease in operating lease liabilities. Proceeds from sale of non-marketable securities to a related party. Changes in right of use asset and lease liabilities due to lease modifications. Initial recognition of right-of-use assets and lease liabilities. Sale of non-marketable securities to related party in exchange for acquisition. Issuance of common stock in exchange for acquisition payment of acquisition. Agape ATP International Holding Limited [Member] Share Exchange Agreement [Member] Mr.How Kok Choong [Member] Subsidiary Company Two [Member] Name of the company name. Subsidiary Company [Member] Subsidiary Company One [Member] Subsidiary Company Five [Member] Subsidiary Company Three [Member] Subsidiary Company Four [Member] Place and date of incorporation. Particulars of issued capital. Principal activities. Prepaid Taxes [Policy Text Block] Prepayments And Deposits [Policy Text Block] Allowance for doubtful accounts, Computer And Office Equipment [Member] Vehicle [Member] Greenpro Capital Corp. [Member] DSwiss Inc [Member] Investment In Marketable Securities [Text Block] Dividend income . Unrealized holding (loss) gain. Exchange rate effect. Investment In Non Marketable Securities [Text Block] Unreserved Sdn Bhd [Member] Phoenix Plus Corporation [Member] Non Marketable Securities [Table Text Block] Investment in non-marketable securities. Directors of Unreserved Investments [Member] Sale of investment in non-marketable securities. Investment in non-marketable securities, net. Schedule Of Other Payables And Accrued Liabilities [Table Text Block] Accrued promotion expenses. Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer. Related parties, relationships, description. Agape ATP Asia Limited [Member] Related parties nature, description. Contributions from non controlling interest shareholders. Hostastay Sdn Bhd [Member] TH3 Technology Sdn Bhd [Member]. Agape Superior Living Pty Ltd [Member] Agape Superior Living Pty Ltd ASLPL [Member] Hostastay Sdn. Bhd.[Member] Schedule Of Estimated Useful Lives Of Property And Equipment [Table Text Block] Schedule Of Estimated Useful Lives Of Intangible Assets Net [Table Text Block] How Kok Choong [Member] Non Marketable Securities [Policy Text Block] Vettons Sdn Bhd One [Member] Forfeited coupon income. Health and Wellness Products [Member] Schedule Of Disaggregated Information Of Revenues [Table Text Block] Survivor Select [Member] Energized Mineral Concentrate [Member] Ionized Cal-Mag [Member] Omega Blend [Member] Beta Maxx [Member] Vege Fruit Fiber [Member] Iron [Member] Young Formula [Member] Organic Youth Care Cleansing Bar [Member] Mitogize [Member] No. 1 MED [Member] Energetique [Member] Trim Plus [Member] Health And Wellness Services [Member] ASL [Member] Shipping and Handling [Policy Text Block] Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller). Defined Contribution Plan [Policy Text Block] Salary percentage. Social Security Organization [Member] Monthly salary. MYR Currency [Member] Employees Provident Fund [Member] Employment Insurance System [Member] Human Resource Development Fund [Member] Noncontrolling Interest [Policy Text Block] Period-end MYR [Member] Period-end HKD [Member] Foreign currency exchange rate period average. Period-average MYR [Member] Period-average HKD [Member] Related Parties [Policy Text Block] Share Forfeiture Agreements [Member] How Kok Choong Talent Limited [Member] Schedule Of Non Controlling Interest [Table Text Block] Non controlling interest paid in capital. Non controlling interest accumulated deficit. Non controlling interest accumulated other comprehensive income. Non controlling interest gross. Non controlling interest asl. Other payables - related party. Agape Superior Living Sdn Bhd [Member] Percentage of common stock issued and outstanding. Cost of revenue. Gross profit. Total operating expenses. Business acquisitions pro-forma income loss before income taxes. Business acquisitions pro-forma income tax expense benefit. Business acquisition pro-forma earnings per share basic and diluted Business acquisition pro-forma weighted average number of common shares outstanding basic snd diluted. Business combination recognized identifiable assets acquired and liabilities assumed current assets receivables related parties. Business combination recognized identifiable assets acquired and liabilities assumed current assets prepaid taxes. Accounts receivable and accounts receivable related parties. Prepayments and Deposits [Text Block] Schedule of Prepaid Expenses and Deposits [Table Text Block] Receivables from sales distributors. Deposits to supplier. Allowance for doubtful accounts receivable exchange rate effect. Prepaid expenses gross. Labuan [Member] Deferred tax assets operating loss carryforwards utilized and reduced. Deferred tax liabilities, depreciation. Unutilized [Member] No Customer [Member]. E-commerce [Member]. Vendor One [Member] Vendor Two [Member] Deposit for insurance. COVID-19 Impact [Member] Other income (expense), net. Schedule of Changes in Allowance for Doubtful Accounts [Table Text Block] SEATech Ventures Corp [Member] Shareholders [Member] HKC Holdings Sdn Bhd [Member] Commission expense. AATP HK [Member] AATP LB, ASL, SEA, WATP, and DSY [Member] AATP LB, ASL, SEA and WATP [Member] Dividend share for common stock. One Vendor [Member] One Sales Distributor [Member] No Sales Distributor [Member] Share Forfeiture Agreement [Member] Lease expiration term. Training Center [Member] Reduction in ROU assets and liabilities. Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. DSY Wellness & Longevity Center Sdn Bhd [Member]. Other Assets Assets Operating Lease, Liability, Noncurrent Liabilities, Noncurrent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Cost of Goods and Services Sold Sales Commissions and Fees General and Administrative Expense Operating Expenses Nonoperating Income (Expense) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss) Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Weighted Average Number of Shares Outstanding, Basic and Diluted Shares, Outstanding Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Increase (Decrease) in Accounts Receivable Increase (Decrease) in Due from Other Related Parties, Current Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Taxes Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Other Accounts Payable Increase (Decrease) in Contract with Customer, Liability IncreaseDecreaseInOperatingLeaseLiabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Payments of Debt Issuance Costs Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Stockholders' Equity Note Disclosure [Text Block] Accounts Receivable [Policy Text Block] Inventory, Policy [Policy Text Block] PrepaymentsAndDepositsPolicyTextBlock Property, Plant and Equipment, Policy [Policy Text Block] Intangible Assets, Finite-Lived, Policy [Policy Text Block] Deferred Charges, Policy [Policy Text Block] Revenue from Contract with Customer [Policy Text Block] Advertising Expense Commission expenses [Default Label] OtherPayablesRelatedPartyCurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities BusinessAcquisitionsProFormaCostOfRevenue BusinessAcquisitionsProFormaGrossProfit Accounts Receivable, before Allowance for Credit Loss, Current Accounts Receivable, Related Parties, Current Accounts receivable and accounts receivable related parties PrepaidExpensesGross Allowance for Doubtful Accounts, Premiums and Other Receivables Accounts Receivable, Allowance for Credit Loss Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Net Dividend income Unrealized holding (loss) gain Exchange rate effect [Default Label] Investment in non-marketable securities [Default Label] Investment in non-marketable securities, net OtherAccountPayableAndAccruedLiabilities Due from Related Parties Due to Related Parties Revenue from Related Parties NonControllingInterestAccumulatedDeficit NonControllingInterestAccumulatedOtherComprehensiveIncome Current State and Local Tax Expense (Benefit) Current Foreign Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Deferred Foreign Income Tax Expense (Benefit) DeferredTaxLiabilitiesDepreciation Deferred Tax Assets, Net Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount EX-101.PRE 26 aatp-20211231_pre.xml XBRL PRESENTATION FILE XML 27 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2021
Mar. 23, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2021    
Current Fiscal Year End Date --12-31    
Entity File Number 333-220144    
Entity Registrant Name AGAPE ATP CORPORATION    
Entity Central Index Key 0001713210    
Entity Tax Identification Number 36-4838886    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One Tower 2    
Entity Address, Address Line Two Faber Towers    
Entity Address, Address Line Three Jalan Desa Bahagia    
Entity Address, City or Town Kuala Lumpur    
Entity Address, Country MY    
Entity Address, Postal Zip Code 58100    
City Area Code (60)    
Local Phone Number 192230099    
Title of 12(b) Security Common Stock, $0.0001 par value    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 914,950,575
Entity Common Stock, Shares Outstanding   75,452,012  
Auditor Name Friedman LLP    
Auditor Firm ID 711    
Auditor Location New York, New York    

XML 28 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
CURRENT ASSETS    
Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.) $ 2,597,848 $ 3,517,600
Accounts receivable 172,757
Amount due from related parties 7,004 3,235
Inventories 375,535 589,814
Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.) 636,218 1,104,495
Prepayments and deposits 295,517 296,370
Total Current Assets 3,912,122 5,684,271
OTHER ASSETS    
Property and equipment, net 215,799 298,309
Intangible assets, net 3,660 5,826
Operating right-of-use assets 237,718 394,141
Investment in marketable securities 89,001 577,035
Investment in non-marketable securities 1,500 1,500
Deferred offering costs 264,735 249,525
Total other assets 812,413 1,526,336
TOTAL ASSETS 4,724,535 7,210,607
CURRENT LIABILITIES    
Accounts payable 13,715
Customer deposits 279,689 236,134
Operating lease liabilities 157,094 154,276
Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.) 858,355 647,677
Income tax payable 3,988
Amount due to a related party 455
Total Current Liabilities 1,312,841 1,038,542
NON-CURRENT LIABILITIES    
Operating lease liabilities 83,484 241,488
Deferred tax liabilities 15,574 5,743
Total Non-current Liabilities 99,058 247,231
TOTAL LIABILITIES 1,411,899 1,285,773
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively. 29,046 37,645
Additional paid in capital 6,449,215 6,440,616
Accumulated deficit (3,258,687) (734,443)
Accumulated other comprehensive income 93,398 181,016
TOTAL AGAPE CORPORATION STOCKHOLDERS’ EQUITY 3,312,972 5,924,834
NON-CONTROLLING INTERESTS (336)
TOTAL EQUITY 3,312,636 5,924,834
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 4,724,535 $ 7,210,607
XML 29 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
VIE consolidated amount of cash and cash equivalents $ 17,493 $ 37,387
VIE consolidated amount of prepaid taxes 1,357 11,330
VIE consolidated amount of other payables and accrued liabilities $ 1,548 $ 1,904
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 290,460,047 376,452,047
Common stock, shares outstanding 290,460,047 376,452,047
XML 30 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
REVENUE $ 1,016,962 $ 3,434,561
REVENUE – RELATED PARTY 18,060
TOTAL REVENUE 1,016,962 3,452,621
COST OF REVENUE (297,333) (775,855)
GROSS PROFIT 719,629 2,676,766
SELLING (394,682) (376,582)
COMMISSION (316,267) (830,659)
GENERAL AND ADMINISTRATIVE (1,745,734) (1,627,660)
PROVISION FOR DOUBTFUL ACCOUNTS (121,514)
TOTAL OPERATING EXPENSES (2,578,197) (2,834,901)
LOSS FROM OPERATIONS (1,858,568) (158,135)
OTHER (EXPENSES) INCOME    
Other (Expenses) Income, net (42,753) 164,283
Unrealized holding (loss) gain on marketable securities (505,231) 350,137
Dividend income from marketable securities 18,939 160,062
TOTAL OTHER (EXPENSES) INCOME, NET (529,045) 674,482
(LOSS) INCOME BEFORE INCOME TAXES (2,387,613) 516,347
PROVISION FOR INCOME TAXES (137,067) (161,581)
NET (LOSS) INCOME (2,524,680) 354,766
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS 436
NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION (2,524,244) 354,766
NET (LOSS) INCOME (2,524,680) 354,766
OTHER COMPREHENSIVE (LOSS) INCOME    
Foreign currency translation adjustment (87,615) 171,231
TOTAL COMPREHENSIVE (LOSS) INCOME (2,612,295) 525,997
Less: Comprehensive loss attributable to non-controlling interests (433)
COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION $ (2,611,862) $ 525,997
(LOSS) EARNINGS PER SHARE    
Basic and diluted $ (0.01) $ 0.00
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING    
Basic and diluted 376,216,452 376,387,778
XML 31 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 37,628 $ 5,293,082 $ (1,089,209) $ 9,785 $ 4,251,286
Shares, Outstanding, Beginning Balance at Dec. 31, 2019 376,275,500          
Net income (loss) 354,766 354,766
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd $ 17 1,147,534 1,147,551
Stock Issued During Period, Shares, New Issues 176,547          
Foreign currency translation adjustment 171,231 171,231
Ending balance, value at Dec. 31, 2020 $ 37,645 6,440,616 (734,443) 181,016 5,924,834
Shares, Outstanding, Ending Balance at Dec. 31, 2020 376,452,047          
Net income (loss) (2,524,244) (436) (2,524,680)
Foreign currency translation adjustment (87,618) 3 (87,615)
Forfeiture of common stock $ (8,599) 8,599
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited (85,992,000)          
Contributions from non-controlling interest shareholders 97 97
Ending balance, value at Dec. 31, 2021 $ 29,046 $ 6,449,215 $ (3,258,687) $ 93,398 $ (336) $ 3,312,636
Shares, Outstanding, Ending Balance at Dec. 31, 2021 290,460,047          
XML 32 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (2,524,680) $ 354,766
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation 75,797 55,407
Amortization 1,961 1,505
Amortization of operating right-of-use assets 139,451 106,561
Unrealized holding loss (gain) on marketable securities 505,231 (350,137)
Dividend income from marketable securities (18,939) (160,062)
Deferred tax expense 10,127 178,329
Inventory write-down 36,241
Provision for doubtful accounts 121,514
Changes in operating assets and liabilities:    
Accounts receivables 167,566 (165,149)
Amount due from a related party (2,417)
Inventories 192,713 78,674
Prepaid taxes 430,062 184,985
Prepayments and deposits (128,363) 352,577
Accounts payable (2,804)
Customer deposits 52,981 (1,421,886)
Other payables and accrued liabilities 226,651 336,709
Operating lease liabilities (138,143) (105,009)
Income tax payables 3,988
Net cash used in operating activities (845,842) (557,951)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of equipment (3,959) (4,734)
Purchase of intangible assets (178)
Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd 1,210,818
Proceeds from sale of marketable securities 121
Proceeds from sale of non-marketable securities to a related party 70,173
Net cash (used in) provided by investing activities (3,959) 1,276,200
CASH FLOWS FROM FINANCING ACTIVITIES:    
Deferred offering costs (15,210) (249,525)
(Advances to) Repayments from related parties (3,851) 227,434
Net cash used in financing activities (19,061) (22,091)
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS (50,890) 76,985
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (919,752) 773,143
CASH AND CASH EQUIVALENTS, beginning of year 3,517,600 2,744,457
CASH AND CASH EQUIVALENTS, end of year 2,597,848 3,517,600
SUPPLEMENTAL CASH FLOWS INFORMATION    
Income taxes paid 326,838 288,929
Interest paid
SUPPLEMENTAL NON-CASH FLOWS INFORMATION    
Changes in right-of-use assets and lease liabilities due to lease modifications 3,250
Initial recognition of right-of-use assets and lease liabilities 483,343
Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL 656,495
Issuance of common stock in exchange for acquisition payment of ASL $ 1,147,551
XML 33 R7.htm IDEA: XBRL DOCUMENT v3.22.1
ORGANIZATION AND BUSINESS BACKGROUND
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
ORGANIZATION AND BUSINESS BACKGROUND

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. (“ASL”), a company incorporated in Malaysia. .

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., a network marketing entity incorporated in Malaysia.

 

Agape Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.

 

On September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (“WATP”), a wholly owned subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.

 

On November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

The Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.

The accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3), and DSY Wellness.

 

Details of the Company’s subsidiaries:

 

    Subsidiary company name  Place and date of incorporation  Particulars of issued capital  Principal activities  Proportional of ownership interest and voting power held 
                  
1.   Agape ATP Corporation  Labuan,
March 6, 2017		  100 shares of ordinary share of US$1 each  Investment holding   100%
                   
2.   Agape ATP International Holding Limited  Hong Kong,
June 1, 2017		  1,000,000 shares of ordinary share of HK$1 each  Wholesaling of health and wellness products; and health solution advisory services   100%
                   
3.   Agape Superior Living Sdn. Bhd.  Malaysia,
August 8, 2003		  9,590,598 shares of ordinary share of RM1 each  Health and wellness products and health solution advisory services via network marketing   99.99%
                   
4.   Agape S.E.A. Sdn. Bhd.  Malaysia,
March 4, 2004		  2 shares of ordinary share of RM1 each  VIE of Agape Superior Living Sdn. Bhd.   VIE 
                   
5.   Wellness ATP International Holdings Sdn, Bhd  Malaysia,
September 11, 2020		  100 shares of ordinary share of RM1 each  The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns   100%
                   
6.   DSY Wellness International Sdn Bhd.  Malaysia,
November 11, 2021		  1,000 shares of ordinary share of RM1 each  Provision of complementary health therapies   60%

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

1. ORGANIZATION AND BUSINESS BACKGROUND (CONT’D)

 

Business Overview

 

Agape ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.

 

Via ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.

 

The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.

 

The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.

 

The Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various wellness programs.

 

To further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 34 R8.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

 

The consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.

 

Principles of consolidation

 

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, no allowance of doubtful accounts was recorded.

 

Inventories

 

Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. For the years ended December 31, 2021, and 2020, the company recorded $36,241 and $0 write-downs for inventory.

 

Prepaid taxes

 

Prepaid taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax.

 

Prepayments and deposits

 

Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, there was $121,514 and $0 allowance for the doubtful accounts recorded.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

    Useful Life
     
Computer and office equipment   5-7 years
Furniture & fixtures  

6-7 years

Leasehold improvements   Lease Term
Vehicle   5 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.

 

Intangible assets, net

 

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

Classification   Useful Life
     
Computer software   5 years

 

Impairment for long-lived assets

 

Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and 2020, no impairment of long-lived assets was recognized.

 

Deferred offering costs

 

Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.

 

Investment in marketable equity securities

 

The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s unaudited condensed consolidated statements of operations and comprehensive loss in the caption of “unrealized holding gain loss on marketable securities” in each reporting period.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Investment in non-marketable equity securities

 

The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

 

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

 

Customer deposits

 

Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.

 

Revenue recognition

 

The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $15,209 and $170,431 as forfeited coupon income.

 

As of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $183,816 which it is expected to fulfill within 12 months from December 31, 2021.

 

Sales of Health and Wellness services

 

- Performance obligations satisfied at a point in time

 

The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person.

 

The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp. For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $7,543 and $0, respectively.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Disaggregated information of revenues by products and services are as follows:

 

       
   For the years ended December 31, 
   2021   2020 
         
Survivor Select  $83,904   $149,897 
Energized Mineral Concentrate   52,047    81,481 
Ionized Cal-Mag   39,527    908,964 
Omega Blend   222,718    495,567 
BetaMaxx   208,043    156,550 
Vege Fruit Fiber   65,757    1,755 
Iron   28,114    133,389 
Young Formula   52,425    653,631 
Organic Youth Care Cleansing Bar   5,137    43,127 
Mitogize   183,800    162,801 
No. 1 MED   15,331    46,713 
Energetique   25,574    253,396 
Trim+   27,042    365,350 
Total revenues – products   1,009,419    3,452,621 
Health and Wellness services   7,543    - 
Total revenues  $1,016,962   $3,452,621 

 

Cost of revenue

 

Cost of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue amounted to $297,333 (including inventory write-downs of $36,241) and $775,855 for the years ended December 31, 2021 and 2020, respectively.

 

Shipping and handling

 

Shipping and handling charges amounted to $11,054 and $9,315 for the years ended December 31, 2021 and 2020, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.

 

Advertising costs

 

Advertising costs amounted to $20,218 and $14,339 for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as incurred and included in selling expenses.

 

Commission expenses

 

Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $316,267 and $830,659 for the years ended December 31, 2021 and 2020, respectively.

 

Defined contribution plan

 

The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $99,488 and $75,802 for the years ended December 31, 2021 and 2020, respectively.

 

The related contribution plans include:

 

  - Social Security Organization (“SOSCO”) – 1.75% based on employee’s monthly salary capped of RM 4,000;
  - Employees Provident Fund (“EPF”) – 12% based on employee’s monthly salary;
  - Employment Insurance System (“EIS”) – 0.2% based on employee’s monthly salary capped of RM 4,000;
  - Human Resource Development Fund (“HRDF”) – 1% based on employee’s monthly salary

 

Income taxes

 

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. $395 and $0 penalties and interest incurred related to underpayment of income tax for the years ended December 31, 2021 and 2020, respectively.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Comprehensive income (loss)

 

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

 

Non-controlling interest

 

Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company.

 

Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2021 and 2020, there were no dilutive shares.

 

Foreign currencies translation and transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statements of operations and comprehensive income (loss).

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

   As of December 31, 
   2021   2020 
         
Period-end MYR : US$1 exchange rate   4.18    4.02 
Period-end HKD : US$1 exchange rate   7.80    7.75 

 

   For the years ended December 31, 
   2021   2020 
         
Period-average MYR : US$1 exchange rate   4.14    4.20 
Period-average HKD : US$1 exchange rate   7.77    7.76 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  ● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Leases

 

The Company adopts ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company’s leases include one or more options to renew, which is typically at the Company’s sole discretion. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications result in re-measurement of the right of use (“ROU”) assets and lease liabilities. Operating ROU assets and lease liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.

 

Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

In October 2020, the FASB issued ASU 2020-08, “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs”. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

In October 2020, the FASB issued ASU 2020-10, “Codification Improvements”. The amendments in this Update represent changes to clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 35 R9.htm IDEA: XBRL DOCUMENT v3.22.1
VARIABLE INTEREST ENTITY (“VIE”)
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VARIABLE INTEREST ENTITY (“VIE”)

3. VARIABLE INTEREST ENTITY (“VIE”)

 

SEA is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided majority of ASL’s purchases. Its equity at risk was insufficient to finance its activities and 100% of its business is transacted with ASL. Therefore, it was considered to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:

 

  a. The power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and
  b. The obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

 

Accordingly, the accounts of SEA is consolidated in the accompanying financial statements.

 

The carrying amount of the VIE’s assets and liabilities were as follows:

         
   As of December 31, 
   2021   2020 
         
Current assets  $18,850   $48,717 
Current liabilities   (51,272)   (53,573)
Net deficit  $(32,422)  $(4,856)

 

         
   As of December 31, 
   2021   2020 
         
Current assets:          
Cash  $17,493   $37,387 
Prepaid taxes   1,357    11,330 
Total current assets  $18,850   $48,717 
           
Current liabilities:          
Accounts payable – intercompany  $49,724   $51,669 
Other payables and accrued liabilities   1,548    1,904 
Total current liabilities  $51,272   $53,573 
           
Net deficit  $(32,422)  $(4,856)

 

The summarized operating results of the VIE’s are as follows:

 

         
   For the years ended December 31, 
   2021   2020 
         
Operating revenues  $-   $346,907 
Gross profit  $-   $4,442 
Loss from operations  $(21,966)  $(10,752)
Net loss  $(27,966)  $(24,014)

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 36 R10.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION
 12 Months Ended
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]  
BUSINESS COMBINATION

4. BUSINESS COMBINATION

 

On May 8, 2020, the Company entered into a Share Exchange Agreement (“SPA”) with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $1,804,046, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $656,495 as of March 31, 2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue 176,547 shares of the Company’s common stock, par value $0.0001, representing approximately 0.0469% of the total issued and outstanding shares in the Company after the issuance of the Shares, which is valued at $1,147,551 based on the closing price of $6.50 of the Company as quoted on the OTC Market on March 31, 2020. As of December 31, 2020, the Company has issued all 176,547 shares of the Company’s common stock.

 

The Company’s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020 as ASL was under the common control of Mr. How.

 

The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.

   Carry Value 
ASSETS     
Current assets     
Cash  $1,206,493 
Other receivables   33,210 
Other receivables - related parties   219,121 
Inventories   616,880 
Prepaid taxes   1,206,821 
Prepayments and other assets   318,267 
Total current assets   3,600,792 
      
Other assets     
Property and equipment, net   325,648 
Intangible assets, net   6,686 
Deferred taxes asset, net   172,250 
Total other assets   504,584 
      
Total assets  $4,105,376 
      
LIABILITIES AND SHAREHOLDERS’ EQUITY     
Current liabilities     
Accounts payable - related party  $491,628 
Customer deposits   1,600,606 
Other payables and accrued liabilities   209,096 
Total current liabilities   2,301,330 
      
Total liabilities  $2,301,330 
      
Total net assets acquired  $1,804,046 

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

4. BUSINESS COMBINATION (CONT’D)

 

The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2020. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2020. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.

 

 

   For the year ended December 31, 2020 
     
Revenue  $4,693,873 
Cost of revenue   (875,708)
Gross profit   3,818,165 
Total operating expenses   (3,839,184)
 Loss from operations   (21,019)
Other income (expense), net   267,633 
Income before income taxes   246,614 
Provision for income taxes   (212,414)
Net income  $34,200 
Net income per common share - basic and diluted  $0.00 
Weighted average number of common shares outstanding - basic and diluted   376,452,047 

 
XML 37 R11.htm IDEA: XBRL DOCUMENT v3.22.1
CASH AND CASH EQUIVALENTS
 12 Months Ended
Dec. 31, 2021
Cash and Cash Equivalents [Abstract]  
CASH AND CASH EQUIVALENTS

5. CASH AND CASH EQUIVALENTS

 

As of December 31, 2021 and 2020 the Company had $2,597,848 and $3,517,600, respectively, of cash and cash equivalents, which consists of $554,864 and $1,112,147, respectively, of cash in banks and $1,975,347 and $2,391,182, respectively, of time deposits placed with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between 1.10% to 1.25% per annum.

 
XML 38 R12.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTS RECEIVABLE
 12 Months Ended
Dec. 31, 2021
Receivables [Abstract]  
ACCOUNTS RECEIVABLE

6. ACCOUNTS RECEIVABLE

           
   As of December 31, 
   2021   2020 
Accounts receivable  $-   $172,757 
Allowance for doubtful accounts   -    - 
Total  $-   $172,757 

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 39 R13.htm IDEA: XBRL DOCUMENT v3.22.1
INVENTORIES
 12 Months Ended
Dec. 31, 2021
Inventory Disclosure [Abstract]  
INVENTORIES

7. INVENTORIES

 

Inventories consist of the following:

         
   As of December 31, 
   2021   2020 
Finished goods  $375,535   $589,814 

 

For the years ended December 31, 2021 and 2020, the Company recognized $36,241 and $0 inventory write-down, respectively.

 
XML 40 R14.htm IDEA: XBRL DOCUMENT v3.22.1
PREPAYMENTS AND DEPOSITS
 12 Months Ended
Dec. 31, 2021
Prepayments And Deposits  
PREPAYMENTS AND DEPOSITS

8. PREPAYMENTS AND DEPOSITS

           
   As of December 31, 
   2021   2020 
Receivables from sales distributors  $115,379   $35,302 
Deposits to suppliers   301,233    261,068 
Subtotal   416,612    296,370 
Less: Provision for doubtful accounts   (121,095)   - 
Total  $295,517   $296,370 

 

Movements of allowance for doubtful accounts are as follows:

 SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS

         
   For the years ended December 31, 
   2021   2020 
Beginning balance  $-   $- 
Addition   121,514    - 
Write off   -    - 
Exchange rate effect   (419)   - 
Ending balance  $121,095   $- 

 
XML 41 R15.htm IDEA: XBRL DOCUMENT v3.22.1
PROPERTY AND EQUIPMENT, NET
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

9. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consist of the following:

 

       
   As of December 31, 
   2021   2020 
Computer and office equipment  $82,298   $81,437 
Furniture & fixtures   122,185    126,966 
Leasehold improvements   202,570    210,496 
Vehicle   98,702    102,564 
Subtotal   505,755    521,463 
Less: accumulated depreciation   (289,956)   (223,154)
Total  $215,799   $298,309 

 

Depreciation expense for the years ended December 31, 2021 and 2020 amounted to $75,797 and $55,407, respectively.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 42 R16.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS, NET
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS, NET

10. INTANGIBLE ASSETS, NET

 

Intangible assets, net, consist of the following:

 

       
   As of December 31, 
   2021   2020 
Computer software  $34,453   $35,801 
Less: accumulated amortization   (30,793)   (29,975)
Total  $3,660   $5,826 

 

Amortization expense for the years ended December 31, 2021 and 2020 amounted to $1,961 and $1,505, respectively.

 
XML 43 R17.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENT IN MARKETABLE SECURITIES
 12 Months Ended
Dec. 31, 2021
Investment In Marketable Securities  
INVESTMENT IN MARKETABLE SECURITIES

11. INVESTMENT IN MARKETABLE SECURITIES

 

  (i) On May 17, 2018, the Company purchased 83,333 shares of common stock in Greenpro Capital Corp. for $500,000 at a purchase price of $6 per share.
     
  (ii) On July 30, 2018, the Company disposed 20 shares of common stock in Greenpro Capital Corp. for $125 at a purchase price of $6.2613 per share.
     
  (iii) On October 16, 2018, the Company purchased 33,333 shares of common stock in Greenpro Capital Corp. for $1,000 at a purchase price of $0.03 per share.
     
  (iv) On November 3, 2020, the Company received dividend of 6,667 shares of common stock in DSwiss, Inc. for $76,671 at fair value of $11.50 per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.’s shares
     
  (v) On December 9, 2020, the Company received dividend of 16,663 shares of common stock in DSwiss, Inc. for $83,315 at fair value of $5 per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.’s shares.
     
  (vi) On September 27, 2021, the Company received dividend of 11,665 shares of common stock in SEATech Ventures Corp. for $18,874 at fair value of $1.62 per share from Greenpro Capital Corp as a dividend income since Greenpro Capital Corp previously owned these shares.

 

   2021   2020 
   As of December 31, 
   2021   2020 
Cost of investment  $577,035   $66,484 
Dividend income from Greenpro Capital Corp.   18,939    160,062 
Unrealized holding (loss) gain   (505,231)   350,137 
Exchange rate effect   (1,742)   352 
Investment in marketable securities  $89,001   $577,035 

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 44 R18.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENT IN NON-MARKETABLE SECURITIES
 12 Months Ended
Dec. 31, 2021
Investment In Non-marketable Securities  
INVESTMENT IN NON-MARKETABLE SECURITIES

12. INVESTMENT IN NON-MARKETABLE SECURITIES

 

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (RM 3,500,000), which approximated 20% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019, Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately 20.0% to approximately 17.86%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.

 

Unreserved Sdn Bhd was incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.

 

On March 3, 2020, the Company agreed to sell the 17.86% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value of $730,637 to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $70,173, and had an amount due from director of $660,464 at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in a transaction which the Company had acquired the CEO’s ownership interest of Agape Superior Living Sdn. Bhd.

 

On April 3, 2019, the Company purchased a 5% of stock or 15,000,000 shares of common stock in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

 

   As of December 31, 
Unreserved Sdn Bhd  2021   2020 
Investment in non-marketable securities  $-   $730,637 
Less: Sale of investment in non-marketable securities   -    (730,637)
Investment in non-marketable securities   -    - 

 

Phoenix Plus Corporation          
Cost of investment   1,500    1,500 
           
Total investment in non-marketable securities  $1,500   $1,500 

 
XML 45 R19.htm IDEA: XBRL DOCUMENT v3.22.1
OTHER PAYABLES AND ACCRUED LIABILITIES
 12 Months Ended
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]  
OTHER PAYABLES AND ACCRUED LIABILITIES

13. OTHER PAYABLES AND ACCRUED LIABILITIES

 

   2021   2020 
   As of December 31, 
   2021   2020 
Professional fees  $436,541   $297,636 
Promotion expenses   36,024    37,433 
Payroll   22,669    23,976 
Commission   219,721    224,711 
Others   143,400    63,921 
           
Total  $858,355   $647,677 

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 46 R20.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY BALANCES AND TRANSACTIONS
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
RELATED PARTY BALANCES AND TRANSACTIONS

14. RELATED PARTY BALANCES AND TRANSACTIONS

 

Related party balances

 

Amount due from related parties

 

Name of Related        As of December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape ATP (Asia) Limited (“AATP Asia”)  Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia  Expenses paid for AATP Asia  $2,214   $2,227 

Hostastay Sdn. Bhd.

“Hostastay” 

  Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay  Sublease rent due from Hostastay   4,790    996 

TH3 Technology Sdn Bhd

“TH3 Technology”

  Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology  Expenses paid for TH3 Technology   -    12 
Total        $7,004   $3,235 

 

Amount due to a Related Party

 

Name of Related        As of December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape Superior Living Pty Ltd “ASLPL”  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  ATP Label Printing Fees   $-   $455 
Total        $-   $455 

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

14. RELATED PARTY BALANCES AND TRANSACTIONS (CONT’D)

 

Related party transactions

 

Revenue

 

Name of Related        For the years ended December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  Sales of products  $-   $18,060 
Vettons Sdn Bhd*  Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021  Sales of products made through its platform   6,625    - 
Total        $6,625   $18,060 

 

* During the year ended December 31, 2021, the Company had sales of $6,625 through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.

 

Purchase

 

         For the years ended December 31, 
Name of Related Party  Relationship  Nature  2021   2020 
               
DSY Wellness & Longevity Center Sdn Bhd  Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd.  Purchase  $718   $- 
Total        $718   $- 

 

Commission expense

 

        For the years ended December 31,  
Name of Related Party  Relationship  Nature  2021   2020 
               
Mr. How Kok Choong  Mr. How Kok Choong, the CEO and director of the Company.  Commission expense  $12,758   $10,740 
Total        $12,758   $10,740 

 

Other income

 

Name of Related Party           For the years ended December 31,  
  Relationship   Nature   2021     2020  
                     
Hostastay Sdn. Bhd.   Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay   Sublease rental income due from Hostastay   $ 4,345     $ 2,881  
Total           $ 4,345     $ 2,881  

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 47 R21.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

15. STOCKHOLDERS’ EQUITY

 

Preferred stock

 

As of December 31, 2021 and 2020, there were 200,000,000 preferred stocks authorized but none were issued and outstanding.

 

Common stock

 

As of December 31, 2021 and 2020, there were 1,000,000,000 common stocks authorized, 290,460,047 and 376,452,047 shares issued and outstanding, respectively.

 

In May 2020, the Company issued 162,694 shares of the Company’s common stock in connection with the acquisition of ASL as part of the acquisition payment.

 

In June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased by $90,043, which required the issuance of an additional 13,853 shares of the Company’s common stock to fully satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The 13,853 additional shares were issued in July 2020.

 

In December 2021, there were share forfeiture agreements (the “Share Forfeiture Agreements”) between the Company and (i) HKC Talent Limited; (ii) various shareholders of the Company (the “Forfeiting Shareholders”), pursuant to which: (i) HKC Talent Limited had agreed to forfeiture of 41,750,000 shares of common stock of the Company, and (ii) the Forfeiting Shareholders had agreed to forfeiture, in aggregate, 44,242,000 shares of common stock of the Company. Included in (ii) is 11,242,000 shares forfeited from HKC Holdings Sdn. Bhd, a company in which Mr. How Kok Choong, the CEO and director of the Company, is a shareholder. As a result, the outstanding shares was reduced by 85,992,000 shares of common stock.

 

There were no stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2021 and 2020.

 
XML 48 R22.htm IDEA: XBRL DOCUMENT v3.22.1
NON-CONTROLLING INTEREST
 12 Months Ended
Dec. 31, 2021
Noncontrolling Interest [Abstract]  
NON-CONTROLLING INTEREST

16. NON-CONTROLLING INTEREST

 

The Company’s non-controlling interest consists of the following:

 

 

   2021   2020 
   As of December 31, 
   2021   2020 
DSY Wellness:      
Paid-in capital  $97   $- 
Accumulated deficit   (436)   - 
Accumulated other comprehensive income   3    - 
 Non Controlling interest Gross   (336)   - 
ASL   -          - 
Total  $(336)  $- 

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 49 R23.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
INCOME TAXES

17. INCOME TAXES

 

The United States and foreign components of (loss) income before income taxes were comprised of the following:

         
   For the years ended December 31, 
   2021   2020 
Tax jurisdictions from:          
Local – United States  $(706,659)  $(735,159)
Foreign – Malaysia   (1,064,314)   1,070,806 
Foreign – Hong Kong   (616,640)   180,700 
(Loss) income before income tax  $(2,387,613)  $516,347 

 

The (provision for) benefit of income taxes consisted of the following:

         
   For the years ended December 31, 
   2021   2020 
Current:        
- Local  $(22,205)  $- 
- Foreign   (104,735)   16,748 
           
Deferred:          
- Local   -    - 
- Foreign   (10,127)   (178,329)
           
Provision for income taxes  $(137,067)  $(161,581)

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a corporate tax rate of 21% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart F income (“Subpart F”) tax, which is a tax primarily on passive income from controlled foreign corporations with a tax rate of 35%. In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax, which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are applied.

 

For the years ended December 31, 2021 and 2020, the Company’s foreign subsidiaries did not generate any income that are subject to Subpart F tax and GILTI tax.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

17. INCOME TAXES (CONT’D)

 

For the year ended December 31, 2021, the Company re-visited its fiscal 2020 U.S. income taxes and determined its stock dividend from Greenpro Capital Corp as a result of its Spin-off of DSwiss Inc.’s shares in 2020 were subject to Subpart F and GILTI taxes. As a result, the Company incurred additional income taxes expenses of $22,205, including interest and penalty of $395, for the year ended December 31, 2021, after utilizing its estimated cumulative net operating losses (“NOL”) of $312,608 as of December 31, 2020. As a result, the Company’s deferred tax assets of estimated NOL of $65,648 were fully utilized and reduced to $0.

 

As of December 31, 2021 and 2020, the operations in the United States of America incurred approximately $729,000 and $0, respectively, of cumulative net operating losses (“NOL”) which can be carried forward to offset future taxable income or Subpart F and GILTI taxes. These balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately $153,000 and $0, respectively.

 

Malaysia

 

Changes to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies incorporated in Labuan to satisfy the “substantial activity requirements” to qualify for the preferential tax rate of 3% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the “substantial activity requirements” was issued. As Agape ATP Corporation did not maintain a permanent establishment in Labuan, and therefore did not satisfy the said requirements, the company was subjected to tax at 24% on its net audited profit. On June 11, 2021, Agape ATP Corporation made an irrevocable election to be taxed under the Malaysian Income Tax Act 1967 as the elected tax regime is more tax efficient to the entity compare to LBATA.

 

Agape Superior Living Sdn Bhd, Agape S.E.A Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of Malaysia and the income taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia, enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate.

 

As of December 31, 2021 and 2020, the operations in the Malaysia incurred approximately $946,000 and $261,000, respectively, of cumulative net operating losses (“NOL”) which can be carried forward to offset future taxable income. Approximately $685,000 and $261,000 of the net operating loss carry forwards will expire in 2028 and 2027, respectively, if unutilized. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately $217,000 and $0, respectively.

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

17. INCOME TAXES (CONT’D)

 

The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:

         
   For the years ended December 31, 
   2021   2020 
U.S. statutory rate   21.0%   21.0%
Valuation allowance   (17.0)%   (4.0)%
Differential tax rate in Malaysia   3.0%   3.0%
Permanent difference   (12.7)%(1)   11.3%(2)
Effective tax rate   (5.7)%   31.3%

 

  (1) The amount comprised:
 
    - 6.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and
    - 6.7% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.
       
  (2) The amount comprised:
 
    - 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;
    -

0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and

    - 1.3% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

         
   As of December 31, 
   2021   2020 
Deferred tax assets:          
Net operating loss carry forwards in U.S.  $153,061   $- 
Net operating loss carry forwards in Malaysia   227,106    62,678 
Less: valuation allowance   (380,167)   -
Deferred tax liabilities:          
Depreciation   (15,574)   (68,421)
Deferred tax liabilities, net  $(15,574)  $(5,743)

 

Uncertain tax positions

 

The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the years ended December 31, 2020 and 2020.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 
XML 50 R24.htm IDEA: XBRL DOCUMENT v3.22.1
CONCENTRATIONS OF RISKS
 12 Months Ended
Dec. 31, 2021
Risks and Uncertainties [Abstract]  
CONCENTRATIONS OF RISKS

18. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the years ended December 31, 2021 and 2020, no customer accounted for 10% or more of the Company’s total revenues.

 

There are no accounts receivable balance as of December 31, 2021. As of December 31, 2020, receivables from a third-party e-commerce company accounted for approximately 100.0% of the total balance of accounts receivable.

 

(b) Major vendors

 

For the year ended December 31, 2021, two vendors accounted for approximately 47.3% and 45.2% of the Company’s total purchases, respectively. For the year ended December 31, 2020, two vendors accounted for approximately 74.1% and 25.9% of the Company’s total purchases. In November and December 2020, the Company received dividend of 23,330 shares of common stock of DSwiss, Inc., represents approximately 0.01% ownership that the Company accounted for as investment in marketable securities (See Note 11). DSwiss, Inc.’s wholly owned subsidiary is the vendor that accounted for the Company’s total purchases of approximately 47.3% and 74.1% for the years ended December 31, 2021 and 2020, respectively.

 

As of December 31, 2021, one vendor accounted for 100% of the total balance of accounts payable. There are no accounts payable balance as of December 31, 2020.

 

(c) Commission Expenses to Sales Distributors and Stockists

 

For the year ended December 31, 2021, one sales distributor accounted for 17.9% of the Company’s total commission expense.

 

For the year ended December 31, 2020, no sales distributor accounted for 10.0% of the Company’s total commission expense.

 

(d) Credit risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December 31, 2021 and 2020, $554,864 and $1,112,147 were deposited with financial institutions, respectively, $295,761 and $563,788 of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

18. CONCENTRATIONS OF RISKS (CONT’D)

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 
XML 51 R25.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

19. COMMITMENTS AND CONTINGENCIES

 

Lease commitments

 

On April 1, 2020, the Company adopted ASC 842 for ASL’s office space lease and sales and training center as the lease commencement date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $490,000, with a corresponding right-of-use (“ROU”) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an effective interest rate of 5.5%, which was determined using the Company’s estimated incremental borrowing rate.

 

On May 31, 2021, the Company entered into two separate two-year leases extension with the modified lease expiring May 31, 2023 for its office space and expiring August 31, 2023 for its training center. The lease modification required the Company to re-measure the ROU assets and lease liabilities based on the modified leases. The Company recognized a reduction of $3,250 in ROU assets and lease liabilities upon lease modifications based on the present value of the future minimum rental payments of the lease, using an effective interest rate of 5.5%, which was determined using the Company’s estimated incremental borrowing rate.

 

As of December 31, 2021, the weighted remaining term of the lease is approximately 1.64 years.

 

The five-year maturity of the Company’s operating lease liabilities is as follow:

Twelve Months Ending December 31,  Operating lease liabilities 
     
2022  $166,426 
2023   84,915 
Thereafter   - 
Total lease payments   251,341 
Less: interest   (10,763)
Present value of lease liabilities  $240,578 

 

Rent expense for the years ended December 31, 2021 and 2020 was $179,562 and $156,716, respectively.

 

Contingencies

 

Legal

 

From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

19. COMMITMENTS AND CONTINGENCIES (CONT’D)

 

COVID-19

 

Since the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO, Malaysia has been put through various stages of lockdowns such as (1) full movement control orders (“MCO”), under which, quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (“RMCO”). On January 12, 2021, due to a resurgence of COVID-19 cases, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the country. February 2021 marked a significant month for Malaysia as all frontline staff of the country, which comprised those in healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defense sectors were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless, COVID-19 cases in the country continue to rise. On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot.

 

Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:

 

  ● temporary closure of offices, travel restrictions, financial impact of the Company’s customers or suspension supplies may be negatively affected, and could continue to negatively affect the demand for the Company’s product;
  ● the Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely affect its financial condition and operating results; and
  ● any disruption of the Company’s supply chain, logistics providers or customers could adversely impact its business and results of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery to its customers, which may also lead to loss of its customers.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that the Company’s total revenues will grow or remain at the similar level year over year in 2021 and 2022.

 
XML 52 R26.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

20. SUBSEQUENT EVENTS

 

Forfeiture of Common Stock

 

A share forfeiture agreement (the “Share Forfeiture Agreement”) dated January 20, 2022, between the Company and Mr. How Kok Choong, the CEO and director of the Company, pursuant to which Mr. How Kok Choong agreed to forfeit 215,008,035 shares of common stock of the Company.
XML 53 R27.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).

 

The consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.

 
Principles of consolidation

Principles of consolidation

 

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE.

 
Use of estimates

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 
Cash and cash equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.
Accounts receivable

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, no allowance of doubtful accounts was recorded.

 
Inventories

Inventories

 

Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. For the years ended December 31, 2021, and 2020, the company recorded $36,241 and $0 write-downs for inventory.

 
Prepaid taxes

Prepaid taxes

 

Prepaid taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax.

 
Prepayments and deposits

Prepayments and deposits

 

Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, there was $121,514 and $0 allowance for the doubtful accounts recorded.
Property and equipment, net

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

    Useful Life
     
Computer and office equipment   5-7 years
Furniture & fixtures  

6-7 years

Leasehold improvements   Lease Term
Vehicle   5 years

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.

 
Intangible assets, net

Intangible assets, net

 

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

Classification   Useful Life
     
Computer software   5 years

 
Impairment for long-lived assets

Impairment for long-lived assets

 

Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and 2020, no impairment of long-lived assets was recognized.

 
Deferred offering costs

Deferred offering costs

 

Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.

 
Investment in marketable equity securities

Investment in marketable equity securities

 

The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s unaudited condensed consolidated statements of operations and comprehensive loss in the caption of “unrealized holding gain loss on marketable securities” in each reporting period.
Investment in non-marketable equity securities

Investment in non-marketable equity securities

 

The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

 

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

 
Customer deposits

Customer deposits

 

Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.

 
Revenue recognition

Revenue recognition

 

The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $15,209 and $170,431 as forfeited coupon income.

 

As of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $183,816 which it is expected to fulfill within 12 months from December 31, 2021.

 

Sales of Health and Wellness services

 

- Performance obligations satisfied at a point in time

 

The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person.

 

The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp. For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $7,543 and $0, respectively.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

Disaggregated information of revenues by products and services are as follows:

 

       
   For the years ended December 31, 
   2021   2020 
         
Survivor Select  $83,904   $149,897 
Energized Mineral Concentrate   52,047    81,481 
Ionized Cal-Mag   39,527    908,964 
Omega Blend   222,718    495,567 
BetaMaxx   208,043    156,550 
Vege Fruit Fiber   65,757    1,755 
Iron   28,114    133,389 
Young Formula   52,425    653,631 
Organic Youth Care Cleansing Bar   5,137    43,127 
Mitogize   183,800    162,801 
No. 1 MED   15,331    46,713 
Energetique   25,574    253,396 
Trim+   27,042    365,350 
Total revenues – products   1,009,419    3,452,621 
Health and Wellness services   7,543    - 
Total revenues  $1,016,962   $3,452,621 

 
Cost of revenue

Cost of revenue

 

Cost of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue amounted to $297,333 (including inventory write-downs of $36,241) and $775,855 for the years ended December 31, 2021 and 2020, respectively.

 
Shipping and handling

Shipping and handling

 

Shipping and handling charges amounted to $11,054 and $9,315 for the years ended December 31, 2021 and 2020, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.

 
Advertising costs

Advertising costs

 

Advertising costs amounted to $20,218 and $14,339 for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as incurred and included in selling expenses.

 
Commission expenses

Commission expenses

 

Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $316,267 and $830,659 for the years ended December 31, 2021 and 2020, respectively.

 
Defined contribution plan

Defined contribution plan

 

The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $99,488 and $75,802 for the years ended December 31, 2021 and 2020, respectively.

 

The related contribution plans include:

 

  - Social Security Organization (“SOSCO”) – 1.75% based on employee’s monthly salary capped of RM 4,000;
  - Employees Provident Fund (“EPF”) – 12% based on employee’s monthly salary;
  - Employment Insurance System (“EIS”) – 0.2% based on employee’s monthly salary capped of RM 4,000;
  - Human Resource Development Fund (“HRDF”) – 1% based on employee’s monthly salary

 
Income taxes

Income taxes

 

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. $395 and $0 penalties and interest incurred related to underpayment of income tax for the years ended December 31, 2021 and 2020, respectively.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 
Comprehensive income (loss)

Comprehensive income (loss)

 

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

 
Non-controlling interest

Non-controlling interest

 

Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company.

 
Earnings (loss) per share

Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the years ended December 31, 2021 and 2020, there were no dilutive shares.

 
Foreign currencies translation and transaction

Foreign currencies translation and transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statements of operations and comprehensive income (loss).

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

   As of December 31, 
   2021   2020 
         
Period-end MYR : US$1 exchange rate   4.18    4.02 
Period-end HKD : US$1 exchange rate   7.80    7.75 

 

   For the years ended December 31, 
   2021   2020 
         
Period-average MYR : US$1 exchange rate   4.14    4.20 
Period-average HKD : US$1 exchange rate   7.77    7.76 

 
Related parties

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 
Fair value of financial instruments

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  ● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.
Leases

Leases

 

The Company adopts ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company’s leases include one or more options to renew, which is typically at the Company’s sole discretion. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications result in re-measurement of the right of use (“ROU”) assets and lease liabilities. Operating ROU assets and lease liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.

 

Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.

 
Recent accounting pronouncements

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information.

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)

 

In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

In October 2020, the FASB issued ASU 2020-08, “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs”. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

 

In October 2020, the FASB issued ASU 2020-10, “Codification Improvements”. The amendments in this Update represent changes to clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.
XML 54 R28.htm IDEA: XBRL DOCUMENT v3.22.1
ORGANIZATION AND BUSINESS BACKGROUND (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
SCHEDULE OF SUBSIDIARIES AND ASSOCIATES

Details of the Company’s subsidiaries:

 

    Subsidiary company name  Place and date of incorporation  Particulars of issued capital  Principal activities  Proportional of ownership interest and voting power held 
                  
1.   Agape ATP Corporation  Labuan,
March 6, 2017		  100 shares of ordinary share of US$1 each  Investment holding   100%
                   
2.   Agape ATP International Holding Limited  Hong Kong,
June 1, 2017		  1,000,000 shares of ordinary share of HK$1 each  Wholesaling of health and wellness products; and health solution advisory services   100%
                   
3.   Agape Superior Living Sdn. Bhd.  Malaysia,
August 8, 2003		  9,590,598 shares of ordinary share of RM1 each  Health and wellness products and health solution advisory services via network marketing   99.99%
                   
4.   Agape S.E.A. Sdn. Bhd.  Malaysia,
March 4, 2004		  2 shares of ordinary share of RM1 each  VIE of Agape Superior Living Sdn. Bhd.   VIE 
                   
5.   Wellness ATP International Holdings Sdn, Bhd  Malaysia,
September 11, 2020		  100 shares of ordinary share of RM1 each  The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns   100%
                   
6.   DSY Wellness International Sdn Bhd.  Malaysia,
November 11, 2021		  1,000 shares of ordinary share of RM1 each  Provision of complementary health therapies   60%
XML 55 R29.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

    Useful Life
     
Computer and office equipment   5-7 years
Furniture & fixtures  

6-7 years

Leasehold improvements   Lease Term
Vehicle   5 years
SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

Classification   Useful Life
     
Computer software   5 years
SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES

Disaggregated information of revenues by products and services are as follows:

 

       
   For the years ended December 31, 
   2021   2020 
         
Survivor Select  $83,904   $149,897 
Energized Mineral Concentrate   52,047    81,481 
Ionized Cal-Mag   39,527    908,964 
Omega Blend   222,718    495,567 
BetaMaxx   208,043    156,550 
Vege Fruit Fiber   65,757    1,755 
Iron   28,114    133,389 
Young Formula   52,425    653,631 
Organic Youth Care Cleansing Bar   5,137    43,127 
Mitogize   183,800    162,801 
No. 1 MED   15,331    46,713 
Energetique   25,574    253,396 
Trim+   27,042    365,350 
Total revenues – products   1,009,419    3,452,621 
Health and Wellness services   7,543    - 
Total revenues  $1,016,962   $3,452,621 
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

   As of December 31, 
   2021   2020 
         
Period-end MYR : US$1 exchange rate   4.18    4.02 
Period-end HKD : US$1 exchange rate   7.80    7.75 

 

   For the years ended December 31, 
   2021   2020 
         
Period-average MYR : US$1 exchange rate   4.14    4.20 
Period-average HKD : US$1 exchange rate   7.77    7.76 
XML 56 R30.htm IDEA: XBRL DOCUMENT v3.22.1
VARIABLE INTEREST ENTITY (“VIE”) (Tables)
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF VARIABLE INTEREST ENTITY

The carrying amount of the VIE’s assets and liabilities were as follows:

         
   As of December 31, 
   2021   2020 
         
Current assets  $18,850   $48,717 
Current liabilities   (51,272)   (53,573)
Net deficit  $(32,422)  $(4,856)

 

         
   As of December 31, 
   2021   2020 
         
Current assets:          
Cash  $17,493   $37,387 
Prepaid taxes   1,357    11,330 
Total current assets  $18,850   $48,717 
           
Current liabilities:          
Accounts payable – intercompany  $49,724   $51,669 
Other payables and accrued liabilities   1,548    1,904 
Total current liabilities  $51,272   $53,573 
           
Net deficit  $(32,422)  $(4,856)

 

The summarized operating results of the VIE’s are as follows:

 

         
   For the years ended December 31, 
   2021   2020 
         
Operating revenues  $-   $346,907 
Gross profit  $-   $4,442 
Loss from operations  $(21,966)  $(10,752)
Net loss  $(27,966)  $(24,014)
XML 57 R31.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION (Tables)
 12 Months Ended
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]  
SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED

The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.

   Carry Value 
ASSETS     
Current assets     
Cash  $1,206,493 
Other receivables   33,210 
Other receivables - related parties   219,121 
Inventories   616,880 
Prepaid taxes   1,206,821 
Prepayments and other assets   318,267 
Total current assets   3,600,792 
      
Other assets     
Property and equipment, net   325,648 
Intangible assets, net   6,686 
Deferred taxes asset, net   172,250 
Total other assets   504,584 
      
Total assets  $4,105,376 
      
LIABILITIES AND SHAREHOLDERS’ EQUITY     
Current liabilities     
Accounts payable - related party  $491,628 
Customer deposits   1,600,606 
Other payables and accrued liabilities   209,096 
Total current liabilities   2,301,330 
      
Total liabilities  $2,301,330 
      
Total net assets acquired  $1,804,046 
SCHEDULE OF PRO FORMA BUSINESS COMBINATION

 

 

   For the year ended December 31, 2020 
     
Revenue  $4,693,873 
Cost of revenue   (875,708)
Gross profit   3,818,165 
Total operating expenses   (3,839,184)
 Loss from operations   (21,019)
Other income (expense), net   267,633 
Income before income taxes   246,614 
Provision for income taxes   (212,414)
Net income  $34,200 
Net income per common share - basic and diluted  $0.00 
Weighted average number of common shares outstanding - basic and diluted   376,452,047 
XML 58 R32.htm IDEA: XBRL DOCUMENT v3.22.1
ACCOUNTS RECEIVABLE (Tables)
 12 Months Ended
Dec. 31, 2021
Receivables [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY

           
   As of December 31, 
   2021   2020 
Accounts receivable  $-   $172,757 
Allowance for doubtful accounts   -    - 
Total  $-   $172,757 
XML 59 R33.htm IDEA: XBRL DOCUMENT v3.22.1
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2021
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORIES

Inventories consist of the following:

         
   As of December 31, 
   2021   2020 
Finished goods  $375,535   $589,814 
XML 60 R34.htm IDEA: XBRL DOCUMENT v3.22.1
PREPAYMENTS AND DEPOSITS (Tables)
 12 Months Ended
Dec. 31, 2021
Prepayments And Deposits  
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS

           
   As of December 31, 
   2021   2020 
Receivables from sales distributors  $115,379   $35,302 
Deposits to suppliers   301,233    261,068 
Subtotal   416,612    296,370 
Less: Provision for doubtful accounts   (121,095)   - 
Total  $295,517   $296,370 
SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS

Movements of allowance for doubtful accounts are as follows:

 SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS

         
   For the years ended December 31, 
   2021   2020 
Beginning balance  $-   $- 
Addition   121,514    - 
Write off   -    - 
Exchange rate effect   (419)   - 
Ending balance  $121,095   $- 
XML 61 R35.htm IDEA: XBRL DOCUMENT v3.22.1
PROPERTY AND EQUIPMENT, NET (Tables)
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT, NET

Property and equipment, net consist of the following:

 

       
   As of December 31, 
   2021   2020 
Computer and office equipment  $82,298   $81,437 
Furniture & fixtures   122,185    126,966 
Leasehold improvements   202,570    210,496 
Vehicle   98,702    102,564 
Subtotal   505,755    521,463 
Less: accumulated depreciation   (289,956)   (223,154)
Total  $215,799   $298,309 
XML 62 R36.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS, NET (Tables)
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS, NET

Intangible assets, net, consist of the following:

 

       
   As of December 31, 
   2021   2020 
Computer software  $34,453   $35,801 
Less: accumulated amortization   (30,793)   (29,975)
Total  $3,660   $5,826 
XML 63 R37.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENT IN MARKETABLE SECURITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Investment In Marketable Securities  
SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES

 

   2021   2020 
   As of December 31, 
   2021   2020 
Cost of investment  $577,035   $66,484 
Dividend income from Greenpro Capital Corp.   18,939    160,062 
Unrealized holding (loss) gain   (505,231)   350,137 
Exchange rate effect   (1,742)   352 
Investment in marketable securities  $89,001   $577,035 
XML 64 R38.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Investment In Non-marketable Securities  
SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES

 

   As of December 31, 
Unreserved Sdn Bhd  2021   2020 
Investment in non-marketable securities  $-   $730,637 
Less: Sale of investment in non-marketable securities   -    (730,637)
Investment in non-marketable securities   -    - 

 

Phoenix Plus Corporation          
Cost of investment   1,500    1,500 
           
Total investment in non-marketable securities  $1,500   $1,500 
XML 65 R39.htm IDEA: XBRL DOCUMENT v3.22.1
OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]  
SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES

 

   2021   2020 
   As of December 31, 
   2021   2020 
Professional fees  $436,541   $297,636 
Promotion expenses   36,024    37,433 
Payroll   22,669    23,976 
Commission   219,721    224,711 
Others   143,400    63,921 
           
Total  $858,355   $647,677 
XML 66 R40.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY BALANCES AND TRANSACTIONS (Tables)
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTIES

 

Name of Related        As of December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape ATP (Asia) Limited (“AATP Asia”)  Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia  Expenses paid for AATP Asia  $2,214   $2,227 

Hostastay Sdn. Bhd.

“Hostastay” 

  Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay  Sublease rent due from Hostastay   4,790    996 

TH3 Technology Sdn Bhd

“TH3 Technology”

  Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology  Expenses paid for TH3 Technology   -    12 
Total        $7,004   $3,235 

 

Amount due to a Related Party

 

Name of Related        As of December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape Superior Living Pty Ltd “ASLPL”  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  ATP Label Printing Fees   $-   $455 
Total        $-   $455 

 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

14. RELATED PARTY BALANCES AND TRANSACTIONS (CONT’D)

 

Related party transactions

 

Revenue

 

Name of Related        For the years ended December 31, 
Party  Relationship  Nature  2021   2020 
               
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  Sales of products  $-   $18,060 
Vettons Sdn Bhd*  Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021  Sales of products made through its platform   6,625    - 
Total        $6,625   $18,060 

 

* During the year ended December 31, 2021, the Company had sales of $6,625 through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.

 

Purchase

 

         For the years ended December 31, 
Name of Related Party  Relationship  Nature  2021   2020 
               
DSY Wellness & Longevity Center Sdn Bhd  Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd.  Purchase  $718   $- 
Total        $718   $- 

 

Commission expense

 

        For the years ended December 31,  
Name of Related Party  Relationship  Nature  2021   2020 
               
Mr. How Kok Choong  Mr. How Kok Choong, the CEO and director of the Company.  Commission expense  $12,758   $10,740 
Total        $12,758   $10,740 

 

Other income

 

Name of Related Party           For the years ended December 31,  
  Relationship   Nature   2021     2020  
                     
Hostastay Sdn. Bhd.   Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay   Sublease rental income due from Hostastay   $ 4,345     $ 2,881  
Total           $ 4,345     $ 2,881  
XML 67 R41.htm IDEA: XBRL DOCUMENT v3.22.1
NON-CONTROLLING INTEREST (Tables)
 12 Months Ended
Dec. 31, 2021
Noncontrolling Interest [Abstract]  
SCHEDULE OF NON CONTROLLING INTEREST

The Company’s non-controlling interest consists of the following:

 

 

   2021   2020 
   As of December 31, 
   2021   2020 
DSY Wellness:      
Paid-in capital  $97   $- 
Accumulated deficit   (436)   - 
Accumulated other comprehensive income   3    - 
 Non Controlling interest Gross   (336)   - 
ASL   -          - 
Total  $(336)  $- 
XML 68 R42.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX

The United States and foreign components of (loss) income before income taxes were comprised of the following:

         
   For the years ended December 31, 
   2021   2020 
Tax jurisdictions from:          
Local – United States  $(706,659)  $(735,159)
Foreign – Malaysia   (1,064,314)   1,070,806 
Foreign – Hong Kong   (616,640)   180,700 
(Loss) income before income tax  $(2,387,613)  $516,347 
SCHEDULE OF PROVISION FOR INCOME TAX

The (provision for) benefit of income taxes consisted of the following:

         
   For the years ended December 31, 
   2021   2020 
Current:        
- Local  $(22,205)  $- 
- Foreign   (104,735)   16,748 
           
Deferred:          
- Local   -    - 
- Foreign   (10,127)   (178,329)
           
Provision for income taxes  $(137,067)  $(161,581)
SCHEDULE OF EFFECTIVE INCOME TAX RATE

The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:

         
   For the years ended December 31, 
   2021   2020 
U.S. statutory rate   21.0%   21.0%
Valuation allowance   (17.0)%   (4.0)%
Differential tax rate in Malaysia   3.0%   3.0%
Permanent difference   (12.7)%(1)   11.3%(2)
Effective tax rate   (5.7)%   31.3%

 

  (1) The amount comprised:
 
    - 6.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and
    - 6.7% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.
       
  (2) The amount comprised:
 
    - 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;
    -

0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and

    - 1.3% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.
SCHEDULE OF DEFERRED TAX ASSETS

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

         
   As of December 31, 
   2021   2020 
Deferred tax assets:          
Net operating loss carry forwards in U.S.  $153,061   $- 
Net operating loss carry forwards in Malaysia   227,106    62,678 
Less: valuation allowance   (380,167)   -
Deferred tax liabilities:          
Depreciation   (15,574)   (68,421)
Deferred tax liabilities, net  $(15,574)  $(5,743)
XML 69 R43.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES (Tables)
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
SCHEDULE OF LEASE COMMITMENTS

The five-year maturity of the Company’s operating lease liabilities is as follow:

Twelve Months Ending December 31,  Operating lease liabilities 
     
2022  $166,426 
2023   84,915 
Thereafter   - 
Total lease payments   251,341 
Less: interest   (10,763)
Present value of lease liabilities  $240,578 
XML 70 R44.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)
 12 Months Ended
Dec. 31, 2021
Nov. 11, 2021
May 08, 2020
Subsidiary Company [Member]      
Subsidiary company name Agape ATP Corporation    
Place and date of incorporation Labuan, March 6, 2017    
Particulars of issued capital 100 shares of ordinary share of US$1 each    
Principal activities Investment holding    
Proportional of ownership interest and voting power held 100.00%    
Subsidiary Company One [Member]      
Subsidiary company name Agape ATP International Holding Limited    
Place and date of incorporation Hong Kong, June 1, 2017    
Particulars of issued capital 1,000,000 shares of ordinary share of HK$1 each    
Principal activities Wholesaling of health and wellness products; and health solution advisory services    
Proportional of ownership interest and voting power held 100.00%    
Subsidiary Company Two [Member]      
Subsidiary company name Agape Superior Living Sdn. Bhd.    
Place and date of incorporation Malaysia, August 8, 2003    
Particulars of issued capital 9,590,598 shares of ordinary share of RM1 each    
Principal activities Health and wellness products and health solution advisory services via network marketing    
Proportional of ownership interest and voting power held 99.99%   99.99%
Subsidiary Company Three [Member]      
Subsidiary company name Agape S.E.A. Sdn. Bhd.    
Place and date of incorporation Malaysia, March 4, 2004    
Particulars of issued capital 2 shares of ordinary share of RM1 each    
Principal activities VIE of Agape Superior Living Sdn. Bhd.    
Proportional of ownership interest and voting power held 100.00%    
Subsidiary Company Four [Member]      
Subsidiary company name Wellness ATP International Holdings Sdn, Bhd    
Place and date of incorporation Malaysia, September 11, 2020    
Particulars of issued capital 100 shares of ordinary share of RM1 each    
Principal activities The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns    
Proportional of ownership interest and voting power held 100.00%    
Subsidiary Company Five [Member]      
Subsidiary company name DSY Wellness International Sdn Bhd.    
Place and date of incorporation Malaysia, November 11, 2021    
Particulars of issued capital 1,000 shares of ordinary share of RM1 each    
Principal activities Provision of complementary health therapies    
Proportional of ownership interest and voting power held 60.00% 60.00%  
XML 71 R45.htm IDEA: XBRL DOCUMENT v3.22.1
ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) - shares
May 08, 2020
Dec. 31, 2021
Nov. 11, 2021
Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]      
Ownership interest percentage 99.99%    
Stock issued during period acquisitions, shares 9,590,596    
Agape ATP International Holding Limited [Member]      
Ownership interest percentage   100.00%  
Subsidiary Company Two [Member]      
Ownership interest percentage 99.99% 99.99%  
Subsidiary Company Five [Member]      
Ownership interest percentage   60.00% 60.00%
XML 72 R46.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)
 12 Months Ended
Dec. 31, 2021
Computer Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 5 years
Computer Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 7 years
Furniture and Fixtures [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 6 years
Furniture and Fixtures [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 7 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Lives of Property and Equipment Lease Term
Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 5 years
XML 73 R47.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)
 12 Months Ended
Dec. 31, 2021
Computer Software, Intangible Asset [Member]  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful lives of intangible assets 5 years
XML 74 R48.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Product Information [Line Items]    
Total revenues $ 1,016,962 $ 3,452,621
Survivor Select [Member]    
Product Information [Line Items]    
Total revenues 83,904 149,897
Energized Mineral Concentrate [Member]    
Product Information [Line Items]    
Total revenues 52,047 81,481
Ionized Cal-Mag [Member]    
Product Information [Line Items]    
Total revenues 39,527 908,964
Omega Blend [Member]    
Product Information [Line Items]    
Total revenues 222,718 495,567
Beta Maxx [Member]    
Product Information [Line Items]    
Total revenues 208,043 156,550
Vege Fruit Fiber [Member]    
Product Information [Line Items]    
Total revenues 65,757 1,755
Iron [Member]    
Product Information [Line Items]    
Total revenues 28,114 133,389
Young Formula [Member]    
Product Information [Line Items]    
Total revenues 52,425 653,631
Organic Youth Care Cleansing Bar [Member]    
Product Information [Line Items]    
Total revenues 5,137 43,127
Mitogize [Member]    
Product Information [Line Items]    
Total revenues 183,800 162,801
No. 1 MED [Member]    
Product Information [Line Items]    
Total revenues 15,331 46,713
Energetique [Member]    
Product Information [Line Items]    
Total revenues 25,574 253,396
Trim Plus [Member]    
Product Information [Line Items]    
Total revenues 27,042 365,350
Product [Member]    
Product Information [Line Items]    
Total revenues 1,009,419 3,452,621
Health And Wellness Services [Member]    
Product Information [Line Items]    
Total revenues $ 7,543
XML 75 R49.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Period-end MYR [Member]    
Debt Instrument [Line Items]    
Foreign Currency Exchange Rate, Translation 4.18 4.02
Period-end HKD [Member]    
Debt Instrument [Line Items]    
Foreign Currency Exchange Rate, Translation 7.80 7.75
Period-average MYR [Member]    
Debt Instrument [Line Items]    
Foreign currency exchange rate period average 4.14 4.20
Period-average HKD [Member]    
Debt Instrument [Line Items]    
Foreign currency exchange rate period average 7.77 7.76
XML 76 R50.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
 12 Months Ended
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
MYR (RM)
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2020
MYR (RM)
shares
Product Information [Line Items]        
Accounts receivable, allowance for credit loss    
Inventories write-down 36,241    
Allowance for doubtful accounts 121,514   0  
Impairment of long-lived assets 0   0  
Forfeited coupon income 15,209   170,431  
Revenue from sales 1,016,962   3,434,561  
Cost of revenue 297,333   775,855  
Selling expenses 394,682   376,582  
Advertising costs 20,218   14,339  
Commission expenses 316,267   830,659  
Defined contribution plan expense $ 99,488   75,802  
Income tax examination, likelihood of unfavorable settlement greater than 50% greater than 50%    
Income tax examination, penalties and interest expense $ 395   $ 0  
Noncontrolling interest, description Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals    
Potentially dilutive securities outstanding | shares 0 0 0 0
Social Security Organization [Member]        
Product Information [Line Items]        
Salary percentage 1.75% 1.75%    
Social Security Organization [Member] | MYR Currency [Member]        
Product Information [Line Items]        
Monthly salary | RM       RM 4,000
Employees Provident Fund [Member]        
Product Information [Line Items]        
Salary percentage 12.00% 12.00%    
Employment Insurance System [Member]        
Product Information [Line Items]        
Salary percentage 0.20% 0.20%    
Employment Insurance System [Member] | MYR Currency [Member]        
Product Information [Line Items]        
Monthly salary | RM   RM 4,000    
Human Resource Development Fund [Member]        
Product Information [Line Items]        
Salary percentage 1.00% 1.00%    
Health and Wellness Products [Member]        
Product Information [Line Items]        
Revenue from sales $ 183,816      
Health And Wellness Services [Member]        
Product Information [Line Items]        
Revenue from sales 7,543   $ 0  
Shipping and Handling [Member]        
Product Information [Line Items]        
Selling expenses $ 11,054   $ 9,315  
XML 77 R51.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF VARIABLE INTEREST ENTITY (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Trading Activity, Gains and Losses, Net [Line Items]    
Total current assets $ 3,912,122 $ 5,684,271
Current liabilities (1,312,841) (1,038,542)
Net deficit 3,312,972 5,924,834
Cash 2,597,848 3,517,600
Prepaid taxes 636,218 1,104,495
Total current liabilities 1,312,841 1,038,542
Operating revenues 1,016,962 3,434,561
Gross profit 719,629 2,676,766
Loss from operations (1,858,568) (158,135)
Net loss (2,524,244) 354,766
Variable Income Interest Rate [Member]    
Trading Activity, Gains and Losses, Net [Line Items]    
Total current assets 18,850 48,717
Current liabilities (51,272) (53,573)
Net deficit (32,422) (4,856)
Cash 17,493 37,387
Prepaid taxes 1,357 11,330
Accounts payable – intercompany 49,724 51,669
Other payables and accrued liabilities 1,548 1,904
Total current liabilities 51,272 53,573
Operating revenues 346,907
Gross profit 4,442
Loss from operations (21,966) (10,752)
Net loss $ (27,966) $ (24,014)
XML 78 R52.htm IDEA: XBRL DOCUMENT v3.22.1
VARIABLE INTEREST ENTITY (“VIE”) (Details Narrative)
Dec. 31, 2021
Subsidiary Company Three [Member]  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]  
Ownership interest percentage 100.00%
XML 79 R53.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)
Dec. 31, 2021
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Cash $ 1,206,493
Other receivables 33,210
Other receivables - related parties 219,121
Inventories 616,880
Prepaid taxes 1,206,821
Prepayments and other assets 318,267
Total current assets 3,600,792
Property and equipment, net 325,648
Intangible assets, net 6,686
Deferred taxes asset, net 172,250
Total other assets 504,584
Total assets 4,105,376
Accounts payable - related party 491,628
Customer deposits 1,600,606
Other payables and accrued liabilities 209,096
Total current liabilities 2,301,330
Total liabilities 2,301,330
Total net assets acquired $ 1,804,046
XML 80 R54.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)
 12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Business Combination and Asset Acquisition [Abstract]  
Revenue $ 4,693,873
Cost of revenue (875,708)
Gross profit 3,818,165
Total operating expenses (3,839,184)
 Loss from operations (21,019)
Other income (expense), net 267,633
Income before income taxes 246,614
Provision for income taxes (212,414)
Net income $ 34,200
Net income per common share - basic and diluted | $ / shares $ 0.00
Weighted average number of common shares outstanding - basic and diluted | shares 376,452,047
XML 81 R55.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Jul. 02, 2020
May 08, 2020
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Common stock par value       $ 0.0001 $ 0.0001
Mr.How Kok Choong [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Purchased price per shares     $ 6.50    
Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued during period acquisitions, shares   9,590,596      
Ownership interest percentage   99.99%      
Share Exchange Agreement [Member] | Mr.How Kok Choong [Member] | Agape Superior Living Sdn Bhd [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued during period acquisitions, shares     176,547    
Ordinary shares no par value   $ 0      
Ownership interest percentage   99.99%      
Purchase consideration value $ 1,804,046        
Loan payable     $ 656,495    
Common stock par value     $ 0.0001    
Percentage of common stock issued and outstanding     0.0469%    
Stock issued during period, value, acquisitions     $ 1,147,551    
Issuance of common stock shares       176,547  
XML 82 R56.htm IDEA: XBRL DOCUMENT v3.22.1
CASH AND CASH EQUIVALENTS (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Cash and cash equivalents $ 2,597,848 $ 3,517,600
Cash in bank 554,864 1,112,147
Time deposits $ 1,975,347 $ 2,391,182
Minimum [Member]    
Percentage of Interest rate for time deposits 1.10%  
Maximum [Member]    
Percentage of Interest rate for time deposits 1.25%  
XML 83 R57.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Receivables [Abstract]    
Accounts receivable $ 172,757
Allowance for doubtful accounts
Total $ 172,757
XML 84 R58.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INVENTORIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Finished goods $ 375,535 $ 589,814
XML 85 R59.htm IDEA: XBRL DOCUMENT v3.22.1
INVENTORIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Inventory write-down $ 36,241
XML 86 R60.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Prepayments And Deposits    
Receivables from sales distributors $ 115,379 $ 35,302
Deposits to suppliers 301,233 261,068
Subtotal 416,612 296,370
Less: Provision for doubtful accounts (121,095)
Total $ 295,517 $ 296,370
XML 87 R61.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Prepayments And Deposits    
Beginning balance
Addition 121,514
Write off
Exchange rate effect (419)
Ending balance $ 121,095
XML 88 R62.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Subtotal $ 505,755 $ 521,463
Less: accumulated depreciation (289,956) (223,154)
Total 215,799 298,309
Computer And Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal 82,298 81,437
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal 122,185 126,966
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal 202,570 210,496
Vehicle [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 98,702 $ 102,564
XML 89 R63.htm IDEA: XBRL DOCUMENT v3.22.1
PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Abstract]    
Depreciation $ 75,797 $ 55,407
XML 90 R64.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INTANGIBLE ASSETS, NET (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]    
Computer software $ 34,453 $ 35,801
Less: accumulated amortization (30,793) (29,975)
Total $ 3,660 $ 5,826
XML 91 R65.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS, NET (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 1,961 $ 1,505
XML 92 R66.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Investment In Marketable Securities    
Cost of investment $ 577,035 $ 66,484
Dividend income from Greenpro Capital Corp. 18,939 160,062
Unrealized holding (loss) gain (505,231) 350,137
Exchange rate effect (1,742) 352
Investment in marketable securities $ 89,001 $ 577,035
XML 93 R67.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) - USD ($)
Dec. 31, 2021
Sep. 27, 2021
Dec. 31, 2020
Dec. 09, 2020
Nov. 03, 2020
Oct. 16, 2018
Jul. 30, 2018
May 17, 2018
Investment amount $ 577,035   $ 66,484          
Greenpro Capital Corp. [Member]                
Investment in securities, shares           33,333 20 83,333
Investment amount           $ 1,000 $ 125 $ 500,000
Purchased price per shares           $ 0.03 $ 6.2613 $ 6
DSwiss Inc [Member]                
Investment in securities, shares       16,663 6,667      
Investment amount       $ 83,315 $ 76,671      
Purchased price per shares       $ 5 $ 11.50      
SEATech Ventures Corp [Member]                
Investment in securities, shares   11,665            
Investment amount   $ 18,874            
Purchased price per shares   $ 1.62            
XML 94 R68.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Apr. 03, 2019
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Cost of investment $ 577,035 $ 66,484  
Total investment in non-marketable securities 1,500 1,500  
Phoenix Plus Corporation [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Cost of investment 1,500 1,500 $ 1,500
Total investment in non-marketable securities 1,500 1,500  
Directors of Unreserved Investments [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Investment in non-marketable securities 730,637  
Less: Sale of investment in non-marketable securities (730,637)  
Investment in non-marketable securities  
XML 95 R69.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)
 3 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2021
MYR (RM)
shares
Mar. 03, 2020
Dec. 31, 2019
USD ($)
Apr. 03, 2019
USD ($)
$ / shares
shares
Mar. 10, 2019
Investment amount   $ 577,035 $ 66,484          
Ordinary shares authorized | shares   1,000,000,000 1,000,000,000 1,000,000,000        
Proceeds from investments $ 70,173 $ 70,173          
Phoenix Plus Corporation [Member]                
Investment amount   1,500 $ 1,500       $ 1,500  
Equity interest percentage             5.00%  
Shares Issued, Price Per Share | $ / shares             $ 0.0001  
Phoenix Plus Corporation [Member] | Common Stock [Member]                
Shares purchased during period | shares             15,000,000  
Maximum [Member]                
Equity interest percentage               20.00%
Minimum [Member]                
Equity interest percentage               17.86%
Director [Member]                
Investment amount   $ 863,592   RM 3,500,000        
Equity interest percentage   20.00%   20.00%        
Mr.How Kok Choong [Member]                
Investment amount           $ 730,637    
Ordinary shares authorized | shares   2,500,000   2,500,000        
Amount due from director $ 660,464              
Unreserved Sdn Bhd [Member]                
Equity interest percentage         17.86%      
XML 96 R70.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Other Liabilities Disclosure [Abstract]    
Professional fees $ 436,541 $ 297,636
Promotion expenses 36,024 37,433
Payroll 22,669 23,976
Commission 219,721 224,711
Others 143,400 63,921
Total $ 858,355 $ 647,677
XML 97 R71.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF RELATED PARTIES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]    
Amount due from related parties $ 7,004 $ 3,235
Amount due from related parties 455
Revenue 6,625 18,060
Purchase 718
Commission expense 12,758 10,740
Other income $ 4,345 $ 2,881
Agape ATP Asia Limited [Member]    
Related Party Transaction [Line Items]    
Relationship Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia
Nature Expenses paid for AATP Asia Expenses paid for AATP Asia
Amount due from related parties $ 2,214 $ 2,227
Hostastay Sdn Bhd [Member]    
Related Party Transaction [Line Items]    
Relationship Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay
Nature Sublease rent due from Hostastay Sublease rent due from Hostastay
Amount due from related parties $ 4,790 $ 996
TH3 Technology Sdn Bhd [Member]    
Related Party Transaction [Line Items]    
Relationship Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology
Nature Expenses paid for TH3 Technology Expenses paid for TH3 Technology
Amount due from related parties $ 12
Agape Superior Living Pty Ltd [Member]    
Related Party Transaction [Line Items]    
Relationship   Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL
Nature   ATP Label Printing Fees
Amount due from related parties $ 455
Agape Superior Living Pty Ltd ASLPL [Member]    
Related Party Transaction [Line Items]    
Relationship Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL
Nature Sales of products Sales of products
Revenue $ 18,060
Agape Superior Living Pty Ltd ASLPL [Member] | Chief Executive Officer [Member]    
Related Party Transaction [Line Items]    
Relationship Mr. How Kok Choong, the CEO and director of the Company Mr. How Kok Choong, the CEO and director of the Company
Vettons Sdn Bhd One [Member]    
Related Party Transaction [Line Items]    
Relationship [1] Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021 Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021
Nature [1] Sales of products made through its platform Sales of products made through its platform
Revenue [1] $ 6,625  
Hostastay Sdn. Bhd [Member]    
Related Party Transaction [Line Items]    
Nature Sublease rental income due from Hostastay Sublease rental income due from Hostastay
Revenue [1]  
Commission expense $ 12,758 10,740
Other income $ 4,345 $ 2,881
Hostastay Sdn. Bhd [Member] | Chief Executive Officer [Member]    
Related Party Transaction [Line Items]    
Relationship Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay
How Kok Choong [Member]    
Related Party Transaction [Line Items]    
Nature Commission expense Commission expense
How Kok Choong [Member] | Chief Executive Officer [Member]    
Related Party Transaction [Line Items]    
Revenue $ 6,625  
DSY Wellness & Longevity Center Sdn Bhd [Member]    
Related Party Transaction [Line Items]    
Nature Purchase Purchase
Purchase $ 718
DSY Wellness & Longevity Center Sdn Bhd [Member] | Chief Executive Officer [Member]    
Related Party Transaction [Line Items]    
Relationship Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd
[1] During the year ended December 31, 2021, the Company had sales of $6,625 through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.
XML 98 R72.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2020
May 31, 2020
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]          
Preferred stock, shares authorized       200,000,000 200,000,000
Preferred stock, shares issued       0 0
Preferred stock, shares outstanding       0 0
Common stock, shares authorized       1,000,000,000 1,000,000,000
Common stock, shares issued       290,460,047 376,452,047
Common stock, shares outstanding       290,460,047 376,452,047
Business combination, recognized identifiable assets acquired and liabilities assumed, assets       $ 4,105,376  
Potentially dilutive securities outstanding       0 0
Share Forfeiture Agreements [Member]          
Restructuring Cost and Reserve [Line Items]          
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited       85,992,000  
Share Forfeiture Agreements [Member] | How Kok Choong Talent Limited [Member]          
Restructuring Cost and Reserve [Line Items]          
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited       41,750,000  
Share Forfeiture Agreements [Member] | How Kok Choong Talent Limited [Member] | Shareholders [Member]          
Restructuring Cost and Reserve [Line Items]          
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited       44,242,000  
Share Forfeiture Agreements [Member] | HKC Holdings Sdn Bhd [Member]          
Restructuring Cost and Reserve [Line Items]          
Shares Issued, Shares, Share-based Payment Arrangement, Forfeited       11,242,000  
ASL [Member]          
Restructuring Cost and Reserve [Line Items]          
Stock issued during period acquisitions, shares 13,853 162,694 13,853    
Business combination, recognized identifiable assets acquired and liabilities assumed, assets     $ 90,043    
XML 99 R73.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF NON CONTROLLING INTEREST (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Noncontrolling Interest [Abstract]    
Paid-in capital $ 97
Accumulated deficit (436)
Accumulated other comprehensive income 3
 Non Controlling interest Gross (336)
ASL
Total $ (336)
XML 100 R74.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Local – United States $ (706,659) $ (735,159)
(Loss) income before income tax (2,387,613) 516,347
MALAYSIA    
Foreign (1,064,314) 1,070,806
HONG KONG    
Foreign $ (616,640) $ 180,700
XML 101 R75.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PROVISION FOR INCOME TAX (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
- Local $ (22,205)
- Foreign (104,735) 16,748
- Local
- Foreign (10,127) (178,329)
Provision for income taxes $ (137,067) $ (161,581)
XML 102 R76.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
U.S. statutory rate 21.00% 21.00%
Valuation allowance (17.00%) (4.00%)
Differential tax rate in Malaysia 3.00% 3.00%
Permanent difference (12.70%) [1] 11.30% [2]
Effective tax rate (5.70%) 31.30%
[1]  The amount comprised: 6.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and 6.7% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.
[2] The amount comprised: 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; 0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and 1.3% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.
XML 103 R77.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Tax percentage   10.20%
AATP HK [Member]    
Tax percentage 6.20% 0.20%
AATP LB, ASL, SEA, WATP, and DSY [Member]    
Tax percentage 6.70%  
AATP LB, ASL, SEA and WATP [Member]    
Tax percentage   1.30%
XML 104 R78.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Less: valuation allowance $ (380,167)
Depreciation (15,574) (68,421)
Deferred tax liabilities, net (15,574) (5,743)
UNITED STATES    
Net operating loss carry forwards 153,061
Less: valuation allowance (153,000) 0
MALAYSIA    
Net operating loss carry forwards 227,106 62,678
Less: valuation allowance $ (217,000) $ 0
XML 105 R79.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Details Narrative) - USD ($)
 12 Months Ended
Jan. 02, 2019
Dec. 31, 2021
Dec. 31, 2020
Operating Loss Carryforwards [Line Items]      
Tax percentage   21.00% 21.00%
Tax rate description   In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax, which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are applied  
Income tax expense benefit   $ 137,067 $ 161,581
Income tax examination penalties and interest expense   395 0
Net operating loss carryforward     312,608
Deferred tax assets operating loss carryforwards   65,648  
Cumulative net operating losses   0  
Deferred tax valuation allowance   $ 380,167
Tax percentage   (5.70%) 31.30%
Unutilized [Member]      
Operating Loss Carryforwards [Line Items]      
Net operating loss carryforward   $ 685,000 $ 261,000
UNITED STATES      
Operating Loss Carryforwards [Line Items]      
Net operating loss carryforward   729,000 0
Deferred tax valuation allowance   $ 153,000 0
Labuan [Member]      
Operating Loss Carryforwards [Line Items]      
Tax percentage 24.00%    
Tax percentage 3.00%    
MALAYSIA      
Operating Loss Carryforwards [Line Items]      
Tax percentage   17.00%  
Net operating loss carryforward   $ 946,000 261,000
Deferred tax valuation allowance   $ 217,000 $ 0
Income tax examination, description   The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate  
HONG KONG      
Operating Loss Carryforwards [Line Items]      
Tax percentage   16.50%  
State and Local Jurisdiction [Member]      
Operating Loss Carryforwards [Line Items]      
Tax percentage   21.00%  
Foreign Tax Authority [Member]      
Operating Loss Carryforwards [Line Items]      
Tax percentage   35.00%  
Domestic Tax Authority [Member]      
Operating Loss Carryforwards [Line Items]      
Income tax expense benefit   $ 22,205  
XML 106 R80.htm IDEA: XBRL DOCUMENT v3.22.1
CONCENTRATIONS OF RISKS (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Nov. 30, 2020
Concentration Risk [Line Items]        
Deposits $ 1,112,147 $ 554,864 $ 1,112,147  
Deposit for insurance $ 563,788 $ 295,761 $ 563,788  
DSwiss Inc [Member]        
Concentration Risk [Line Items]        
[custom:DividendShareForCommonStock] 23,330      
Proportional of ownership interest and voting power held       0.01%
No Customer [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage   10.00% 10.00%  
Vendor One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member] | E-commerce [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage     100.00%  
Vendor One [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage   47.30% 74.10%  
Vendor One [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | DSwiss Inc [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage   47.30% 74.10%  
Vendor Two [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage   45.20% 25.90%  
One Vendor [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage   100.00%    
One Sales Distributor [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage   17.90%    
No Sales Distributor [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]        
Concentration Risk [Line Items]        
Concentrations of risk percentage     10.00%  
XML 107 R81.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF LEASE COMMITMENTS (Details)
Dec. 31, 2021
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2022 $ 166,426
2023 84,915
Thereafter
Total lease payments 251,341
Less: interest (10,763)
Present value of lease liabilities $ 240,578
XML 108 R82.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 12 Months Ended
May 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Apr. 01, 2020
Restructuring Cost and Reserve [Line Items]        
Operating lease liability   $ 240,578    
Lease expiration term May 31, 2023      
Reduction in ROU assets and liabilities $ 3,250      
Operating lease, rent expenses   $ 179,562 $ 156,716  
COVID-19 Impact [Member]        
Restructuring Cost and Reserve [Line Items]        
COVID-19 impact description   On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot    
Training Center [Member]        
Restructuring Cost and Reserve [Line Items]        
Lease expiration term Aug. 31, 2023      
ASL [Member]        
Restructuring Cost and Reserve [Line Items]        
Operating lease liability       $ 490,000
Operating lease effective interest rate 5.50%     5.50%
Operating lease, weighted average remaining lease term   1 year 7 months 20 days    
XML 109 R83.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS (Details Narrative)
 1 Months Ended
Jan. 20, 2022
USD ($)
Subsequent Event [Member] | Mr.How Kok Choong [Member] | Share Forfeiture Agreement [Member]  
Subsequent Event [Line Items]  
Company share forfeiture $ 215,008,035
XML 110 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001713210 2021-01-01 2021-12-31 0001713210 2021-06-30 0001713210 2022-03-23 0001713210 2021-12-31 0001713210 2020-12-31 0001713210 2020-01-01 2020-12-31 0001713210 us-gaap:CommonStockMember 2019-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001713210 us-gaap:RetainedEarningsMember 2019-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2019-12-31 0001713210 2019-12-31 0001713210 us-gaap:CommonStockMember 2020-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001713210 us-gaap:RetainedEarningsMember 2020-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2020-12-31 0001713210 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001713210 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001713210 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001713210 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001713210 us-gaap:CommonStockMember 2021-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001713210 us-gaap:RetainedEarningsMember 2021-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001713210 us-gaap:NoncontrollingInterestMember 2021-12-31 0001713210 AATP:AgapeATPInternationalHoldingLimitedMember 2021-12-31 0001713210 AATP:MrHowKokChoongMember AATP:ShareExchangeAgreementMember 2020-05-07 2020-05-08 0001713210 AATP:SubsidiaryCompanyTwoMember 2020-05-08 0001713210 AATP:SubsidiaryCompanyFiveMember 2021-11-11 0001713210 AATP:MrHowKokChoongMember AATP:ShareExchangeAgreementMember 2020-05-08 0001713210 AATP:SubsidiaryCompanyMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyOneMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyOneMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyTwoMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyTwoMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyThreeMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyFourMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyFourMember 2021-12-31 0001713210 AATP:SubsidiaryCompanyFiveMember 2021-01-01 2021-12-31 0001713210 AATP:SubsidiaryCompanyFiveMember 2021-12-31 0001713210 AATP:HealthAndWellnessProductsMember 2021-01-01 2021-12-31 0001713210 AATP:HealthAndWellnessServicesMember 2021-01-01 2021-12-31 0001713210 AATP:HealthAndWellnessServicesMember 2020-01-01 2020-12-31 0001713210 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-12-31 0001713210 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0001713210 AATP:SocialSecurityOrganizationMember 2021-01-01 2021-12-31 0001713210 AATP:MYRCurrencyMember AATP:SocialSecurityOrganizationMember 2020-01-01 2020-12-31 0001713210 AATP:EmployeesProvidentFundMember 2021-01-01 2021-12-31 0001713210 AATP:EmploymentInsuranceSystemMember 2021-01-01 2021-12-31 0001713210 AATP:MYRCurrencyMember AATP:EmploymentInsuranceSystemMember 2021-01-01 2021-12-31 0001713210 AATP:HumanResourceDevelopmentFundMember 2021-01-01 2021-12-31 0001713210 srt:MinimumMember us-gaap:ComputerEquipmentMember 2021-01-01 2021-12-31 0001713210 srt:MaximumMember us-gaap:ComputerEquipmentMember 2021-01-01 2021-12-31 0001713210 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-12-31 0001713210 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001713210 us-gaap:VehiclesMember 2021-01-01 2021-12-31 0001713210 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-01 2021-12-31 0001713210 AATP:SurvivorSelectMember 2021-01-01 2021-12-31 0001713210 AATP:SurvivorSelectMember 2020-01-01 2020-12-31 0001713210 AATP:EnergizedMineralConcentrateMember 2021-01-01 2021-12-31 0001713210 AATP:EnergizedMineralConcentrateMember 2020-01-01 2020-12-31 0001713210 AATP:IonizedCalMagMember 2021-01-01 2021-12-31 0001713210 AATP:IonizedCalMagMember 2020-01-01 2020-12-31 0001713210 AATP:OmegaBlendMember 2021-01-01 2021-12-31 0001713210 AATP:OmegaBlendMember 2020-01-01 2020-12-31 0001713210 AATP:BetaMaxxMember 2021-01-01 2021-12-31 0001713210 AATP:BetaMaxxMember 2020-01-01 2020-12-31 0001713210 AATP:VegeFruitFiberMember 2021-01-01 2021-12-31 0001713210 AATP:VegeFruitFiberMember 2020-01-01 2020-12-31 0001713210 AATP:IronMember 2021-01-01 2021-12-31 0001713210 AATP:IronMember 2020-01-01 2020-12-31 0001713210 AATP:YoungFormulaMember 2021-01-01 2021-12-31 0001713210 AATP:YoungFormulaMember 2020-01-01 2020-12-31 0001713210 AATP:OrganicYouthCareCleansingBarMember 2021-01-01 2021-12-31 0001713210 AATP:OrganicYouthCareCleansingBarMember 2020-01-01 2020-12-31 0001713210 AATP:MitogizeMember 2021-01-01 2021-12-31 0001713210 AATP:MitogizeMember 2020-01-01 2020-12-31 0001713210 AATP:NoOneMEDMember 2021-01-01 2021-12-31 0001713210 AATP:NoOneMEDMember 2020-01-01 2020-12-31 0001713210 AATP:EnergetiqueMember 2021-01-01 2021-12-31 0001713210 AATP:EnergetiqueMember 2020-01-01 2020-12-31 0001713210 AATP:TrimPlusMember 2021-01-01 2021-12-31 0001713210 AATP:TrimPlusMember 2020-01-01 2020-12-31 0001713210 us-gaap:ProductMember 2021-01-01 2021-12-31 0001713210 us-gaap:ProductMember 2020-01-01 2020-12-31 0001713210 AATP:PeriodEndMYRMember 2021-12-31 0001713210 AATP:PeriodEndMYRMember 2020-12-31 0001713210 AATP:PeriodEndHKDMember 2021-12-31 0001713210 AATP:PeriodEndHKDMember 2020-12-31 0001713210 AATP:PeriodAverageMYRMember 2021-01-01 2021-12-31 0001713210 AATP:PeriodAverageMYRMember 2020-01-01 2020-12-31 0001713210 AATP:PeriodAverageHKDMember 2021-01-01 2021-12-31 0001713210 AATP:PeriodAverageHKDMember 2020-01-01 2020-12-31 0001713210 AATP:SubsidiaryCompanyThreeMember 2021-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2021-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2021-01-01 2021-12-31 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-01-01 2020-12-31 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-05-08 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-06-29 2020-07-02 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-01-01 2020-03-31 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-03-31 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-01-01 2020-12-31 0001713210 srt:MinimumMember 2021-12-31 0001713210 srt:MaximumMember 2021-12-31 0001713210 AATP:ComputerAndOfficeEquipmentMember 2021-12-31 0001713210 AATP:ComputerAndOfficeEquipmentMember 2020-12-31 0001713210 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001713210 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001713210 AATP:VehicleMember 2021-12-31 0001713210 AATP:VehicleMember 2020-12-31 0001713210 AATP:GreenproCapitalCorpMember 2018-05-17 0001713210 AATP:GreenproCapitalCorpMember 2018-07-30 0001713210 AATP:GreenproCapitalCorpMember 2018-10-16 0001713210 AATP:DSwissIncMember 2020-11-03 0001713210 AATP:DSwissIncMember 2020-12-09 0001713210 AATP:SEATechVenturesCorpMember 2021-09-27 0001713210 srt:DirectorMember 2021-12-31 0001713210 srt:MaximumMember 2019-03-10 0001713210 srt:MinimumMember 2019-03-10 0001713210 AATP:MrHowKokChoongMember 2021-12-31 0001713210 AATP:UnreservedSdnBhdMember 2020-03-03 0001713210 AATP:MrHowKokChoongMember 2019-12-31 0001713210 2020-01-01 2020-03-31 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 us-gaap:CommonStockMember AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2021-12-31 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2020-12-31 0001713210 AATP:PhoenixPlusCorpMember 2021-12-31 0001713210 AATP:PhoenixPlusCorpMember 2020-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2021-01-01 2021-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2021-12-31 0001713210 AATP:AgapeATPAsiaLimitedMember 2020-12-31 0001713210 AATP:HostastaySdnBhdMember 2021-01-01 2021-12-31 0001713210 AATP:HostastaySdnBhdMember 2020-01-01 2020-12-31 0001713210 AATP:HostastaySdnBhdMember 2021-12-31 0001713210 AATP:HostastaySdnBhdMember 2020-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2021-01-01 2021-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2020-01-01 2020-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2021-12-31 0001713210 AATP:THThreeTechnologySdnBhdMember 2020-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2021-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2020-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2021-01-01 2021-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-01-01 2020-12-31 0001713210 AATP:VettonsSdnBhdOneMember 2021-01-01 2021-12-31 0001713210 AATP:VettonsSdnBhdOneMember 2020-01-01 2020-12-31 0001713210 AATP:HostastaySdnBhdOneMember 2020-01-01 2020-12-31 0001713210 srt:ChiefExecutiveOfficerMember AATP:HowKokChoongMember 2021-01-01 2021-12-31 0001713210 srt:ChiefExecutiveOfficerMember AATP:DSYWellnessAndLongevityCenterSdnBhdMember 2020-01-01 2020-12-31 0001713210 srt:ChiefExecutiveOfficerMember AATP:DSYWellnessAndLongevityCenterSdnBhdMember 2021-01-01 2021-12-31 0001713210 AATP:DSYWellnessAndLongevityCenterSdnBhdMember 2020-01-01 2020-12-31 0001713210 AATP:DSYWellnessAndLongevityCenterSdnBhdMember 2021-01-01 2021-12-31 0001713210 srt:ChiefExecutiveOfficerMember AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2021-01-01 2021-12-31 0001713210 srt:ChiefExecutiveOfficerMember AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-01-01 2020-12-31 0001713210 AATP:HowKokChoongMember 2021-01-01 2021-12-31 0001713210 AATP:HowKokChoongMember 2020-01-01 2020-12-31 0001713210 AATP:HostastaySdnBhdOneMember 2021-01-01 2021-12-31 0001713210 srt:ChiefExecutiveOfficerMember AATP:HostastaySdnBhdOneMember 2021-01-01 2021-12-31 0001713210 srt:ChiefExecutiveOfficerMember AATP:HostastaySdnBhdOneMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-05-01 2020-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2021-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2021-01-01 2021-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-06-29 2020-07-31 0001713210 AATP:HowKokChoongTalentLimitedMember AATP:ShareForfeitureAgreementsMember 2021-01-01 2021-12-31 0001713210 AATP:ShareholdersMember AATP:HowKokChoongTalentLimitedMember AATP:ShareForfeitureAgreementsMember 2021-01-01 2021-12-31 0001713210 AATP:HKCHoldingsSdnBhdMember AATP:ShareForfeitureAgreementsMember 2021-01-01 2021-12-31 0001713210 AATP:ShareForfeitureAgreementsMember 2021-01-01 2021-12-31 0001713210 country:MY 2021-01-01 2021-12-31 0001713210 country:MY 2020-01-01 2020-12-31 0001713210 country:HK 2021-01-01 2021-12-31 0001713210 country:HK 2020-01-01 2020-12-31 0001713210 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-12-31 0001713210 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001713210 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001713210 country:US 2021-12-31 0001713210 country:US 2020-12-31 0001713210 AATP:LabuanMember 2018-12-28 2019-01-02 0001713210 country:MY 2021-12-31 0001713210 country:MY 2020-12-31 0001713210 AATP:UnutilizedMember 2021-12-31 0001713210 AATP:UnutilizedMember 2020-12-31 0001713210 AATP:AATPHKMember 2021-01-01 2021-12-31 0001713210 AATP:AATPLBASLSEAWATPAndDSYMember 2021-01-01 2021-12-31 0001713210 AATP:AATPHKMember 2020-01-01 2020-12-31 0001713210 AATP:AATPLBASLSEAAndWATPMember 2020-01-01 2020-12-31 0001713210 AATP:NoCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:NoCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001713210 AATP:VendorOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember AATP:ECommerceCompanyMember 2020-01-01 2020-12-31 0001713210 AATP:VendorOneMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:VendorTwoMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:VendorOneMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001713210 AATP:VendorTwoMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001713210 AATP:DSwissIncMember 2020-12-01 2020-12-31 0001713210 AATP:DSwissIncMember 2020-11-30 0001713210 AATP:VendorOneMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember AATP:DSwissIncMember 2021-01-01 2021-12-31 0001713210 AATP:VendorOneMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember AATP:DSwissIncMember 2020-01-01 2020-12-31 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:OneSalesDistributorMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001713210 AATP:NoSalesDistributorMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-04-01 0001713210 2021-05-30 2021-05-31 0001713210 AATP:TrainingCenterMember 2021-05-30 2021-05-31 0001713210 2021-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2021-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2021-12-31 0001713210 AATP:COVIDNineteenImpactMember 2021-01-01 2021-12-31 0001713210 AATP:MrHowKokChoongMember us-gaap:SubsequentEventMember AATP:ShareForfeitureAgreementMember 2022-01-01 2022-01-20 iso4217:USD shares iso4217:USD shares iso4217:MYR pure 0001713210 false FY Yes Yes 10-K true 2021-12-31 --12-31 2021 false 333-220144 AGAPE ATP CORPORATION NV 36-4838886 Tower 2 Faber Towers Jalan Desa Bahagia 58100 Kuala Lumpur MY (60) 192230099 Common Stock, $0.0001 par value No No Non-accelerated Filer true false true false 914950575 75452012 Friedman LLP 711 Friedman LLP New York, New York 17493 37387 2597848 3517600 172757 7004 3235 375535 589814 1357 11330 636218 1104495 295517 296370 3912122 5684271 215799 298309 3660 5826 237718 394141 89001 577035 1500 1500 264735 249525 812413 1526336 4724535 7210607 13715 279689 236134 157094 154276 1548 1904 858355 647677 3988 455 1312841 1038542 83484 241488 15574 5743 99058 247231 1411899 1285773 0.0001 0.0001 200000000 200000000 0 0 0 0 0.0001 0.0001 1000000000 1000000000 290460047 290460047 376452047 376452047 29046 37645 6449215 6440616 -3258687 -734443 93398 181016 3312972 5924834 -336 3312636 5924834 4724535 7210607 1016962 3434561 18060 1016962 3452621 297333 775855 719629 2676766 394682 376582 316267 830659 1745734 1627660 121514 2578197 2834901 -1858568 -158135 -42753 164283 -505231 350137 -18939 -160062 -529045 674482 -2387613 516347 137067 161581 -2524680 354766 -436 -2524244 354766 -2524680 354766 -87615 171231 -2612295 525997 -433 -2611862 525997 -0.01 0.00 376216452 376387778 376275500 37628 5293082 -1089209 9785 4251286 354766 354766 176547 17 1147534 1147551 171231 171231 376452047 37645 6440616 -734443 181016 5924834 85992000 -8599 8599 97 97 -2524244 -436 -2524680 -2524244 -436 -2524680 -87618 3 -87615 290460047 29046 6449215 -3258687 93398 -336 3312636 -2524680 354766 75797 55407 1961 1505 139451 106561 -505231 350137 -18939 -160062 10127 178329 36241 121514 -167566 165149 2417 -192713 -78674 -430062 -184985 128363 -352577 -2804 52981 -1421886 226651 336709 -138143 -105009 3988 -845842 -557951 3959 4734 178 1210818 121 70173 -3959 1276200 15210 249525 -3851 227434 -19061 -22091 -50890 76985 -919752 773143 3517600 2744457 2597848 3517600 326838 288929 3250 483343 656495 1147551 <p id="xdx_808_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zjryWW5VR6N1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82D_zuTOrtJQ1rSi">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. (“ASL”), a company incorporated in Malaysia. .</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_zhzQsicOITE6" title="Ownership interest percentage">100</span>% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zFkZqBDvcHa1" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, no par value, equivalent to approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zZfcYS6QRELe" title="Ownership interest percentage">99.99</span>% of the equity interest in Agape Superior Living Sdn. Bhd., a network marketing entity incorporated in Malaysia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (“WATP”), a wholly owned subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211111__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zwxMW21cPNK6" title="Ownership interest percentage">60</span>% of the equity interest, to pursue the business of providing complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3), and DSY Wellness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zwe7aFvThaG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zj3z0IqpFBQk" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left; vertical-align: top"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Subsidiary company name</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Place and date of incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proportional of ownership interest and voting power held</td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: right; vertical-align: top"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 6%; vertical-align: top">1.</td> <td style="width: 2%"> </td> <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zJXEvi6NRyUh" style="vertical-align: top; width: 16%; text-align: center" title="Subsidiary company name">Agape ATP Corporation</td><td style="width: 2%"> </td> <td id="xdx_98B_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zzkn5rj3Uck" style="vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation">Labuan, <br/> March 6, 2017</td><td style="width: 2%"> </td> <td id="xdx_984_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsgpDyy2TMMl" style="vertical-align: top; width: 16%; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of US$1 each</td><td style="width: 2%"> </td> <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zoZtxcXvENgf" style="vertical-align: top; width: 16%; text-align: center" title="Principal activities">Investment holding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zicZ1wjT3AE4" style="vertical-align: top; width: 18%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; width: 1%; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">2.</td> <td> </td> <td id="xdx_98C_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zaubThxHYBVh" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape ATP International Holding Limited</td><td> </td> <td id="xdx_989_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zuC7GgYsCeD7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Hong Kong,<br/> June 1, 2017</td><td> </td> <td id="xdx_98E_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zdSzsaNpIea4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000,000 shares of ordinary share of HK$1 each</td><td> </td> <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zocye911l2qg" style="vertical-align: top; text-align: center" title="Principal activities">Wholesaling of health and wellness products; and health solution advisory services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z1c7ZCaUNV1f" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">3.</td> <td> </td> <td id="xdx_985_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zRcFlMWvqJ7l" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape Superior Living Sdn. Bhd.</td><td> </td> <td id="xdx_984_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zcs7sN0Nu5q7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> August 8, 2003</td><td> </td> <td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z5dnt8C8MCpe" style="vertical-align: top; text-align: center" title="Particulars of issued capital">9,590,598 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zpruVcSAlxS2" style="vertical-align: top; text-align: center" title="Principal activities">Health and wellness products and health solution advisory services via network marketing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z8X5TglxoRU1" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">99.99</td><td style="vertical-align: top; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">4.</td> <td> </td> <td id="xdx_986_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zOSA8SvcFSe8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape S.E.A. Sdn. Bhd.</td><td> </td> <td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_z5D1tm2kmR9j" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> March 4, 2004</td><td> </td> <td id="xdx_985_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zKXQYjcIaqj4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">2 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zycxkWzXgPB5" style="vertical-align: top; text-align: center" title="Principal activities">VIE of Agape Superior Living Sdn. Bhd.</td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE</span></td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">5.</td> <td> </td> <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zlD30iy2ipI8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Wellness ATP International Holdings Sdn, Bhd</td><td> </td> <td id="xdx_98E_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zQBdLUuSkqZi" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> September 11, 2020</td><td> </td> <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z7oHDCHRFsp5" style="vertical-align: top; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zIVr6Myj4za4" style="vertical-align: top; text-align: center" title="Principal activities">The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zuZTuMiA4XY6" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">6.</td> <td> </td> <td id="xdx_989_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zTc8c6JIi7r7" style="vertical-align: top; text-align: center" title="Subsidiary company name">DSY Wellness International Sdn Bhd.</td><td> </td> <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zKS9tx910Yg9" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> November 11, 2021</td><td> </td> <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_z1CtNu8Ndnue" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zJKc7Z8ErKth" style="vertical-align: top; text-align: center" title="Principal activities">Provision of complementary health therapies</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zolorxDKUq1i" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">60</td><td style="vertical-align: top; text-align: right">%</td></tr> </table> <p id="xdx_8AD_zX77UpgzHdI7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. ORGANIZATION AND BUSINESS BACKGROUND (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business Overview</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNAp4MKs5WLe">99.99</span>% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Via ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various wellness programs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">To further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 9590596 0.9999 0.60 <p id="xdx_899_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zwe7aFvThaG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zj3z0IqpFBQk" style="display: none">SCHEDULE OF SUBSIDIARIES AND ASSOCIATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left; vertical-align: top"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Subsidiary company name</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Place and date of incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proportional of ownership interest and voting power held</td><td style="text-align: right; padding-bottom: 1.5pt; font-weight: bold; vertical-align: top"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: right; vertical-align: top"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 6%; vertical-align: top">1.</td> <td style="width: 2%"> </td> <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zJXEvi6NRyUh" style="vertical-align: top; width: 16%; text-align: center" title="Subsidiary company name">Agape ATP Corporation</td><td style="width: 2%"> </td> <td id="xdx_98B_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zzkn5rj3Uck" style="vertical-align: top; width: 16%; text-align: center" title="Place and date of incorporation">Labuan, <br/> March 6, 2017</td><td style="width: 2%"> </td> <td id="xdx_984_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zsgpDyy2TMMl" style="vertical-align: top; width: 16%; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of US$1 each</td><td style="width: 2%"> </td> <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zoZtxcXvENgf" style="vertical-align: top; width: 16%; text-align: center" title="Principal activities">Investment holding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zicZ1wjT3AE4" style="vertical-align: top; width: 18%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; width: 1%; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">2.</td> <td> </td> <td id="xdx_98C_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zaubThxHYBVh" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape ATP International Holding Limited</td><td> </td> <td id="xdx_989_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zuC7GgYsCeD7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Hong Kong,<br/> June 1, 2017</td><td> </td> <td id="xdx_98E_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zdSzsaNpIea4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000,000 shares of ordinary share of HK$1 each</td><td> </td> <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_zocye911l2qg" style="vertical-align: top; text-align: center" title="Principal activities">Wholesaling of health and wellness products; and health solution advisory services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z1c7ZCaUNV1f" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">3.</td> <td> </td> <td id="xdx_985_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zRcFlMWvqJ7l" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape Superior Living Sdn. Bhd.</td><td> </td> <td id="xdx_984_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zcs7sN0Nu5q7" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> August 8, 2003</td><td> </td> <td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z5dnt8C8MCpe" style="vertical-align: top; text-align: center" title="Particulars of issued capital">9,590,598 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zpruVcSAlxS2" style="vertical-align: top; text-align: center" title="Principal activities">Health and wellness products and health solution advisory services via network marketing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_z8X5TglxoRU1" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">99.99</td><td style="vertical-align: top; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">4.</td> <td> </td> <td id="xdx_986_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zOSA8SvcFSe8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Agape S.E.A. Sdn. Bhd.</td><td> </td> <td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_z5D1tm2kmR9j" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> March 4, 2004</td><td> </td> <td id="xdx_985_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zKXQYjcIaqj4" style="vertical-align: top; text-align: center" title="Particulars of issued capital">2 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zycxkWzXgPB5" style="vertical-align: top; text-align: center" title="Principal activities">VIE of Agape Superior Living Sdn. Bhd.</td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE</span></td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">5.</td> <td> </td> <td id="xdx_981_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zlD30iy2ipI8" style="vertical-align: top; text-align: center" title="Subsidiary company name">Wellness ATP International Holdings Sdn, Bhd</td><td> </td> <td id="xdx_98E_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zQBdLUuSkqZi" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> September 11, 2020</td><td> </td> <td id="xdx_98D_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_z7oHDCHRFsp5" style="vertical-align: top; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zIVr6Myj4za4" style="vertical-align: top; text-align: center" title="Principal activities">The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFourMember_zuZTuMiA4XY6" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="vertical-align: top; text-align: right">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"> </td> <td> </td> <td style="text-align: center; vertical-align: top"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: right"> </td><td style="vertical-align: top; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">6.</td> <td> </td> <td id="xdx_989_ecustom--NameOftheCompany_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zTc8c6JIi7r7" style="vertical-align: top; text-align: center" title="Subsidiary company name">DSY Wellness International Sdn Bhd.</td><td> </td> <td id="xdx_98C_ecustom--PlaceAndDateOfIncorporation_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zKS9tx910Yg9" style="vertical-align: top; text-align: center" title="Place and date of incorporation">Malaysia, <br/> November 11, 2021</td><td> </td> <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_z1CtNu8Ndnue" style="vertical-align: top; text-align: center" title="Particulars of issued capital">1,000 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zJKc7Z8ErKth" style="vertical-align: top; text-align: center" title="Principal activities">Provision of complementary health therapies</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyFiveMember_zolorxDKUq1i" style="vertical-align: top; text-align: right" title="Proportional of ownership interest and voting power held">60</td><td style="vertical-align: top; text-align: right">%</td></tr> </table> Agape ATP Corporation Labuan, March 6, 2017 100 shares of ordinary share of US$1 each Investment holding 1 Agape ATP International Holding Limited Hong Kong, June 1, 2017 1,000,000 shares of ordinary share of HK$1 each Wholesaling of health and wellness products; and health solution advisory services 1 Agape Superior Living Sdn. Bhd. Malaysia, August 8, 2003 9,590,598 shares of ordinary share of RM1 each Health and wellness products and health solution advisory services via network marketing 0.9999 Agape S.E.A. Sdn. Bhd. Malaysia, March 4, 2004 2 shares of ordinary share of RM1 each VIE of Agape Superior Living Sdn. Bhd. Wellness ATP International Holdings Sdn, Bhd Malaysia, September 11, 2020 100 shares of ordinary share of RM1 each The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns 1 DSY Wellness International Sdn Bhd. Malaysia, November 11, 2021 1,000 shares of ordinary share of RM1 each Provision of complementary health therapies 0.60 0.9999 <p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zuQiQKgWfU4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_829_zm1kCRUSRHuc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeDlPoyXheKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis of presentation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zIzk1snyltAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principles of consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zJNbiMqwRbCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3rzciRsd7ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash and cash equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.</span></p> <p id="xdx_85A_z7h8mKQ3Eo71" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zfLkXh3OhBMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts receivable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, <span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20211231_zZpkZXBfDhF1" title="Accounts receivable, allowance for credit loss::XDX::-"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20201231_z2gRSfBQ4YQh" title="Accounts receivable, allowance for credit loss::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0613"><span style="-sec-ix-hidden: xdx2ixbrl0615">no</span></span></span></span> allowance of doubtful accounts was recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdaWn6gJJjD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventories</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021, and 2020, the company recorded $<span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zz2wt2LAgfC5" title="Inventories write-down">36,241</span> and $<span id="xdx_908_eus-gaap--InventoryWriteDown_pp0p0_dxL_c20200101__20201231_zB3vozrYmlpa" title="Inventories write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0621">0</span></span> write-downs for inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zdZoMb8wzNHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepaid taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Prepaid taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zqkBitGlXc97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepayments and deposits</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, there was $<span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20211231_zOfQcpaErBJ1" title="Allowance for doubtful accounts">121,514</span> and $<span id="xdx_906_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zdfQOpCLD4Ne" title="Allowance for doubtful accounts">0</span> allowance for the doubtful accounts recorded.</span></p> <p id="xdx_851_zmKlSpfnevK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7cYcWhlN8v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property and equipment, net</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zSzEw3lfeing" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture &amp; fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment">7</span> years</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment">5</span> years</span></td></tr> </table> <p id="xdx_8A9_zEFPE25M0ylf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zHEzuq48QgQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible assets, net</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zvU7SXf61uW4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets">5</span> years</span></td></tr> </table> <p id="xdx_8A7_zorLQNME5Hh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5qzlK0tNytk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment for long-lived assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and 2020, <span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20210101__20211231_zrSWi5qIbct2" title="Impairment of long-lived assets"><span id="xdx_902_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zLQgENYYhvLc" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--DeferredChargesPolicyTextBlock_z36dlBRJQxUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred offering costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--MarketableSecuritiesPolicy_zgB7vO5Vnsi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment in marketable equity securities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company follows the provisions of ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s unaudited condensed consolidated statements of operations and comprehensive loss in the caption of “unrealized holding gain loss on marketable securities” in each reporting period</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p id="xdx_854_zmZq0CFspjHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--NonMarketableSecuritiesPolicyTextBlock_z3ijwap9sP65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment in non-marketable equity securities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the provisions of ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zTvWJ7as6POh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customer deposits</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zMrTajC1AXKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales of Health and Wellness products</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <i>Performance obligations satisfied at a point in time</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_906_ecustom--ForfeitedCouponIncome_pp0p0_c20210101__20211231_zh7G9r61F1ta">15,209</span> and $<span id="xdx_908_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zkpNQLzrUHHf" title="Forfeited coupon income">170,431</span> as forfeited coupon income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_za2TyjvrR2mg" title="Revenue from sales">183,816</span> which it is expected to fulfill within 12 months from December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales of Health and Wellness services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <i>Performance obligations satisfied at a point in time</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zHfubZZIitA3">7,543</span> and $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zqmC0FnEsRM2">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated information of revenues by products and services are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Survivor Select</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,904</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,897</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Energized Mineral Concentrate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,481</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ionized Cal-Mag</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">908,964</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Omega Blend</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">222,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">BetaMaxx</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,043</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vege Fruit Fiber</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,757</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Iron</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Young Formula</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organic Youth Care Cleansing Bar</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Mitogize</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,801</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">No. 1 MED</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Energetique</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,574</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">253,396</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trim+</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,042</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenues – products</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,009,419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Health and Wellness services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0721"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenues</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,016,962</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zKKWWqhhjikh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_z0ZV9KzHWuv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost of revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cost of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue amounted to $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231_zQDKOqYEwgwe" title="Cost of revenue">297,333</span> (including inventory write-downs of $<span id="xdx_907_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zAnOlYDliz7l" title="Inventories write-down">36,241</span>) and $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20200101__20201231_z1I0GRSSjKHh" title="Cost of revenue">775,855</span> for the years ended December 31, 2021 and 2020, respectively</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--ShippingAndHandlingPolicyTextBlock_zHjEmh7vgPHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Shipping and handling</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z39I3F7j8mE9" title="Selling expenses">11,054</span> and $<span id="xdx_900_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zzZpeqTGyBZa" title="Selling expenses">9,315</span> for the years ended December 31, 2021 and 2020, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zOiXHeocTzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs amounted to $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z2FuMLE61324" title="Advertising costs">20,218</span> and $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zuyisFdiELCe" title="Advertising costs">14,339</span> for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zbeXzIh9K1Xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Commission expenses </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $<span id="xdx_909_ecustom--SalesCommissionsAndFees1_pp0p0_c20210101__20211231_z6ZNeK45NC3j" title="Commission expenses">316,267</span> and $<span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zSxc8j1L6f32" title="Commission expenses">830,659</span> for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--DefinedContributionPlanPolicyTextBlock_zkZvS1Yq0XF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span style="text-decoration: underline">Defined contribution plan</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Total expenses for the plans were $<span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20210101__20211231_zgJgN31MZHD5" title="Defined contribution plan expense">99,488</span> and $<span id="xdx_90B_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_z5f6ZzaKecgf" title="Defined contribution plan expense">75,802</span> for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related contribution plans include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social Security Organization (“SOSCO”) – <span id="xdx_90E_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_ze4TdFb1Fj2" title="Salary percentage">1.75</span>% based on employee’s monthly salary capped of RM <span id="xdx_90C_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zUmbVWZyicu9" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees Provident Fund (“EPF”) – <span id="xdx_905_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_zVn7Eiyly6O8" title="Salary percentage">12</span>% based on employee’s monthly salary;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Insurance System (“EIS”) – <span id="xdx_906_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zhFZHd7oCLi1" title="Salary percentage">0.2</span>% based on employee’s monthly salary capped of RM <span id="xdx_903_ecustom--MonthlySalary_pp0p0_uRM_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zavxrZi1P9Ul" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human Resource Development Fund (“HRDF”) – <span id="xdx_900_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zt0N8oBqBNq" title="Salary percentage">1</span>% based on employee’s monthly salary</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z5jmFnxmDe13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is <span id="xdx_907_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_zI0BK4zQ6X15" title="Income tax examination, likelihood of unfavorable settlement">greater than 50%</span> likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. $<span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20210101__20211231_zhtHJHFt04F7" title="Income tax examination, penalties and interest expense">395</span> and $<span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20200101__20201231_zwgUz8si7Xxk" title="Income tax examination, penalties and interest expense">0</span> penalties and interest incurred related to underpayment of income tax for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zFmJhQqD6MOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive income (loss)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zvodLWm7yptb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-controlling interest</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--MinorityInterestDescription_c20210101__20211231_z2jVyFk7GMzi" title="Noncontrolling interest, description">Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals</span>. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZGPhNuzFDjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Earnings (loss) per share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the years ended December 31, 2021 and 2020, there were <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20210101__20211231_z6oZ7p2bv9Mf" title="Potentially dilutive securities outstanding"><span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20200101__20201231_zVXiU2cpuCAc" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8AGmGK5QsX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign currencies translation and transaction</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statements of operations and comprehensive income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.20</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zqNifIeILn8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--RelatedPartiesPolicyTextBlock_zrQDAfgxw1sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related parties</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFEmgvJtixod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair value of financial instruments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.</span></p> <p id="xdx_854_zbiKkVXe0pQi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zZNdDkKBmvPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopts ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company’s leases include one or more options to renew, which is typically at the Company’s sole discretion. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications result in re-measurement of the right of use (“ROU”) assets and lease liabilities. Operating ROU assets and lease liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwRa40sJZ3q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent accounting pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2020, the FASB issued ASU 2020-08, “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs”. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2020, the FASB issued ASU 2020-10, “Codification Improvements”. The amendments in this Update represent changes to clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p> <p id="xdx_85B_z1wiGXOwYsl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeDlPoyXheKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Basis of presentation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zIzk1snyltAf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principles of consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zJNbiMqwRbCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3rzciRsd7ae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cash and cash equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.</span></p> <p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zfLkXh3OhBMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts receivable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, <span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20211231_zZpkZXBfDhF1" title="Accounts receivable, allowance for credit loss::XDX::-"><span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_dxL_c20201231_z2gRSfBQ4YQh" title="Accounts receivable, allowance for credit loss::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0613"><span style="-sec-ix-hidden: xdx2ixbrl0615">no</span></span></span></span> allowance of doubtful accounts was recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zdaWn6gJJjD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Inventories</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021, and 2020, the company recorded $<span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zz2wt2LAgfC5" title="Inventories write-down">36,241</span> and $<span id="xdx_908_eus-gaap--InventoryWriteDown_pp0p0_dxL_c20200101__20201231_zB3vozrYmlpa" title="Inventories write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0621">0</span></span> write-downs for inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 36241 <p id="xdx_84E_ecustom--PrepaidTaxesPolicyTextBlock_zdZoMb8wzNHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepaid taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Prepaid taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zqkBitGlXc97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Prepayments and deposits</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, there was $<span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20211231_zOfQcpaErBJ1" title="Allowance for doubtful accounts">121,514</span> and $<span id="xdx_906_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20201231_zdfQOpCLD4Ne" title="Allowance for doubtful accounts">0</span> allowance for the doubtful accounts recorded.</span></p> 121514 0 <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z7cYcWhlN8v6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property and equipment, net</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zSzEw3lfeing" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture &amp; fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment">7</span> years</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment">5</span> years</span></td></tr> </table> <p id="xdx_8A9_zEFPE25M0ylf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zcYvH2EGUA5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zSzEw3lfeing" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer and office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zILKLk2jWb88" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zVIngcAzkRgh" title="Estimated Useful Life of Property and Equipment">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture &amp; fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zwho1log7657" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zIs7CsFbZYD5" title="Estimated Useful Life of Property and Equipment">7</span> years</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmgE0bOPjr4" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zbd2hPBiDOUd" title="Estimated Useful Life of Property and Equipment">5</span> years</span></td></tr> </table> P5Y P7Y P6Y P7Y Lease Term P5Y <p id="xdx_842_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zHEzuq48QgQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Intangible assets, net</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zvU7SXf61uW4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets">5</span> years</span></td></tr> </table> <p id="xdx_8A7_zorLQNME5Hh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zv1BOp6XFFZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zvU7SXf61uW4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 78%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zca1fIdObWL3" title="Estimated useful lives of intangible assets">5</span> years</span></td></tr> </table> P5Y <p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5qzlK0tNytk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Impairment for long-lived assets</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and 2020, <span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20210101__20211231_zrSWi5qIbct2" title="Impairment of long-lived assets"><span id="xdx_902_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20201231_zLQgENYYhvLc" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_84B_eus-gaap--DeferredChargesPolicyTextBlock_z36dlBRJQxUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Deferred offering costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--MarketableSecuritiesPolicy_zgB7vO5Vnsi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment in marketable equity securities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company follows the provisions of ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s unaudited condensed consolidated statements of operations and comprehensive loss in the caption of “unrealized holding gain loss on marketable securities” in each reporting period</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p id="xdx_84E_ecustom--NonMarketableSecuritiesPolicyTextBlock_z3ijwap9sP65" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Investment in non-marketable equity securities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the provisions of ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zTvWJ7as6POh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Customer deposits</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--RevenueRecognitionPolicyTextBlock_zMrTajC1AXKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales of Health and Wellness products</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <i>Performance obligations satisfied at a point in time</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_906_ecustom--ForfeitedCouponIncome_pp0p0_c20210101__20211231_zh7G9r61F1ta">15,209</span> and $<span id="xdx_908_ecustom--ForfeitedCouponIncome_pp0p0_c20200101__20201231_zkpNQLzrUHHf" title="Forfeited coupon income">170,431</span> as forfeited coupon income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_90A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_za2TyjvrR2mg" title="Revenue from sales">183,816</span> which it is expected to fulfill within 12 months from December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales of Health and Wellness services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <i>Performance obligations satisfied at a point in time</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zHfubZZIitA3">7,543</span> and $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zqmC0FnEsRM2">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated information of revenues by products and services are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Survivor Select</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,904</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,897</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Energized Mineral Concentrate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,481</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ionized Cal-Mag</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">908,964</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Omega Blend</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">222,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">BetaMaxx</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,043</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vege Fruit Fiber</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,757</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Iron</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Young Formula</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organic Youth Care Cleansing Bar</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Mitogize</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,801</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">No. 1 MED</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Energetique</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,574</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">253,396</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trim+</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,042</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenues – products</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,009,419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Health and Wellness services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0721"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenues</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,016,962</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zKKWWqhhjikh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 15209 170431 183816 7543 0 <p id="xdx_89F_ecustom--ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock_zkmuvW28sUI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disaggregated information of revenues by products and services are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zuVJZ1iqIPmh" style="display: none">SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_498_20210101__20211231_zhirVNeIixxg" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20200101__20201231_zB046sfKYTKb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--SurvivorSelectMember_zFPlS5kcjBb4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Survivor Select</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">83,904</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,897</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_zgVNyG2mmIQi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Energized Mineral Concentrate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,047</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,481</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IonizedCalMagMember_zYrcdDYqLKCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ionized Cal-Mag</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,527</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">908,964</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OmegaBlendMember_zumKe3E53hpk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Omega Blend</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">222,718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--BetaMaxxMember_zBzRTVi7tKfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">BetaMaxx</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">208,043</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,550</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--VegeFruitFiberMember_zfCONoCM8MTl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vege Fruit Fiber</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">65,757</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--IronMember_zS5MatRAD6x9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Iron</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,114</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">133,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--YoungFormulaMember_zBa2mCXtbBJf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Young Formula</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,425</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">653,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_zkCSQ3jcvpig" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Organic Youth Care Cleansing Bar</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--MitogizeMember_zzGNk90CssIj" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Mitogize</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,801</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--NoOneMEDMember_zRO8tXf5VUsa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">No. 1 MED</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">46,713</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--EnergetiqueMember_zB2EXGB7UiI5" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Energetique</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,574</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">253,396</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--TrimPlusMember_zGv3az04WLA6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trim+</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,042</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">365,350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zGW9GECs8Nfj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total revenues – products</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,009,419</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--Revenues_hsrt--ProductOrServiceAxis__custom--HealthAndWellnessServicesMember_zO862Rt2XIV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Health and Wellness services</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0721"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_zE1YDwJaYoyk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenues</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,016,962</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,452,621</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 83904 149897 52047 81481 39527 908964 222718 495567 208043 156550 65757 1755 28114 133389 52425 653631 5137 43127 183800 162801 15331 46713 25574 253396 27042 365350 1009419 3452621 7543 1016962 3452621 <p id="xdx_840_eus-gaap--CostOfSalesPolicyTextBlock_z0ZV9KzHWuv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Cost of revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cost of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue amounted to $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20210101__20211231_zQDKOqYEwgwe" title="Cost of revenue">297,333</span> (including inventory write-downs of $<span id="xdx_907_eus-gaap--InventoryWriteDown_pp0p0_c20210101__20211231_zAnOlYDliz7l" title="Inventories write-down">36,241</span>) and $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20200101__20201231_z1I0GRSSjKHh" title="Cost of revenue">775,855</span> for the years ended December 31, 2021 and 2020, respectively</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 297333 36241 775855 <p id="xdx_847_ecustom--ShippingAndHandlingPolicyTextBlock_zHjEmh7vgPHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Shipping and handling</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping and handling charges amounted to $<span id="xdx_90E_eus-gaap--SellingExpense_pp0p0_c20210101__20211231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_z39I3F7j8mE9" title="Selling expenses">11,054</span> and $<span id="xdx_900_eus-gaap--SellingExpense_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zzZpeqTGyBZa" title="Selling expenses">9,315</span> for the years ended December 31, 2021 and 2020, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11054 9315 <p id="xdx_847_eus-gaap--AdvertisingCostsPolicyTextBlock_zOiXHeocTzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Advertising costs</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs amounted to $<span id="xdx_90D_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z2FuMLE61324" title="Advertising costs">20,218</span> and $<span id="xdx_901_eus-gaap--AdvertisingExpense_pp0p0_c20200101__20201231_zuyisFdiELCe" title="Advertising costs">14,339</span> for the years ended December 31, 2021 and 2020, respectively. Advertising costs are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 20218 14339 <p id="xdx_848_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zbeXzIh9K1Xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Commission expenses </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $<span id="xdx_909_ecustom--SalesCommissionsAndFees1_pp0p0_c20210101__20211231_z6ZNeK45NC3j" title="Commission expenses">316,267</span> and $<span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20201231_zSxc8j1L6f32" title="Commission expenses">830,659</span> for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 316267 830659 <p id="xdx_846_ecustom--DefinedContributionPlanPolicyTextBlock_zkZvS1Yq0XF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><span style="text-decoration: underline">Defined contribution plan</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Total expenses for the plans were $<span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20210101__20211231_zgJgN31MZHD5" title="Defined contribution plan expense">99,488</span> and $<span id="xdx_90B_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_pp0p0_c20200101__20201231_z5f6ZzaKecgf" title="Defined contribution plan expense">75,802</span> for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related contribution plans include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social Security Organization (“SOSCO”) – <span id="xdx_90E_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_ze4TdFb1Fj2" title="Salary percentage">1.75</span>% based on employee’s monthly salary capped of RM <span id="xdx_90C_ecustom--MonthlySalary_pp0p0_uRM_c20200101__20201231__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zUmbVWZyicu9" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees Provident Fund (“EPF”) – <span id="xdx_905_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_zVn7Eiyly6O8" title="Salary percentage">12</span>% based on employee’s monthly salary;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Insurance System (“EIS”) – <span id="xdx_906_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zhFZHd7oCLi1" title="Salary percentage">0.2</span>% based on employee’s monthly salary capped of RM <span id="xdx_903_ecustom--MonthlySalary_pp0p0_uRM_c20210101__20211231__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zavxrZi1P9Ul" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Human Resource Development Fund (“HRDF”) – <span id="xdx_900_ecustom--SalaryPercentage_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zt0N8oBqBNq" title="Salary percentage">1</span>% based on employee’s monthly salary</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 99488 75802 0.0175 4000 0.12 0.002 4000 0.01 <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_z5jmFnxmDe13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Income taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is <span id="xdx_907_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20210101__20211231_zI0BK4zQ6X15" title="Income tax examination, likelihood of unfavorable settlement">greater than 50%</span> likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. $<span id="xdx_902_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20210101__20211231_zhtHJHFt04F7" title="Income tax examination, penalties and interest expense">395</span> and $<span id="xdx_90C_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_c20200101__20201231_zwgUz8si7Xxk" title="Income tax examination, penalties and interest expense">0</span> penalties and interest incurred related to underpayment of income tax for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> greater than 50% 395 0 <p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zFmJhQqD6MOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Comprehensive income (loss)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zvodLWm7yptb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-controlling interest</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--MinorityInterestDescription_c20210101__20211231_z2jVyFk7GMzi" title="Noncontrolling interest, description">Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals</span>. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zZGPhNuzFDjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Earnings (loss) per share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the years ended December 31, 2021 and 2020, there were <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20210101__20211231_z6oZ7p2bv9Mf" title="Potentially dilutive securities outstanding"><span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_do_c20200101__20201231_zVXiU2cpuCAc" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_842_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8AGmGK5QsX6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Foreign currencies translation and transaction</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statements of operations and comprehensive income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.20</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zqNifIeILn8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_z1zruFnPlty9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zgOIc5Kc2gPb" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_zv4j3bcrzZ6i" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_z836Xayf8zO6" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">4.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20211231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_zhfYni53E5k2" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20201231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_z8DhCjyk2Tz3" style="text-align: right" title="Foreign Currency Exchange Rate, Translation"><span style="font-family: Times New Roman, Times, Serif">7.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_z24OtfFXFGCf" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_zKltJKHCAmgb" style="width: 16%; text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">4.20</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ForeignCurrencyExchangeRateAverage_c20210101__20211231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_zRb361XLeqdc" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--ForeignCurrencyExchangeRateAverage_c20200101__20201231__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_z29DWbF4rog5" style="text-align: right" title="Foreign currency exchange rate period average"><span style="font-family: Times New Roman, Times, Serif">7.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 4.18 4.02 7.80 7.75 4.14 4.20 7.77 7.76 <p id="xdx_846_ecustom--RelatedPartiesPolicyTextBlock_zrQDAfgxw1sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related parties</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zFEmgvJtixod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Fair value of financial instruments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.</span></p> <p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zZNdDkKBmvPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Leases</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopts ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company’s leases include one or more options to renew, which is typically at the Company’s sole discretion. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications result in re-measurement of the right of use (“ROU”) assets and lease liabilities. Operating ROU assets and lease liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwRa40sJZ3q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recent accounting pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2020, the FASB issued ASU 2020-08, “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs”. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2020, the FASB issued ASU 2020-10, “Codification Improvements”. The amendments in this Update represent changes to clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.</span></p> <p id="xdx_80E_eus-gaap--VariableInterestEntityDisclosureTextBlock_zgIAe8pTJwf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.<span id="xdx_826_zJTc7N756JKh"> VARIABLE INTEREST ENTITY (“VIE”)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEA is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided majority of ASL’s purchases. Its equity at risk was insufficient to finance its activities and <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember_zCTAPQB3ObJb" title="Ownership interest percentage">100</span>% of its business is transacted with ASL. Therefore, it was considered to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, the accounts of SEA is consolidated in the accompanying financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_ziGf9DSLZguk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of the VIE’s assets and liabilities were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_z3zsHjUhKgR2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF VARIABLE INTEREST ENTITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zBBDeiE1qBYf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_z2TTLKve29le"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AssetsCurrent_iI_zG66KK7YK2o8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_iNI_di_zPrH2WbQg587" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--StockholdersEquity_iI_zPkIAvNRIe8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zW698uRlRrVl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zWYlp147wSI9"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_zMxrxRs5Smr9" style="vertical-align: bottom; background-color: White"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,387</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PrepaidTaxes_iI_zRfWUPLsX9ga" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,357</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--AssetsCurrent_iI_zEyDHieHajs8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_z8jU9wyuZVP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--OtherPayablesRelatedPartyCurrent_iI_z1TajavnLNl5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iI_zNU60IeGzAIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--StockholdersEquity_iI_zbeklS8QD69c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The summarized operating results of the VIE’s are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20210101__20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zi6p0xMmPGM2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zk2JEF1orUyc"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJkAWrUJn7vg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating revenues</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">346,907</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--GrossProfit_z8WN2B2SZ4M4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,442</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_z7P4DubEetea" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_z9kg1Cro03Zj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,014</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p id="xdx_8A5_z9XMfeKjRbje" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 <p id="xdx_899_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_ziGf9DSLZguk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of the VIE’s assets and liabilities were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_z3zsHjUhKgR2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF VARIABLE INTEREST ENTITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zBBDeiE1qBYf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_z2TTLKve29le"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AssetsCurrent_iI_zG66KK7YK2o8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesCurrent_iNI_di_zPrH2WbQg587" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--StockholdersEquity_iI_zPkIAvNRIe8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zW698uRlRrVl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zWYlp147wSI9"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_zMxrxRs5Smr9" style="vertical-align: bottom; background-color: White"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,387</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PrepaidTaxes_iI_zRfWUPLsX9ga" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,357</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--AssetsCurrent_iI_zEyDHieHajs8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,850</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,717</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_z8jU9wyuZVP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--OtherPayablesRelatedPartyCurrent_iI_z1TajavnLNl5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,904</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_iI_zNU60IeGzAIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,272</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">53,573</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--StockholdersEquity_iI_zbeklS8QD69c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deficit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,422</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,856</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The summarized operating results of the VIE’s are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20210101__20211231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zi6p0xMmPGM2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20200101__20201231__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zk2JEF1orUyc"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zJkAWrUJn7vg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating revenues</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">346,907</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--GrossProfit_z8WN2B2SZ4M4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,442</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_z7P4DubEetea" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,752</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_z9kg1Cro03Zj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(27,966</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,014</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> 18850 48717 51272 53573 -32422 -4856 17493 37387 1357 11330 18850 48717 49724 51669 1548 1904 51272 53573 -32422 -4856 346907 4442 -21966 -10752 -27966 -24014 <p id="xdx_807_eus-gaap--BusinessCombinationDisclosureTextBlock_zHKYl8jArZKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82E_znKBt4nMZKba">BUSINESS COMBINATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 8, 2020, the Company entered into a Share Exchange Agreement (“SPA”) with Mr. How Kok Choong, CEO and director of the Company to acquire <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zpoIx15294x9" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, <span id="xdx_903_eus-gaap--CommonStockNoParValue_iI_pid_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zusXLrQtxMGg" title="Ordinary shares no par value">no</span> par value, equivalent to approximately <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_znvYx7HfnLQh" title="Ownership interest percentage">99.99</span>% of the equity interest in ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200629__20200702__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zDegVsPKsyCi" title="Purchase consideration value">1,804,046</span>, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $<span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zqnnhV1u2Yrl" title="Loan payable">656,495</span> as of March 31, 2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_z1n36MvAuTgd" title="Stock issued during period acquisitions, shares">176,547</span> shares of the Company’s common stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zweck9JWKzxa" title="Common stock par value">0.0001</span>, representing approximately <span id="xdx_90F_ecustom--PercentageOfCommonStockIssuedAndOutstanding_pid_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_ztBialGaIA75" title="Percentage of common stock issued and outstanding">0.0469</span>% of the total issued and outstanding shares in the Company after the issuance of the Shares, which is valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zcDFdmnq1Mob" title="Stock issued during period, value, acquisitions">1,147,551</span> based on the closing price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zweSXWsFrjuc" title="Purchased price per shares">6.50</span> of the Company as quoted on the OTC Market on March 31, 2020. As of December 31, 2020, the Company has issued all <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zOYczuv65Dse" title="Issuance of common stock shares">176,547</span> shares of the Company’s common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020 as ASL was under the common control of Mr. How.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9hQbHfHjE47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_zZ9ze4vUt6Xf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211231_zi5gZGfDW912" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Carry Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zFootoo6DkQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 80%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zPCfRzzCqFe2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_iI_zvU4mN9Vlab4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables - related parties</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,121</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z4KcdNuvJtvf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Inventories</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">616,880</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_iI_zIZKzHM3w2W" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,821</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zUn3enkZbJpk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepayments and other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">318,267</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zKz3awcUZDTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,600,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_ztkI3wRKXP4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment, net</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">325,648</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zLClQ04mPaFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,686</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_z5dLrc78mnxc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred taxes asset, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,250</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zBZrA7c0ltt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">504,584</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zPuB2iDXZjri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,105,376</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND SHAREHOLDERS’ EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zT38U9zsO3Kf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable - related party</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">491,628</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_zhCBrTvOaBml" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,600,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_z9N5VJeANSV8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,096</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_zCmXdCjZO6z7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zQvCrxEVwmn1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zq2ThSccWRP9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total net assets acquired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,804,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_zv4jqD0Ky8K6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. BUSINESS COMBINATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2020. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2020. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.</span></p> <p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zseqpulCa5J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B9_zZVcZYoKTnPc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE OF PRO FORMA BUSINESS COMBINATION</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20200101__20201231_zuUagwDfcb66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the year ended December 31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zuz6pejZgaNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,693,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_zhoMOdVTbnj8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(875,708</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_406_ecustom--BusinessAcquisitionsProFormaGrossProfit_zEF3eZHqnGUj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,818,165</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zXatwYMBeZoa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,839,184</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zBEyIiiyyL8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> Loss from operations</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,019</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_zWFdgUfqokuj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other income (expense), net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">267,633</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_z7tgSGvyyUyh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income before income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">246,614</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zGrdUgLWVzZ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(212,414</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBg35qlM6qO3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zX5mlxsNMQ4h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income per common share - basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zq1dvEl2L7o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of common shares outstanding - basic and diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">376,452,047</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_zbm6HAfwykq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 9590596 0 0.9999 1804046 656495 176547 0.0001 0.000469 1147551 6.50 176547 <p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9hQbHfHjE47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_zZ9ze4vUt6Xf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211231_zi5gZGfDW912" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Carry Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zFootoo6DkQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 80%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zPCfRzzCqFe2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,210</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_iI_zvU4mN9Vlab4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other receivables - related parties</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,121</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z4KcdNuvJtvf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Inventories</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">616,880</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_iI_zIZKzHM3w2W" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,206,821</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zUn3enkZbJpk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepayments and other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">318,267</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zKz3awcUZDTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,600,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_ztkI3wRKXP4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment, net</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">325,648</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zLClQ04mPaFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,686</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_z5dLrc78mnxc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred taxes asset, net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,250</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zBZrA7c0ltt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total other assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">504,584</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zPuB2iDXZjri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,105,376</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND SHAREHOLDERS’ EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zT38U9zsO3Kf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable - related party</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">491,628</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iI_zhCBrTvOaBml" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Customer deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,600,606</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iI_z9N5VJeANSV8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,096</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_zCmXdCjZO6z7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zQvCrxEVwmn1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,301,330</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zq2ThSccWRP9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total net assets acquired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,804,046</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1206493 33210 219121 616880 1206821 318267 3600792 325648 6686 172250 504584 4105376 491628 1600606 209096 2301330 2301330 1804046 <p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zseqpulCa5J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_8B9_zZVcZYoKTnPc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE OF PRO FORMA BUSINESS COMBINATION</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20200101__20201231_zuUagwDfcb66" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the year ended December 31, 2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zuz6pejZgaNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,693,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_zhoMOdVTbnj8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(875,708</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_406_ecustom--BusinessAcquisitionsProFormaGrossProfit_zEF3eZHqnGUj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,818,165</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zXatwYMBeZoa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,839,184</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40A_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zBEyIiiyyL8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> Loss from operations</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(21,019</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_zWFdgUfqokuj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other income (expense), net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">267,633</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_z7tgSGvyyUyh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income before income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">246,614</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zGrdUgLWVzZ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income taxes</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(212,414</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_407_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zBg35qlM6qO3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zX5mlxsNMQ4h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net income per common share - basic and diluted</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zq1dvEl2L7o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of common shares outstanding - basic and diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">376,452,047</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 4693873 -875708 3818165 -3839184 -21019 267633 246614 -212414 34200 0.00 376452047 <p id="xdx_800_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zN9IiYDlrq18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.<span id="xdx_821_zPrw6JX8HjPe"> CASH AND CASH EQUIVALENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of December 31, 2021 and 2020 the Company had $<span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20211231_zAF6iYXW4g7d" title="Cash and cash equivalents">2,597,848</span> and $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20201231_zFh1Og884st3" title="Cash and cash equivalents">3,517,600</span>, respectively, of cash and cash equivalents, which consists of $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20211231_zvcHm0WlQDP8" title="Cash in bank">554,864</span> and $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20201231_zyxICel5xP62" title="Cash in bank">1,112,147</span>, respectively, of cash in banks and </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90C_eus-gaap--TimeDeposits_iI_pp0p0_c20211231_zWVS7j9hfk68" title="Time deposits">1,975,347 </span><span style="background-color: white">and $</span><span id="xdx_905_eus-gaap--TimeDeposits_iI_pp0p0_c20201231_zaqEdjOZL1ua" title="Time deposits">2,391,182</span><span style="background-color: white">, respectively, of time deposits placed with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between <span id="xdx_90D_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MinimumMember_zuytjcggSXAi" title="Percentage of Interest rate for time deposits">1.10</span>% to <span id="xdx_905_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pid_dp_uPure_c20211231__srt--RangeAxis__srt--MaximumMember_zTHpOlCuwpM7" title="Percentage of Interest rate for time deposits">1.25</span>% per annum.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 2597848 3517600 554864 1112147 1975347 2391182 0.0110 0.0125 <p id="xdx_802_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zANB6XTXVI5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>6. <span id="xdx_82C_zYmOLmtj2Z9j">ACCOUNTS RECEIVABLE </span></b></span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zHmyEyZzWE14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BC_ze0iPUfvtWL5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_49F_20211231_z9PPc3k8pk4f" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_490_20201231_zpm43E1b5fV" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zQm67i8MAm51" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_z7wtfqwZytyb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zPkkNTIE1sq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0980">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_z5OUP4FoMg1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zHmyEyZzWE14" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BC_ze0iPUfvtWL5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_49F_20211231_z9PPc3k8pk4f" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_490_20201231_zpm43E1b5fV" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_zQm67i8MAm51" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARNCzL7F_maARAARzRRC_z7wtfqwZytyb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARzRRC_zPkkNTIE1sq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0980">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,757</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 172757 172757 <p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zWQmZCymz9Tf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_82C_zeqCj0uim1ai">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zruvM8S4PaXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zGTxmw5qLZR1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF INVENTORIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20211231_ztBtShzWBIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20201231_zNoSlNQMm9L6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_zBWMRwP1vewa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">375,535</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,814</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zUGBK5Y1QI1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the Company recognized $<span id="xdx_90F_eus-gaap--InventoryWriteDown_c20210101__20211231_z979lnJ6UNTe" title="Inventory write-down">36,241</span> and $<span id="xdx_900_eus-gaap--InventoryWriteDown_dxL_c20200101__20201231_zzWgX0JuZkbf" title="Inventory write-down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0992">0</span></span> inventory write-down, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zruvM8S4PaXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_zGTxmw5qLZR1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF INVENTORIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20211231_ztBtShzWBIic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20201231_zNoSlNQMm9L6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_zBWMRwP1vewa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">375,535</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">589,814</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 375535 589814 36241 <p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zi54yOr6XXOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>8.<span id="xdx_828_zvy7XAm3hLm9"> PREPAYMENTS AND DEPOSITS</span></b></span></p> <p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zAtd04mFJGJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B8_zF59P1dp47df" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_494_20211231_ziMwpEOwIyHf" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_499_20201231_zDrpQH6b7sf8" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zH01auAciTqf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Receivables from sales distributors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,379</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,302</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zE6hh4Mu4raj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deposits to suppliers</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">301,233</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">261,068</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--PrepaidExpensesGross_iTI_pp0p0_mtPEGzE1e_maPEAOAzys7_z6VlCHZfPes6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">416,612</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_di_msPEAOAzys7_zq8mIhkKa9yd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Provision for doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(121,095</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzys7_z2yGv6cu952d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">295,517</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_zFsIeNl1R1Hk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_zZ1SZcciBJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements of allowance for doubtful accounts are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zOtTmiuBvtG2">SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20210101__20211231_zZywmLOnsVpa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20201231_zsnq60MWSzPj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z4xFzw1tofAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1015">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zMeD0XKlg3s3" style="vertical-align: bottom; background-color: White"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Addition</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">121,514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1019"> </span></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_zegPRvqut4vb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write off</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1021"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1022"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_zpM2sAxNIGX1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(419</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1025"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_zFnjY6bhglQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right">121,095</td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zl57uYqJW8je" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_zAtd04mFJGJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B8_zF59P1dp47df" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_494_20211231_ziMwpEOwIyHf" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_499_20201231_zDrpQH6b7sf8" style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zH01auAciTqf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Receivables from sales distributors</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,379</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,302</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzhWX_maPEGzE1e_zE6hh4Mu4raj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Deposits to suppliers</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">301,233</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">261,068</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--PrepaidExpensesGross_iTI_pp0p0_mtPEGzE1e_maPEAOAzys7_z6VlCHZfPes6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">416,612</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iNI_di_msPEAOAzys7_zq8mIhkKa9yd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Provision for doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(121,095</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzys7_z2yGv6cu952d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">295,517</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">296,370</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 115379 35302 301233 261068 416612 296370 121095 295517 296370 <p id="xdx_89C_ecustom--ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock_zZ1SZcciBJrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements of allowance for doubtful accounts are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zOtTmiuBvtG2">SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20210101__20211231_zZywmLOnsVpa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20201231_zsnq60MWSzPj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z4xFzw1tofAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Beginning balance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1015">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zMeD0XKlg3s3" style="vertical-align: bottom; background-color: White"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Addition</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">121,514</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1019"> </span></span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_zegPRvqut4vb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Write off</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1021"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1022"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--AllowanceForDoubtfulAccountsReceivableExchangeRateEffect_zpM2sAxNIGX1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(419</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1025"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_zFnjY6bhglQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right">121,095</td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 121514 -419 121095 <p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zdFbnLwIqJU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_823_zFwRIn243Otd">PROPERTY AND EQUIPMENT, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zEBQDGv1UhV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z6ieX65Jn6Ue" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20211231_z69fX0OmVDf5" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20201231_zRECSdxyxbj9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z1Gff565WJv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer and office equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,298</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,437</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zo9mxKzC7fRe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture &amp; fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122,185</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">126,966</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zzUJMFAELrt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zwHzILui9WXb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicle</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,702</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,564</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz5ZB_zFJIlVBSdyEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">505,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">521,463</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz5ZB_ztuoRLZe8B4l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(289,956</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(223,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz5ZB_zinKGvSYnjR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">215,799</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298,309</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zJqojgI1LHf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the years ended December 31, 2021 and 2020 amounted to $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zJNO1NybsZH9" title="Depreciation">75,797</span> and $<span id="xdx_905_eus-gaap--Depreciation_pp0p0_c20200101__20201231_z0ECCJVEMrdg" title="Depreciation">55,407</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--PropertyPlantAndEquipmentTextBlock_zEBQDGv1UhV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z6ieX65Jn6Ue" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20211231_z69fX0OmVDf5" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20201231_zRECSdxyxbj9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember_z1Gff565WJv3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer and office equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">82,298</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,437</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zo9mxKzC7fRe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture &amp; fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">122,185</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">126,966</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zzUJMFAELrt3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">202,570</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--VehicleMember_zwHzILui9WXb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vehicle</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">98,702</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,564</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENz5ZB_zFJIlVBSdyEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Subtotal</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">505,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">521,463</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENz5ZB_ztuoRLZe8B4l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(289,956</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(223,154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENz5ZB_zinKGvSYnjR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">215,799</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">298,309</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 82298 81437 122185 126966 202570 210496 98702 102564 505755 521463 289956 223154 215799 298309 75797 55407 <p id="xdx_80B_eus-gaap--IntangibleAssetsDisclosureTextBlock_zGFkmRZ9XRW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_827_zTIa8dhIaRyj">INTANGIBLE ASSETS, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zc9eZtE2O7pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net, consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zvNaeIFuni2l" style="display: none">SCHEDULE OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20211231_zlsQm9npWeH9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20201231_zQQB9ihbGkUb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzvmN_zYwict1pvqZf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer software</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,453</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,801</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzvmN_zOdvLeC8fWvk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30,793</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzvmN_zOsuj2cfJOZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,660</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,826</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zaBwp2p2Umjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for the years ended December 31, 2021 and 2020 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_zDu4asXu3k5g" title="Amortization expense">1,961</span> and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20200101__20201231_zwHERLSxH47b" title="Amortization expense">1,505</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zc9eZtE2O7pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net, consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zvNaeIFuni2l" style="display: none">SCHEDULE OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20211231_zlsQm9npWeH9" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2021</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; font-weight: bold; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20201231_zQQB9ihbGkUb" style="border-bottom: Black 1.5pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif">2020</span></td><td style="display: none; padding-bottom: 1.5pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzvmN_zYwict1pvqZf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer software</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,453</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,801</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzvmN_zOdvLeC8fWvk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: accumulated amortization</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30,793</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29,975</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzvmN_zOsuj2cfJOZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,660</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,826</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 34453 35801 30793 29975 3660 5826 1961 1505 <p id="xdx_801_ecustom--InvestmentInMarketableSecuritiesTextBlock_z0AE31WvZSt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_829_z7a3r8822GN1">INVESTMENT IN MARKETABLE SECURITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 17, 2018, the Company purchased <span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zW7uOLKzpNUd" title="Investment in securities, shares">83,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">500,000</span> at a purchase price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zvq8oNqx3jSf" title="Purchased price per shares">6</span> per share.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 30, 2018, the Company disposed <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares">20</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90D_eus-gaap--InvestmentOwnedAtCost_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">125</span> at a purchase price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180730__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_ztkqpm5Y2GG2" title="Purchased price per shares">6.2613</span> per share.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 16, 2018, the Company purchased <span id="xdx_907_eus-gaap--InvestmentOwnedBalanceShares_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pdd" title="Investment in securities, shares">33,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90B_eus-gaap--InvestmentOwnedAtCost_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">1,000</span> at a purchase price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zHz9zDfeYGA5" title="Purchased price per shares">0.03</span> per share.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 3, 2020, the Company received dividend of <span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares">6,667</span> shares of common stock in DSwiss, Inc. for $<span id="xdx_902_eus-gaap--InvestmentOwnedAtCost_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_pp0p0" title="Investment amount">76,671</span> at fair value of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20201103__dei--LegalEntityAxis__custom--DSwissIncMember_ztuzYabimIV3" title="Purchased price per shares">11.50</span> per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.’s shares</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 9, 2020, the Company received dividend of <span id="xdx_909_eus-gaap--InvestmentOwnedBalanceShares_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Investment in securities, shares">16,663</span> shares of common stock in DSwiss, Inc. for $<span id="xdx_904_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_zQYdItS6YA95" title="Investment amount">83,315</span> at fair value of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_c20201209__dei--LegalEntityAxis__custom--DSwissIncMember_pdd" title="Purchased price per shares">5</span> per share from Greenpro Capital Corporation as result of its Spin-off of DSwiss, Inc.’s shares.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 27, 2021, the Company received dividend of <span id="xdx_90A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zWxOSeW7TGKc" title="Investment in securities, shares">11,665</span> shares of common stock in SEATech Ventures Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_zFB6M57yUM7h" title="Investment amount">18,874</span> at fair value of $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210927__dei--LegalEntityAxis__custom--SEATechVenturesCorpMember_z7ktyxfuiRa9" title="Purchased price per shares">1.62</span> per share from Greenpro Capital Corp as a dividend income since Greenpro Capital Corp previously owned these shares.</span></td></tr> </table> <p id="xdx_895_eus-gaap--MarketableSecuritiesTextBlock_zFEm35wnJK17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zsAchnQKts4f" style="display: none">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211231_zOIHppVaOEHj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20201231_zzMhWcyrOVu3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzd9C_zg0L5qKThXZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,484</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--InvestmentsIncomeDividend_iNI_pp0p0_di_msMSNzd9C_zsGc1FQujud7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend income from Greenpro Capital Corp.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingGainLoss_iNI_pp0p0_di_msMSNzd9C_zVxQoo2AjMif" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized holding (loss) gain</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(505,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">350,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzd9C_zePn8dcJ0vrh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzd9C_z7o7Scdcq463" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">89,001</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zNnaIx5tgoTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 83333 500000 6 20 125 6.2613 33333 1000 0.03 6667 76671 11.50 16663 83315 5 11665 18874 1.62 <p id="xdx_895_eus-gaap--MarketableSecuritiesTextBlock_zFEm35wnJK17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zsAchnQKts4f" style="display: none">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20211231_zOIHppVaOEHj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20201231_zzMhWcyrOVu3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzd9C_zg0L5qKThXZ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,484</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--InvestmentsIncomeDividend_iNI_pp0p0_di_msMSNzd9C_zsGc1FQujud7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend income from Greenpro Capital Corp.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,939</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160,062</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--MarketableSecuritiesUnrealizedHoldingGainLoss_iNI_pp0p0_di_msMSNzd9C_zVxQoo2AjMif" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Unrealized holding (loss) gain</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(505,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">350,137</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzd9C_zePn8dcJ0vrh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Exchange rate effect</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">352</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzd9C_z7o7Scdcq463" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">89,001</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">577,035</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 577035 66484 -18939 -160062 505231 -350137 -1742 352 89001 577035 <p id="xdx_803_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zKKN32Sk8rPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_82B_zFhzKN0NPudl">INVESTMENT IN NON-MARKETABLE SECURITIES</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invested in Unreserved Sdn Bhd with the investment amount of $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_zOzj0LJ5N4hf" title="Investment amount">863,592</span> (RM <span id="xdx_90C_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_uRM_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_za2jMxdkzOql" title="Investment amount">3,500,000</span>), which approximated <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--TitleOfIndividualAxis__srt--DirectorMember_z1zlrHooYPvc" title="Equity interest percentage">20</span>% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019, Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MaximumMember_zljfcnZ7avah" title="Equity interest percentage">20.0</span>% to approximately <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190310__srt--RangeAxis__srt--MinimumMember_zGiCNJfyafw3" title="Equity interest percentage">17.86</span>%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unreserved Sdn Bhd was incorporated in Malaysia with <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zhdFQ9osSjyf" title="Ordinary shares authorized">2,500,000</span> ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 3, 2020, the Company agreed to sell the <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200303__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zaojmIJ84KR8" title="Equity interest percentage">17.86</span>% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value of $<span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_z4ELyUEMCqE6" title="Investment amount">730,637</span> to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $<span id="xdx_901_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_pp0p0_c20200101__20200331_zPNqRIEKcNS" title="Proceeds from investments">70,173</span>, and had an amount due from director of $<span id="xdx_900_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zenllgMTtRwd" title="Amount due from director">660,464</span> at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in a transaction which the Company had acquired the CEO’s ownership interest of Agape Superior Living Sdn. Bhd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 3, 2019, the Company purchased a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zxu1gkHqNZ41" title="Equity interest percentage">5</span>% of stock or <span id="xdx_905_eus-gaap--InvestmentOwnedBalanceShares_iI_pid_c20190403__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z7xvZX5Hj17d" title="Shares purchased during period">15,000,000</span> shares of common stock in Phoenix Plus Corp. for $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zJOhCu4LBiZ2" title="Investment amount">1,500</span> at purchase price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zr5Q9hljmw52" title="Shares Issued, Price Per Share">0.0001</span> per share.</span></p> <p id="xdx_89A_ecustom--NonMarketableSecuritiesTableTextBlock_zkOWturFo6n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zfbB1nvQU2N9" style="display: none">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Unreserved Sdn Bhd</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable securities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zf4RgvPstRU5" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--InvestmentInNonMarketableSecuritiesGross_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">730,637</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Sale of investment in non-marketable securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zQs5QiPliqOi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1167">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">(730,637</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zgdeHJqreulj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--InvestmentInNonmarketableSecuritiesNet_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Phoenix Plus Corporation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zgS1H7OUcv5i" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total investment in non-marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z4dw6o4mr5x8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_zdXgg29CBYk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 863592 3500000 0.20 0.200 0.1786 2500000 0.1786 730637 70173 660464 0.05 15000000 1500 0.0001 <p id="xdx_89A_ecustom--NonMarketableSecuritiesTableTextBlock_zkOWturFo6n8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zfbB1nvQU2N9" style="display: none">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Unreserved Sdn Bhd</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable securities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesGross_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zf4RgvPstRU5" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--InvestmentInNonMarketableSecuritiesGross_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">730,637</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Sale of investment in non-marketable securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--SaleOfInvestmentInNonmarketableSecurities_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zQs5QiPliqOi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1167">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">(730,637</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Investment in non-marketable securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--InvestmentInNonmarketableSecuritiesNet_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_zgdeHJqreulj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--InvestmentInNonmarketableSecuritiesNet_c20201231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Phoenix Plus Corporation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of investment</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zgS1H7OUcv5i" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtCost_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Cost of investment"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total investment in non-marketable securities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_z4dw6o4mr5x8" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20201231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities"><span style="font-family: Times New Roman, Times, Serif">1,500</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 730637 -730637 1500 1500 1500 1500 <p id="xdx_80B_eus-gaap--OtherLiabilitiesDisclosureTextBlock_z13zBm5NrVYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_828_zttG9nD8Dwia">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <p id="xdx_898_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zRfJrGJiy5X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zQzlwQRdDWch" style="display: none">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20211231_zEx06MSFkNDg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20201231_z914hOdXEpA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">436,541</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">297,636</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--AccruedPromotionExpenses_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,433</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Payroll</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,976</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Commission</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,721</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">224,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">143,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,921</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--OtherAccountPayableAndAccruedLiabilities_iTIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">858,355</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">647,677</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_z5O1v57TAlQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zRfJrGJiy5X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zQzlwQRdDWch" style="display: none">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20211231_zEx06MSFkNDg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20201231_z914hOdXEpA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional fees</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">436,541</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">297,636</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--AccruedPromotionExpenses_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Promotion expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,433</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Payroll</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,976</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Commission</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,721</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">224,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">143,400</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">63,921</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--OtherAccountPayableAndAccruedLiabilities_iTIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">858,355</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">647,677</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 436541 297636 36024 37433 22669 23976 219721 224711 143400 63921 858355 647677 <p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zy6L4RvrFZF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. <span id="xdx_827_zRgcik2Js4A6">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related party balances</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount due from related parties</b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zcAQ3zTAOKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z8lWSWKWUU0c" style="display: none">SCHEDULE OF RELATED PARTIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP (Asia) Limited (“AATP Asia”)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zFh7IyxtMaig" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zrYM4jVMEh4i" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zT5TKVhB1k1h" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zuDhF7hq7hH3" title="Nature">Expenses paid for AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zBPYNcd3xTze" style="width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,214</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zWkTG45rUsf" style="width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,227</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Hostastay Sdn. Bhd.</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">“Hostastay” </span></p></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoHMJVFDgqqg" title="Relationship"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zj7Cls3LGfj1" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_z96bkEc6Hqk9" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zOKpJukAbQx8" title="Nature">Sublease rent due from Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zIRfbce6jjj6" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">4,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zf4Uas6lnH9a" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">TH3 Technology Sdn Bhd</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">“TH3 </span>Technology”</p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdMAMDlv2nHd" title="Relationship"><span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zRRw54uNEw4h" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zF0Z2g5QwuVc" title="Nature"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zOLs3a1wFca1" title="Nature">Expenses paid for TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zBS833tKI6Ca" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdoHLYF8dUGb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231_zXf0bP8Tyebk" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">7,004</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_z1apLzBjnaN1" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">3,235</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount due to a Related Party</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior Living Pty Ltd</span> “ASLPL”</td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zjaffT4I6jli" style="font-family: Times New Roman, Times, Serif" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt; width: 18%; text-align: center"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zTcNtnTuIgMj" style="font-family: Times New Roman, Times, Serif">ATP Label Printing Fees</span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zGltgxrHs6Fk" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zfnwEeWUjRli" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zO3PaOw8ZMM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zonoooHgiBe8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. RELATED PARTY BALANCES AND TRANSACTIONS (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related party transactions </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior Living Pty Ltd (“ASLPL”)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zcC2giDupOh6" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zW9HzqMSxgMb" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; width: 18%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z4Lv347M7n3e" title="Nature"><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zH9KjlqHYSA1" title="Nature">Sales of products</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zGbEXE87uPu9" style="width: 14%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLj2DGzHvADi" style="width: 12%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><span id="xdx_F4C_zm8QfSbpOFne" style="font-family: Times New Roman, Times, Serif">Vettons Sdn Bhd*</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zugLfroRtprc" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zZvVq3EoCVc1" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zuQtzdRYWHvj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zb7z4MtJu9pk" title="Nature">Sales of products made through its platform</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____z2oh2awX7Fzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_fKg_____zvzZZ9Lr1X8e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231_zZMNas14GZie" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zbXwpniv32xe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b id="xdx_F07_z3qCnTQjHwmg">*</b></span></td> <td style="text-align: justify"><span id="xdx_F1F_zurIKlX1VP8l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company had sales of $<span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue">6,625</span> through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt">DSY Wellness &amp; Longevity Center Sdn Bhd</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zztjihGbEJi" title="Relationship"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKgGDN0XOXqi" title="Relationship">Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd</span></span>.</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z4AK4a2VPoge" title="Nature"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zd3zORUqsxXh" title="Nature">Purchase</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z0MaSzrnIaGf" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Purchase">718</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zcp8pULpTfJd" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231_zxjPSxdzQeW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">718</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231_zWmsGiHMPUr3" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1305">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission expense</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"/><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended December 31, </b></span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related Party</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr. How Kok Choong</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zS3c71XRkOpc" title="Relationship"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKe4t3D9pIBh" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company</span></span>.</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zGlq7z43t2vb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zpnZEXPuCsjk" title="Nature">Commission expense</span></span></span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zVewcRjCItP4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_z6srxupaaap9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SalesCommissionsAndFee_pdp0_c20210101__20211231_zMp01UdDmLWb" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SalesCommissionsAndFee_pp0p0_c20200101__20201231_zIjLrUletGIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other income</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td rowspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Related Party</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hostastay Sdn. Bhd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQlgHq1wqYgl" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdoJWj8m3jsi" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zZNbTceC974g" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zhxZicsFyDNg" title="Nature">Sublease rental income due from Hostastay</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--OtherIncome_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zutdgJUpW8Cf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--OtherIncome_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zvIxFJm9Nj04" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20210101__20211231_zid26QmKtftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zjuv3Lyf9VN9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zcO7cQRA7zP9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zcAQ3zTAOKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z8lWSWKWUU0c" style="display: none">SCHEDULE OF RELATED PARTIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape ATP (Asia) Limited (“AATP Asia”)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zFh7IyxtMaig" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zrYM4jVMEh4i" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zT5TKVhB1k1h" title="Nature"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zuDhF7hq7hH3" title="Nature">Expenses paid for AATP Asia</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zBPYNcd3xTze" style="width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,214</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--DueFromRelatedParties_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedMember_zWkTG45rUsf" style="width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">2,227</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Hostastay Sdn. Bhd.</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">“Hostastay” </span></p></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zoHMJVFDgqqg" title="Relationship"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zj7Cls3LGfj1" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_z96bkEc6Hqk9" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zOKpJukAbQx8" title="Nature">Sublease rent due from Hostastay</span></span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zIRfbce6jjj6" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">4,790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdMember_zf4Uas6lnH9a" style="text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">TH3 Technology Sdn Bhd</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">“TH3 </span>Technology”</p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdMAMDlv2nHd" title="Relationship"><span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zRRw54uNEw4h" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zF0Z2g5QwuVc" title="Nature"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zOLs3a1wFca1" title="Nature">Expenses paid for TH3 Technology</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zBS833tKI6Ca" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--THThreeTechnologySdnBhdMember_zdoHLYF8dUGb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20211231_zXf0bP8Tyebk" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">7,004</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueFromRelatedParties_iI_pp0p0_c20201231_z1apLzBjnaN1" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">3,235</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount due to a Related Party</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior Living Pty Ltd</span> “ASLPL”</td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span id="xdx_903_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zjaffT4I6jli" style="font-family: Times New Roman, Times, Serif" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: bottom; padding-bottom: 1.5pt; width: 18%; text-align: center"><span id="xdx_909_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zTcNtnTuIgMj" style="font-family: Times New Roman, Times, Serif">ATP Label Printing Fees</span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zGltgxrHs6Fk" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdMember_zfnwEeWUjRli" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zO3PaOw8ZMM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231_zonoooHgiBe8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties"><span style="font-family: Times New Roman, Times, Serif">455</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14. RELATED PARTY BALANCES AND TRANSACTIONS (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Related party transactions </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Party</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agape Superior Living Pty Ltd (“ASLPL”)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zcC2giDupOh6" title="Relationship"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zW9HzqMSxgMb" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center; width: 18%; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_z4Lv347M7n3e" title="Nature"><span id="xdx_901_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zH9KjlqHYSA1" title="Nature">Sales of products</span></span></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zGbEXE87uPu9" style="width: 14%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLj2DGzHvADi" style="width: 12%; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: left"><span id="xdx_F4C_zm8QfSbpOFne" style="font-family: Times New Roman, Times, Serif">Vettons Sdn Bhd*</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zugLfroRtprc" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zZvVq3EoCVc1" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zuQtzdRYWHvj" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____zb7z4MtJu9pk" title="Nature">Sales of products made through its platform</span></span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VettonsSdnBhdOneMember_fKg_____z2oh2awX7Fzd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_fKg_____zvzZZ9Lr1X8e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromRelatedParties_pdp0_c20210101__20211231_zZMNas14GZie" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">6,625</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromRelatedParties_pp0p0_c20200101__20201231_zbXwpniv32xe" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue"><span style="font-family: Times New Roman, Times, Serif">18,060</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b id="xdx_F07_z3qCnTQjHwmg">*</b></span></td> <td style="text-align: justify"><span id="xdx_F1F_zurIKlX1VP8l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company had sales of $<span id="xdx_90F_eus-gaap--RevenueFromRelatedParties_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_za0RKbuWThr6" title="Revenue">6,625</span> through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 22%; text-align: left; padding-bottom: 1.5pt">DSY Wellness &amp; Longevity Center Sdn Bhd</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_906_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zztjihGbEJi" title="Relationship"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKgGDN0XOXqi" title="Relationship">Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness &amp; Longevity Center Sdn Bhd</span></span>.</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z4AK4a2VPoge" title="Nature"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zd3zORUqsxXh" title="Nature">Purchase</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_z0MaSzrnIaGf" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Purchase">718</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DSYWellnessAndLongevityCenterSdnBhdMember_zcp8pULpTfJd" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; vertical-align: top">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20210101__20211231_zxjPSxdzQeW2" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase">718</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RelatedPartyTransactionPurchasesFromRelatedParty_pp0p0_c20200101__20201231_zWmsGiHMPUr3" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase"><span style="-sec-ix-hidden: xdx2ixbrl1305">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission expense</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-weight: bold"/><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended December 31, </b></span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name of Related Party</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Relationship</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Nature</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr. How Kok Choong</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zS3c71XRkOpc" title="Relationship"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zKe4t3D9pIBh" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company</span></span>.</span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zGlq7z43t2vb" title="Nature"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongMember_zpnZEXPuCsjk" title="Nature">Commission expense</span></span></span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zVewcRjCItP4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SalesCommissionsAndFee_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_z6srxupaaap9" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SalesCommissionsAndFee_pdp0_c20210101__20211231_zMp01UdDmLWb" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">12,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SalesCommissionsAndFee_pp0p0_c20200101__20201231_zIjLrUletGIk" style="border-bottom: Black 2.5pt double; text-align: right" title="Commission expense"><span style="font-family: Times New Roman, Times, Serif">10,740</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other income</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td rowspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Related Party</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hostastay Sdn. Bhd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQlgHq1wqYgl" title="Relationship"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zdoJWj8m3jsi" title="Relationship">Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--RelatedPartiesNatureDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zZNbTceC974g" title="Nature"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zhxZicsFyDNg" title="Nature">Sublease rental income due from Hostastay</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_eus-gaap--OtherIncome_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zutdgJUpW8Cf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--OtherIncome_pdp0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HostastaySdnBhdOneMember_zvIxFJm9Nj04" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 12%; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--OtherIncome_pp0p0_c20210101__20211231_zid26QmKtftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,345</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--OtherIncome_pp0p0_c20200101__20201231_zjuv3Lyf9VN9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,881</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia Expenses paid for AATP Asia Expenses paid for AATP Asia 2214 2227 Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Sublease rent due from Hostastay Sublease rent due from Hostastay 4790 996 Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology Expenses paid for TH3 Technology Expenses paid for TH3 Technology 12 7004 3235 Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL ATP Label Printing Fees 455 455 Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Sales of products Sales of products 18060 Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021 Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021 Sales of products made through its platform Sales of products made through its platform 6625 6625 18060 6625 Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd Purchase Purchase 718 718 Mr. How Kok Choong, the CEO and director of the Company Mr. How Kok Choong, the CEO and director of the Company Commission expense Commission expense 12758 10740 12758 10740 Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Sublease rental income due from Hostastay Sublease rental income due from Hostastay 4345 2881 4345 2881 <p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z1EoTOmM1nR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_825_zWGqCJHetoAe">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Preferred stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, there were <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zzJK3vpWjnfd" title="Preferred stock, shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zZTCjEPkdvyc" title="Preferred stock, shares authorized">200,000,000</span></span> preferred stocks authorized but <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_zeqmFolebPa9" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zlgRdq6m3g6k" title="Preferred stock, shares outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_dn_c20201231_zScliMtehWfh" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20201231_zwdvKtJIUPNb" title="Preferred stock, shares outstanding">none</span></span></span></span> were issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Common stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, there were <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_z22kJHDEj365" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_znNHnqB3ZfWf" title="Common stock, shares authorized">1,000,000,000</span></span> common stocks authorized, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20211231_zmGeXMXqDgp7" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zKb4SWubZpV8" title="Common stock, shares outstanding">290,460,047</span></span> and <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20201231_zgegkGXH9Sq7" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20201231_zmPjVDc0StK9" title="Common stock, shares outstanding">376,452,047</span></span> shares issued and outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2020, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zKsJrx6OXHpk" title="Stock issued during period acquisitions, shares">162,694</span> shares of the Company’s common stock in connection with the acquisition of ASL as part of the acquisition payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased by $<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pp0p0_c20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zInmgVQjYzad" title="Business combination, recognized identifiable assets acquired and liabilities assumed, assets">90,043</span>, which required the issuance of an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_z4q91pPPvi19" title="Stock issued during period acquisitions, shares">13,853</span> shares of the Company’s common stock to fully satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20200629__20200731__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zBR0sNWMhk1a" title="Stock issued during period acquisitions, shares">13,853</span> additional shares were issued in July 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2021, there were share forfeiture agreements (the “<b>Share Forfeiture Agreements</b>”) between the Company and (i) HKC Talent Limited; (ii) various shareholders of the Company (the “<b>Forfeiting Shareholders</b>”), pursuant to which: (i) HKC Talent Limited had agreed to forfeiture of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember_zjZh4vmwzQ37">41,750,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company, and (ii) the Forfeiting Shareholders had agreed to forfeiture, in aggregate, <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HowKokChoongTalentLimitedMember__srt--TitleOfIndividualAxis__custom--ShareholdersMember_zEG1iaTobXDh">44,242,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company. Included in (ii) is <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HKCHoldingsSdnBhdMember_z7s7tathq1Bi">11,242,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares forfeited from HKC Holdings Sdn. Bhd, a company in which <span style="background-color: white">Mr. How Kok Choong, </span>the CEO and director of the Company, is a shareholder. As a result, the outstanding shares was reduced by <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementsMember_zRAYMhCL1ktc">85,992,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20211231_z5AQ422mtOye" title="Potentially dilutive securities outstanding"><span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20200101__20201231_zFHH6aethW6" title="Potentially dilutive securities outstanding">no</span></span> stock options, warrants or other potentially dilutive securities outstanding as of December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 200000000 200000000 0 0 0 0 1000000000 1000000000 290460047 290460047 376452047 376452047 162694 90043 13853 13853 41750000 44242000 11242000 85992000 0 0 <p id="xdx_800_eus-gaap--MinorityInterestDisclosureTextBlock_zDBeMDPckdHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_822_zrFQDIpLMPz7">NON-CONTROLLING INTEREST</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_ecustom--ScheduleOfNonControllingInterestTableTextBlock_zZBI5QjC7oDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s non-controlling interest consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zwxpd85H2Q5j" style="display: none">SCHEDULE OF NON CONTROLLING INTEREST</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20211231_zwr96En8RGd1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20201231_z2Eht72PAx95" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">DSY Wellness:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--NonControllingInterestPaidinCapital_iI_zcfm1r481Hek" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paid-in capital</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">97</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--NonControllingInterestAccumulatedDeficit_iI_zIssv5YTi0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(436</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1387"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--NonControllingInterestAccumulatedOtherComprehensiveIncome_iI_zF3o95vL91Vk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1390"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--NonControllingInterestNonControllingInterestGross_iI_zDeVDEDJx5b8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> <span style="display: none; font-size: 10pt">Non Controlling interest Gross</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1393"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--NonControllingInterestAsl_iI_zFpZKA8KAfQ5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ASL</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1395"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl1396"> </span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--MinorityInterest_iI_zW9WYiMyfzZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8AF_zikBXzqt0zpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--ScheduleOfNonControllingInterestTableTextBlock_zZBI5QjC7oDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s non-controlling interest consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zwxpd85H2Q5j" style="display: none">SCHEDULE OF NON CONTROLLING INTEREST</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20211231_zwr96En8RGd1" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20201231_z2Eht72PAx95" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">DSY Wellness:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"/><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_ecustom--NonControllingInterestPaidinCapital_iI_zcfm1r481Hek" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paid-in capital</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">97</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--NonControllingInterestAccumulatedDeficit_iI_zIssv5YTi0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(436</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1387"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--NonControllingInterestAccumulatedOtherComprehensiveIncome_iI_zF3o95vL91Vk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1390"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--NonControllingInterestNonControllingInterestGross_iI_zDeVDEDJx5b8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> <span style="display: none; font-size: 10pt">Non Controlling interest Gross</span></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1393"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_ecustom--NonControllingInterestAsl_iI_zFpZKA8KAfQ5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ASL</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1395"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl1396"> </span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--MinorityInterest_iI_zW9WYiMyfzZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(336</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 97 -436 3 -336 -336 <p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zx1vaESLje23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. <span id="xdx_825_zIseJE7OXP2i">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zJ7stTvKpSRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The United States and foreign components of (loss) income before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zTWxPdCJiCud" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_zrZAXd34Xik3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20200101__20201231_zfXKIGzf6yU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax jurisdictions from:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zAlLrtxOUl7e" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Local – United States</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(706,659</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(735,159</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--MY_zEclGmfB1wAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign – Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,064,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,070,806</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--HK_zhAbaLKDIFKc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign – Hong Kong</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(616,640</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zWJCB0DdrB88" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwsoXAMvtkTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">(Loss) income before income tax</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,387,613</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">516,347</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AA_zQwZHDkY8Q04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPwBaAA1nP6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The (provision for) benefit of income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BE_zbupPTnAP3g2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF PROVISION FOR INCOME TAX</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210101__20211231_zwjEcbQqFP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20200101__20201231_zSSX7rLf21y8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Current:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_iN_di_maITEBzB5L_zh20qlTxQ03d" style="vertical-align: bottom; background-color: White"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,205</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--CurrentForeignTaxExpenseBenefit_iN_di_maITEBzB5L_zverS48xQVVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(104,735</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,748</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Deferred:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_zFpxBWlN3REh" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1428"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_z2R5c2TT0h88" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(178,329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzB5L_zOZ0Dm8bu8Jl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income taxes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(137,067</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(161,581</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> <p id="xdx_8A8_zhWYBUgr16K4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United States of America</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a corporate tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zr4IRO9K2cXa" title="Tax percentage">21</span>% on its taxable income. Agape ATP Corporation also subject to controlled foreign corporations Subpart F income (“Subpart F”) tax, which is a tax primarily on passive income from controlled foreign corporations with a tax rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z04iJ8TfDm6c" title="Tax percentage">35</span>%. <span id="xdx_909_eus-gaap--TaxCutsAndJobsActOf2017OtherTaxEffectDescription_c20210101__20211231_zq9p5RQTNMfe" title="Tax rate description">In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax, which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are applied</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, the Company’s foreign subsidiaries did not generate any income that are subject to Subpart F tax and GILTI tax.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. INCOME TAXES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2021, the Company re-visited its fiscal 2020 U.S. income taxes and determined its stock dividend from Greenpro Capital Corp as a result of its Spin-off of DSwiss Inc.’s shares in 2020 were subject to Subpart F and GILTI taxes. As a result, the Company incurred additional income taxes expenses of $<span id="xdx_901_eus-gaap--IncomeTaxExpenseBenefit_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zdqT2ffrpzXb" title="Income tax expense benefit">22,205</span>, including interest and penalty of $<span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20210101__20211231_zJzyKKFFpTmi" title="Income tax examination penalties and interest expense">395</span>, for the year ended December 31, 2021, after utilizing its estimated cumulative net operating losses (“NOL”) of $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_c20201231_zeijZGafqpS5" title="Cumulative net operating loss">312,608</span> as of December 31, 2020. As a result, the Company’s deferred tax assets of estimated NOL of $<span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20211231_z5ngiqBIt3Pl" title="Deferred tax assets operating loss carryforwards">65,648</span> were fully utilized and reduced to $<span id="xdx_901_ecustom--DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced_iI_c20211231_zhTUhZUCdzcb" title="Cumulative net operating losses">0</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, the operations in the United States of America incurred approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_ziRZzDY5u6oc" title="Operating loss">729,000</span> and $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_zIL3DbXUwtg8" title="Operating loss">0</span>, respectively, of cumulative net operating losses (“NOL”) which can be carried forward to offset future taxable income or Subpart F and GILTI taxes. These balance can be carried forward indefinitely. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately $<span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_zVzqt9niPNK6" title="Deferred tax valuation allowance">153,000</span> and $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--US_z1ArW8tk0za1" title="Deferred tax valuation allowance">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Malaysia</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies incorporated in Labuan to satisfy the “substantial activity requirements” to qualify for the preferential tax rate of <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zruGRczcdzU" title="Tax percentage">3</span>% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the “substantial activity requirements” was issued. As Agape ATP Corporation did not maintain a permanent establishment in Labuan, and therefore did not satisfy the said requirements, the company was subjected to tax at <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zWXtzm0GkKIe" title="Taxp percentage">24</span>% on its net audited profit. On June 11, 2021, Agape ATP Corporation made an irrevocable election to be taxed under the Malaysian Income Tax Act 1967 as the elected tax regime is more tax efficient to the entity compare to LBATA.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape Superior Living Sdn Bhd, Agape S.E.A Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of Malaysia and the income taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia, enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. <span id="xdx_903_eus-gaap--IncomeTaxExaminationDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zMBjQTPtIlL7" title="Income tax examination, description">The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--MY_zC5zcFsPH3Hh" title="Tax percentage">17</span>% for the first RM 600,000 (or approximately $150,000) for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, the operations in the Malaysia incurred approximately $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_zp1K6Soyryma">946,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zVmjPSCCLqIi">261,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, of cumulative net operating losses (“NOL”) which can be carried forward to offset future taxable income. Approximately $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_c20211231__srt--StatementScenarioAxis__custom--UnutilizedMember_zrQFP7JnakLe" title="Net operating loss carryforward">685,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20201231__srt--StatementScenarioAxis__custom--UnutilizedMember_zPSOKkOKBiY8">261,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the net operating loss carry forwards will expire in 2028 and 2027, respectively, if unutilized. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately $<span id="xdx_907_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--MY_z29Vtxjgn5qh">217,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20201231__srt--StatementGeographicalAxis__country--MY_zkaVl3EJUUUa">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hong Kong</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of <span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20210101__20211231__srt--StatementGeographicalAxis__country--HK_z7Hvvs9O4ON2" title="Tax percentage">16.5</span>% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17. INCOME TAXES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zh8ZLrOPYINk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B6_zC5lQXfhDLsc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF EFFECTIVE INCOME TAX RATE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20211231_zHodPO8OlDVc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231_zIF4l0FDdfkl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zsEs0VSP47W2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">U.S. statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zTUSVlHzwV1b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zLMg3hNPRqq6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Differential tax rate in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zm9NRd88iKhh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Permanent difference</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F2F_zxSNVakO0EU2" style="font-family: Times New Roman, Times, Serif">)%(1)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11.3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F27_zzkQrrHwK2g8" style="font-family: Times New Roman, Times, Serif">%(2)</span></td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zWHBlQpZ9SX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effective tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount comprised:</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p id="xdx_F03_z9Nlra0fsGci" style="display: none; margin-top: 0; margin-bottom: 0">(1)</p></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zYdaYzTyVkc3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> The amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate">6.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate">6.7</span>% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_za3LDb8OY7Ml" title="Tax percentage">6.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_zJiKLXcUTRUk" title="Tax percentage">6.7</span>% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount comprised:</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td id="xdx_F06_z335a6X6xzjc" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify">(2)</td> <td colspan="2" id="xdx_F18_zVtSsVaotcc4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd">10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; </span></span><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate">0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate">1.3</span>% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z809m78MTHpj" title="Tax percentage">10.2</span>% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zmVeWeVqoWCj" title="Tax percentage">0.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zN2k4pv648T2" title="Tax percentage">1.3</span>% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8A5_zRf8gZITjCH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTgDaFWwPnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B6_z6PE7E8dFond" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF DEFERRED TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20211231_zbi55i6TjUyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20201231_z9HNpNIBftu7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--US_zdlrLW0iyXZk" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards in U.S.</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153,061</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--MY_zTYHWbFloxwf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">227,106</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,678</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zNxv9yYvsNDg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net operating loss carry forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less: valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20211231_zGKJemF1HSjc" style="text-align: right" title="Less: valuation allowance"><span style="font-family: Times New Roman, Times, Serif">(380,167</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20201231_zhbZnY4zYwHl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iI_zHyYEH4A3upj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,421</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> </tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_di_zOrcgklJh9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,743</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> </tr> </table> <p id="xdx_8A7_zkxctfdEx5Kf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Uncertain tax positions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the years ended December 31, 2020 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zJ7stTvKpSRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The United States and foreign components of (loss) income before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zTWxPdCJiCud" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_zrZAXd34Xik3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20200101__20201231_zfXKIGzf6yU7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Tax jurisdictions from:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zAlLrtxOUl7e" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Local – United States</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(706,659</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(735,159</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--MY_zEclGmfB1wAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Foreign – Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,064,314</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,070,806</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_hsrt--StatementGeographicalAxis__country--HK_zhAbaLKDIFKc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Foreign – Hong Kong</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(616,640</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_zWJCB0DdrB88" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zwsoXAMvtkTi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">(Loss) income before income tax</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,387,613</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">516,347</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> -706659 -735159 -1064314 1070806 -616640 180700 -2387613 516347 <p id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPwBaAA1nP6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The (provision for) benefit of income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BE_zbupPTnAP3g2" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF PROVISION FOR INCOME TAX</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210101__20211231_zwjEcbQqFP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20200101__20201231_zSSX7rLf21y8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Current:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_iN_di_maITEBzB5L_zh20qlTxQ03d" style="vertical-align: bottom; background-color: White"> <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(22,205</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--CurrentForeignTaxExpenseBenefit_iN_di_maITEBzB5L_zverS48xQVVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(104,735</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,748</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Deferred:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_zFpxBWlN3REh" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">- Local</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1428"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429"> </span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_iN_di_maITEBzB5L_z2R5c2TT0h88" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">- Foreign</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,127</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(178,329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iNT_pp0p0_di_mtITEBzB5L_zOZ0Dm8bu8Jl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Provision for income taxes</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(137,067</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(161,581</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table> 22205 104735 -16748 10127 178329 137067 161581 0.21 0.35 In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax, which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are applied 22205 395 312608 65648 0 729000 0 153000 0 0.03 0.24 The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate 0.17 946000 261000 685000 261000 217000 0 0.165 <p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zh8ZLrOPYINk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B6_zC5lQXfhDLsc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF EFFECTIVE INCOME TAX RATE</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20211231_zHodPO8OlDVc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231_zIF4l0FDdfkl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the years ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_zsEs0VSP47W2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">U.S. statutory rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21.0</span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_uPure_zTUSVlHzwV1b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr> <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_uPure_zLMg3hNPRqq6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Differential tax rate in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_uPure_zm9NRd88iKhh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Permanent difference</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(12.7</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F2F_zxSNVakO0EU2" style="font-family: Times New Roman, Times, Serif">)%(1)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11.3</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span id="xdx_F27_zzkQrrHwK2g8" style="font-family: Times New Roman, Times, Serif">%(2)</span></td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_zWHBlQpZ9SX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Effective tax rate</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">31.3</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount comprised:</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p id="xdx_F03_z9Nlra0fsGci" style="display: none; margin-top: 0; margin-bottom: 0">(1)</p></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zYdaYzTyVkc3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> The amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zkx8Ftrs7L89" title="Non-deductible tax rate">6.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_z7zr0BljaQM3" title="Non-deductible tax rate">6.7</span>% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_za3LDb8OY7Ml" title="Tax percentage">6.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAWATPAndDSYMember_zJiKLXcUTRUk" title="Tax percentage">6.7</span>% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount comprised:</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td id="xdx_F06_z335a6X6xzjc" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify">(2)</td> <td colspan="2" id="xdx_F18_zVtSsVaotcc4" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount comprised: <span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231_zv1NMsh9HgPd">10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; </span></span><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_pid_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zyI1Oi1dqqbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Non-deductible tax rate">0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zAbCSjiqlxJf" title="Non-deductible tax rate">1.3</span>% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231_z809m78MTHpj" title="Tax percentage">10.2</span>% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPHKMember_zmVeWeVqoWCj" title="Tax percentage">0.2</span>% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23.35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtICBTQ0hFRFVMRSBPRiBFRkZFQ1RJVkUgSU5DT01FIFRBWCBSQVRFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_uPure_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--AATPLBASLSEAAndWATPMember_zN2k4pv648T2" title="Tax percentage">1.3</span>% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 0.210 0.210 -0.170 -0.040 0.030 0.030 -0.127 0.113 -0.057 0.313 0.062 0.067 0.062 0.067 0.102 0.002 0.013 0.102 0.002 0.013 <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zTgDaFWwPnw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B6_z6PE7E8dFond" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF DEFERRED TAX ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20211231_zbi55i6TjUyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20201231_z9HNpNIBftu7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--US_zdlrLW0iyXZk" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards in U.S.</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153,061</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_hsrt--StatementGeographicalAxis__country--MY_zTYHWbFloxwf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating loss carry forwards in Malaysia</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">227,106</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,678</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_zNxv9yYvsNDg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net operating loss carry forwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less: valuation allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20211231_zGKJemF1HSjc" style="text-align: right" title="Less: valuation allowance"><span style="font-family: Times New Roman, Times, Serif">(380,167</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_c20201231_zhbZnY4zYwHl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1528">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td> </tr> <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iI_zHyYEH4A3upj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,421</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> </tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iNI_di_zOrcgklJh9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,574</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,743</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td> </tr> </table> 153061 227106 62678 380167 -15574 -68421 15574 5743 <p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zppyeLFDtlc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18. <span id="xdx_820_zzEoSomjbVI4">CONCENTRATIONS OF RISKS</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2021 and 2020, no customer accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZ7wcEon2T32" title="Concentrations of risk percentage"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsbNNSoACeck" title="Concentrations of risk percentage">10</span></span>% or more of the Company’s total revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no accounts receivable balance as of December 31, 2021. As of December 31, 2020, receivables from a third-party e-commerce company accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zqs9F210iL0g" title="Concentrations of risk percentage">100.0</span>% of the total balance of accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2021, two vendors accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zifQOunHx8X4">47.3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zbnvccvXJhJ6">45.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Company’s total purchases, respectively. For the year ended December 31, 2020, two vendors accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zqi8p3G09a0g">74.1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zl7EPVu4Wdga">25.9</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Company’s total purchases. In November and December 2020, the Company received dividend of <span id="xdx_905_ecustom--DividendShareForCommonStock_pid_c20201201__20201231__dei--LegalEntityAxis__custom--DSwissIncMember_zdhCwhkcasw6">23,330 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of DSwiss, Inc., represents approximately <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201130__dei--LegalEntityAxis__custom--DSwissIncMember_zw6R8eDBrN83">0.01</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% ownership that the Company accounted for as investment in marketable securities (See Note 11). DSwiss, Inc.’s wholly owned subsidiary is the vendor that accounted for the Company’s total purchases of approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--VendorOneMember__dei--LegalEntityAxis__custom--DSwissIncMember_z5XgWCTZ2QHe">47.3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__dei--LegalEntityAxis__custom--DSwissIncMember_zg8t0GgGDGZf">74.1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, one vendor accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--OneVendorMember_zTe2C8rp2Ttd" title="Concentrations of risk percentage">100</span>% of the total balance of accounts payable. There are no accounts payable balance as of December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Commission Expenses to Sales Distributors and Stockists</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2021, one sales distributor accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--OneSalesDistributorMember_zKKo21123UW9" title="Concentrations of risk percentage">17.9</span>% of the Company’s total commission expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2020, no sales distributor accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--NoSalesDistributorMember_zjvXG0OU1Tma">10.0</span>% of the Company’s total commission expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December 31, 2021 and 2020, $<span id="xdx_90A_eus-gaap--Deposits_iI_pp0p0_c20211231_ztTFsOM43Hc6" title="Deposits">554,864</span> and $<span id="xdx_90B_eus-gaap--Deposits_iI_pp0p0_c20201231_zP2NpPQh02g1" title="Deposits">1,112,147</span> were deposited with financial institutions, respectively, $<span id="xdx_905_ecustom--DepositForInsurance_iI_pp0p0_c20211231_zUuFnX1Pw8Bd" title="Deposit for insurance">295,761</span> and $<span id="xdx_908_ecustom--DepositForInsurance_iI_pp0p0_c20201231_z7hIHHO8Zb2j" title="Deposit for insurance">563,788</span> of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18. CONCENTRATIONS OF RISKS (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Exchange rate risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.10 0.10 1.000 0.473 0.452 0.741 0.259 23330 0.0001 0.473 0.741 1 0.179 0.100 554864 1112147 295761 563788 <p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zikBWEXc7Rr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19. <span id="xdx_824_zqFHuwr8qXXa">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Lease commitments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 1, 2020, the Company adopted ASC 842 for ASL’s office space lease and sales and training center as the lease commencement date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_ztm1zkup7YVb" title="Operating lease liability">490,000</span>, with a corresponding right-of-use (“ROU”) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an effective interest rate of <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20200401__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zY9XWuKi7CWk" title="Operating lease effective interest rate">5.5</span>%, which was determined using the Company’s estimated incremental borrowing rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 31, 2021, the Company entered into two separate two-year leases extension with the modified lease expiring <span id="xdx_90C_ecustom--LeaseExpirationTerm_dd_c20210530__20210531_zg0t1LRbg2ml" title="Lease expiration term">May 31, 2023</span> for its office space and expiring <span id="xdx_90A_ecustom--LeaseExpirationTerm_dd_c20210530__20210531__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TrainingCenterMember_zHbo9BMQZEYk" title="Lease expiration term">August 31, 2023</span> for its training center. The lease modification required the Company to re-measure the ROU assets and lease liabilities based on the modified leases. The Company recognized a reduction of $<span id="xdx_90E_ecustom--IncreaseDecreaseInROUAssetsAndLiabilities_iI_c20210531_zIq3NCDGKYMc" title="Reduction in ROU assets and liabilities">3,250</span> in ROU assets and lease liabilities upon lease modifications based on the present value of the future minimum rental payments of the lease, using an effective interest rate of <span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20210531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zkrbAxBZJ3S4" title="Operating lease effective interest rate">5.5</span>%, which was determined using the Company’s estimated incremental borrowing rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of December 31, 2021, the weighted remaining term of the lease is approximately <span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zLuEApcD1dr2" title="Operating lease, weighted average remaining lease term">1.64</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zLwSIOUdEDJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The five-year maturity of the Company’s operating lease liabilities is as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_z5HQRQCGEsN1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF LEASE COMMITMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Twelve Months Ending December 31,</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20211231_zrSpkKZ0riRb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Operating lease liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzA1T_z29WVvrhY7u3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">166,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzA1T_zFb9TaYVqEpi" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">84,915</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzA1T_zgoP2DMVzy8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1587"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_zO7qR3PO3eAe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">251,341</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSNfOKjtmRf5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,763</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,578</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A7_zXefQuQgchwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_90F_eus-gaap--OperatingLeaseExpense_pp0p0_c20210101__20211231_z4zUzdOiLlIk" title="Operating lease, rent expenses">179,562</span> and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zlihFIIH9S6h" title="Operating lease, rent expenses">156,716</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contingencies</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19. COMMITMENTS AND CONTINGENCIES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COVID-19</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO, Malaysia has been put through various stages of lockdowns such as (1) full movement control orders (“MCO”), under which, quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (“RMCO”). On January 12, 2021, due to a resurgence of COVID-19 cases, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the country. February 2021 marked a significant month for Malaysia as all frontline staff of the country, which comprised those in healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defense sectors were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless, COVID-19 cases in the country continue to rise. <span id="xdx_90A_eus-gaap--UnusualRiskOrUncertaintyImpact_c20210101__20211231__us-gaap--UnusualRiskOrUncertaintyByNatureAxis__custom--COVIDNineteenImpactMember_zcGtXlDQGj5f" title="COVID-19 impact description">On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">temporary closure of offices, travel restrictions, financial impact of the Company’s customers or suspension supplies may be negatively affected, and could continue to negatively affect the demand for the Company’s product;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely affect its financial condition and operating results; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any disruption of the Company’s supply chain, logistics providers or customers could adversely impact its business and results of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery to its customers, which may also lead to loss of its customers.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that the Company’s total revenues will grow or remain at the similar level year over year in 2021 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 490000 0.055 2023-05-31 2023-08-31 3250 0.055 P1Y7M20D <p id="xdx_891_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zLwSIOUdEDJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The five-year maturity of the Company’s operating lease liabilities is as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_z5HQRQCGEsN1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF LEASE COMMITMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Twelve Months Ending December 31,</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20211231_zrSpkKZ0riRb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Operating lease liabilities</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzA1T_z29WVvrhY7u3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">166,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzA1T_zFb9TaYVqEpi" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">84,915</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzA1T_zgoP2DMVzy8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1587"> </span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzA1T_zO7qR3PO3eAe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">251,341</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSNfOKjtmRf5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,763</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,578</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 166426 84915 251341 10763 240578 179562 156716 On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot <p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_znAil92WMLS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20. <span id="xdx_825_ztm6LAGqhyCc">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Forfeiture of Common Stock</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A share forfeiture agreement (the “Share Forfeiture Agreement”) dated January 20, 2022, between the Company and Mr. How Kok Choong, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the CEO and director of the Company<span style="background-color: white">, pursuant to which Mr. How Kok Choong agreed to forfeit <span id="xdx_904_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20220101__20220120__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--TypeOfArrangementAxis__custom--ShareForfeitureAgreementMember_zvhF4E0oB6R4" title="Company share forfeiture">215,008,035</span> shares of common stock of the Company.</span></span></p> 215008035 During the year ended December 31, 2021, the Company had sales of $6,625 through the online platform owned by Vettons Sdn Bhd (“Vettons”). Vettons is a related party since Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021.  The amount comprised: 6.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and 6.7% being expenses incurred in AATP LB, ASL, SEA, WATP, and DSY Wellness that are not deductible in the Malaysia tax return. The amount comprised: 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; 0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and 1.3% being expenses incurred in AATP LB, ASL, SEA and WATP that are not deductible in the Malaysia tax return. EXCEL 111 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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�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�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�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�]OIR*KJSEG@$\!6)_ACK,@[=<>\]^2.C=H\D6[\<:=V]D(\M3 M.8_IQY:3*J3 _EJSNL"?U6]97?!3R_M:-7GS&Q>8?7#T0],7=)'P5-Z>BS-3 MW?]C3&6'LXR\#&K7*Q9$U175]OMY>K M$XM+==-F7AF\P>>EFA([5]S]5Q4N$VHU43XS;;6+1!<5)>Z4.15@?;@Q"=G5 M0BW\?(SO_D6'# A^7F17/?OM+H7S1[G6G+NE-G_ MUMQ#O=9D22J].CY9OX/PFO#U?E8+L&L_2?/W*/Q+05[5:(A1^A>HV>5;#3/N5A&:-D$1N\MPD5N]6/;'W#*2X^S%1) M_\$RG(M)NBR09"&4^T*(7B#C=Z"0R=LKM MN4.JH$B:1WB5A$T;R+;+-R16YE38HC?MJD2-E4UCMH6%N]S4/[0 M%?]Q1@X>T!:P]V-G&.!9_-(I=J8>R;>T\2;'X](U0DJIDPL$GPD;96HT;VA> MZB&N^<+%7EN+SZC2RVBY5@=UUA=FEQ_8"G-/_3A"42B^GW]<9F:6IW37PVNR MJ+]/BK/XO2*WD]DCSUCR=&BV)K3%('$[16\W>U9+CGC,]=]>S5/SKDU ZHYN MP2.0!XQ9E& K)]59S[5JR?JCWK+1T7N,61 M5S_MZ.' M?4!?6L6=2-*29@G91[D6\T,\*NT-L(L*MA0NUEI,(5T\.R2)'@+*.3H$+Y.M M;<]S#'Y3S&ZG@3$<1^)TCW^DE!E_3T134KSY(!T"ND7P;S2/P)QS;#6L/PE3 MEJZ'FG49:.7=R[1\.;+**N9O$EH.#]':/S(V$ZMIF!83QJMT'-AZ1BIT&!EX M?Z*=&EY###+ Y\=*Y8FL]Q]](8.%OVD,UVW$Q91D)2O[9B H\;3=;W6CRP@ M0!;WF4VJK1 IN>+LQ^N7/CC0>57^G7-?8]Y0FE3X0"U6O 1CGR=.&B74+'\BU6G#OV:HDFPE[B5''K]XE\\@K MD>67E^GU;?9,]A++V$!CBM)\IW1/]WD@G[!FL M/>>C]F)?M2(0+&\0 :Z<:1&76#8\F&4H M1(7/1 H+>V=XL*F5MD%/N;%CV#U_O3;7MC\GS-Q]VR#%^@&]OI4.5M1 P2"W/T$=%IE*8A WS\PX@^1KZ0)G#6^C^;_T^VUDQC+'MSLE87M]'U5GV)RNAH1QDKB?W7ANR,3?$6.JHZ_GAA?8">EA MIYJG7>Z7Q+OT?%]POW&5L(<<5S39Y7FQCZ;\I)MCVTX4WC5U3QA<^GABTLF5"?>/^\KW++/2"_,FBJ2?MW< M.=T#3_6B&5FAIG XMU^4 ZU)^]=RD23]'MWU(H4,W1KAWK$4PQS;,DKE7&F& M?VNK]LGSG>-H^<=ZT>,[PEG#E70]PLV)K7>8$I925U2]VR9A[TH;S_?UK).[ M&0T(%+5UA7&$Z$,K0DUV2V";XCX:.!^OXAYR[# B4OK%(AZD]G7OK7WQXE:] M'5;G(X5.P7+KP$7O*GS3'L%H]A-0.F!(Z>@YOG.]?C>VDN\YE5WYD9.B M;CA/JD?Z=="U7T>%>8RZG,]75W9.(?KJV8Y'8/Y,R1GMUT*/!IMN@\0T3^[0 M$8J[H9SO-LJD1 +J5^Z.\D?@V;7WO?CG^@(G8<9HGR:UMF-YX?)V;*_7R[YT M)?NXU0L4B3P>7WZ4^;'G1(J*J[W43WM7Z$?6444GSFO =X1O"Z_"M;%AR$;P M<+6G5/PQGVEE@O-/5Z0Z.C-;=777L6]A>\=C34DM(; M<36#CG]T&6DM@T=6+JYPNJ6K*#0VU/V0UP6?XOXVB1MAGV>D^3"&'+WR%7^B ML9TTLW;)RV?"K]W.4X<65*@Z:U<*HXX?W .*XYH57MHT%9GT?&V%13RHN9F] M<'THZI^3A^2_[Z2>NBP_PJ$E3Q5T";W5]U-E.G1_2BKHTO\65+[=2U%\EO;. M/'H$I$V(5UYU!/=5/ )K+#WMWHCC1V!,[E/9;XVB=U .V_-F =)1XKJU MN?>)O6J-841D],+O1([QKV(2X/O] @$>0.F^ M-*%1 >J-@O.YM]QY)"W'3;/&L2?M>7HK_,!>Z?LXV$/[;8 B2H;&(V#6B,O1 M/?U78,#%,*!BVWCVN6QM<"*-\-RJ)J7;D2FI=ZFP1(A0[4($?0/W#[K=7_OJ MM4T]8L4RO#[LSO<=!?=2SXROY84JGD%[G)>'S['U M+4';?Q\OLZBL3;![7J P']M4;UU)YB#A)0T[N%&(]?XXQOG0V/TF% M(.\8 AEDHFU\X9:!RW:S[G;\ M95.OH)[+),'HMOOA)2$ 9\6@=#\R7%=K*=@[LS/5=)D11_<#@]7H!OM$74UR MO*ZNAY57*AN4/5M9^&O,!K[/_'%G7"G/[5.QN7X: !9,.8.G(#8UGMR9NX8] M)@/;8M-1OZ L!9;_=I;-J[ K,)K0#/]* R'$'L#,GJE\CA]F$_[$E8WJM,RYC:L^=S=YGD3@HOK3_)64[G=ZL57DN=+\QI\5HS6 MBZ@^0@T2B9(B _@\0Y[G['9+5O5 MN@C-CW/C3A&:$B?LJSD*KC2N7%:8C4>?N)6_1>IQD;X89E'J3E$CCU.]7K6# MMM8W-S;%'#B^O:A('A7!<7S55@IK:H<5P@S[T:)]X'4&X$*<12<+WS?D;ON? MF+M*)YV8)RH6;7G^O+9TZ<+![10JTQ!-.[635?_@?5^__FFMJM"P.-\!-Z-Z MRXK_SP(#A$V)YKTPY8GAI'&&Q_:N:?ITUCO9(C8[$F.J:H*TB'/^^?R^0[N# MYUQF3.*ZVXLZJS6)LL$F>%O-SH7#,:C,\ ;T2-:>>]H'N[%(.3"KKHJ+!D;" M1#YLVG-@G:*-/:^E*=9K64&X8T5/5(4X6*"GD6JT7,WEY_L/NZ>SXDJF:<0< MPF?TZ:5)CK\KVG\=I&M6/O!*3C1ATWWAGFC!QW[-3P_934'$ZYCM1OJ-]$!9 M2H3_[4@<_O/KE-XP3LD5FEODV71TQN^5"M>)F"?$VX7]_U4B310F0O1GY^N_ZM!W>-N_-TBH+"*HO,5I'SK/2.L.ANZ^@; "^JCSD6UU:N29_[B#\[$$K[BR0NX'Y!&U6\VM1DE[]_."1D9ZT5= M#]*+7,J$X>PFAAC\;L5O]MN] XT=A?](%+CRR^D/?YU;^RZY*N]Z?(11]*38OJQ^]CG5+"B,%6'DQ7S"<_&O\]? LQ6ISRQ\J%BW MKSH\$_PD[T,8=5V1_+-\1%AK$](:J]@D^,U!?\)[!:I R&4"IJB9)#LPO/VP MU%,J/E4C XZ@U12!SD^V2CI8VQZW>-^\X1WGH?$FR5]-!K[TAENEP3Y!S=]C^CUVS M*2+8A[8UK#\X9*Q37)R]7_]^Q3NH@;1';*:&45DI. M]^REW76/%+O9Y-D;O;G5_LN26RWY28>$M\\8M&;G:Q/PV,G>;!;[6^F[,9ZH M$#&25S-LYPN#RQ;YF6YQ?@=\DB3?X%>C,>@9G2&"]/39>3?H>ZQ6+#E-## M*>O-B_(IPQTE!M6^.Y_R\:K@%_B,!O'P*.^B* M^WKEGR6+&<=,2<*L MC8N!FY4,C*Z\;U]5H,-SJ:V-1'!%;P$CX7\#JK& J> M/9OM.G(OR?_JX:]2$D<;5]0KQ=V[;V@@LESH*L8COSGNG&RQ4N/:^P@8-:OX M.C#(6#?"#U K&KU?.B<>&;[P%QWC&QNT)DOO9_P6AR)IY*$@9N+=[HD-_T%1 M_Z-N$LM\>^BU,>-VT+!:J9T N5Z+^/2O8H;@D;<(XFWRRBYQ_6L^CY)Z6,;^ MH+_[H)+8+$\*$VS#Q<4P2HVR8NTVK_"U]XX[/ EJ/?V26SHYZ_S0KOW:+/*R MGP9$;4AV7SI8BTN];]"JZ)!KM;UE_RFG;?M7LZZ/8A3:YA>JWJG)A-BJ1(X> MP@T%/3DB?07XO_FF]VS8NMN)[M" %$PK_C8R"\)ER^!$W,4DK"DBB$H(,U4( MYTMLK37N>\&[8!DC4NUYWXQP'Y[_[J8/@H)55R\>@5 )&]](U@#FS)?1I_S; M5_.FEZG[G6_=KRY)&JJ2#\O74_"M3:99KT19+39Q7Y9(V+]# MCJ I5ZSI^TXJ^_GK1K2.V6C1/?=X97)=5>STZ!6>P2G_@/D]R_3**_NMD%51 MG .G66@^XZAR(D]$@X=0JN]^J3;.BV>]B'U"HTO$ZYEW ';;^D,=>JKWRH-/ M1Z:D6B9**?TA37)907T&CVS7GD+)6LFXM;T>6WK*E.P)BHXZ8PCH'J.TZK-< M&MCOJ_7.(_!@NWIRH*'5S6E-W7F;CND7-_9B301V9C.<:2-Y.ZU[O8M-0L+, M/+T?@9Q$5E#\9D*('-O2 ]P;@=]OT1[^"%P4QWH=GD7#00HW:OVM'\J4TJM[:>["$/PI[A6V#;0W29,$ONS@&UULG&I*1OL_T@;E MGWG+S-;_WKH/1FN&$@GE"6OGJIGUD\:*]BVD_XXN%N8;,O #'U>:-?],D[5O M/_BAL<%>-BE!N)OXMQ+BRC&(IUPY4)<:K_73F"PT=+X]>UW_,FY)D:$A>,.U M ZNIXJZS';OR"$NM.+.Z<];:@&%WOLU)?:QVF(FK7D!+=H&M-;.WW)R^QEV4 MVM3^E_8$5H]^4L[;G?HORP,$4!#'5&9QN9JX4BOS=QTX6#\RC5K5D&';4>-: M=WD[G57@CT46%UQ MAZ&PHI(WT9CH1V6OGB?*9_0G8D:_*CP47)V[BQZH3A[^N";:"&<2Q]SQ#\W. MSEYLH&9S1RZ5HW4,*6/M*":C19E(X4AOW=/_2!]#/1+P"(C$Z'0C^9+Q>AG+ M-#X"AOE&-'GO(&P%".!X*)19.8+&ZOV#75X^T4U*3KF6 _-53:(D7BL/9(L: M-"'_9,A:Q_N=PH] C#_D(!<2Z:ZKLY7D@J@SO_FS[&JS0H-+US?)(*D/?K#] M2TTT]K3(F][UZ-Q+0;C7R%&.-G$2&AXQ7U77BK@GM-^F*C(\ BY<;!V 1WX. M+,[AD(F5=6I"*@^PB9#*1\MSJ"H&'^AGUV+)*LL*OI_3^?[M@&.0*Z&'R&_, M]VYZ[W_Q#XA_4-!JPT8$(QZ[T"=#3Y<#/JAD+9!P.AZA4 ^X--W2[$(#:Q=V ME.;!*0JJ5'D(4/1, TL6#LV?'L789;E>G0:&,TK-).Z&$ZSEO _ZI!]0?0BE M#BTQB:Z(CM=JTX?,=MB4B##D] MN?DL0!1)Y7\Z5OB_$9 >?_\/4$L#!!0 ( "1W?%2*@2 2VV )9G - M :6UA9V5?,# X+FIP9^R[=5Q4W[\WNF& 20$Z1H$)$6)H6- I7OHE)(8 MI$N0%$$Z0E.;!WSGGWG.?\SWW/L_S]]V\/HN]UEZS M]_[4^_U9KUES.WV[ -Q7E%60!3 P, #3NS_@=A9X#N#BX(!QL''!8# >'BX^ M 1DAP;U[!-2D#XC)Z&D@#/0T='2,+$_8&)D>,]/1L0MQ/.;AA4*A$#81"6$^ M\2?\4+Z_-\' P\,CN$= 14A(Q?>0[B'?__9QVP:0X&+J8#* ,)@ 3!(,$ G& M;2< 0 ,;(Q_'<"_'QB8("QL'# N'OZ]NPFU]P%,#! ($PN$C8V%=7?5]^XZ M@$6"3?J05QKG@889F,F9C"\PYA,N\[/*K^3PD=\L_.8N[_#P*2BIJ&D>L;*Q MWKW]T;'QB M'1\O:=--;89^<&TT]TX4R5_P MQ@>.8;MBQ.N5MJX_99;CSQ_\Q#IQCL<"W]8BQC'&_-M-_=<[ M;@%F_].[CR=GGO^^!7I_74>XZN<. .X M:]G(SY9?BK[4CW,L[:K=YA:85_O-6L# //H1M.OK:^'XN^Q!.-Q9B@'9E!YD M05EW=FIK2L.2$(-$X&Q=@BTTW+S_-G$#11!3;$.Z+ZRV26 MC.%"V/GZP V%=-"YZ3#87<9%_>R+_+=50+<=CC.?9$ZAR+*8 ' M,G6<17C!)4GOJ)(671\3[N_/<76@&S/Z@IB6JVB%+RU(BB@;R0[\GTF>>\FT M?GKU7):ID[:?%7B.*![# [GVY,KH,SJ]DNWR\#?LX=11J5VZA4;S4(K+5@'L ML;5-3P&]/PVPN^=^3TGY.GM)N)=ZQG"M9ZRHM/%*UX*:B2S1(A+7N-A?TE]Q M.8 A?G$T0"C_P'XL<\ZPBZI'K,\B<[1Z;;)69,KN9U/X^I\WS\\C$1'46=@Q M\]:_H!',WLVD_@:.9%9Q4%PAHO&[?RFYH&H9(:A5,O$ =;Y5^##O>>Z $#0E M"[P6/L8O:X/Q'UVKNZX""KCSF_+7]N9XU:4[YC&)7N#J&#-G_AY#3'779@P;X MWT?@Z$@E6(Y@UU*;UNYX,M:B3A\*SI._XCV-3L M[/FDO!$1.^;)6G7ARSW2[W ^'HNH52-/<.,5(E1=#+X^'^>9ATDIG#L$C5<' M52N@E$>M B,'6&W_&M?CKW'O?/7O7?A=*W-G5(?\$:E[J+_G3VP&'I$!C;D# M__"^LC;9 910JU@DX&&3/[IV=]Z8OQ8^?.==5ILL[.R[<:/1M524T3#F7_(]3%@V^ZD*P]^HN07(FV+H#QT@1Q,XQ$NPCL,R\_!AGDB%YY8(U+0U5R4J.#V7W-^0:]HTCX\J?%RYQ2"&7(9[B0F-7L'3@ MM88,&?#?27A_Z. .N99EK!-0]L!@(G=\3[&(:8;_LO;D%K"YO 6>#M:+:_J9 MU2K)SQ(+/0WJU;AA.Z=9P>&5NB8 M_,M.=^W_RW/_45 <[!C_9M&<.V]@KB7];4<4E*1P;%W_AC!9? T 'X6K@XKZ M.^_+\$.SAL%F6=OS?K-*W=?[\BML^Y<0__63[1'=Y"*1;>,O0<6^3=-='-=7 M4M9LB0RMR[? 5!:A]W_#(,)J]XVH3XI^SR:*,UV:NL#X[)[DM\(.A%H@QP=L M-^\1- !'KF:KJ&V6M-+=JSS,+8"K8\+A(U+=(THRP",R#2GL_TW!X>"PR<+* M3@Q7Q]100K)C<-S%"[Z!XIT%LI& P=^W KJX :L AMJ1,S/GHM9K)]@%Z209 M":4#F'SX[ U&B?!QP"VP<49643^Q M+^^1[\AP:XSQRX.OQ_OD3,:EW=G9"LDH,AARX[!GI<=0*N@ MFML%(D4:_:\DZ#]*#1#?<*<0>W9B &DBT@!0-,"64*]<4 =)#:@1$#(#X&4= M^^-3/\- P7\%PT:\O@'[17Y8A/[Q/Z])FH7"_['CXICW4K\&$0F66Z!,O M M\,S U!VJ(0.0_1>1[T'$;?!+,4@6%.U/YI'3:(4IO^B?%N"K<*C5T^QZF"C> MTA&DPMD>C$C18\B.OF_?@V93K++0V;#-_UDY!FT+@M:L17Q F&E*W9/E:&E- MIRV\7Q/?F!U &JX1@^*5PD/R_G530W:Z+#O5#(>S[%\+=;'^$\L8 +QWRC/F MYF4'?OP/2_R-&FYN-N@GA1T;(#M/R9:E>YQM@W-'5'D@HHW]3Q;!#DT,HQ<1 MN<* P_/'0HX/:L$M M17,$/B.H"7M>-=EK3M;1V6I\8*@W;ZF,GL]DNG PDP?F-,S40E6D$M]Q1H.R MSX>T^W,"463F:6;1'M!@.@\H@?TCX9(+.+G93 ITAB]J1!"7PADAPOE8>B= M9F'^'9%+7*_,PLHKP&65(&GE=*I.BSJQ/U?'\O$>055 +T,V:;7"9$F6HT="1)\3&.0=%<5+1)TXP?!P+#5#2@%7T7$ MW$.< R9M;& [613ULZBGL&@2=RJ;N#^:KMCV#_&H8(G&1G7]/*.N3 U1>V( M[_+P,%USW'&)\V;=R+&47ZW+'1E00$V0V-PD0*R3\AP\T.!4)P_=>3KXHD MAS!N@42+PZ*[Z@435BU]"XA/'>;L5/@/"5P5*QH 43O#_D./KHK\AG#OYMF= M:]V!_%!T>)_#8[1GL&1975GW_:,SV,RPKYW)VD2MF!%IRSLNXF8:;Q2 M1&39T9K! 'L!OKVP.B;20%%#'IML2UJ1(Z!&0TD*F_L1]QU2PX?O8$5)ZMY? ME-60X?YW&%22PI/A?G1GBX8<,@)%10_V+)P1I('R\$,.0NI<*(%M?IPJ=$R* M0(":_&&AI8^3Z# 3-9%DK?'J6UVET$$&P3E^'8\_$HCT\WL@J_=@+T>^N5D9 MT7<4+X@PMM_QP[4EV&ZD)F$G^Y";=YRK//^%21V(1^%V%"![O3&>@8L2>E+R&GH,B<\HHT)(D98=;FO:!';],\N MF4?L2M%@9L ,!@T;/[6A)#HNO]V0>]Q++H T._DVWVB582WETHT!!8 -IC;T M0.,)0EJ*E#A/6!-;G ;PX&A/G6HL8&\[R0('JF*B.-H#Z"2*VE-507?D:Z#H M?H?5C'FYF*/#'!THTT?<3]BS,!-C$^\(FL/F7P!OP)YWARP<-O]&V__2?N#? M8I#5)CLV %_1X+E49VY>85Z&L*QQ^[4*(#SNL!66: INT;3KV\,SM/G=^LO_ M=X&<=2*Q6 J=]S&Y^-3T8QS=Y"7>X)N#@L=FNXA)4&A.G!R7.;$JP/.T]/5I\SJ M<39"Y 0-[R0(0#UM6:5ZO"O0J*4= ;%4H9E<)>(_5(>2(4U*W(KWVL0;<0XF M:-]QY9-;2$0JC,8+0:]JG7N+#SY]CO!/!TBIB$R[!G?!@'+KG;__'2/%+ MU- V/+^0,BS40-R=>0VR?*$3P'BA;BI'Q5+^EW1 X=,NF#?#I.4;JTTLJ!6ORR-S6E"OI:";M M@AI9/TZ!Y*M04N?>.;^XI]! H=Z^T\*Y3>X2M"9^41X[C^Q=8@!%&B$4CC2%037ODH_[7SGYM_E7I% @%0W^K8QC M_U==9P"PYT!'MS!8 N_R]=F4$YL^Y>^UDG1%OK.HQ^"L?<6-5S.*>:=A*;") MCL"M<=JW'^7VK=J.#9Y0/.Z#.D>E!%PAJE\6]2(%72\T1_L?K43TC!]IOK]W M!P#JPWEA?1C&P]VMN8G/ZC:K>Y149!AMF-&C<=I/GZ)WEOB, ME&,*]WK(3C$]$#T3M=^,^?A>^?3Z[=B-3_&7G/W,_46!:M8M2.O(;-/EHHLS MF2/5STL8TNPKM=;G9K+'Y]YF-KB$-TR4@?HE39 !QVBT:.^LP9ZI4*V0XL@+ M_*JA[^E2QVC]-YI(MZP;#@?.:IW5CQLHQ.[H+N4H&>1LHT2;O&JW)MB71&X3 M/KGV\+] K&X7V:_%1XY[1CE^X3"T1VW?E;S*_+U&B4GYH1MQ\$GN*:=83OML MU$$6[XZM HLU=/YD?Q00H!E64"T;]_$UKK(Q("=1(W%QPFC_T8.^;/V M0 LIU5A/)%9C#3Z$+1N3=$KO?QIX+#XYDY[=(H_6H_C".+8G^1+6]]KR8\B< MGP3,8#)2O>U^6]!P$.H']-2*6Z#1=56BB("D=5X=P QH*0.L\;48_=<2U^$*XDG_B(7 W:&I^XJ9-)3>_U M>EU%(, %(3AA1&LO3R.V>(A-6%917%:E6Z$I\GCD/WT@D,!D;K IN[6!)YI0R&] M+IJ00/+K-'0=5P/=Q>, 5(W(.EK#GFFDJ1O&^?$*9GH+>#^":=QUA.";UJ8K*XMKVU\_ M/!F=_9W/&K/W*_1I:FH3KE,\ )!ZYE&6;7WZ"5ZKXI-+[ @#H\F7IZ]&MOUA MUR=*UPDB(*$I2!#J[DI,$8J/"VKKLIXZFWEY=GFRZWRA]Z_T1/\N54^;;>8Q,%(5YK*_%8 M%X72/&/?>#L:XJ)Y1.9]D^>KF]$[D*-)Z:$%KMC&EJ8O\7WN8KV=MP!)"+/P6($OS2YBRG2>OJL988_#):28"#^OXU'(Z5N9MCDVO'/_$.5)G M?'^X)&$WN/I[N9I#>RTZ46S/\N!_^?PI5\]K[QMVR6KWCU+1!#T>2]YL?HWQM5 MN'Z3HZ9TI&WK.> MR0Q'KL=4,4O NC^)Z=I&DCT$ON@2(=I611ZJ9B92IF[I^=4$9%B M#!-,ZY'7#7G?AUVRM]G$(8.9!'&&E3:6L7S.B1']<>?:I-];\" 1\M45VT$J MJIW"1O-!G:)IECGV9\Y/FG7Q&=37/3MD5E1 M><(##$14.B.=*NZ\";A?/KB"D6Y]S_82Y5,B>0XR)',M==*_?+)V67W8'"(+ M>@27DH!],IFV4$5,OITU^([W(80LQIMY:; Y2(^Q6\<(W-C8L2"+L M_%VX2Q>>P[M+MYHI[5J!&DW!*J&1VO$M1T)90%C :\6/;T** M&CG1MATM#4,;JC%(+M"J+#<^.#JW+]%>N(C=&' 30X\OS.E";@&\M8R&G_;N MF:?:_D4E,6^&Y-P(CL3E+M'4O5=5G"VY$#B]2-D'94)V@2#'I1::Y;WYXHS% MB:1S9$/3)&JZ^Y/=4.FW&^AYSIQ1>641*D:KWGLH3+TF?DFL\"7D9S1-72QD MD?%&X!FW%P(\GSO=.E\8!O/Q,X_COE$!5&KE#M0QU_>UQ/_9(AI_U7Y]Z-)0[J2X]7=B8W1PI7'+QZ3,;Y#)3Y/Y38F%X[Y$U8,,\:E] M&USA_F1;K.;%=5OOG;"LF0^&C@M?ZH\G\[ZM^RJ!6=BSPJ]^P"/S&#HX5^TI M7#PE&IQ7)CGB2:"_X.C$?SZ5:?13V9S]2(DI5H%4WO!\TD$PK1 @"O HG7]: MQ6WV4L>;L ?IEBP$RSD"&3N.(1?>JRV_2K@AY0YC/?2ICV.)(G&L>0"#](L^2"8DSVQNJ[Y^ MI'[&H2#)^;+TU]/589WO)L2M:4'0F!>2>5&KHS6[/N2O[N,LZ5M)='M$C65. M1BI6SQF-YU2N[S=$\_8MEA/\5^7NF2VP]MIM!]ZL/+^84GF5M7GA!+&ND^HXF[V;.):+ M7E;E_4'5GYO73!ON5JAQN%=06?1Q6\LJ_KG+>O4CF]!'$?7\E9MIZO(B7;J1 MRMF='UC"*X^+#FJE/@5T;VJO"FMJ5A:R .'>!\] X_\SH/P+5%(/?@^]$P8$8ZEM 8DNJ,>!@>"WE5Z1OL0U@DVS1FJ=%_O-C:A5GQ7FQ#)U' M/@]&A51!5+,^U, \0Y57!30?'X7@X8U1[&C("MQ4$5^''O1@9>8]?'FT+442 M%-(K+, WQ"KL(.JJ"^6B*J^5J [H#34JVI\FSG-X.%SFB&HSD(W$,_XJB.F+ M03?Y.WN5=KZ;OSB'RV#]\2&IBS/*T)-_B$[:RP.?SU?%;=3F@F7L',]EN!]= M4Y#2!Y/=/M."GWG\4GM31KKX<]+FM*CG3P@BG1KMH%B"9R/E1CL='UVX7'=7 MZ=,$;.J.O#.8.-@-NBJIUE0#U]KM9+M>VM)A359G?3/LS;G.94KN6,7X('%M M-R*\CPRAK&\Z(G]6U\W>%OG>/W,RRF+:[U>3^,VC>^/F^:$8[-3"XC1[@YFO M6)4,VGJ^J#]0N(XQ];I\;'I1V*56Z=M=4M;S0)PS-NV^D[/:B[EDR32"*=,+ MAG16I6=>*U?K5S8OB:40D+3-4CM;[]KS3LN@6 ML)R"^XA8^B,UCLUNR HZZB+:8LVZ^:C\@QGZS7:S7+ZYNV!@KCGDG VP)"4% MD)RFO%W_$])DL6@H"]LNZ)GP;X\_TQD)^'X4M)UP"^#[#9J?UMP"N2[/]HX MW_R7^4>C"06Q&I?MW\%%K$V5BTH\JJR9$(T;LL5%);H]/E6_W+OG#)KMFD;J MS+.P.&6Y4Y%;?,%8GCXP5GSCT.7$LQNYVMJ>R\ P]N&J&O;GQUK!#_ER1U"R MSCUJ4!&]K^WPNL<>QI!P6=8;?]79^E[A'C7>UNY2N3Q]N?:V5C3,[,G21>=; MNBR,S(Q?:*4*B@WA?6.#:0,N!XH1T':%UA)[4C;[!8&FGC^O[RL/$7ZR6/8? MM+RG8'(6"EVU_MG6*SSGJ^UB@&A\4:MBN^31TLL7KARY)I\#:LSDFO%KH$HA M5%[,+_/5SG1VZ1$3N/&848-U"7D-B(^LA=2UGZB181C86&X_6)Y&?6^(E?51^)-86Y"T8C?A^ +D*HZF_]AJX!;)H,""B M3F^7$M30S$Z=^-KEDOGK.6IFRU0# I$RPD3'?7QVZ:D$5%>(B?*+ZB%_@Y*, M"<34]4LZ%\3FWHM3QC0,#LF:H-'\)BK.7WDO1+6T=%YU_<18&)GV)*-[J]X@ M )-QA_(JH66:P-G59U;5$22Q-(VP?9VY- MDYF+M+&)7'.N%6%1>%9LJ2N6T\7B\7P^)%(38+MBMF-_:N<3F5[5>"U]DV#P MD@A!$@L77H'L2,(RN')BLZ.XR\R&P$\L=XRF:GZ461MNRU]MK$HW?UM9GSKL M,K@$?%74)\BRTI/&MUZ/ M>50J=0?@_<6R7O2N6JO87M"]"SQ9;QF!5^/;B6G$+;(B9#N322)R2J+/0=^X MWK^ ?^_) J%6Q(70/4(?:]G?IR 7OW6J^7[VR[+^C78D48&<.@>NW2]=M_OB M''H+A!TO;\EXH2>S8NQK.?:81V_S*!,62DVXU_5==^R/+'YJC2/8V- MHHFASGV UZA[)KC0.5JKOQ&\B0I]DZ3L9<#E-? ];,)^)+=GO)#13V!])BG8 M@?OX=(+A0BS>E(4-6\E!POEL0@7RO'&2H 1A@<.(1^2<=N&\:_ <6[IK*%.F M,>T@(><1@XK^ULA+-;ZZ6:'PR S70O#-^6/;/F>_GK5WXT33Z5$W?2:OYXFG MF/UCL5][*I#Y\W%L9YUEL_3WN"!AS4ZM(T6^\+ SQ-/M-1A:>UOE%GC)/!KT M*Q'RJ&[^%A"!C5;-G07=D&KAVGQ2213UO%SZV%P+B'4$EK^7R1/)P=#8!]VV@2V; M59+S_J)++J+Q/OO"1G,_(9XM M96FD$2"2G\2*,@@+R>9=C\2&1@KG04/"@D,3>7(;OUJ,HP(UOROH17U16]4Q M2B\@:VM6QYA);^_4<,9_YTT KU]4"L#AR!WFX]^$ZP$SZ.1;('_S%OB$'U&L M KMY-OGRY"?L^*'6^R'Y;"1'Z'^A9:%.HS-KG5N@7*3U&&2@G5Y>Y$^$"!6M MSB@&$_;./+,K(]2BI"&=:KBC)5YZN?G(V*.:J-7X\\-)!EO.C$2^X,D_;'=\Q MBT;**X_Y*/^06+&W//XV4JRIU-[]\PY#B\T?O1/(;]7834$:D@FEN?THR M[29*JX_FLNA7X%*WP)=JK84,0_W1-R_MRN3*[WBR9^GM75UJB*4*^]$+FZPK M^&9OJ-Q?('"LD"W\6LY([U+ =M)D?4!>#;&?B#YF:4RC\_R&GVECJ;1 MV),4OQ^69!FEO73$/>6;LB5V>;/=$02&;!XZX66[!3&9#@DE+JOVJAN#XI_[ MA/53@]*T/"G59PQ;.O>*: @J)8J^]98][>$J3'6/,V;U\>7'-SF M>DL?_ACJ5HA'3<'2'=^\E+GI'M41 NWRW1Q:W0(VIQ=$":Y&53-MGE5YC5=)[G]XQ]G=) M]@.<897Q9.:HN0+8V>YS=L*E=:)&G985#\;6P[(C]0.)R!@_[G(FE,"YOV^M M(N'7WOW,!;/1RA)X(L-]DP&Q' /UDM"T7V(ZU@\7[9GV+O7?[2Z[OV,[,I % MKS''!,VMM4@)4M(W:2O1%NZ_9FP.Y8E\,RE#( *$A]^X<\2!OJAXZ7VW*.>J MM6-(I,0O[.Z;7\D[6XI)HPM?)S?.DTPA>U\MZ22W;/*ZA+X8%)3 "/#> I,E M"L) K-RZMH84V$O)T%;+(_<:-JCY>W)N'X03KRLZ'*F0>[:4S>G>*(4U@P6 MG!R\P;=C[ZT#1$I4GR%8FMN@BZQ@<@P,^2=;K9HJ1SGKIC%#A53DV:D/T2$H8*B,";QIPAC4^>?S9^,&^:"3[@X>7R($+ M_+)/6DY $95;@5!&28Z&*,!/7;""I-TA2@QT(5=T"90=W M4?CLDX6F[=S6Z;^A@\Y'Z]P1&?)G_^4;A'?GXC\EUV#[+[Z=!VF.6=)FNY]@ MJ8._VW?0J#NK.'EFEJ,YET<;.!V\R4Y9=MX49E*SU2JA/E;),YP$UPIN0%W/ M)]\1@9]KGV)^"_R%JJ@MM;!@W9,7(8@9'OJ^I9RIMY+^&'H4 $]E^,E MI4H3V\[4M$.'TVL_>CM\7,O&1GDS=4N_%&'0ML%Z!^5;\#XC6\.*O^)\K+V/ M$&_AJ#_Y!X5%NPSQDN0T[PJN&X$B=VOR@@^)>*E>8=B&7W9.2S7R$* >-[RX0"\T? P[#3&M88DZ,D>3+3^$=9U]_OXW*G/'J\ZG9/8 ((X/8\O MC'7-(0\]'9Y_3IZM?RABG!LT=/!TV= 4Q^@^+C-5<9*W"GHG1CPFO/MK")EK MN 4;]8ZH3LTJ8;Z+EN8ED\P2(9_L3#WC+5#[CLPU4I5'I.2CK\,F;51>YAIG4:*^L M7L^O],R\G*_T(7/BK5FQAA9\,VIL UQ<]'A M)M$&81Q>7!P-R>](#3_6$)#_=+ M*4ID''>Q$"B!92+()BW," 'I@5Q5?8:WH4<(@)C']KX ME5QT/.;6K59#P1S UW#>O!S8H]CGJC C4S2K1#'Y,"W:58TWYH^K&I"A986R MU&)S!?QJ2\+-:^_5/3M_'C0^;K.E '<:5W!U,,)Q O]IUO9HK"?=C7@>-^<" MX^URFHAM63H61'J,UQ(IK4P,M$$4<]FL#P\Q.>A6CJ^*J4_?T;^:4Y.A+^HN MJ JK^]3W?4"#Y:V+$88^;Y8P];;\8.YBN4R"1N]U0E0UL #EO=7 MQ<42Y[DLE>?I417"I0JR^12RFWN M RKT;?O:=%JO&M(%PY[3JU#1+:."AG2$Z;2R#E"3 @^F,W2"A)>A):R$/(>^ MFP6,VIQU1(:)"4>3N81:VN&RC3;;CC6D+^F"D\I'RSV[V 8>4A ]KT2CE M%0UM9S#9^P-IZ/L1IXKW8ZZ**M Q##3*@L;5O7 F@$H-K3^*L^OPW7],W9^S M&''ZCK_<@/@TZE @5\'ZTUVF6P;_PQ85"$]?[(KS9(P+<:VD*HNI;4X95TC9 MNJ_$!QRJ[?,QN2>\BK(ZH<>! STE -VN>R:Q]6"T$54M^)/8Z#?O MD#(^G/CYUPM-M-S^$OARHLY<=C%!;5R;_2=>?[=QQ$C5%Z3_H@F5=]"-C.W6 MD8GO)P>F#+/7;63LBH$[_A #]UKT9^_@SZ4![*['=)!M0TK* ;(ULD ]C#ZK MGN.R4+DYVV:J09,+6Z.UY2D!JFDKWRVPK+K_Q-R\!H:AA;RGV*697S%6&- M-,V,TQ$BO@*RL:(R9U)K<2(NF/7 >)F=VV.9U]=GY*;/L@B_8YR63C1^3LI^ M#]EU'Y (BO7IBQ3#Z((6=3B;P)^FF$;M"P\U=FEE:B))7SC'.O^P3?QEV?O( M18YS2'VNG\6EWVNSR\*0!%OUP#L)W_[;/+/0GS( K(Q[8D 'L M<" HZ,JDUE&>F8?D;>LM0C:'7ZE8CD\+TY%U5 3K,=H>P99]D\H,/TJB3>B_ MTF+;"7-5.^#[!:$2N-<=0OUI9M**9>;9/[9S(VQJ?KB&FT<+R@C.SVM1V]*HEVW*>H=CMZRVLLG, M96W/_Q2)YW5C"^0P%RAN*>2PL72"T5@'*F"DR!5'/M<]%"&K+P=>@3.&2+XU M6>Z!"AO2\QXAM$/50J-R*;W-;*GFL]A0*#>XV7^#M9I8<\#VS#&3Q. 6:+L% MCG'03$H2.$AV-.X_;8"3M/H,KX][2B<"0O6CA_6[CX3]_WVD?+00DO. MA-!I8FX__QCSC01[^+*K55D?ZFU*KV MR5/ITYYK5G'_-\Z&F\-TD^2Y?-#"KT088(E*PWXNJ:8RD-DU[L:&KW>?(O>_S-5VOYS3QM']WQA0,#";^>JXW5 MVM_[,3VH,^:R->V(D=6LJSE7""MD2A&H[22IB2S4\'IDR':NPS7/80Y_1"#* MN\41N/^$V692(87V7?-'"%J7T\[.I^]SW-SVP'=YG$U +3E'/0>_JN_1#J_ M=YI/4B+8.+*?*N39'G/&V\GY+1%JHY]S@\XTIF_Q;<8*&F MOED97@.*2?SW MW-+.65F9V;/>9:6Y#QVCH1O$:.OO>57+1^B*;X)8N3;"Y2P&B;"BW=Y^"/A1_UU8&?M$STYFVS?ZK=5L*KV!C'I:P0T M$L:3($-U6I0'#Y7J@TY3XJLP#+!9AN3NOHT$Y0G[U619A5N@?'+GC B<;, X MT0^B$&+#7!062^F[FCE;WY#S*PQ8+?LR;[?1ZMS*I=7Q9-W!7U:#ZZ70*D/XK=A.MVX>.UP23ZN)3Y/:#6X8/Z4:=:_#M M&%2>:G:950G^_!B.RIA>4O8>I[/*).D,&V#?$ZR!3F6L;ZH9>=]HTZQCYH(W M4=.]T8 L[E(J?8W\;-W*!2I2Z7VXBXMOR9-;0#TS.'SG^>9DI&[#RT^UC\;O MF^G_[LG:5UDN42WWEUBX-M..3>QZ[V M_O?51;U8EKHR."5.ZEZGES8?D(4WVRW%2Y= MYHR1K?T,K%E8SQ!%YJ!FXA]&%+BE]=@,I:6!8LXN)JLFGR4KMWVH=LU8MAVJ M-YBFY]54'BV7OL9^L1N$A+&NQ_%E+4+ U9R95F7ZY+@_)'U-OWH5<>T<- MS+BBOO;^D&K09?;P'I-:2XXK\2R*+U!'C"K3#Q>G#\@#9 ,_AJ#=\7)],+1) M#.M ;,P ZQP1@L23>NN8-KD/\IFL,5OW<3/Q:Y(N^;Q 6F\MB&T]75*!C"M9 M'+;.@*+SE^75A#KN^[B]POD+1#HUHVT2!>^7R1!H- M@(\]O;;(5*VWX]/G7H4KC$0(FBVXHRG$#4ZB*IU G>N8=(4P W :/9CO*^ M9KF7[FAW!P4-*-":'HSF2/@62\E^]X2^4*Y,*\]C4S07E&/*<+++?K)&J&<0 MXI UGITB?(YM.$VQ0F_[I09NE34NFT_CG/] ILU!8?-NK49C"QTC#X&@7Y_I M6;\,O6"&C%9&F=2V+&(/UO1<5E1>RSBJN8KL>&K]MY&]N1031;XUW_HZZ19X M+A"M*JHKO?SF*I-J*RRRFN+J_*9V,"[2+K)LW9T[ND?\9%^5GI/_FU9HR/-9 M4(OIQ$!UX*S',UDTEW.LKXR:8!H- M]RB#G#!.#>-'9F5VT$D1%[P).>P?F5J)&B[9H3B96 M"&F"/^*N/-74*5 5+7 QLN;FMBBK9YGM5H-GYW?+%W+3NI<^5E60\E=T[XSM MN2?.>QX)^R!''/> MR^JY6Q@,E%YS*,?(YWZD9'0=T+5+'E[V7M_6$WFRKJS)RJLH@N^ZJW*X]^&G M7$&'=]JK#^NZ.HOZ;TS]:1H*E0I%5"7PAU68*![(/#QFU/[P3B3)*29I>NP0 MLB^T0*A LP>BEZPM1LZZ%6>_UP]W=G4!Y/^F?XOO1(402G&QO;)GP'FGSEQ*\AB=LE M-;517E,T1R12["GZ*>(W,Y4$7IEW,M+9,/59^.P(30UNVO,;$4NO#0_$WLVK03@A[ 6HO ML@=:CS&9(G11W27NJIPJ1F@XG="H*PZG,>% Z]/BCG\_(5M6A@)CRFQ,:<[' M^9!VE&FGA-VGWXY7(:S_L0%^W76F"8)S"_1:.5[\<;S&L\M.B3\50[%GU_'] M4V4G_F")L2?BA.1F%'(54ML?=UQ6O23'(#+.>PLHMQX;3#TPV3>N[YV5+&-[#C1> M'R7XNU3L'7CH+R[@#KTU82CC!JXD$'.60$T.U8J?=@KBZR.Z$_)\8F4X?.T9 MXGN\Q1@JGNC'TB?-#$YUKP%&_GWFF?,=WZ(Z.56_I<707 MI^@"'X\9JF^3"\5M[G 63N(*(MX;_T*Y6M9SV3J9$]6)6.">**XXA0U/;$L8 M*CZ;U[M/T;U8#;E&;*H2E8O&?#]/D)2-=-A9.G2^F?47+>U999YI^@B-$+W0 M3;SWM;&/C0"WK]C3CP;%;ADK%OI36X$QG$Z'+T?"8'Q2P"S;6L%<;CJKY^KH MY:KF>1A-DD=[I$)Q'>20N/[._G97Q5L8R!D)(@6'_EUG"U<&X^77+B)?(9,% M;!);R-Y13*RZK!!F,^7E3+0)B"N2'S[[JD_/EE;&(>M\O9U4MV\I?Y7:G +/%/M MP8.51G"% &%-TLR+<",\[J%YV@K)[,_C<3\RUEG\V"644Z-$9Y[EIGD(V"FV M^M=WYO6:7%W@_XBQ%TCU>$.DYLZ\1CZD8G-**=W(E6;I@8Y3T=]S;WKB)$7A((K:986,-:D:SSF7[: MX9F:EG=%\URK=T/RE8J[A=O7T!BA^QL*ZQD3J43-[E3 %UDN0;DG.S^V7&S+ M/ ]P(, G=PE-"9I?AC5?@GS@/M.K"E\A!M\:#R@3.+1W["(B?E*1F1-7HG>% M7B1NE$Y9YGHMOD4-.M6AXW^[VZP0!;Q'US!=P,[W?MN)9(@/V M5A:?5 ]H\0_"JV)BMK@$__"1 E^WN!!ZO2N\R_.5)UBOOA5NSGR^TC(IW>WH M,W[H5F^!H;,8OX16^GHJ$)-GM-?XBNHK-?J=IWS ,6ME_OX]&IVHQU^#J'FG MO<=.=_O(M4:[W97@R..9P*J]LP]_DL29[Y0>HAC0]Q?[WQ(==D$Z)9-CE M_M8;1/-[2\G=B->.R'=;N\J0Z:Q)_\,V=G"0CR+DP @!OFGTWZ@M4X6EM VX MWP(/DAPCG@S]B>6_!2+Q5Q:-PE%KA2W+9:E_%#Z 1@L1_ DO'S.T((X$NUB. MR8/%4@HDU[)&B&L_?/?M$9.Q62"2D"@65G^1#-J&TZW/-!9P5;N5?NCN,E9] M>V10^*97?%)8H,1A-EM3E2"%J?_BII9]68#4K4OQLW85I@SA V*-T4K+<[V5 MR8T5'9D=*Y'9H"&!!S(RT2"UW2X9!H,7JJFAU,<#]K /Y>H.S^D"+NAH0MOA M/\C6R9OY[IB9[Z<1RRL*+\QE6D\Z/VT6E/N.W'IMM"^.?X*4UE&T*U)%D;%T M<%E-9 P]_2?"/\$D"C4TIG:E9/_!D=L_P2!]@INN[J9C15AD%[D5-KP8^[E4 M*U:?C%_9O%L5U+/AK1/H1.+<0PYG7TFK.A_KWGZGT9[!.<9&)< M\2W.D%#8 M0:'4WDMO)O_7_BV@.,6"_VW*F**3G^"JO7';AV"6V-^6EJ[D&Y3JX;VWR]#6 M&;%E#B93-Y9(CG*7EE^8A=\\+U,O$/:8HGN+YMEKOFV;] M>P/Q7;.CY.OJ8!C=KS;_UAM?+AS;D6Y,=H;QKB9W*G"@(;L8[25MR0EMH;Z" MK9-V_')EEPY[1^%2$ZW=F<-N)^6&)2@W8*7\;%0IVT0.I&+3YPJ(LZ]6;B,G M^=[2=-<_;=:4.Z,[Y=BD%:$B?YI1+&]#QK-3YAG"YD-9]@;>_0 MKH_\G-E.+&5GMUM8\N=<@BO2,!OB1 4S<#5NQAA2;-=:9?,8-$CVA.O&B6$4 MRI'HT\CTIRV+E%6K?C'<-EVE]I^G]]WN-?!\!52VH??OO0FLN&64H M\]M$V[ IZG[YP/#TZ5K! +V!!!LMD2XT6[TM,J3*T?V25GCJR2LK:JVP-;;# M4MIRLI\BOW!2.;-NV!9NM"=$^\48M!_3&Z03MI+I_Z7G>WE/]4YO2F MFR<3"N?RUHZ :25I(A>*[^<4B*]O&DUP-G+I;402H9]Z*YFY)1,(Q36*: 8: MCJ0-9NEX9%J[,#U:MO_^@YH*_=9.P>>JHH>A-H+&U=Y&E377*/6U2IO(>HNP MM<..JP[SV(W]J- "9UN]S'KY9'/.,T=?(C8="7R>%R8JWX7)/869TL,?()5] M)DHY"KF8.912YE"2\6OBZCF8J(DFGKO\??O0,ZI3DS!^BY+VY MPOWUW5]Q>9E*-;EL>VF4^$S1WDGT1_E-R$EG8'"7F<0@RA]/]<(X>A>,->E; MY>#[,UC)_Z&71^3XV0-S_/:<*E'&,*ZQ+QQX(@.8T8=V":GX1**3P6$/&'XI M#FXBZ\VGHZ,TM,&%>97%F7F*$@CR!1=.LW"=TMXW DIPY4XZH@0W(MOJGK7V M;[L*)9_0U,$$YDK).6P82X'^J[MXAA#EM\1H]T$ M42TM$Q5UXTG,U2>WP D\CR5.MYIBG _H=.3ZL&%_U1(!;L1P/J(P2;A M(JIU0(9:VW"M3",BX@_@='Q3))G;9Z#B\1DBESW=I'()R%]()H_@$:Z X%0J%: MXI%G#&:E^]>?,>]$EHKL#I2>I-=2/J;3;N]9Y_TF.:'26?7G>$5;Q3[9MH)8C[P>Z>5&]Q],PW)_IXIQR!8D=C!>Q0B$'<+K(N MEM_"0X+KHZJ"0<^7 I8ZD7G7<*UB@)F9[;BPCZ#SKBQA-PN*!#L;$VQOV!BP MO.Y@%SV5X+*5G+!"ONZ-?5).LEB]16@Z"XUU$I:>.T4KV8K74WN811GAKZ:/ MB2"ZJNP*2QT]:T=%W3#=7V;PWTSO26SCKRNA0,G):@Q"X*B8*'_%K?L]HCSA M 6=MC_DX'A]O?WL;,1E:W+-??E7E.)104J#10K YY59>WI>F-^17BYAIW]J_ M5B;J$!X4OMH>L?@]G^3*CC)T4\I8AG' 5$/*"'ES[+.*"S=[R*=Z=UVL41TV M:)]!BE_M22ZF TRR8H%') ;WSQ1_^D^I,$-.I2#+QDA;T^M-X=-]G>7*^G"? M;PV7J#R%ZLA\6\FH/9%M8\YYW'=RM!"?6R!8VPL0>N^]@X!TB/0JH1,@)#3I3:1( M[RT(H4COH"!(A]_[>N?[Y_[WZ<[JV6MW4+Y@TLN.F\[B$* M;*EN,E:'[QQ;MTJQZV!O Y%:CM4.=+?SWJH@G*RSEK/#"?S^(29:%YV;V8AC*?# M)YNZ6>!Q"92K?B4\:\54>%$5K^W4^(>Q+_E9*[]WW &.;_:NVF\035C1U=8W M^#94=X"__TC"NA+'(B9=]=_R0M\W<.QYX?2E/LL_"NCJ]RZ +%WK,!QI&03_ M0-P!MEV, [T[S1Q]@+%GPFS[E@RY'J=E#K'F99)?4Z $'H9I]"C+9^%AV>I! MH2$JHI=0@M"$F9)&I]J"@VQM)CJVO7E<^'[W1!,*5*S)_I#&TSY01EF\J6(X M!II+(&=O>HW>N_0N8J+?O??F'BM^ (#OT"'?Z9%J8X3XA @3_<91BCXLV\9> ML=U/C: >\HAFZ(K:*-%OXK$^:UH8TH9+4*EH4"0K,3N=0K+,!^/M4*"67 MV<0(T(=MK&]BIH:2*=$FV)=5?M_Q"@&-P27H7)%6! MFN:+G%@9Q_L!OH>1?PFS?V2,!I* T8YFAG.I)CQ"JK>%R,;,@B!PA?R'GGFQ M9LWO]^&;$!J6ZE;;63I4FGAA(TKP7SHGLZ*EE%]H/EN>E440^*X!?[S+8-_<'2.G,,B%OBLGE@7E0 U?2@&QK7C,>L!5?)ZWFJO=2A M]KQT1/!I&"+Z"R><>4">\HF'UAO5U'&^'K"@I+MD41W--/6RNYLVE\V"]QNI M'8V%):I7ZK]%IED]QOPWT$8*Q]TXRHHR9CJV[B.5_AZZ72U^B]J>E_RT%@CG M0/9*^:?*_"BXW< )RI7:;X0[>RH!9K:G^TP)Z O!^3(<_@R>E_C7G 5&[2%] MARY$A__TK2%D1'N/M1"^S?,?QW7D:KGO3'GQ[>FWA1OJ.T"<7]R5N2AY;YO! MZO(CKM2;P4$)4/N:L=('G[=XY26>6K.A7)3612.R@O=RQ=IS7)4\&IC^],&4 MET^+1H!9',%"M%,9#>RB)Z@P>5*'UXL/[Y\(EGU,BK4!9J+:N;X5UF4(C14[ MT<46U;\"LI^L%AHC"8&L)2\S'FU*?L>5%1^BK0&+C!KCPCI=K4@F%'5QH'. M+!&S'6@MOC=.P+GC< :^[G:.\ *HN=#$GZ\6W\Y,5E(]U7B7SB*^..%P$2Z"JPE6/=Z'I]KI*G%I;Z@5(K!BQ:Q\9:.PY8N*SCK M JZ>ZJM2BOBY/ 4?7O7=MZZ0[P7S)=*:XK RWM5/DAE:=;:>SA EGG%%"\@-J76WA"<"GEBQ$&OB4X$-[GH>WL M%!V!'V48)LCE*O%_LG#248^G\ Z9A!ZD^B/$=Y][(*G=N7QPL=)+!B^WBYG:N#,Q_RG- MPLU6NGUER5Y_'[3 ^BG^$48\2/=>W,C 9L-F]9_13)\1ZCT5.X5=00QF5OS4 M\F7BT?G4IJ,J&ZG+9XO79<).SROPG'F2%7Y-1M5RD!$RP(1H7J IAVO:W.2# M80C+XTC%-(8#*&2FST2]K(9C80Q/;*+S3JR,.]-#QQS:I\ACZ'<%B+[R[ M[P!?W31QYY&'N[ZK\8+3M7@I*>J;275?=&"M<@4&.8G.MZEKQAPNI\0>Z0_6*S@/ M1D FGCQMLJ&=+/^H8R%!36>'9FJ4&3$$+?7&OX5EA%FZVJTEZ0#C785/>FP5 MK$UC+#E3%OQU580U$4Z>0KLC4D6725M+R:DG]'63#B*QLCO*8BU3,24I22H\ MI.)IST57<]W"5,0!=ZMX[I%"#_#RGRGD"/".+LMHY3,L!]^W21_]?Z0L=G6OJI(1( (]WH: MO)^V_B(N*=*BCZ &4]?<1E61FD&E2PR(\.ESMJ=1>?MD"1;-/\ZG[9OT.: LTE#*./*1@,E639TZTT[+%ACCE+\RUO(]E2 MBDKY>3'SQ4IOMG$1/]&N\ZI$!U@R*&Z)\K^H;I(A'4Q E*3;R,KHZO5E?-UJ MKQ>,$[?HB)+X"#'7YEZFLX;&G+]0D]=-LE%T3RIR&+PTO-)^C@M53%LK0 M3JW'*=(+5?K!"C=EDYR%^7@?#\K?#YNE/^5M_M '6AO_BU)PW$J*9]-UX.(9 ML0*R;CNNYY;(1?.?'SXC2')OQJD5RQ1L']O]'MYH=';FV8%=9JN(9S!J2AF[ M[E!VO@:[E3\<]O0;E_#5+2%S#Y==G!9-F8T\U.BORD:^J MQP186]^^2^+-MH"P71 H= !!%7*"%]Z7V.,Y6SG(4HG5W)4Z6R-/[NR>X3?T MBG=+Z@!-VM^.CLK."?^3TM[1\*T]0ZW(QA0Q8NH8S1G"#&.[KD&C4-\-H746 MEPI;V^IH_4J3(HN$"A]-N[\).>/O@Y=!JNY<\74GY+"GP+31!TO8=P!;= MERZ_AF57L="@IL8GSWNDQ6Y2-?A=\\$2F(E$> M+Q2S?T#T'6:3OY^=842>(N;(MRJZ_#W+1\C$+;,(-PR)QZM#-< B:.+O;1R\ M]H^&LPU4D4;PJ+T1%LH+7CC" MPFW4;MCA[?$)^2)JJ0*D)+VD)3;8'8XX?4,H.6X;SLW$F\SW\Z-$L=]F%(IG M^)B$OGX7]UY<-LTY,#XRM5@,?[[PH2 >"1M?3WP'P M:%KN !H')ZB6+RPVGGY6B\C.EW*&%C-H?BLU5?#7MBGDU]C?^-Z0P:6=8U@K MN(H.'%G/0@?M\WJ!WC[C[2PF*+9MC6>+D-\/JN_'QA<=WLN1)Y#A5(#2M\/F MJEW'R35ZS-%;B,DIRXW$&_OE4Y"#M+8%Y=$_0E(V]$%Q#S9.S=3STBY_'J-K MG2E>X]-_-U%-L9:, NIP?#(H3__5GI#I,<+9-C2?_'F1X8@)^FFQ)5 ^Z&]9 M08*;Z-]&O(*<:?H\'E!#75G[P2<[SLIQ/O:;?:]"6_ZRI$RIZ(2N=)H1L&+< M2&N4-T.7NPJK3*^N.Y1H0/&MQG262EA_P['_OK7)3)U6+IA/*7L!=C',;32[ M-H68D Y3Y#20%H[Y(Y*V\>=]I5'B:U?\UW+UAHG,Z?<; :5"^*@5'>:LH2:W M+<:!JTH40XZ1._UL\J#@KK^6T3L#T->W^Y/,D>]-FQGQ!D9>(Y_2>)OS"A;. M$WE0=Q-ZNZJ;8J_"%XGHXMXO%ZOD>[@AA/JM6-U1!9U %.E@2\C>NTY'S'Q# MO-"(#5^Y2KW_*>UIU4NV\9DMXS1AFC!ZK,'^AF&-YR%[6]ML+]'U[G:F*C6W M4&43-D('G1*;W_M0E4CLX;J.D?C"W,)HOMGS&K!RXE#N]/DJ :_<-!23B^G2 M>:$BC@Q9S:6D1QZ56@1Q!VA'?!&L3.,D@3&ES[LM90O\02,_ _!#21]V(#P> M.".+(8OX/E#+P6W_%V5>+&,A.VJ/ZI))U5L2ZS;D8'"LGZF.(,O+[HR7/@"1 MS;(%G#)R.'HK'LNA<9D;J*+Z 8O/ MXQ=$)7^=$1-;61E%JGTI5+B>WVRY7&1EOMZ\7S]IMV0ZKG)"E8;SU_)&%_[Q'UT]_ M]/$+%B@GD%$70G4=+'=[7I%C\H;/(RDW+>V^W]>(]OGG ME;'OF\M*_U8WO&#GI_GE48#U(JR)I53W!8ZIH V-:/EH7\S^B-P ^).=1M!: M>@+U6FJUUM6D3'>T_GXXAF5=FEV]_FS9-[P5._[&DK>,CQ9_7,?-5:7E/>%@ M84C'CHRRW"LD8:$0ELM[0VP.,OR)>7]0$$)$^71'A9FLI!FCO97!4_1RL/R^ M>6&RC*02+9Z.\REK_GV"(7_BGO3#@&:>E($5&<&>FGVCUFF!Y*1 /NB)$[U2 M\_L:_,8JR-M/*P,L8(Z]>N$_1K&N?4Z/WP, X&]Q9.6;9?J<(.&N'JOF2"P! M95X6X9>]2UT7/=R#S/C7+8EF1=22 6_N ":7T!'O;+/_+GA+^U1,F!3:I:3P M8\,LS=$];BZJS?#?: $_' T4/MH_3.1 +WB:S298Z&PVP%=Y:TK-C#-7Z>Z) MV4\#02)-(<=%8N17G/O!:L,,@F:OZHX-%ICD^&T IG)%&W^ MJ]4(4#N8B[S-'[0<&ZR(]BDR, KUC@C^A6>(Y=[9>UJ2^[*"V56%T*OG_:#V M,;B@;;S2Z5C#!V7^P/*KE>J,UCE\-8>%;G161Q-&&5*6KM:P$GA>>IW&$L^F M^5;NOC>$B'_0>?NGL@4$E&?\0.H^IH/V6$8QR%)LSP*DM\'=<+[ -AH89QSO M^R9;CGT_*]]4>(KSL!P909C2(BETP>YR "(\K.BZ\:VPL*RWUFR=>VRD-XKI M5V])BBT=\7#_SJ$L+=MQ!=^=N=W.O@Z;!Y+VMGQYW/AL)83A^]B?\BUB]SWS M%?:D14/KD#L (W;L+.%/140?;&B2^@UU*/)V MY:*@$OQ>I=B@E,6SH8S$3S?K!&IJ":9]_C9-^%&+B;[>R<2K49.W[1V6I6F] M#OI0/4:GVAEO5]T4T?SFLH:H?%Y^&;X"$W#J=J=EF*RS<347.I";LU0)Z.]I MKT?H9;.X^D,MTP6(]63)\23%E]):(1VA3$SN@/*J [;A=^\?\LH[\WT$#V:; M9_Z4U>$L@((#PK\N\K@=KR7!X5(^#N"\SYB;29'-.I4_"X.8;3(%]>]5E#]: M]4T&B?N2F_N>5]J!19 %JKK8^[H_F'A(G![%6@BM5LZ;&!+HG5$D4SDOS9YB MLHAC0Z7.*DAYN0T'^P7".BM*H2F(N&&,NWNC^9N3^D;MI7-<14Z;T&8CEC)_ M2U3;?JT)'59:!25F72[3&,3IV62$=:*?O;5W37)3?4(\MXBW[41;='NCR2-.=#_>E9SK<#J$>NQ!!\8 A$*V@WNY[ZZ5TT+PS(LU< MD^R6A#BVBC8BPRJJN5\9LH>-*9:?&,:G9 M4!^R&]3%_7E1,T;)2@D0Y**7(Q-\;7JNJ[Q6Z6?O[;_UR5VP.J?:Q" M(P698!_UV)H+?Q+K)__*S_IJ_V&A8(<8NSE&Z-;K?H9K#S9J7"MU@\4'K5!4 M_@E/DK]\%YD, *9P88(W$+>O2Y4\^-L#!PBR[1JD(8<0>?-^K:9+XH'FZ9(\ M1CKDN'8ZP@B[AT?"G&"HJU%R+O0XAFO>PY]X%Q7E/O=57CFG)#8X9ZTW'ABAS75B%\U\G)O#;$+-I,SF,Z3\O@ M\Q-,A#H&H,X-.%#Z/T0W0AFBOPH]JW^8S%MMW"OAP[;]_:KBX-?\'T)W..!H MU:J^)<"@%$$3/4I'4WH'H/@%3:H!C]>/D>,<&N9?TQON2GBYAFU*W\@U'HO^ MR+:'"BPQM!R[K'$2"<:O$&C< >C[J@@O/-3IS<&KM4@^A&]FW/5'*IB1\;1*%'-.@7V R\2 ML1XS#E%C'$T?Q:MO*,0AX_2.2"QMLMA>7=,X1Z70K/IEA>78BK[V[:KZ]XE( M,)'99L/T$F3YC#=Y.];*XY!]TO#EKMMIJ?6DBU/M-X(^E1&DL9V;X1 CEUV5>JL:,/+/+FV&;GR MZX( ?VQ)8K1^@#C60+!/L-)Y\'0?>8R5YO(8 Q;0UT2EQR844WA#>;,-4BQ# MI7BZ^?BEQ8R:K^.,,G6'HB'?V?!C&=IT,C1K@^B"(>C;"1O>C\-?/0_@MC3^ MMAPD75Y&D]QB8XIM/,/,-D HCV-%:LJ_%V36SB 337^);K2M>56>!).57[-X M>0$8@"C=X(TW+%.)_MU3XK8S]23\Q24\#;:)3I)NN X=5D,5^\4KG(BP%:67 M-U+4QGS]O4N.%"$/>%7>7W*H?Q;/FL:KU>5%#;UZM,K_1\LB43ED5^:PWDY LYZ MJ<+&L4./V)!)$_E/K$+(U!2U4]-TP!2:C]<=/B_\8?2>HXT>V29]<# CF0"* M.AF#&.,6\[_FJK%).CH)8G[=[QN)&AJ]$(CA&] M5#>X:MY$VDWP?AC%=[JVX[]Z%I,SE_4J9AY7F-P+S4S9.,8976%,(%7FR5&0 M2F&1_F+WD+'G6[10QX0'TZ,3V-(MM;DFJ,E 0#B=Z32]BG ML,T%V"0AN$!HHOB)E3:"&JAG^$ S/]FNW8YZ^8E#@:P308A@5+YD-Q7%QK+KS!P(3(9E4JAB+^H MC#8+8!+2AB]^KED<8;W(7AO7>L+&X@BJ93 SZD&%58 Z7]RLUW[C?0HYO/DDU350D8_"1.UK9/*$ H+R>C_M8%&?>\C4WT]?!2/ M!!Q!F^R?LFMO_[]M@_]W0.8^="ZP=08IF+M%RJEWW$BA6?/)"'5_4X[SY+W+ MVMC[JV^P=Z9W2\LPVEQ5/^3D.M/X1<&%]U2?"KCO!;T#J-1@&8]=G) Y(LZT M"06[$L0^%)O5RN6\9/:#316DTBM_9'M5Z,_[[@#*-NM!)!)D/."8B M:;UZ%&NTON,K%* LN-3(9@>Y@2DW4SJO?I>XFS==$@ GB%/-:SSSSV3AY3/# MJ^N_1XYS@B!(N/N( <[P4,"A_$(03QX5&38;'T,8N$/W_U2UXDF\3U9 M:K+(-NX>FH1,RAN9=SBOK)L]VX1K@EI?U>$)\U;D:&0PN;WOXA0+?6;E01V= M4'S0*)YX^#3GRB?\<>&;%P4KKQ;J8Q*TW>!Z/BQ':)W//BZC+<@5 \/KFJ:2 M/.)>)[YMUKE+>BJ]K+0NF;%/_FGWFP4@3D71PP[*F8[;)X MAN$FK8/_%@_A)4NPJQT\"O5H/:EXN1*0<'% ?;TK\[M[<5-MIFP6N__&3N:Y MB4MSWQ.*)KFM$IW_\J3?-<(L3+!)H"S1&S:XJ6GL5$(1U"E2O\ M#J_N .F,-RK*#<]*W;^4!*7.D)Z:7^*VXQ]*,7G&)8A%*".\UFYF:6^!2^4\ M5?+304!&=1'B"3,JJ'3/M^A5IM^G)SD6PDBQ5G>4<)Q70,X6":R)'8) MY+BU^CLM.='2)KBWSG2BG+%WR+/_]'G92?@,)AO:/S*=LABGET1 \2[!3+6( M4^4-O(9P2@E/_>LN,D4#.>(^[[3BIZ:6ZBJ.JG]VS_N#CI]S&B&LG2#"1_S% MIDY$ .9ZY!;_M") C'URB)12/^767X+S#C!SS8I//*_8]G6C;V[M]D_"YQO" M\]5&QY,A!WKS=Y9BED%Z=X"H%=W_85?]!Y"T_B3;>1'"Z69&Y.Y#)54=<_K* M5<7C3!S?=CI'0#-)GE;.O35$XA>)Q3$$IZ&Z6KWY9QMW&KGV*@%'H?:ST>GB M#O#Q=[!B"802KD6Y^[M?N BNG=#Q Z/M,?_=@P+NBTSGPS*K=]P2?(I($([? MH/Y0_E#\5'A8S*&TZ7?N)R'K9^;/S&8(V!(Z:(/2/G%L\O[8OFW5X_-*N;J#Z7PL/-E^G MILB$P\C52,"00^9&P$*G*."$MWL@;UBS^(3SS%+K?,*4OY,@FU3#((TIE'Q- M,Z:OXMF]\6)J3)>9ZI,;-CQ3+4P[@JT+!D"D%SS1^MJY)_EDCK(LWV)(>>(R%Z"ZR';!8^6>+:+J^%]S7=+C1,.:P3 M&^GLGLS\U3B>5[@#W+L(SF7WG'3)<7\O'_B\^08O_Z%HI[QECXD*4>.],U$? MXKP?$#-^ YG1.P"O\AW KSIAB!(//O5@U^[QD "/#'.8X" ;J$5OO\)\ON9A MIW&4L]K6#"J?S,VS[9WR=0S#U:\?QR/Z"9)CEU+@/?LZ_&^V#+Q^^N3F_ ^RC?_Z.&[D#2.S= 8*"K]BW60N738.[A 2N M[P )5W_N '/:$^=^A)=#:)H;+/ZU@S67ZN!-5V? = MX)]BX,%2->^%3'@>3D1*99?SJ]]TZ*25V"]_? M ;PDT?_/O\GX_P,2=W/_!5!+ P04 " D=WQ4"?@'5U<( #J" #0 M &EM86=E7S P.2YJ<&>=T7DXU(T6!_#?^&&,04;*O@^&09E!MI*R1T*2L36B MA&3)KI0UDZ6Q)&-)]F48R;PILF??*96ER);(,KR-J,R-3(P "@0"7]@M@3@*G 0YV=B@[&P<4"H7!.#BY^+FY MX' N(;Z#!_C%A"7$Q81%1261*O*2TDHRHJ*H8PI*1U75U-0DY+6.:V)T5;!J MF-]'(# 8C O.)F0#B77UCX)Q'A80%!*6E9-'*2BJJ6L]QE-_0;<# P*#@D-BXZ)C8N_ET!(34O/>)CY M*(M44%A47%):5EY1^ZR.^L?S^A[]A]FYS_,+ MBTO+7U8VMVC;.W]^I^\R?KL@ CY1_ZC"['O8F%E!5FAOUT0EN#?"PA6-BE5 M=CY]*RC>[Z TYBX'_RGBDZ>M,!FL]<8A5_\1SL-(M5G9S=^TOV3_'2SJ_Y+] M$_8OUP> "X3L/P]$ 'K =P:*O&:)HX[6R$TYQ7VJ_&*CT DG6>H7S=P;*:BW MI1/!_FXEI")VD F8?:C9O)ZQ[%C8U3!!6F*LP20\PR[>"L= M&:K,1%6/QF;:>%FY(ESY(SXZEQ24/^#QTX,V@.V-MCN3\ #CXR:9N&.-+A\9AE_L!B4G MD.W>^3Q/:$X^F5NX_.,M-ZHB?MEKI*X&(\-L&VX\3XH//"1K,SIY._M [5RU MW=A8IMK!+=WW:(TH JJ2UXY[CM9\#KU\QR[ $9I0-$TVUVNXR^"<[1;R)6+^*5^4.%VTN>+EXZOC;^/07T M_!-WW_QA&KG!3EX"MX;N:1+8#7J99@!A&R;LD-:*3:VCHI9#-5_>'JS4-^2_ M$'\TV3?Q%EO$PAR,5N&(B MR#:$4J'SL>Y;+!!I$)$:; ILY;K@1&8L5.GEY M#EX].>TG@W53=^2?5 UH8%:R:WPUQ6*OZBBEFH0G[Y3B,3$&*66B/RXDB*]; M\*RW8GX][CC\^4<7=(OB3.'?Z._CH?CL]LSHY88[754>@F*3*N3G^:T,31?3 MJ0D1N<);EM_:NK8IV>M(S%1WQR:)(?*:1V9C,+]K+X3HHF766J04=I4PFO4Q M*NB%V:FS&XT\B]6X8QG"G^O)?0DMTRFX/*%:&280S'C;XQ&N6%RG/7UX67G; M_"R )S%8V ^P>O.<1ND51PQ="ZDQS\58LC0ECY0*:"OGY$<)RW[9)GLJ6Z(Q MF=B$, **/'1TJ=%G5E?FMBEP'11O).SVAIJZ0BCYMV5>N$"G +\7=RBY*NZ( MITND4>@5$8/W1L$MKA:H)IBH?JB.R2\OC;D@WW;-DE)>*7GBY&:55G*6J[;! M3%U6GGN0[F(3:<.@,Y+CG:K@A^Q(Q5W_X9QR2M$)@4'WC1A/4UDDWKY_OOI; M=5"ZE>$5_YS(CC;C:!4.B8[FV(A)[6<-O.0IVET2X_(<4BX2ZB0II).60N>E M*--=.)LJ*\C$2HCP1OOQH=V?GG.K29?61/+T,)ANH[>#M[A/H-S3.!]T#S3D MG[*X!9GCUI[YL#=YCM= 6BLN\L$E,*F4MA=X(M:+N^EQ8&4?2UEZ%C^K$((" M3UFBOS5K?%48K_)P:BS7GR8N3#SCO?*L8S.MFZ<>:3?\$281&?,Q+TUBP=EJ M4WSA"-4+_BB]HDZP]6LKQ8YN"C>,_OKZNK)KEKK87/#XONL2/J05 MI#MOB_?RW-*B*-#Q*6L#5K?P-DP@Q8Y,?[9G>/\;]D?S5V>%3P/.Q^'G&QKR M8.Z$\UOQ&5$!.=M5TI3#UG3[9>G%(5RVS6C)R0%PU\8HO!K"GEN^PFNO7I(" M@_L%BJP"5_MLQ?R N708O>L9E\CW-'XZ&7TFSV!-7$^0^>*)?5Y M[57B]*0]_&8&GFJ=72(3X+9$#5MO!YD ?Z?>Y%[Z_*O1^2KPCP("6N8@V)FR M0#?[56/9,_G51:.8UC9XR+3/+2=E!;TR>3^DNFH^*N2M29$UF:PIW=A^D:YZ M+0#;5^)IZ2VXU)MQ#$+?J8Q)G2JCCF^5!6JDGHR63;%HB=3.H HI%VXU1=IJ MV3!H3F[-;%3ZT+=U)7?QAD>1JC;Z&UY./K*-3Q/#XB[_0I_UR%8PF'6Q"K_C MJF@BWW"3XD>W?TPW1GZZV^@?OGF18==:Z8&T5^\_W? %!+ P04 " D M=WQ4]M/QX9-- #W3@ #0 &EM86=E7S Q,"YJ<&>L]V50'$S0QXLNNKB[ M:W""NP99W-W=(;@3+$#8+.[N[NX)[N[! BQ. C00C#M,)!T,#@,6&@<.&^1@$ M4 ( , @P_VN _]-@8.'@$1"!2,@HJ/\%M& !8&'@X&#AX1 0X.'_\P;]YP? M8R/@4'-*(N*JFP-IW/"X0A,*D&B_-/3A:\Q=TG%;N(GG[^/KYAW^/B(SZ M$0U.3$I.24U+S\@L+"HN*2TKKZAL;&IN:6UK[^CL'Q@<&AX9'1N?7UA<6EY9 M_;.VLPO=VS\X/#H^N;J^N;V[?WA\>OX?+A@ ',S_9?\?N;#_XX*%AX>#!_X/ M%PRLS_\$8,,C4',BXDBJ \W=<&FX0I'POB04-/0ATW)K7.);N,^A$-#Q[-!? M_0_:_Y+]OP,+^_^)[/\&^W^XU@!H<##_%0\.&R .>'AF+ Q!^=]]Q.7(=:$O M=T->&%3HDDW&^)QWF8\NQ))HL[*?4<*_*Y)+*TT*.N!6"JC# R61#U7GALD% M#^!'M2UOU)U_ ,* YC)N T97TJ:GK*S6'P#/Q@^ I@H%ZU+1&L.LQQN4[ ,P MBJU]5K3\ ?" JROLD+GJK'L-M%NYNGFEU@OFU*R+Y8$D4'7]^ "TN8P\V>2U MEFVP>R;KT/C^EG0'WD/LY&:FJW]/:I>WG-$$^OGG%-GFWZ2].B3OWIO9S:F# M/."+.*=(X[3-' SR4?YOHO]_[>K3,X?Y8748F]3]2!VDR,/G/,ESNY;>N>K3 M&@LD.HY^]$%H)6@N>$L4>%/]$/ &$K $L77OEX.*>*I]Q;00)CC M)+7-BWF'I@[Y-9RE/@"L21&O00Y:T;1&S"%,;^6"(^1VC B\.2"$D-*SM)?^ M2%D& 4T)]-7BRP] S>=440]EQE[P[0Y(]@ ME #67+UAR7.FC(3@;DRH3!(VZK'.]#='O9D=;?K+\SPFX7_SS:G>PX)TSUHSI !^ ";GDP]N: M 6:NMS7P+D(B!_[X8;Q$R9UGJW-@_^BXLN60&UR'D\WMI%7PIPK=(:%_M@^= M(ACBJ\EQ1PYK4G2VL-#]6Q:)V#-5KD'9@%J!HM4I9_Y'!/ 'X#)K8UA+-7\# M\X)H#TB9CD_C>S]I.[W@133SYJ'SKBQEN"$"^=O%4!BRA-W6Q=92,RS>$V^W M5]V:^/)[&SPT^NJ7WT%]T!X%]VY@*'Z+6#.T^P' G&ASJ7$JZ00Z1UT+#%FS MA8V]MVZ"7N&U"(7(T+CBAV*?#$Q_&>=M$=BJ$S253',3E-B]_=)/_@ 8M"?2 MY;DM_8KB/;@^:H7?5;1[NOO"5#:@(T]PIQV35;J\G@#BM>X6QVH2Y0+?T,^7 MM5F_B!7Y44R'NAC"74XIDYZZL(";5T'=3[KR;5QS=ZF+BST0K M(/Y4QTR8U\.#7@^)G&PQA]MQZD_%=D2GB2=I/ _ZE_Y2PE@&[Z8-&;R:GC;K M4>96L'R^0:S^'&.CS<87[9H?["[S]1 R] $P=:WU:M;E^,7?"!-X2GH4 M??I2O_H:HTH)N;6EY&D"S5SU?@!FM9EO<^=-?<\]\724OC',T5D@EL#&<]^T MSAR".PC*S#DT\>^:SH];M07?'&7H[LW=E_# )U#FOJB&*3:._S>OABM0BO7* M_@KIDR\D#;NHT=4[:138MERUMJZ_5J%'*STV)KKZG+28F3<8_D[_(XB=YK\C M15ATUW1#;DO!BHI96?&W-&FQPQW*!J_']^B>7 H4&969NN"BWPGF](F:ZRT, M=#GI?$D-ZU"P1,O/^XZTHDS7W^E>#E48PR/P;NK)60P8O[^P"/(RX8HS#LEU M%E#Z,:(2:BEA3C7'.3C*,^?=(40UE"-6$)\4:_TL[_<_O,Z7+I1=TR\TC]WT MD&M#FFISA/M+$^H'%XQ5AKSMXL,&X)E!=-7#+"_#1>ZE]SM"%VAFY5"(MR<1 M**;DJLB'QY:)!8RT,/R!_A.G5=S[HNO2US9?^,*(YIT(=.+<3<=PM*;:2=?X MZ1;>\1.C-S89B=2B/%,R=$5PBB%)P#1U^_"M!#&$]H41#E!!J6#>EH$YKE7+ M"V,13%O@E4#*AVI[8( MP%%=(!;?/"."9<3/9^$I!5C:Z]''1*Z4N3B<7*!_\5E4$CFT,XJSTA3HWYU6/FU?DOF5G<<.D-_?5/O@VXV.\Z7]'E+_!8:+%\32:M0#UBX43% M)#R7J1P.:79R([@"[RT-F"F18W_"8\GF"5=?/!A'7B3FGVO8P7_YW\VMK'\J M>Z.7LCFX""$3\05S./@>7C';\B>,S6CBY.V#.^G)$./K;^T^ /W)"1 X)& ; M"VBI2_YM9UR'I.R')9H!B[XH,'7@B43U4=[+M^'@6%W@HE&6DX M)3'%AWIZ3([V?(],XQZ?8(ER(VQ(^NIG&($SS;Z*'^-)[S??BA%(\Z5<*FK[ MU2F!QQ.N!E+&BF_\V:TGWA@.#T!US\4EP\@FSE;?F?XAN \_>F'(7QC*CY9! M_+1K_L8\Z?^>1 WCA<3ECQA(N=PHDB4/>NZR_0!X5=25K/$15S>J:I0)%"ZM MV#[$3AY!>UJRQ+0G/\=V60'Q!02)\4?XHLK$/Q'CBE4ID_#6BW=V^?%U!H+IA0\]?K(H%J-=M%S_-<\ /5A/>'.@$ ,_UO9HHI(KXT_4 M_;1";_@G>^T*3)<-5FCXNNM!/R[#E^6&TS"23JX/ZC@4+[$GLT:VGP1*RM#4 M6Z,58_EC*QI3F3_63/ISU7\ \M*#;SGUG#X />87AB8<5+[^LJ($=JKOT@;] M'M'H/$;>C*?0R=G:Y'NE%82=X]&E@I-OYB91Y9\S2C>81CCS]DWTB^4LEVF) M>S$$JSG9EVUXQ>C\%^2)TA-5M@5O*^#@YLM-#10]&YHU4GJ/5Y>RK*TBU/]Z M,/;QS@4I/^,>I/'T^YOMIM^P.DSN(9C(3W'06U26I&]CR/.F^-2MK7/HW7 . M?Y/2>\YM_^HC W<67@K2J?4Z8"1B3OF'7,?U2_1O:MJ6)7/KZBT;MWJ<>O0F M)M7U[\TJ>5H!<18F("6ONQ@B Z%1TLS676U'TZI-%\=-\G$9V\3WCB)O\4DJ MZ*><@XFX5%E\>#E:"(!S W*09YBLPGYH^F1G+UL@E(L!\J^[*P(#.GD%W9%' MYBOR\ J-I@B3I^>@^R:E6=K?^H#K$5N3\A K"B;>5?S.+/NJ,+U_,_GD,OK& M&C2([N@6Z 4_ &_V]J'=GW?$1YX6AA:5D'#0,@\K!>@2BN.Y=F#Z,Q$L*W"& M06IVJ 0"*-S_6'*XN&YY_.KB?2B$U( 2LWW4&^K(=T.\-;36O;:J#T3@(<,. M+3-!V&(2"/2Q',Y^=Y-B*2$Y-$2R?)G8[7JC 5JAOMR8IIWN!7A#D./5/0\+ MX4'3;#2?5/HSP]*+-RP?36'=S;8>>?RLK5[%:*9 DN E9TK=%"Z!RV-7"6B= MEAS58"*0CLAZT P;$0F3*%9\<7HMQC1(.W/-QJ8:^68'D^OD1SN3@*D"4BW# MX["F)SG# ,$LVE0C[[K$,K+@A>PQ30%TKR<(UJC,9 4O[H8$"[C(QE#V[ICO M/B=@4[K)RF(@\$B2[*%!<@=G$;ZR,A+%[L"<8]C/LW+MVF(4BDWF.-A&3"0V M=1ZV.;B/4+DJ%=<]R.6C*.(%CI#5I]ZRQ.VK)B%;-\H1)XKA@!?M%N1 B/7LX'"*J)72IR-M=[Q\E06W'EUB&785()\ MU]0"T\-EY/7UEG3YV! *63O81D$E.&IRF*?1=\^?/-.^FRO$9M68UQ6OO;(R MLU0? #\92FY\8?.$8%H)?'HLD1\+Z_UG"P>0\/!C'8U^V"R(#8/3'EU4W$UF MKD#4^&26'IH9/T K'P'/"*7B*QWW5_T#SW.(Y.&I6C%_0?K3#Y"((N7*[)LX ME'2[=8%#%Q*3DKI<]$"(G##!*2B()NTT& M*3/;<^1IJW:?V-_R*L9=CW$9&N?I?<&Q9\VYLW-"?Z)B\A]]Y;^;SB;#5!EI MP[.'Y68:[B@68@CKP M!\ #&BF"O/@!&(P].X4'PQK3^H$SR;@+H8;:T3M..4QQ;[SBHSJ;.JAO6Q3? M)[S-?!=M^].^S6#_)V6J]%@EXT/<00;K5PM.E\XO_D0S_]-=H&'"L2W+>9(C M%BPU4XX<<%0%==2-R:!JFMQYM!KJ\43,= !N5$U' U/51->N M&*IXA5GMMN13 .S<@18.\MY\LML^O &21.03##MRWV'N*8 +%'.'V!;"8C^ M=Q:5M_?V)0STJD*&&OY6X)6Q'BT&S0ZKPS)[[ZX":,)4RLL5C30!$ZJR@<"! M=@BVJ ?:7.JAY1FHN4Z-'J0/#88[F3VWNLDA,R$]5#X0XDB*2$VPX69S8^Y4 M"<(':,*(=FHDQT)4/Y5.P8:TPXP(\!3G M+F8<9&ZGF)&Z@$P5 -^NN\_%)&H\@71.%>6D_8!OU0XL]40DG]E MP4>37E40:K4#S-Z]5%VI*(9#9& _\S4(L7LCBBU]OI\S06MUQ*TLQ0*^.Q[>X.>"@99JPGQSE)'>H_/\N&@I.->_\.%^NR M#M0*%L.'MC&(-5=S5^%(^'-ESQ.$N@[6 >-JW%7TL2PLLN\J9!9_<%7+/<^9 M"6UQCBA@TA+7*KZ8>+F'C,H1'^O0+K&K!4YELB)>) F]K4/B[I,U39B*GZSD M]DP#P>/OJ^GLWN$:(]5B,%Y#!*BI[^.T\8T#-'M[R?$WDO%[X709#*%T?GBK M=S^R<60Y%Y=*>B(E)? +FQ6+-UE=.[$'J)CE:V BMKW/E'!'9CGPR1IW0BD5 M4L<5=L?WHXQTG*=WK)F;7)R+DW1*XYEQ5/%U]CX A1/OQ]6'U?IV"Y<5TS^B MWEK?O5KTM@B-.]$87B9'/@ 4O$WZYOCE4G-$$]X>IEA8OT-YS81^A']3PKRM M594WK*,3N4'&3\;O'4;PSN4!/'+K LO^9+9O?M(.$A/Q)JH1K-$'=5I&>[O+ M-.>=9UYV6-%J.\'D<7P A!X$,<]-*2*[V9UR'#1 KZVTE#%$,0GX0A1-!6N; MA2">1,289/(>1V_[P!)V5VQ9OAP-OBO8T\S>B7Z7_RR$2D M*ICXOW<,J4P,"\7_:!K=0H:^F2 +X&_9\_VU7K"(@T _=7'@=9R4WAMD:H#= M._)59/C); 7*0Q-R4I(1_DE6"*Z'FIP?RE7C,8T^Y-=KL\H!/)) !DX)U0U$ M&]9R?0_Y0):J$.W09W5(SI]#(GR%^3XV%PH9[W4(P@R^^'I-]PY1^X^V!Q^/ M3(///R6L3N3)FS;4O&.Y8+XNQQ3HU8^(VKF +@7VF9D10X1,P?V'LH7"U?% MUALE'I#81KT-UAF!R@&]\G>KFI/HKH8;+J1RIE45\@1+J8[EY.#H0IB9 MS'&Y^!Z,HP3(C_>B6,,3A2F2 5V=AV66CEP-,@IJW0* "2'69&6.3H;^X;478"CC69 MZZ&P)U^D:M5V=H@ <2S2=];F+?D-&1?NFD$8S$0 M5= F&%FK^ T!!,VEE=M'Q5J81_',O,_4!05'7RL@KL6W/)$RH@L_?WJSRQYS M@H_('XU6J .]445P5*Z7EF3[=K\$P53O=Q1[$WO^;;?P+36FO)4/WN Q\8!S M]8^-VLKP^]Z8E;?#F_U.H-ZU4Q"'N?82*?YX5>,P>?GP&L+Z =AX+VT^<3U9 M+.Q.VS-GFU0E# FDK();^#?S6C7C&=Z2@T= !4&[Q3_*9=5XQUG2\N+[SS'5 M_"02(\WT3C]D:6+4]\WL&#G?+1B;*-+R;6/ M4*1T!;O?4U!&BH2R,*J)HQS@62%<;'5O]-<-J#;25,U1CY?$'HBH;7ID)H?D M?_:/OJ]G7MHO\Q#6"\J7KSN#3G]SRKRE,]^/Z>$T D7MW'A9.W=3U6[<#P7H M6SD3RZV!'UQH?JD&CV=SYW;[:U!D:^K72QR?!+$L&&0FVBY7F)YXKP6*60]L MWTLN+JO4[?I6_Y2TCZX5POWCF)BYZUBA/#29M7%[7\LJR\6SPLIKP\O"^,_N MQ.#NH/!1'@W;6UJ +B#S,/-R*!C>%6WIXJ!GDQ,-F,>.]\[._++N*IRI M*D&9B1*^J&%+;H_J?(0\=B81Y0KB@7"U:\;YV[WL'8IM)7-C80#RX29A^+%D MA:XD$GP0R.6FF1!W>[,M\;HD!,GM8#CX$XMMBS0**]$8 >I==. OPNZ<4P 6 M'%G".O_IYD2_K^<2\ R- M0F_< ^87%$-/[#V4O@BY *SNIJC5L&+#U\)ZO4H3AY[)+&L O"@ V$3OJRE1 MY/71@S"A /5A_UG85,!NYL@RQ+PIZ;:TZ_N7P1# V!0G4>ZGSDQT/NU6A'V[ M#:@ C-M8K>.7JT"AK]\?5,;GUW_U$3MQPQUKFCY&0HT6]Q9X&,/EQC4,HXBU M% Z[Z:V_.NZ.-;_),A[:;(2,=L!$E97X:QW3RP\K:ML>F.T]):F.;GT (O*< MCE^ZD-N"FWM1VFRA-6)&Q.=*5O?7,Y0Q[N^?&UK:KJ3Y[B]9W3B,Q\.)QVJ[ MWK%Z4!QE,@H382![OSB?EE1R"3A^VK\,#FN3>A\9J^+:/1#]J:+)^R:>8]J2 M2UJ092PA)_Z':H7J'7EVGTZRTG+VJZ;1->VC[5#]@+/'0>D=?/@BQ7")^;&6 MLD;2[TS*YL3'A&.?5G](&M^\C$\CXSH7K-AEC2^X,DSXO1G\1RW(SEJ'[/Z@ M^^#<$R>5:$HG498N= &OB9N'84)08+>JBO,G>[M#0H*#WP= AN)GWG*GHX9R M<_ Y^("73]P^-,#/HM/0Z*?OTSO)5";U"J"9%0_']RCHI+4HU)K%9U5&U57N M^_;VGL?CDK%ZZ,*!V%**KH/[;7""K6X!^R9B;_ "O'B)G;8H/9H_;R)%%2SF MJZ?V>*7#K.+8-Y#PQLQ*TN3E>WYNZW7PT:?NDB5H"EW?1C')78P55.JW^.T% MPWN8X_0G"76Y$RU=1%'AH=H(&6.N5R4*JH'?O,-&1_V'(U<;\D2]YI,2^5EB,FI@5M,0N'HWVOB;I6APB\]W,*X'(%#91- MW3")ICMNS#*SV3L7J*0[M5Q^R,^P>/"8,^P"[\)PK-[6<:IB/8WHK]Z$QB&+ M\ 677^0S,I^M7'()B(OAF\3@R08J4 MNJD= !2L!9FN;&Y65^)-'N)\2J7'/? M8 MX>,G_+HY<&!M4&1 '8J/&UOVVT.-)P)O+W K1>0[6NNWL$K\C;TD$R>OI6RE M&IXL2[;8 ^3T.U-UC_V)H'A#TVO(\=&UCG1/4MG-??[BM:_4D[XYJ4M.(=+ M",23X"UZ1/ $2Z963P8&SG CB8Y#U7L6.0LLH "K1>XM*1CD=A?:B MMMC,7 M]A*<#9I!L#R2(/Q+YIV6?U/I?JI?&:31!1)@F8DS!\L2+S*=]6.,^'FQ24Y, M6SW%)%]S>XPXN%?;2,8M(JR--V?, L+F"7BI,).6*XR,**[BD1N M-(DM*^=E!I$I#>'!'C*03QFEI&/Z7"_^FM_*]]#ZM9CKAW5VB/ SD3,SSRK/ MS@:G=;-]/1;8@XDSFIZ"/_.-66^.1CXI3)*A%$'T)V8GMQH97 -1Z=RPD%;6 MM2AF#R?* +.KJZJ_S":D'I!;)%AZ(5PO(Q:"_L>!>'B[>^]% R#K-\5$I0;3 MGSBR4 /3]T^&W8'LS ;!\"NE@IEB?("5NO*H!AZ*/$J$< <>X( *0X5) +;R MPOZ7[W4O&9X(9HVB:YBCMX:>53!R7S$!#DMRMJ!I9QDQ;]_CQ- G6Q+95*5$ MN3[RI,?H=VSCEI+"M?4? ]P,ING+!K[^@X^1HFIT#E?#7X:+ /P/50ZX$$J> MU!Y1N>ROA:O!D3R,M^A,- +\.($+XE7^00AN%"Q N:MLGQ](:!-4XM,]4F'( M%WK^%Y%G+??1A[8Q1?"PWVU:!W35*O=%<\YE] 1E1W=;CE-OAN]KLZN(?KPZ M.N[R[L4?+[>.[NO(TH>(NFF MG^8+VYWO,\FK,'6M*25DR,87/E$GK=\ )J" ME?*:\ AS$EG-R$V0#$_?3O-U;Q1!^]S2"]UV*(*-=8=FWO#6%CXB. MQ@K"54]SRWP;^.[N 3:=4O9!CM;.Y$4Q5[+X:4T4XL]W14ZV?& 7U\8/ ($0 M2G^I4'-M78%;$8*-/G =-IF"PZ]\;'3;)CEIK5TY"C<6J%#CQI\*')=C(/.N M(,(0I,4G2W3RLIA)!A MK=&FRJU-X%J.(0QT4RDT"/W'175[>%/5V):!$\]%%'>HGWGJW)04BW+WZH@& MNBPYFA"%4_T Q#O7O;FI[C%/@5Q@UZ6!$B&8X\4UA=4)DQK+B)Z*5Q\ E?_M M4_N-LTS 0O!MCK*//?_/4[BX5\^5#"FJ $_BF7&6*-+9Y=Q)Z^P2%_T ?E[3 MH:3T9ANXQW04L#R$D#KDV*BVJ7:FRCB]-;E-*J2LH[Q(]RU7+0C-06'.NDOK M/[D/L10D+N.@'@/&*01U1L0(OI/(>ZR([';K7- *&] YK@B6)DZ[G;@R@;.0 MZ*.KA )EH>J1XH$)!O2UW]?.1YS-,9,L\8+XRDL=/'X&$)MZDWXE6_IN@:1< M%KK<( *B,L>#(XW[]"NQ^KTNZK>U9:D!;:;%#*WY3QABO1?:T!P2 H,OEL5(GI3&5*BB*SC4]#-7LN*:B9*0B&%$X M*U&>NBYB',GX0_*.EXJW9&"?=UZ+!9.H[!U:>[[ZCT+)Z@WZ\/MY<8I!LGF! MZK_I^?$I^\[28)"\S 7FS.2<(JXA(O9(*D6OQ-$:#:=UC^T3EW''E/&3X5:R M:PK^[K."\O(L5WA)8N>*MV9_]D^$H3 M<5$J9'ASE6?9TTSG73ELTXR4&[! JX9=@YE/G+M]=EY6VWAGDE5MM\.U%W9, MPE+GOUP(-XG]=^F)@64]?G'@5TZ/G1[EW=4+FQ&.21"\/^ZIT9*][-8@BA5IZ]AQ_$B^KUD'=&T%#,N- [LT9?_H-E<\M"=7 M.&<7^*TS7&6%GQ=Q;CR,;=GJ)5->>RF'H73TN&''CK[U(B%PM:L+H0?82 27"E('#&PXHFHM[FR<=K M3?BVNDY8*TP6+##1F#\]BW3V^+R\&,\UG-#;SP-,B"TLH:.>EI^1-/@26#EE M%$7ZSP)4<8+9Q%>PE >_76X2;##+?\#O>M4*T\OKC+&3T_6M><7N_73;-@33 M/S,N:V<6QZZ:%^GA\_FZVVEHME:%#QFD/3# LH;W7G:TD+SW*H6#]NN -8Z$#1"KA5M3]5)16LC^;8I/)0[ M:D.,XP!D:!Y;R1PP/Z9X.,:(#^);!6";B5SHF^+2\'%#YJFFD6GQS@9CTTOS M-SVPQ+?P0L#0@R4R?P'\N5'QN557Q"WY6N>.9=*%J=I<"3165&>B$Q:&AF8? MFBP:HA$3+;)EDVX?PT:W,=@6>J"3N215_;2JI-X:E%/+R,L3\,X[$_V.!S[R M#W1LY3650! "L^0?L/S] (P*G;ZW_[[FA:ZQS>384CZ$H=RSS&61AI[B!C-? MKA(=/YP2B[,PTG3_ZQ.6E9%9USBH25D[[9OA'3:-8W]7ZT&>.33^5OVR@]$- MWO.2O!EA\"9;H4=V@&X,MVFYK%-N5,Q<@IW*$KE#(0M.\HG+8FZ]%382[CWR M=8+'U#46VCKLW=Z\#3OM2IG?$SE>PL%CS.H@AZ- O@CUO\ #$9)__:#<9MWT M_!YHX33P4X>S@J98&359Q).,)S\[K4Y\PXXJ1;9W4+(_=;1<]$86C^\A6XRM;*5)*K951E^?HF3&(?7-8W.#9"!V?)/!- M3R,B98S[0@&3EQ0S7?.T?=$++K9[07Y8L#H.ZV2LQ"Z-W\E/1OA;3X4@'4-A MQ^$[8RYTB$*D99Y-=[*M-9X8: ;S%%VG&4GD;*Z7'T,3XXL2 F.B>KF\;'CF M?F&8J;N!+"',*>IA4CZ3,$:,/\5\PI:@;&S:(8P-/A!QBI??^;G?KCR*2TL> M9VF0]-=) ![WB"7BOZ_F1\B"; ;R7S=7">;N>%&66.T4O_*!DI]9S<:3IA$- MA,M?C5RKD(B?,^^8J-OGIR))N[>QD)ME7*K+K5;I_K2+4O7I-<$!W+E[MN9::_ >6H^AA^:N: MR2S=0><3T2BX[9T?M+'LDE2M?VK@;F(H8#?Z%'H2U2YVEU7Y^%=Z/B55,251 M_17[9@JPEUHF+6$FVG/LL=9^<+5!\(QGD++?]&7^]_G.Y@V7]U>'DYH#Q2R[ M TA.(Z.UV*!&.],G%5*&&I9VO;%W+YQ??^,3NNH6M8- FBT+K&L'YS)RBSX7 M2E^_Z*67[CLE"D/C:E2[R5DCS?0_63:_@_LC Y6.G@A@NS)YUS39J.5? M6,E)2YCHN7>D.&2--^MXJQ-FYQ+=5^&9KB>^9+,<.NYR@9:MC$1PL&"',"[Y ML4_I4=Y3G[A7+DLK*U-IQ3G'#D)&R&9A&T1CR"CDB/$V#AI%I"K)&63;N_6V MOH0#&*EZ :Z:GW6Y2N2OEH;+H%:W.1)"LY0&CJ&2= M9DC^%1BQC;H1H466=;]-:1#W[MA8] _LL@KW,$OZ E*0I-[MAK)GFE)@ MHI2EP,BA/K?>.2[9&.#VZ[&^T!SL[L);57K?!^!7A.-$GA@6)R3[73NZ/"5- M;\'R_>Y6(?BBI380='EV_%30$Z=5^%_'.:1M)VY-]B]XU][9HHF:(%BHLP:L M=(QRX\99FO#7&%:OR5X]I$A6NV$=EM"AF[".=608#/*YK<*_OJP,N4M'@>MU,V!#LT\A/;MH;R6:4G!Y(I;>:C8.I!GB74: MO$S]HSUFHK/A!-/-.&9S_DM)ID01\=YNM\;"@-BGL%.^>T)L.0S^\-"G%75@ MF%?/EW/L*H>:R)<)8CKHJ9% IN>^^*[!&[]5OV9+M=W?QPZ1O_7''+QWK]GH M1=2.4OWO2-?LLG6U"6+%4SV6TSJ?KWCGCL4H%CQ9@MF'-RV=S(M/INYX2SON MZE1BD.; WT$3/G[H[A+XQ]1^:K+G.6:\AA^ MF8:YZOZ>]<(AG/!9Z(6NU X;NRBEJF/@@='^.F6 R-Y[BU1_+I%=]?R+UN#* M"D#8A6Q8^'.+UP2LK*0:D$ALM[5_MD(^8$;YV\-BS9TM>Z!X<+F)ZGTT[<+M MH;MR3QDF?Q>_TXLN3J;SK]]7,*S.;,O"I-PWY:8[FG]/')>\'.L:[ E] "F< M@Y-(Q'U#KF* ]C!T?ITK]-L_J?(*710"9._%RV?8=+4)(X]#:]"A%8X"8>E0 M;(]>,@R6=5J;QOH(I8!4@44<3"64RRK[X2*H ,-ZAW6W#@"RYU+WS9,]PL?Y M@6QND^P7RW)P,#RPD7FN1K]OR]>HL(6;1=WI)CH]BCZ.@)0M03I\%31$#SZV0KA M'F^0N&/!T3=$?2_]4@]!C:(#*/$TGJY^F0.V0ZASN&2 M2H?:KX6I:&C%[)S-%-FZ3;XVGYM\/51#PJ][.Q@V;#(WTH5;4X?[MS&*W^QL MJ#0QT?_B_ZQ]+!R0BOX^'RXVK\,Y]AK$E+IFT.0DX/(F-'^XW/X;YN_&UA_3 M$]VD"L/HZW!O;RA$UV3R#[2LAF4#M[/]>O5":6;JW+ZXG J'*X#BUF=:L)1S M^WF!#GL< BE(OI0\5C,U?HN=EQ_D4E)S3:C5_Q56CS 3[47JD[J%Z@CPD\YC M/3R-18!UZA1AR_\9T4ZBW3E>1G5V<7MLB(*OBP(@YV"9#N3?-?[V,.18\G=' M&\ZO7!<(OE434HL@#)+$UZ66@$VCI3O(5-G8"P'Z[_/FD=L_*PUO8:UHQNW$ M99,$H#>W">WZ[F:"1&[KF.)&*.B6>'G;ZENUO060=,M6>(_O2]TDQ5<+ZA!%NY$G_W63 M9-&,[]*14D78DHRBI=3H^[0KB]#LP^K"[,(\33L_K-R7> P,QY*.="F7>8+A MN>=EF[ P4?')$[V#_*7SP/6("$RXU#J%Y&5*Y*FE'%2YY*4Q'V]RORGC)N$D M#S1_;0)F";@6/;!4G 2"K[>[Y<\&WL7?['T/T;WX18XH0\YDXH,;F25EO2NX M?G4/NB6.TJB3AHV7+//]JOO;7Z']6Y%QH]X,S2+7-+/ M[1AN1IIU[@E,7GTFOM4%]Q6\[9/L@R(V?@3_8R5VS'NHLZ2">H")YP*S/X? !,,O,AATFFBHNC>[R; M5/I_@RIH;2)M)RIK7?T/DA3G;D^%4Q>],]AM1.0.!>XI4OXT5E>TA%#=(3:5 MS>TFQW0HN7/.ZJ:!)TY4E.?\Q3F'QS9C6Q*U(I*34NFH3^.4ED9%EB((=#:V M P=]>#/KMPQH+P9_8&B%CU+!-KWK5SJF*?_2>ILJ!EBOYDD^ZYH6'O/K^IBND^R9;?(_ M_\"D0?@ [%;\(K_4R2I@3$AQ^>K1/D6U1WD/4J0 M1@K0B7+9]AL5?_,_"Z2L&RKW=5C3/X0HXC@EX\[&?@!2%'=_HPWL!B!\;X_T M7>><:!.X ZYU&(OON$4:;3E4SQX>R.FZ[!PI8P84&"@H%_FH7REU0F+*'MW% M6XQN_9Y!6'>?&@+5BV1*?(5VU6F--J=';=N_*5)^E31>SK.T+3- #2#28$R" M,%YY5W(9DHOGP&4V&P\]NM$WFY!ZIX^0A?E8V[@4 MP7VJ/?BM(T PH5)#3;*3 E8Q4F*LYPHNVHM\JHS/,$11$8+3:7R'0F>[RDE_9Z+ MM"]UW1F&[NOS\Q9JOSM1968N_<%3_.*'>&-E+4-\2X4U<0F0A M&J6I:J-$J@LJ>FO]>P:+*0I?XH,P0Q?$[+T9EP;_LB):^&BQ+IM2RS_AY3V MZ)?%0'YUQ.(Y"4MP G33BE'!!>$$]T\OD:=16XKDRAU#= /:#\.SO6LQ^[ 5 MO6H=28I"YN2I8RA]1"C2:_?J8_33(3 K:Q&+Z?]<_V*]@NASNKT)//!RI5YZ M>R2JWHEF=^:;?8UWHNL^&=_(4S\U^@,^KO,P^35' MFX)1D.P.+&%;+:@ZL%8DU8Z4IT1")?_+>'R6^^7T[]B[:]_OPZEWM3YTXEQ+V@&6$G?YXEI']%MT3 M=\5=4NO^;[Q>ZWO##B7U_;7^2ZW#"^H:8E<,FM8>Y+E@#$E7H8!E[E$]0A?C M6(>67SL8QM'DKO8OUQ[K+3+V'244/S;'GW&8G!#^^6?^MG=YX H1@/C!#$7U?HMF=@Z*C@J15V=^@2[*.Z44<$T@>31*>GBE:%_:*>@NBD-YEE MJ\6$2-Z53\ L>BBS2LZ4N(\KAU$,)*JZ)"[0FJQP2JN&Z3K3AY#& MR.6/F"V)E?]@'!-::OHP1JA@N1\NMZ;]I[1''"876.E#A%7^T+VVE([$"JW, MF;EN#1,F+L5O#AJO"E]EWY=A,/.[5R)#,[\Y-@-P!"\4Z'H%S]1'MPRXKUVY M0Y5T0RPM8TYZJ4"' 2)"9!6BC=M#7-V[:.Q["[PW7A,T4!J_*VFD#SY;([ SB/5[')/Y)BN;R1VJ/UI:=6R]Z"6T3;NR3 M_C#_R=N_Q1%_(N]LQ<7&F'.W%GFR$[ND3*/4U S^*@$N]2W^T>U( Q>F M+P_X)DB3$[(\Q9/KZL@%-6IMZXI=9&U4F$__(3.J ;!,NJ7)*SE).-'I>Z!* M2E17I;(*L8/] #!7^^=V+^G&3:=-V17B@-YK,MQ!=3QCO'H$]C32J9J$SP,D M!*AG=U7"8[3AS;>[/V$4A$^CSTMCS/_@F86=8TX&5>[1=W_? @0PT8K_)AV MFZE3L'+Q?MT$P=^+*^"0PJ%W33)<%]E+]";9T6'6",DBDW)22Y [\$$R0C>^ ME+^D;[\LQ G"6V$OX WR$0<>P6%(XJOJ!]/*=OONZQE)#PI[DFDO"0 A%H7M M+>#K3Y&[/(E (RZ.4PENVKY[-_U'AY6)!"NNH6Q_W5J-1 )A+F\%S9,Q3O>%62 4U]3$L?TZ'KRB[$+)["11SDDR)V+ MI7,E4)JG&.M+H>/8-[U"S435BEJM5^%%\3;KCCAU.;:)5%T)GY BTYEVH'[ M3D6Y?C]V]I+I8QLX7[B%6:V3:+!W@ZUD?9IJFVUG\D2 ^Y;5N1#<\:-..UI- MXA_XO?.SVV(P?BQ'!]NY/<&7&R&B/U]N+01XYALL,M12M;W8BTK]M3C8]MRV M,JQUH^,M(5@>"L[0Z+T$&-VD, ^-ZTRGTT1W+:L\_PPG+9_/1^36H\ R_"H6 MCESZTP$R'=.HQ;.$:7Y;,G_MI:ZP@$GIE^[Z[80%6F+\+-[80<"_^ :G;4[: M^DH*(N^D7>NT_);DO-'@&(,H!&MH3EFB0UTXRN_!25MA5JN1@["&JJL^OW>( MMACN\E$A>*.799)F6T!4.E;\"FJ29V+7B_HS7P@U&O@NXE#4H5@Q[J@@MG6X MJ,OMR:^$IZM:$W<[++8TY?Q9T.'&ZG? )P_57:N$6@YFBX[^YSD2:)(!7V; MAL5_ HZ%F$T>8FCM6YCH?0TU"MUJ=6HVSA?9>-%^";!SQ@81WU44MVM!>9(@ M@7\62.P=1F(2/BT1#4FR@LL\LJ'YE6DDX/+^N^HG=NOD??=@E&B5Y^3]U1;1 M=<+[$L.8"7!Q@]'H*C8GQ9T%N=AE]G= 0.;00O;F/[H_UI]0W.8S'VC=4#6" M;8P:3@KSWE+X_8"_\141]-]2M?^ 9O825I8SZ%8?Q%**>608/K-0EAC\5 FC MT$8,4G9&ZZSRKT+5I$!EJC5D1U/_5F/HO=PP0*1E7/5ZHBU1E*LLD!3+LCBP MPS2[Y-!KW(N&$BMC,[S,+#F#5ZG"9>^18,RV =?"@S4I=SJ?EK.UB&83C[J> M),>7,EI:09<-P5C\70(0:KS#Q+3WC_XL6OGT_7!2-:7I#K\DDW.[?-G+[?GIV4Y#\09UGT8'@/\;Z1#G^ MD'55 Z7 P0^ @:,T!"7[L,Y #>/M4 M2E;&;@N4HL#K-G!W"XK2;:0>'^H(BMW=CV;7)Q-7$7:;Q>!BGA-)@72I: MLC;6H>2V3H<:VP&?&)SB0&+):,:]NJ?9#LDBLEY@Z/B^/L$UQ:W0R 2D>GZV M:"AK7TST*]&S:;.GMD:!PR*K1QV#AL[@KX3UFG>^J,G*(L$'S )96$X4RWD[ MDJ;T4.#UK0#CF*QR(Z*](TK:3\9U7GIL1O+HO^.ML ]=#J8YW(Z$ Y87$%B1 MU>2.W.8+VMO"MIDGP8-D%4>@^1#.S^>[\Y_-)Q.;.63GN2X8Z']HD[TC-3$ MJ!SH\<$8OVY[\UXL1LYH*#E#J3'.RNPV'R1%FS1YWWZM<(XVY0+*Q#OWDBAZ_/JD^_.UIDC);VDRXMW UOP,#)%^/Q=XO1:OP= MI_<+%"%W_[O=4!)-([KM0B/91-K <23+$2?M>#A\RUA90;(5?%NNXLM-'K W M#!PX[C$,Y.N0 -=;Z' ?-L,/.V@.IYKYU%& MMQMVX+;#1%@J4-1 ?>%8DPULF/F+DJC%K(YB1>F0 CN6@%X9XUX+U5]WXF>B'T64=EFRK*>>7=+,U%2R>-4NQL6_ ' M^:P7/,&" ]P]?<<72'K#7\3@UGXG)4C:)6C\ /2W.B _?/X +%@];5@KOC^AM@0G:!\;,G<@PPW M5X\(@5I!?@8K>^#X3Q]"ZOJJ5+'%H9:.]GC$<::J9T^L'U+;!*)3=H%%V>'& MR1P.BIE./0_423ZGSW047GPQKX,S*T>4C"L"U="C \@F4J:1=?3J]TIQ/8A+@MX,$P.MT. M,WG(E8D*E)]_POIT#1D0Z(.M'L&LL\UGOX2MXCUV4U@^[&Z:]-W4QK(X]1_AE: MY[H6NA#G&;Q:SBBD]AC,L3D0WIVKXF$MT^('ZEAEFE)?ARKT!H]]D]T_,?&^=)_Q@XYOZL=HK@\4[ M^Q6V:$'44XMNJFPO:2QLHHS1HQ26L^U@T@> P$QU+L;C-[1D;[2JX>167<:3 M*,*OY7Z5%W5;17S>2OSQBO>8]_#AOD*LK/P#X#NYI+YAM^/%$NKE/XGQY9*Y M6<;G1;MJD^9ZV8],6I][K?S]DD^D%'ALU,+4^B=PE6A(IS&T)80+'7GS0D"URL6;2[#VON2DM M/$I+;)X6JL:&>_%8#Q&V2N]==8?Y_U'+F85#X;!O>.PJ2Q@U]F$L8ZMLH3"6 MANS;S%B2+4N198B1;:QADK4QDE"#;*.(#$ID[%LDDMT0,R(_C%_VKY/_X?_D MNZ[OX#Y]K_?H>=[[Y(5.4Z4E_!Q_"ZM>"-,Z801Q(63:$@.G"RX+M^!UN1%Y MZ[W30#^G%,%KIB)ON+,B^6QO1+^82FT5Z.BZ-I9CCO]Q;)[^I'D/*XS+K5OB?(3%M'JV>*KCB4 -!626_8PN75YQ[51HB. M,I;>?7KGF\Y[:2$']L'?\(HA()(ZJ=$L;=/=I_XZGKS*7 XI0+ED\.CA7U3/ MBW!>@ /JM(#OV3>J+^?N!.R5FW*%=(_6K]RJJ+T=)G:C]\P+$VO"T8D@J=PO M9*[7#H[P J'I,96ALH8%]\?XJDJ0:^QLTOZ- .GW6GWKE@6+4MXH[CP:+M5U MNDG<1Z_AQ4TYGX%F]?A^/B&F5GZM,C&U_0)XD2Q-JKB[F!P._B9;U&ZT=_?9 MT40:5_%D3LLB8F_[NIP?65F^]$UZB7'4?00^%O9F-TJ MYO!K^WX]!VM8><*3G$^:6GKC@%]Q^D3 LAV4DSD.;=IHY O25;-@CRE2 6>! MYZ=:<7E7KE+%=.%@NXLLZ5'CSYA"K(%Q_EP[\=EC^1Q:][UV<%FBZ>/W@9KY M?T0B1;^PR'B2%_@.OLHZB4]P_[$3ZM\H4WUWW4,-)!&E_D8I*"B0WEZ!DLYX MX>>%L(0TZ^@MBS8]Q0I7T)TY@5N:_ Z[U>SA!$-^L-<,^Y<(K2'];3,30J,A MM#MTV%J#?8T8/,A*C*LB+Z#>='0-MD$(=1Y9IM7C-NSJ M)\)U^:+J?<4F(SLUE4<\9V;9]GA+LUF.4FM;<)&M:X62]K9FI.5HCM(.A*^> ./LC8%F+;F&9.?QN M,=$F_JVT0HP([D"*F#,G]$CFD:;$!E3=6$&AE[]N41%3.;WM@*':E;>&"0UF M::ZX=L%2'D0E/E-?4YM4:+6F.>U$0(RSQ.J&) [K!8YVD)@9XF!/JO)TFH?. MH=UQ6\>P[:!/:^6)F%/S(":'UU=_?M')08);;KE+MZ&( CP%"*>9/'\0UVZ) ME%KH%8OQ.[JXM\.;!Q^9R'%+B4Q_> HPF8'1"DM. 3JH@)[$,!%LOL&#Q)/F MW /

'$;47C2F5<59?_R!]6#/8#(L@#;EI@@0-:6?2 M\[H!@%JW_QG;' $'"/17(8.]**Z:^QODMOYR4C;V6J"!^_0CCI87" M08+:$\W4I(L'=%)%\54D=@H@<[R MAK61?%WW+@=T%QF#?,N<<=;/N :2 U$+:N;X$7#1^,^BN_;ADP_/:+L$*]I0 MTK4!7RU4#F*1F"R@9!LÐ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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 113 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 114 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 223 372 1 true 102 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://agapeatp.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://agapeatp.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://agapeatp.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss) Sheet http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss Consolidated Statements of Operations and Comprehensive Income (Loss) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://agapeatp.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground ORGANIZATION AND BUSINESS BACKGROUND Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) Sheet http://agapeatp.com/role/VariableInterestEntityVie VARIABLE INTEREST ENTITY (???VIE???) Notes 9 false false R10.htm 00000010 - Disclosure - BUSINESS COMBINATION Sheet http://agapeatp.com/role/BusinessCombination BUSINESS COMBINATION Notes 10 false false R11.htm 00000011 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://agapeatp.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS Notes 11 false false R12.htm 00000012 - Disclosure - ACCOUNTS RECEIVABLE Sheet http://agapeatp.com/role/AccountsReceivable ACCOUNTS RECEIVABLE Notes 12 false false R13.htm 00000013 - Disclosure - INVENTORIES Sheet http://agapeatp.com/role/Inventories INVENTORIES Notes 13 false false R14.htm 00000014 - Disclosure - PREPAYMENTS AND DEPOSITS Sheet http://agapeatp.com/role/PrepaymentsAndDeposits PREPAYMENTS AND DEPOSITS Notes 14 false false R15.htm 00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://agapeatp.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 15 false false R16.htm 00000016 - Disclosure - INTANGIBLE ASSETS, NET Sheet http://agapeatp.com/role/IntangibleAssetsNet INTANGIBLE ASSETS, NET Notes 16 false false R17.htm 00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES Sheet http://agapeatp.com/role/InvestmentInMarketableSecurities INVESTMENT IN MARKETABLE SECURITIES Notes 17 false false R18.htm 00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecurities INVESTMENT IN NON-MARKETABLE SECURITIES Notes 18 false false R19.htm 00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities OTHER PAYABLES AND ACCRUED LIABILITIES Notes 19 false false R20.htm 00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS Sheet http://agapeatp.com/role/RelatedPartyBalancesAndTransactions RELATED PARTY BALANCES AND TRANSACTIONS Notes 20 false false R21.htm 00000021 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://agapeatp.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 21 false false R22.htm 00000022 - Disclosure - NON-CONTROLLING INTEREST Sheet http://agapeatp.com/role/Non-controllingInterest NON-CONTROLLING INTEREST Notes 22 false false R23.htm 00000023 - Disclosure - INCOME TAXES Sheet http://agapeatp.com/role/IncomeTaxes INCOME TAXES Notes 23 false false R24.htm 00000024 - Disclosure - CONCENTRATIONS OF RISKS Sheet http://agapeatp.com/role/ConcentrationsOfRisks CONCENTRATIONS OF RISKS Notes 24 false false R25.htm 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://agapeatp.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 25 false false R26.htm 00000026 - Disclosure - SUBSEQUENT EVENTS Sheet http://agapeatp.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 26 false false R27.htm 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 27 false false R28.htm 00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables ORGANIZATION AND BUSINESS BACKGROUND (Tables) Tables http://agapeatp.com/role/OrganizationAndBusinessBackground 28 false false R29.htm 00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 29 false false R30.htm 00000030 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Tables) Sheet http://agapeatp.com/role/VariableInterestEntityVieTables VARIABLE INTEREST ENTITY (???VIE???) (Tables) Tables http://agapeatp.com/role/VariableInterestEntityVie 30 false false R31.htm 00000031 - Disclosure - BUSINESS COMBINATION (Tables) Sheet http://agapeatp.com/role/BusinessCombinationTables BUSINESS COMBINATION (Tables) Tables http://agapeatp.com/role/BusinessCombination 31 false false R32.htm 00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables) Sheet http://agapeatp.com/role/AccountsReceivableTables ACCOUNTS RECEIVABLE (Tables) Tables http://agapeatp.com/role/AccountsReceivable 32 false false R33.htm 00000033 - Disclosure - INVENTORIES (Tables) Sheet http://agapeatp.com/role/InventoriesTables INVENTORIES (Tables) Tables http://agapeatp.com/role/Inventories 33 false false R34.htm 00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables) Sheet http://agapeatp.com/role/PrepaymentsAndDepositsTables PREPAYMENTS AND DEPOSITS (Tables) Tables http://agapeatp.com/role/PrepaymentsAndDeposits 34 false false R35.htm 00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://agapeatp.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://agapeatp.com/role/PropertyAndEquipmentNet 35 false false R36.htm 00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables) Sheet http://agapeatp.com/role/IntangibleAssetsNetTables INTANGIBLE ASSETS, NET (Tables) Tables http://agapeatp.com/role/IntangibleAssetsNet 36 false false R37.htm 00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables INVESTMENT IN MARKETABLE SECURITIES (Tables) Tables http://agapeatp.com/role/InvestmentInMarketableSecurities 37 false false R38.htm 00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables INVESTMENT IN NON-MARKETABLE SECURITIES (Tables) Tables http://agapeatp.com/role/InvestmentInNon-marketableSecurities 38 false false R39.htm 00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities 39 false false R40.htm 00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Sheet http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Tables http://agapeatp.com/role/RelatedPartyBalancesAndTransactions 40 false false R41.htm 00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables) Sheet http://agapeatp.com/role/Non-controllingInterestTables NON-CONTROLLING INTEREST (Tables) Tables http://agapeatp.com/role/Non-controllingInterest 41 false false R42.htm 00000042 - Disclosure - INCOME TAXES (Tables) Sheet http://agapeatp.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://agapeatp.com/role/IncomeTaxes 42 false false R43.htm 00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://agapeatp.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://agapeatp.com/role/CommitmentsAndContingencies 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details) Sheet http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details) Details 44 false false R45.htm 00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Details http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) Sheet http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) Details 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details) Sheet http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details) Details 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details) Sheet http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details) Details 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Sheet http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Details 49 false false R50.htm 00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Sheet http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Details 51 false false R52.htm 00000052 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative) Sheet http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative) Details http://agapeatp.com/role/VariableInterestEntityVieTables 52 false false R53.htm 00000053 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Sheet http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details) Sheet http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details) Details 54 false false R55.htm 00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative) Sheet http://agapeatp.com/role/BusinessCombinationDetailsNarrative BUSINESS COMBINATION (Details Narrative) Details http://agapeatp.com/role/BusinessCombinationTables 55 false false R56.htm 00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) Sheet http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative CASH AND CASH EQUIVALENTS (Details Narrative) Details http://agapeatp.com/role/CashAndCashEquivalents 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details) Sheet http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details) Details 57 false false R58.htm 00000058 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://agapeatp.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 58 false false R59.htm 00000059 - Disclosure - INVENTORIES (Details Narrative) Sheet http://agapeatp.com/role/InventoriesDetailsNarrative INVENTORIES (Details Narrative) Details http://agapeatp.com/role/InventoriesTables 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) Sheet http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) Details 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) Sheet http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) Details 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Sheet http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Details 62 false false R63.htm 00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) Sheet http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative PROPERTY AND EQUIPMENT, NET (Details Narrative) Details http://agapeatp.com/role/PropertyAndEquipmentNetTables 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details) Sheet http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails SCHEDULE OF INTANGIBLE ASSETS, NET (Details) Details 64 false false R65.htm 00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) Sheet http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative INTANGIBLE ASSETS, NET (Details Narrative) Details http://agapeatp.com/role/IntangibleAssetsNetTables 65 false false R66.htm 00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) Sheet http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) Details 66 false false R67.htm 00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) Details http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) Sheet http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) Details 68 false false R69.htm 00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) Details http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Sheet http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Details 70 false false R71.htm 00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details) Sheet http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails SCHEDULE OF RELATED PARTIES (Details) Details 71 false false R72.htm 00000072 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://agapeatp.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://agapeatp.com/role/StockholdersEquity 72 false false R73.htm 00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details) Sheet http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails SCHEDULE OF NON CONTROLLING INTEREST (Details) Details 73 false false R74.htm 00000074 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) Sheet http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) Details 74 false false R75.htm 00000075 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details) Sheet http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails SCHEDULE OF PROVISION FOR INCOME TAX (Details) Details 75 false false R76.htm 00000076 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) Sheet http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) Details 76 false false R77.htm 00000077 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical) Sheet http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical) Details 77 false false R78.htm 00000078 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 78 false false R79.htm 00000079 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://agapeatp.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://agapeatp.com/role/IncomeTaxesTables 79 false false R80.htm 00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative) Sheet http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative CONCENTRATIONS OF RISKS (Details Narrative) Details http://agapeatp.com/role/ConcentrationsOfRisks 80 false false R81.htm 00000081 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details) Sheet http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails SCHEDULE OF LEASE COMMITMENTS (Details) Details 81 false false R82.htm 00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://agapeatp.com/role/CommitmentsAndContingenciesTables 82 false false R83.htm 00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://agapeatp.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://agapeatp.com/role/SubsequentEvents 83 false false All Reports Book All Reports form10-k.htm aatp-20211231.xsd aatp-20211231_cal.xml aatp-20211231_def.xml aatp-20211231_lab.xml aatp-20211231_pre.xml ex31-1.htm ex32-1.htm image_001.jpg image_002.jpg image_003.jpg image_004.jpg image_005.jpg image_006.jpg image_007.jpg image_008.jpg image_009.jpg image_010.jpg image_011.jpg image_012.jpg image_013.jpg image_014.jpg image_015.jpg image_016.jpg report_001.jpg report_002.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 117 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 22, "contextCount": 223, "dts": { "calculationLink": { "local": [ "aatp-20211231_cal.xml" ] }, "definitionLink": { "local": [ "aatp-20211231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "aatp-20211231_lab.xml" ] }, "presentationLink": { "local": [ "aatp-20211231_pre.xml" ] }, "schema": { "local": [ "aatp-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 612, "entityCount": 1, "hidden": { "http://agapeatp.com/20211231": 22, "http://fasb.org/us-gaap/2021-01-31": 74, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 101 }, "keyCustom": 80, "keyStandard": 292, "memberCustom": 71, "memberStandard": 30, "nsprefix": "AATP", "nsuri": "http://agapeatp.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://agapeatp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - BUSINESS COMBINATION", "role": "http://agapeatp.com/role/BusinessCombination", "shortName": "BUSINESS COMBINATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CASH AND CASH EQUIVALENTS", "role": "http://agapeatp.com/role/CashAndCashEquivalents", "shortName": "CASH AND CASH EQUIVALENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - ACCOUNTS RECEIVABLE", "role": "http://agapeatp.com/role/AccountsReceivable", "shortName": "ACCOUNTS RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INVENTORIES", "role": "http://agapeatp.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:PrepaymentsAndDepositsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - PREPAYMENTS AND DEPOSITS", "role": "http://agapeatp.com/role/PrepaymentsAndDeposits", "shortName": "PREPAYMENTS AND DEPOSITS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:PrepaymentsAndDepositsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET", "role": "http://agapeatp.com/role/PropertyAndEquipmentNet", "shortName": "PROPERTY AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - INTANGIBLE ASSETS, NET", "role": "http://agapeatp.com/role/IntangibleAssetsNet", "shortName": "INTANGIBLE ASSETS, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES", "role": "http://agapeatp.com/role/InvestmentInMarketableSecurities", "shortName": "INVESTMENT IN MARKETABLE SECURITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES", "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecurities", "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES", "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "role": "http://agapeatp.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS", "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://agapeatp.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - NON-CONTROLLING INTEREST", "role": "http://agapeatp.com/role/Non-controllingInterest", "shortName": "NON-CONTROLLING INTEREST", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - INCOME TAXES", "role": "http://agapeatp.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - CONCENTRATIONS OF RISKS", "role": "http://agapeatp.com/role/ConcentrationsOfRisks", "shortName": "CONCENTRATIONS OF RISKS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://agapeatp.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SUBSEQUENT EVENTS", "role": "http://agapeatp.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://agapeatp.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)", "role": "http://agapeatp.com/role/VariableInterestEntityVieTables", "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - BUSINESS COMBINATION (Tables)", "role": "http://agapeatp.com/role/BusinessCombinationTables", "shortName": "BUSINESS COMBINATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)", "role": "http://agapeatp.com/role/AccountsReceivableTables", "shortName": "ACCOUNTS RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - INVENTORIES (Tables)", "role": "http://agapeatp.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)", "role": "http://agapeatp.com/role/PrepaymentsAndDepositsTables", "shortName": "PREPAYMENTS AND DEPOSITS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "role": "http://agapeatp.com/role/PropertyAndEquipmentNetTables", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - INTANGIBLE ASSETS, NET (Tables)", "role": "http://agapeatp.com/role/IntangibleAssetsNetTables", "shortName": "INTANGIBLE ASSETS, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)", "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables", "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:NonMarketableSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)", "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables", "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:NonMarketableSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)", "role": "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss", "shortName": "Consolidated Statements of Operations and Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "lang": null, "name": "AATP:RevenueFromRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfNonControllingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - NON-CONTROLLING INTEREST (Tables)", "role": "http://agapeatp.com/role/Non-controllingInterestTables", "shortName": "NON-CONTROLLING INTEREST (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfNonControllingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - INCOME TAXES (Tables)", "role": "http://agapeatp.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://agapeatp.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_SubsidiaryCompanyMember", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:NameOftheCompany", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)", "role": "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "shortName": "SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_SubsidiaryCompanyMember", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:NameOftheCompany", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-05-08_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_AgapeATPInternationalHoldingLimitedMember", "decimals": "INF", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)", "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)", "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_ComputerSoftwareIntangibleAssetMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)", "role": "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails", "shortName": "SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_SurvivorSelectMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_PeriodEndMYRMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "role": "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails", "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_PeriodEndMYRMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "role": "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryWriteDown", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "AATP:PrepaymentsAndDepositsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "AATP:AllowanceForDoubtfulAccountsReceivablesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "role": "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_us-gaap_VariableIncomeInterestRateMember", "decimals": "0", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_SubsidiaryCompanyThreeMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)", "role": "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative", "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "role": "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)", "role": "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails", "shortName": "SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - BUSINESS COMBINATION (Details Narrative)", "role": "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "shortName": "BUSINESS COMBINATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-03-31_custom_MrHowKokChoongMember", "decimals": "INF", "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)", "role": "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "shortName": "CASH AND CASH EQUIVALENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)", "role": "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfInventoriesDetails", "shortName": "SCHEDULE OF INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryWriteDown", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - INVENTORIES (Details Narrative)", "role": "http://agapeatp.com/role/InventoriesDetailsNarrative", "shortName": "INVENTORIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "role": "http://agapeatp.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AATP:ReceivablesFromSalesDistributors", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)", "role": "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails", "shortName": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AATP:ReceivablesFromSalesDistributors", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock", "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)", "role": "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails", "shortName": "SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock", "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "role": "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)", "role": "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalizedComputerSoftwareGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS, NET (Details)", "role": "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalizedComputerSoftwareGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)", "role": "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative", "shortName": "INTANGIBLE ASSETS, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails", "shortName": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "AATP:InvestmentsIncomeDividend", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)", "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2018-10-16_custom_GreenproCapitalCorpMember", "decimals": "INF", "lang": null, "name": "us-gaap:InvestmentOwnedBalanceShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "shortName": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:NonMarketableSecuritiesTableTextBlock", "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_PhoenixPlusCorpMember", "decimals": "0", "lang": null, "name": "AATP:InvestmentInNonMarketableSecuritiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)", "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-04-03_custom_PhoenixPlusCorpMember", "decimals": "INF", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND", "role": "http://agapeatp.com/role/OrganizationAndBusinessBackground", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails", "shortName": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SCHEDULE OF RELATED PARTIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails", "shortName": "SCHEDULE OF RELATED PARTIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "role": "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_ShareForfeitureAgreementsMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfNonControllingInterestTableTextBlock", "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AATP:NonControllingInterestPaidinCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SCHEDULE OF NON CONTROLLING INTEREST (Details)", "role": "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails", "shortName": "SCHEDULE OF NON CONTROLLING INTEREST (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AATP:ScheduleOfNonControllingInterestTableTextBlock", "us-gaap:MinorityInterestDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AATP:NonControllingInterestPaidinCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)", "role": "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "shortName": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)", "role": "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails", "shortName": "SCHEDULE OF PROVISION FOR INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)", "role": "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails", "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)", "role": "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical", "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "link:footnote", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "role": "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "AATP:DeferredTaxLiabilitiesDepreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000079 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "lang": "en-US", "name": "us-gaap:TaxCutsAndJobsActOf2017OtherTaxEffectDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Deposits", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000080 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)", "role": "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "shortName": "CONCENTRATIONS OF RISKS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:Deposits", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000081 - Disclosure - SCHEDULE OF LEASE COMMITMENTS (Details)", "role": "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails", "shortName": "SCHEDULE OF LEASE COMMITMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000082 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-05-302021-05-31", "decimals": null, "lang": "en-US", "name": "AATP:LeaseExpirationTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000083 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://agapeatp.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-01-20_us-gaap_SubsequentEventMember_custom_MrHowKokChoongMember_custom_ShareForfeitureAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d)", "role": "http://agapeatp.com/role/VariableInterestEntityVie", "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 102, "tag": { "AATP_AATPHKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AATP HK [Member]", "label": "AATP HK [Member]" } } }, "localname": "AATPHKMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AATP_AATPLBASLSEAAndWATPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AATP LB, ASL, SEA and WATP [Member]", "label": "AATP LB, ASL, SEA and WATP [Member]" } } }, "localname": "AATPLBASLSEAAndWATPMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AATP_AATPLBASLSEAWATPAndDSYMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AATP LB, ASL, SEA, WATP, and DSY [Member]", "label": "AATP LB, ASL, SEA, WATP, and DSY [Member]" } } }, "localname": "AATPLBASLSEAWATPAndDSYMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AATP_AccountsReceivableAndAccountsReceivableRelatedParties": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts receivable and accounts receivable related parties.", "label": "Accounts receivable and accounts receivable related parties", "totalLabel": "Total" } } }, "localname": "AccountsReceivableAndAccountsReceivableRelatedParties", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "AATP_AccruedPromotionExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued promotion expenses.", "label": "Promotion expenses" } } }, "localname": "AccruedPromotionExpenses", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_AgapeATPAsiaLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agape ATP Asia Limited [Member]", "label": "Agape ATP Asia Limited [Member]" } } }, "localname": "AgapeATPAsiaLimitedMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_AgapeATPInternationalHoldingLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agape ATP International Holding Limited [Member]", "label": "Agape ATP International Holding Limited [Member]" } } }, "localname": "AgapeATPInternationalHoldingLimitedMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ASL [Member]", "label": "ASL [Member]" } } }, "localname": "AgapeSuperiorLivingMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingPtyLtdASLPLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agape Superior Living Pty Ltd ASLPL [Member]", "label": "Agape Superior Living Pty Ltd ASLPL [Member]" } } }, "localname": "AgapeSuperiorLivingPtyLtdASLPLMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingPtyLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agape Superior Living Pty Ltd [Member]", "label": "Agape Superior Living Pty Ltd [Member]" } } }, "localname": "AgapeSuperiorLivingPtyLtdMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agape Superior Living Sdn Bhd [Member]", "label": "Agape Superior Living Sdn Bhd [Member]" } } }, "localname": "AgapeSuperiorLivingSdnBhdMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_AllowanceForDoubtfulAccountsReceivableExchangeRateEffect": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allowance for doubtful accounts receivable exchange rate effect.", "label": "Exchange rate effect" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableExchangeRateEffect", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_AllowanceForDoubtfulAccountsReceivablesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for doubtful accounts,", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablesCurrent", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_BetaMaxxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Beta Maxx [Member]", "label": "Beta Maxx [Member]" } } }, "localname": "BetaMaxxMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition pro-forma earnings per share basic and diluted", "label": "Net income per common share - basic and diluted" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareBasicDiluted", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "perShareItemType" }, "AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition pro-forma weighted average number of common shares outstanding basic snd diluted.", "label": "Weighted average number of common shares outstanding - basic and diluted" } } }, "localname": "BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "AATP_BusinessAcquisitionsProFormaCostOfRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cost of revenue.", "label": "BusinessAcquisitionsProFormaCostOfRevenue", "verboseLabel": "Cost of revenue" } } }, "localname": "BusinessAcquisitionsProFormaCostOfRevenue", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaGrossProfit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross profit.", "label": "BusinessAcquisitionsProFormaGrossProfit", "verboseLabel": "Gross profit" } } }, "localname": "BusinessAcquisitionsProFormaGrossProfit", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro-forma income loss before income taxes.", "label": "Income before income taxes" } } }, "localname": "BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro-forma income tax expense benefit.", "label": "Provision for income taxes" } } }, "localname": "BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaOperatingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total operating expenses.", "label": "Total operating expenses" } } }, "localname": "BusinessAcquisitionsProFormaOperatingExpenses", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other income (expense), net.", "label": "Other income (expense), net" } } }, "localname": "BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current assets prepaid taxes.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes", "verboseLabel": "Prepaid taxes" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current assets receivables related parties.", "label": "Other receivables - related parties" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "AATP_COVIDNineteenImpactMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "COVID-19 Impact [Member]", "label": "COVID-19 Impact [Member]" } } }, "localname": "COVIDNineteenImpactMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Changes in right of use asset and lease liabilities due to lease modifications.", "label": "Changes in right-of-use assets and lease liabilities due to lease modifications" } } }, "localname": "ChangesInRightofuseAssetsAndLeaseLiabilitiesDueToLeaseModifications", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_ComputerAndOfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer And Office Equipment [Member]", "label": "Computer And Office Equipment [Member]" } } }, "localname": "ComputerAndOfficeEquipmentMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "AATP_ContributionsFromNoncontrollingInterestShareholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contributions from non controlling interest shareholders.", "label": "Contributions from non-controlling interest shareholders" } } }, "localname": "ContributionsFromNoncontrollingInterestShareholders", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "AATP_DSYWellnessAndLongevityCenterSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSY Wellness & Longevity Center Sdn Bhd [Member].", "label": "DSY Wellness & Longevity Center Sdn Bhd [Member]" } } }, "localname": "DSYWellnessAndLongevityCenterSdnBhdMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_DSwissIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DSwiss Inc [Member]", "label": "DSwiss Inc [Member]" } } }, "localname": "DSwissIncMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets operating loss carryforwards utilized and reduced.", "label": "Cumulative net operating losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsUtilizedAndReduced", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_DeferredTaxLiabilitiesDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities, depreciation.", "label": "DeferredTaxLiabilitiesDepreciation", "verboseLabel": "Depreciation" } } }, "localname": "DeferredTaxLiabilitiesDepreciation", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_DefinedContributionPlanPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Contribution Plan [Policy Text Block]", "label": "Defined contribution plan" } } }, "localname": "DefinedContributionPlanPolicyTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_DepositForInsurance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deposit for insurance.", "label": "Deposit for insurance" } } }, "localname": "DepositForInsurance", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_DepositsToSupplier": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 2.0, "parentTag": "AATP_PrepaidExpensesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deposits to supplier.", "label": "Deposits to suppliers" } } }, "localname": "DepositsToSupplier", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_DirectorsOfUnreservedInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Directors of Unreserved Investments [Member]", "label": "Directors of Unreserved Investments [Member]" } } }, "localname": "DirectorsOfUnreservedInvestmentMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "AATP_DisclosureInvestmentInMarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment In Marketable Securities", "verboseLabel": "Schedule Of Investment In Marketable Securities" } } }, "localname": "DisclosureInvestmentInMarketableSecuritiesAbstract", "nsuri": "http://agapeatp.com/20211231", "xbrltype": "stringItemType" }, "AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment In Non-marketable Securities" } } }, "localname": "DisclosureInvestmentInNonmarketableSecuritiesAbstract", "nsuri": "http://agapeatp.com/20211231", "xbrltype": "stringItemType" }, "AATP_DisclosurePrepaymentsAndDepositsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepayments And Deposits", "terseLabel": "Schedule Of Changes In Allowance For Doubtful Accounts", "verboseLabel": "Schedule Of Prepaid Expenses And Deposits" } } }, "localname": "DisclosurePrepaymentsAndDepositsAbstract", "nsuri": "http://agapeatp.com/20211231", "xbrltype": "stringItemType" }, "AATP_DividendShareForCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dividend share for common stock.", "label": "[custom:DividendShareForCommonStock]" } } }, "localname": "DividendShareForCommonStock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AATP_ECommerceCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "E-commerce [Member].", "label": "E-commerce [Member]" } } }, "localname": "ECommerceCompanyMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_EmployeesProvidentFundMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees Provident Fund [Member]", "label": "Employees Provident Fund [Member]" } } }, "localname": "EmployeesProvidentFundMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_EmploymentInsuranceSystemMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employment Insurance System [Member]", "label": "Employment Insurance System [Member]" } } }, "localname": "EmploymentInsuranceSystemMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_EnergetiqueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energetique [Member]", "label": "Energetique [Member]" } } }, "localname": "EnergetiqueMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_EnergizedMineralConcentrateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energized Mineral Concentrate [Member]", "label": "Energized Mineral Concentrate [Member]" } } }, "localname": "EnergizedMineralConcentrateMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": 4.0, "parentTag": "us-gaap_MarketableSecuritiesNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Exchange rate effect.", "label": "Exchange rate effect [Default Label]", "verboseLabel": "Exchange rate effect" } } }, "localname": "ExchangeRateEffectOnInvestmentInMarketableSecurites", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_ForeignCurrencyExchangeRateAverage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign currency exchange rate period average.", "label": "Foreign currency exchange rate period average" } } }, "localname": "ForeignCurrencyExchangeRateAverage", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "pureItemType" }, "AATP_ForfeitedCouponIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Forfeited coupon income.", "label": "Forfeited coupon income" } } }, "localname": "ForfeitedCouponIncome", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_GreenproCapitalCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Greenpro Capital Corp. [Member]", "label": "Greenpro Capital Corp. [Member]" } } }, "localname": "GreenproCapitalCorpMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HKCHoldingsSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HKC Holdings Sdn Bhd [Member]", "label": "HKC Holdings Sdn Bhd [Member]" } } }, "localname": "HKCHoldingsSdnBhdMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HealthAndWellnessProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health and Wellness Products [Member]", "label": "Health and Wellness Products [Member]" } } }, "localname": "HealthAndWellnessProductsMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HealthAndWellnessServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health And Wellness Services [Member]", "label": "Health And Wellness Services [Member]" } } }, "localname": "HealthAndWellnessServicesMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HostastaySdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hostastay Sdn Bhd [Member]", "label": "Hostastay Sdn Bhd [Member]" } } }, "localname": "HostastaySdnBhdMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_HostastaySdnBhdOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hostastay Sdn. Bhd.[Member]", "label": "Hostastay Sdn. Bhd [Member]" } } }, "localname": "HostastaySdnBhdOneMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_HowKokChoongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "How Kok Choong [Member]", "label": "How Kok Choong [Member]" } } }, "localname": "HowKokChoongMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_HowKokChoongTalentLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "How Kok Choong Talent Limited [Member]", "label": "How Kok Choong Talent Limited [Member]" } } }, "localname": "HowKokChoongTalentLimitedMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HumanResourceDevelopmentFundMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Human Resource Development Fund [Member]", "label": "Human Resource Development Fund [Member]" } } }, "localname": "HumanResourceDevelopmentFundMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_IncreaseDecreaseInOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in operating lease liabilities.", "label": "IncreaseDecreaseInOperatingLeaseLiabilities", "verboseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilities", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_IncreaseDecreaseInROUAssetsAndLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reduction in ROU assets and liabilities.", "label": "Reduction in ROU assets and liabilities" } } }, "localname": "IncreaseDecreaseInROUAssetsAndLiabilities", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial recognition of right-of-use assets and lease liabilities.", "label": "Initial recognition of right-of-use assets and lease liabilities" } } }, "localname": "InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_InvestmentInMarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment In Marketable Securities [Text Block]", "label": "INVESTMENT IN MARKETABLE SECURITIES" } } }, "localname": "InvestmentInMarketableSecuritiesTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecurities" ], "xbrltype": "textBlockItemType" }, "AATP_InvestmentInNonMarketableSecuritiesGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in non-marketable securities.", "label": "Investment in non-marketable securities [Default Label]", "verboseLabel": "Investment in non-marketable securities" } } }, "localname": "InvestmentInNonMarketableSecuritiesGross", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_InvestmentInNonMarketableSecuritiesNoncurrent": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in non-marketable securities.", "label": "Investment in non-marketable securities", "verboseLabel": "Total investment in non-marketable securities" } } }, "localname": "InvestmentInNonMarketableSecuritiesNoncurrent", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_InvestmentInNonMarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment In Non Marketable Securities [Text Block]", "label": "INVESTMENT IN NON-MARKETABLE SECURITIES" } } }, "localname": "InvestmentInNonMarketableSecuritiesTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecurities" ], "xbrltype": "textBlockItemType" }, "AATP_InvestmentInNonmarketableSecuritiesNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in non-marketable securities, net.", "label": "Investment in non-marketable securities, net", "verboseLabel": "Investment in non-marketable securities" } } }, "localname": "InvestmentInNonmarketableSecuritiesNet", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_InvestmentsIncomeDividend": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_MarketableSecuritiesNoncurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Dividend income .", "label": "Dividend income", "negatedLabel": "Dividend income from Greenpro Capital Corp." } } }, "localname": "InvestmentsIncomeDividend", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_IonizedCalMagMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ionized Cal-Mag [Member]", "label": "Ionized Cal-Mag [Member]" } } }, "localname": "IonizedCalMagMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_IronMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Iron [Member]", "label": "Iron [Member]" } } }, "localname": "IronMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in exchange for acquisition payment of acquisition.", "label": "Issuance of common stock in exchange for acquisition payment of ASL" } } }, "localname": "IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAcquisition", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_LabuanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Labuan [Member]", "label": "Labuan [Member]" } } }, "localname": "LabuanMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_LeaseExpirationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease expiration term.", "label": "Lease expiration term" } } }, "localname": "LeaseExpirationTerm", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "dateItemType" }, "AATP_MYRCurrencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MYR Currency [Member]", "label": "MYR Currency [Member]" } } }, "localname": "MYRCurrencyMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_MarketableSecuritiesUnrealizedHoldingGainLoss": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_MarketableSecuritiesNoncurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrealized holding (loss) gain.", "label": "Unrealized holding (loss) gain", "negatedLabel": "Unrealized holding (loss) gain" } } }, "localname": "MarketableSecuritiesUnrealizedHoldingGainLoss", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_MitogizeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mitogize [Member]", "label": "Mitogize [Member]" } } }, "localname": "MitogizeMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_MonthlySalary": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Monthly salary.", "label": "Monthly salary" } } }, "localname": "MonthlySalary", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_MrHowKokChoongMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr.How Kok Choong [Member]", "label": "Mr.How Kok Choong [Member]" } } }, "localname": "MrHowKokChoongMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_NameOftheCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the company name.", "label": "Subsidiary company name" } } }, "localname": "NameOftheCompany", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_NoCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No Customer [Member].", "label": "No Customer [Member]" } } }, "localname": "NoCustomerMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_NoOneMEDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No. 1 MED [Member]", "label": "No. 1 MED [Member]" } } }, "localname": "NoOneMEDMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_NoSalesDistributorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No Sales Distributor [Member]", "label": "No Sales Distributor [Member]" } } }, "localname": "NoSalesDistributorMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_NonControllingInterestAccumulatedDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest accumulated deficit.", "label": "NonControllingInterestAccumulatedDeficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "NonControllingInterestAccumulatedDeficit", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" ], "xbrltype": "monetaryItemType" }, "AATP_NonControllingInterestAccumulatedOtherComprehensiveIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest accumulated other comprehensive income.", "label": "NonControllingInterestAccumulatedOtherComprehensiveIncome", "verboseLabel": "Accumulated other comprehensive income" } } }, "localname": "NonControllingInterestAccumulatedOtherComprehensiveIncome", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" ], "xbrltype": "monetaryItemType" }, "AATP_NonControllingInterestAsl": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest asl.", "label": "ASL" } } }, "localname": "NonControllingInterestAsl", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" ], "xbrltype": "monetaryItemType" }, "AATP_NonControllingInterestNonControllingInterestGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest gross.", "label": "Non Controlling interest Gross" } } }, "localname": "NonControllingInterestNonControllingInterestGross", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" ], "xbrltype": "monetaryItemType" }, "AATP_NonControllingInterestPaidinCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest paid in capital.", "label": "Paid-in capital" } } }, "localname": "NonControllingInterestPaidinCapital", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" ], "xbrltype": "monetaryItemType" }, "AATP_NonMarketableSecuritiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Marketable Securities [Policy Text Block]", "label": "Investment in non-marketable equity securities" } } }, "localname": "NonMarketableSecuritiesPolicyTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_NonMarketableSecuritiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Marketable Securities [Table Text Block]", "label": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES" } } }, "localname": "NonMarketableSecuritiesTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "AATP_NoncontrollingInterestPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncontrolling Interest [Policy Text Block]", "label": "Non-controlling interest" } } }, "localname": "NoncontrollingInterestPolicyTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_OmegaBlendMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Omega Blend [Member]", "label": "Omega Blend [Member]" } } }, "localname": "OmegaBlendMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_OneSalesDistributorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Sales Distributor [Member]", "label": "One Sales Distributor [Member]" } } }, "localname": "OneSalesDistributorMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_OneVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Vendor [Member]", "label": "One Vendor [Member]" } } }, "localname": "OneVendorMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_OrganicYouthCareCleansingBarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organic Youth Care Cleansing Bar [Member]", "label": "Organic Youth Care Cleansing Bar [Member]" } } }, "localname": "OrganicYouthCareCleansingBarMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_OtherAccountPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.", "label": "OtherAccountPayableAndAccruedLiabilities", "totalLabel": "Total" } } }, "localname": "OtherAccountPayableAndAccruedLiabilities", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_OtherPayablesRelatedPartyCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other payables - related party.", "label": "OtherPayablesRelatedPartyCurrent", "verboseLabel": "Other payables and accrued liabilities" } } }, "localname": "OtherPayablesRelatedPartyCurrent", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "AATP_ParticularsOfIssuedCapital": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Particulars of issued capital.", "label": "Particulars of issued capital" } } }, "localname": "ParticularsOfIssuedCapital", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_PercentageOfCommonStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock issued and outstanding.", "label": "Percentage of common stock issued and outstanding" } } }, "localname": "PercentageOfCommonStockIssuedAndOutstanding", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "percentItemType" }, "AATP_PeriodAverageHKDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period-average HKD [Member]", "label": "Period-average HKD [Member]" } } }, "localname": "PeriodAverageHKDMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PeriodAverageMYRMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period-average MYR [Member]", "label": "Period-average MYR [Member]" } } }, "localname": "PeriodAverageMYRMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PeriodEndHKDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period-end HKD [Member]", "label": "Period-end HKD [Member]" } } }, "localname": "PeriodEndHKDMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PeriodEndMYRMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period-end MYR [Member]", "label": "Period-end MYR [Member]" } } }, "localname": "PeriodEndMYRMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PhoenixPlusCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phoenix Plus Corporation [Member]", "label": "Phoenix Plus Corporation [Member]" } } }, "localname": "PhoenixPlusCorpMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "AATP_PlaceAndDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Place and date of incorporation.", "label": "Place and date of incorporation" } } }, "localname": "PlaceAndDateOfIncorporation", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_PreferredStockDividendIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Dividend income from marketable securities", "negatedLabel": "Dividend income from marketable securities" } } }, "localname": "PreferredStockDividendIncomeStatementImpact", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "AATP_PrepaidExpensesGross": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid expenses gross.", "label": "PrepaidExpensesGross", "totalLabel": "Subtotal" } } }, "localname": "PrepaidExpensesGross", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_PrepaidTaxesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepaid Taxes [Policy Text Block]", "label": "Prepaid taxes" } } }, "localname": "PrepaidTaxesPolicyTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_PrepaymentsAndDepositsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayments And Deposits [Policy Text Block]", "label": "PrepaymentsAndDepositsPolicyTextBlock", "verboseLabel": "Prepayments and deposits" } } }, "localname": "PrepaymentsAndDepositsPolicyTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_PrepaymentsAndDepositsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepayments and Deposits [Text Block]", "label": "PREPAYMENTS AND DEPOSITS" } } }, "localname": "PrepaymentsAndDepositsTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/PrepaymentsAndDeposits" ], "xbrltype": "textBlockItemType" }, "AATP_PrincipalActivities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Principal activities.", "label": "Principal activities" } } }, "localname": "PrincipalActivities", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of non-marketable securities to a related party.", "label": "Proceeds from sale of non-marketable securities to a related party", "verboseLabel": "Proceeds from investments" } } }, "localname": "ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_ReceivablesFromSalesDistributors": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 1.0, "parentTag": "AATP_PrepaidExpensesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivables from sales distributors.", "label": "Receivables from sales distributors" } } }, "localname": "ReceivablesFromSalesDistributors", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_RelatedPartiesNatureDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related parties nature, description.", "label": "Nature" } } }, "localname": "RelatedPartiesNatureDescription", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "AATP_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Parties [Policy Text Block]", "label": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_RelatedPartiesRelationshipsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related parties, relationships, description.", "label": "Relationship" } } }, "localname": "RelatedPartiesRelationshipsDescription", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "AATP_RevenueFromRelatedParty": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "REVENUE \u2013 RELATED PARTY" } } }, "localname": "RevenueFromRelatedParty", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "AATP_SEATechVenturesCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SEATech Ventures Corp [Member]", "label": "SEATech Ventures Corp [Member]" } } }, "localname": "SEATechVenturesCorpMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_SalaryPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Salary percentage.", "label": "Salary percentage" } } }, "localname": "SalaryPercentage", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "AATP_SaleOfInvestmentInNonmarketableSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale of investment in non-marketable securities.", "label": "Less: Sale of investment in non-marketable securities" } } }, "localname": "SaleOfInvestmentInNonmarketableSecurities", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale of non-marketable securities to related party in exchange for acquisition.", "label": "Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL" } } }, "localname": "SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAcquisition", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_SalesCommissionsAndFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Commission expense.", "label": "Commission expense" } } }, "localname": "SalesCommissionsAndFee", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_SalesCommissionsAndFees1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).", "label": "Commission expenses [Default Label]", "verboseLabel": "Commission expenses" } } }, "localname": "SalesCommissionsAndFees1", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Changes in Allowance for Doubtful Accounts [Table Text Block]", "label": "SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS" } } }, "localname": "ScheduleOfChangesInAllowanceForDoubtfulAccountsTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/PrepaymentsAndDepositsTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Disaggregated Information Of Revenues [Table Text Block]", "label": "SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES" } } }, "localname": "ScheduleOfDisaggregatedInformationOfRevenuesTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Estimated Useful Lives Of Intangible Assets Net [Table Text Block]", "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Estimated Useful Lives Of Property And Equipment [Table Text Block]", "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfNonControllingInterestTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Non Controlling Interest [Table Text Block]", "label": "SCHEDULE OF NON CONTROLLING INTEREST" } } }, "localname": "ScheduleOfNonControllingInterestTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/Non-controllingInterestTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Other Payables And Accrued Liabilities [Table Text Block]", "label": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Prepaid Expenses and Deposits [Table Text Block]", "label": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS" } } }, "localname": "ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/PrepaymentsAndDepositsTables" ], "xbrltype": "textBlockItemType" }, "AATP_ShareExchangeAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Exchange Agreement [Member]", "label": "Share Exchange Agreement [Member]" } } }, "localname": "ShareExchangeAgreementMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_ShareForfeitureAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Forfeiture Agreement [Member]", "label": "Share Forfeiture Agreement [Member]" } } }, "localname": "ShareForfeitureAgreementMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_ShareForfeitureAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Forfeiture Agreements [Member]", "label": "Share Forfeiture Agreements [Member]" } } }, "localname": "ShareForfeitureAgreementsMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_ShareholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholders [Member]", "label": "Shareholders [Member]" } } }, "localname": "ShareholdersMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_ShippingAndHandlingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shipping and Handling [Policy Text Block]", "label": "Shipping and handling" } } }, "localname": "ShippingAndHandlingPolicyTextBlock", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_SocialSecurityOrganizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Social Security Organization [Member]", "label": "Social Security Organization [Member]" } } }, "localname": "SocialSecurityOrganizationMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsidiary Company Five [Member]", "label": "Subsidiary Company Five [Member]" } } }, "localname": "SubsidiaryCompanyFiveMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsidiary Company Four [Member]", "label": "Subsidiary Company Four [Member]" } } }, "localname": "SubsidiaryCompanyFourMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsidiary Company [Member]", "label": "Subsidiary Company [Member]" } } }, "localname": "SubsidiaryCompanyMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsidiary Company One [Member]", "label": "Subsidiary Company One [Member]" } } }, "localname": "SubsidiaryCompanyOneMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsidiary Company Three [Member]", "label": "Subsidiary Company Three [Member]" } } }, "localname": "SubsidiaryCompanyThreeMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsidiary Company Two [Member]", "label": "Subsidiary Company Two [Member]" } } }, "localname": "SubsidiaryCompanyTwoMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SurvivorSelectMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Survivor Select [Member]", "label": "Survivor Select [Member]" } } }, "localname": "SurvivorSelectMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_THThreeTechnologySdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TH3 Technology Sdn Bhd [Member].", "label": "TH3 Technology Sdn Bhd [Member]" } } }, "localname": "THThreeTechnologySdnBhdMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_TrainingCenterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Training Center [Member]", "label": "Training Center [Member]" } } }, "localname": "TrainingCenterMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_TrimPlusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trim Plus [Member]", "label": "Trim Plus [Member]" } } }, "localname": "TrimPlusMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_UnreservedSdnBhdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unreserved Sdn Bhd [Member]", "label": "Unreserved Sdn Bhd [Member]" } } }, "localname": "UnreservedSdnBhdMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_UnutilizedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unutilized [Member]", "label": "Unutilized [Member]" } } }, "localname": "UnutilizedMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "VIE consolidated amount of cash and cash equivalents.", "label": "VIE consolidated amount of cash and cash equivalents" } } }, "localname": "VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "VIE consolidated amount of other payables and accrued liabilities.", "label": "VIE consolidated amount of other payables and accrued liabilities" } } }, "localname": "VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "VIE consolidated amount of Prepaid taxes .", "label": "VIE consolidated amount of prepaid taxes" } } }, "localname": "VariableInterestEntityConsolidatedAmountOfPrepaidTaxes", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "AATP_VegeFruitFiberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vege Fruit Fiber [Member]", "label": "Vege Fruit Fiber [Member]" } } }, "localname": "VegeFruitFiberMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_VehicleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vehicle [Member]", "label": "Vehicle [Member]" } } }, "localname": "VehicleMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "AATP_VendorOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor One [Member]", "label": "Vendor One [Member]" } } }, "localname": "VendorOneMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_VendorTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor Two [Member]", "label": "Vendor Two [Member]" } } }, "localname": "VendorTwoMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_VettonsSdnBhdOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vettons Sdn Bhd One [Member]", "label": "Vettons Sdn Bhd One [Member]" } } }, "localname": "VettonsSdnBhdOneMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "AATP_YoungFormulaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Young Formula [Member]", "label": "Young Formula [Member]" } } }, "localname": "YoungFormulaMember", "nsuri": "http://agapeatp.com/20211231", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HONG KONG" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" ], "xbrltype": "domainItemType" }, "country_MY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MALAYSIA" } } }, "localname": "MY", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r574", "r576", "r577" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r574", "r576", "r577" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r574", "r576", "r577" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r574", "r576", "r577" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r572" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r122", "r237", "r242", "r248", "r390", "r391", "r399", "r400", "r456", "r559" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r122", "r237", "r242", "r248", "r390", "r391", "r399", "r400", "r456", "r559" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r177", "r304", "r308", "r529" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r253", "r274", "r316", "r319", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r526", "r530", "r560", "r561" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r253", "r274", "r316", "r319", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r526", "r530", "r560", "r561" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r177", "r304", "r308", "r529" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r174", "r304", "r306", "r476", "r525", "r527" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r174", "r304", "r306", "r476", "r525", "r527" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r253", "r274", "r313", "r316", "r319", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r526", "r530", "r560", "r561" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r253", "r274", "r313", "r316", "r319", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r526", "r530", "r560", "r561" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r132", "r136", "r317" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r175", "r176", "r304", "r307", "r528", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r175", "r176", "r304", "r307", "r528", "r544", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r132", "r136", "r235", "r317", "r462" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r178", "r452" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Others" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts payable \u2013 intercompany" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r12", "r45" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r179", "r180" ], "calculation": { "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": { "order": 1.0, "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r6", "r26", "r179", "r180" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedPartiesCurrent": { "auth_ref": [ "r53", "r121", "r450", "r453" ], "calculation": { "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": { "order": 2.0, "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.", "label": "Accounts Receivable, Related Parties, Current", "verboseLabel": "Allowance for doubtful accounts" } } }, "localname": "AccountsReceivableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r12", "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Payroll" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r11", "r12", "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r11", "r12", "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Commission" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r43", "r221" ], "calculation": { "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r29", "r63", "r65", "r66", "r511", "r535", "r536" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r62", "r66", "r74", "r75", "r76", "r124", "r125", "r126", "r397", "r531", "r532", "r583" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r27", "r329", "r459" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r124", "r125", "r126", "r326", "r327", "r328", "r416" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net (loss) income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "verboseLabel": "Advertising costs" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": { "auth_ref": [ "r185" ], "calculation": { "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.", "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables", "negatedLabel": "Less: Provision for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r185", "r193", "r194", "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r33", "r185", "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts receivable, allowance for credit loss" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.", "label": "Addition" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r196" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Write off" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfChangesInAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r102", "r207", "r213" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Potentially dilutive securities outstanding" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r116", "r163", "r166", "r172", "r191", "r237", "r238", "r239", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r390", "r399", "r423", "r457", "r459", "r493", "r510" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r10", "r60", "r116", "r191", "r237", "r238", "r239", "r241", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r390", "r399", "r423", "r457", "r459" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total current assets", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r321", "r325" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r315", "r318" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r315", "r318", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r370", "r371" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "SCHEDULE OF PRO FORMA BUSINESS COMBINATION" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": { "auth_ref": [ "r370", "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.", "label": "Loss from operations" } } }, "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r370", "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Net income" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r370", "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r379", "r380", "r381" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Purchase consideration value" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r378", "r379", "r380", "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Loan payable" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Total assets", "verboseLabel": "Business combination, recognized identifiable assets acquired and liabilities assumed, assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "verboseLabel": "Total current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Prepayments and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Other receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "verboseLabel": "Total current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Accounts payable - related party" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "verboseLabel": "Customer deposits" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "verboseLabel": "Other payables and accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Deferred taxes asset, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "verboseLabel": "Intangible assets, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r374", "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r375" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Total liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r374", "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Total net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Total other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r374", "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "verboseLabel": "Property and equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r3", "r123", "r159" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "ORGANIZATION AND BUSINESS BACKGROUND" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackground" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r562" ], "calculation": { "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Computer software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r39", "r459", "r538", "r539" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash in bank" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r92" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r39", "r104" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "CASH AND CASH EQUIVALENTS" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r18", "r105" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r98", "r104", "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of year", "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r98", "r424" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommissionsExpensePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations.", "label": "Commission expenses" } } }, "localname": "CommissionsExpensePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r232", "r233", "r234", "r236", "r546" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r124", "r125", "r416" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Ordinary shares no par value" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "verboseLabel": "Ordinary shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r25", "r286" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r25", "r459" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r68", "r70", "r71", "r82", "r503", "r521" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r68", "r70", "r81", "r388", "r389", "r408", "r502", "r520" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Less: Comprehensive loss attributable to non-controlling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r68", "r70", "r80", "r387", "r408", "r501", "r519" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "TOTAL COMPREHENSIVE (LOSS) INCOME" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r208", "r211", "r377" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r153", "r154", "r177", "r420", "r421", "r545" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r153", "r154", "r177", "r420", "r421", "r537", "r545" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r153", "r154", "r177", "r420", "r421", "r537", "r545" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS OF RISKS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisks" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r153", "r154", "r177", "r420", "r421" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentrations of risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r151", "r153", "r154", "r155", "r420", "r422", "r545" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r153", "r154", "r177", "r420", "r421", "r545" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "auth_ref": [ "r398", "r409" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r109", "r392" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r293", "r294", "r305" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Customer deposits" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r88", "r476" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "COST OF REVENUE", "verboseLabel": "Cost of revenue" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAmortization": { "auth_ref": [ "r85" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.", "label": "Amortization" } } }, "localname": "CostOfGoodsAndServicesSoldAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsTotalMember": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service Benchmark [Member]" } } }, "localname": "CostOfGoodsTotalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of revenue" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r117", "r353" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "negatedLabel": "- Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r117", "r353", "r360" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "negatedLabel": "- Local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r152", "r177" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r51", "r115", "r122", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r287", "r288", "r289", "r290", "r434", "r435", "r436", "r437", "r508" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "verboseLabel": "Deferred offering costs" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r117", "r354", "r360" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "negatedLabel": "- Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r102", "r117", "r354", "r360", "r361", "r362" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax expense" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r335", "r336" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r59", "r205" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r117", "r354", "r360" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "negatedLabel": "- Local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r346" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "negatedLabel": "Deferred tax liabilities, net" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r351", "r352" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred tax assets operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r351", "r352" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Net operating loss carry forwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred tax valuation allowance", "negatedLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined contribution plan expense" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Deposits": { "auth_ref": [ "r497" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.", "label": "Deposits" } } }, "localname": "Deposits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r102", "r219" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative", "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DueFromOfficersOrStockholdersCurrent": { "auth_ref": [ "r53", "r450", "r452" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amounts due from owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are usually due within 1 year (or 1 business cycle).", "label": "Amount due from director" } } }, "localname": "DueFromOfficersOrStockholdersCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r121", "r240", "r242", "r243", "r247", "r248", "r249", "r450", "r496", "r517" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due from Related Parties", "verboseLabel": "Amount due from related parties" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r45", "r121", "r240", "r242", "r243", "r247", "r248", "r249", "r450" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Amount due to a related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r121", "r240", "r242", "r243", "r247", "r248", "r249", "r450", "r498", "r516" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "verboseLabel": "Amount due from related parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(LOSS) EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r143", "r144" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings (loss) per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r424" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective tax rate", "verboseLabel": "Tax percentage" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r119", "r338", "r364" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "U.S. statutory rate", "verboseLabel": "Tax percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r338", "r364" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r338", "r364" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Differential tax rate in Malaysia" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r338", "r364" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Tax percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r338", "r364" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Permanent difference" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r74", "r75", "r76", "r124", "r125", "r126", "r128", "r133", "r135", "r146", "r192", "r286", "r291", "r326", "r327", "r328", "r356", "r357", "r416", "r425", "r426", "r427", "r428", "r429", "r430", "r531", "r532", "r533", "r583" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Proportional of ownership interest and voting power held", "terseLabel": "Equity interest percentage", "verboseLabel": "Ownership interest percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Estimated useful lives of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r212" ], "calculation": { "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Less: accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r208", "r209", "r212", "r214", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r208", "r211" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r212", "r477" ], "calculation": { "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign Currency Exchange Rate, Translation" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign currencies translation and transaction" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r89" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedLabel": "GENERAL AND ADMINISTRATIVE" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r87", "r116", "r163", "r165", "r168", "r171", "r173", "r191", "r237", "r238", "r239", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r423" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r102", "r218" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r216", "r223" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment for long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r118", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Local \u2013 United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r78", "r163", "r165", "r168", "r171", "r173", "r491", "r499", "r504", "r522" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "(Loss) income before income tax", "totalLabel": "(LOSS) INCOME BEFORE INCOME TAXES" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r118", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r119", "r339", "r343", "r348", "r358", "r365", "r367", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income tax examination, description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r332", "r341" ], "lang": { "en-us": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Income tax examination, likelihood of unfavorable settlement" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.", "label": "Income tax examination, penalties and interest expense", "verboseLabel": "Income tax examination penalties and interest expense" } } }, "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r120", "r134", "r135", "r162", "r337", "r359", "r366", "r523" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense benefit", "negatedLabel": "PROVISION FOR INCOME TAXES", "negatedTotalLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r72", "r333", "r334", "r343", "r344", "r347", "r355" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Income tax payables" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r101", "r471" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Customer deposits" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in related party receivables classified as other, due within one year or operating cycle, if longer.", "label": "Increase (Decrease) in Due from Other Related Parties, Current", "negatedLabel": "Amount due from a related party" } } }, "localname": "IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Increase (Decrease) in Other Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Other payables and accrued liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepayments and deposits" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidTaxes": { "auth_ref": [ "r101" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Taxes", "negatedLabel": "Prepaid taxes" } } }, "localname": "IncreaseDecreaseInPrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS, NET" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r110", "r211", "r473", "r474", "r475", "r477" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "verboseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r206", "r210" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r96", "r99", "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r5", "r57", "r459" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r13", "r58", "r111", "r145", "r199", "r201", "r202", "r472" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r200" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory write-down", "verboseLabel": "Inventories write-down" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InventoriesDetailsNarrative", "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r540" ], "calculation": { "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_MarketableSecuritiesNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of the investment.", "label": "Cost of investment", "verboseLabel": "Investment amount" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r541", "r543" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment in securities, shares", "verboseLabel": "Shares purchased during period" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r445" ], "calculation": { "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r445" ], "calculation": { "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r445" ], "calculation": { "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r445" ], "calculation": { "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r445" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r47", "r116", "r167", "r191", "r237", "r238", "r239", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r391", "r399", "r400", "r423", "r457", "r458" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r32", "r116", "r191", "r423", "r459", "r495", "r514" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r50", "r116", "r191", "r237", "r238", "r239", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r391", "r399", "r400", "r423", "r457", "r458", "r459" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities", "negatedLabel": "Current liabilities", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r15", "r16", "r17", "r22", "r23", "r116", "r191", "r237", "r238", "r239", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r391", "r399", "r400", "r423", "r457", "r458" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Non-current Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CURRENT LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "ACCOUNTS RECEIVABLE" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/AccountsReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as noncurrent.", "label": "Investment in marketable securities", "totalLabel": "Investment in marketable securities" } } }, "localname": "MarketableSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Investment in marketable equity securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r84" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Unrealized holding (loss) gain on marketable securities", "negatedLabel": "Unrealized holding loss (gain) on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r55", "r116", "r191", "r237", "r242", "r243", "r244", "r248", "r249", "r423", "r494", "r513" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "NON-CONTROLLING INTERESTS", "verboseLabel": "Total" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfNonControllingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders.", "label": "Noncontrolling interest, description" } } }, "localname": "MinorityInterestDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestDisclosureTextBlock": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "NON-CONTROLLING INTEREST" } } }, "localname": "MinorityInterestDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/Non-controllingInterest" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r98", "r100", "r103" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r67", "r69", "r76", "r79", "r103", "r116", "r127", "r129", "r130", "r131", "r132", "r134", "r135", "r139", "r163", "r165", "r168", "r171", "r173", "r191", "r237", "r238", "r239", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r417", "r423", "r500", "r518" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r67", "r69", "r76", "r134", "r135", "r394", "r407" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r129", "r130", "r131", "r132", "r137", "r138", "r140", "r142", "r163", "r165", "r168", "r171", "r173" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "NET (LOSS) INCOME", "terseLabel": "Net (loss) income", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL NON-CASH FLOWS INFORMATION" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r124", "r125", "r126", "r291", "r385" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r90" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "TOTAL OTHER (EXPENSES) INCOME, NET" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER (EXPENSES) INCOME" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NotesReceivableRelatedPartiesCurrent": { "auth_ref": [ "r53", "r121", "r450" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due within 1 year (or 1 business cycle).", "label": "Amount due from related parties" } } }, "localname": "NotesReceivableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedTotalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r163", "r165", "r168", "r171", "r173" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "LOSS FROM OPERATIONS", "verboseLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r441" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating lease, rent expenses" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r440" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r440" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r440" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "verboseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r439" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r102" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of operating right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r444", "r446" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating lease effective interest rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r443", "r446" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating lease, weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r349" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.", "label": "Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.)" } } }, "localname": "OtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r21", "r492", "r509" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "totalLabel": "Total other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER ASSETS" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r387", "r388", "r396" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER COMPREHENSIVE (LOSS) INCOME" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r524" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "OTHER PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r91" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other (Expenses) Income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r95" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Deferred offering costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r94" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r94" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of interest-bearing domestic time deposit liabilities to total deposit liabilities.", "label": "Percentage of Interest rate for time deposits" } } }, "localname": "PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r24", "r272" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r24", "r272" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r24", "r459" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r8", "r37", "r38" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepayments and deposits", "totalLabel": "Total" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r7", "r9", "r203", "r204" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)", "verboseLabel": "Prepaid taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "(Advances to) Repayments from related parties" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfInvestmentProjects": { "auth_ref": [ "r93" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.", "label": "Proceeds from sale of marketable securities" } } }, "localname": "ProceedsFromSaleOfInvestmentProjects", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r67", "r69", "r76", "r97", "r116", "r127", "r134", "r135", "r163", "r165", "r168", "r171", "r173", "r191", "r237", "r238", "r239", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r387", "r393", "r395", "r407", "r408", "r417", "r423", "r504" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "NET (LOSS) INCOME" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r43", "r222" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r224", "r547", "r548", "r549" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Estimated Useful Lives of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r42", "r220" ], "calculation": { "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Subtotal" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r19", "r20", "r222", "r459", "r506", "r515" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Total" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r41", "r222", "r547", "r548" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r19", "r222" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r19", "r220" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated Useful Life of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r83", "r195" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for doubtful accounts", "negatedLabel": "PROVISION FOR DOUBTFUL ACCOUNTS" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r314", "r449", "r450" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Purchase" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r314", "r449", "r453", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r447", "r448", "r450", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY BALANCES AND TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r28", "r291", "r329", "r459", "r512", "r534", "r536" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r124", "r125", "r126", "r128", "r133", "r135", "r192", "r326", "r327", "r328", "r356", "r357", "r416", "r531", "r533" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r160", "r161", "r164", "r169", "r170", "r174", "r175", "r177", "r303", "r304", "r476" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "REVENUE", "terseLabel": "Operating revenues", "verboseLabel": "Revenue from sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r153", "r177" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r112", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r309" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "verboseLabel": "Customer deposits" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r86", "r240", "r242", "r243", "r247", "r248", "r249", "r542" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r112", "r113" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r77", "r116", "r160", "r161", "r164", "r169", "r170", "r174", "r175", "r177", "r191", "r237", "r238", "r239", "r242", "r243", "r244", "r245", "r246", "r248", "r249", "r423", "r504" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Total revenues", "totalLabel": "TOTAL REVENUE" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalesCommissionsAndFees": { "auth_ref": [ "r89" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).", "label": "Sales Commissions and Fees", "negatedLabel": "COMMISSION" } } }, "localname": "SalesCommissionsAndFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/AccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF PROVISION FOR INCOME TAX" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r208", "r211", "r477" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r208", "r211" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "SCHEDULE OF INTANGIBLE ASSETS, NET" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.", "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES" } } }, "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "SCHEDULE OF LEASE COMMITMENTS" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r13", "r34", "r35", "r36" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORIES" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDis-aggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r43", "r222" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r451", "r453" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "SCHEDULE OF RELATED PARTIES" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r225", "r226", "r227", "r228", "r229", "r230", "r231" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.", "label": "SCHEDULE OF SUBSIDIARIES AND ASSOCIATES" } } }, "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "auth_ref": [ "r401", "r402", "r403", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "SCHEDULE OF VARIABLE INTEREST ENTITY" } } }, "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/VariableInterestEntityVieTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingExpense": { "auth_ref": [ "r89" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services.", "label": "Selling expenses", "negatedLabel": "SELLING" } } }, "localname": "SellingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r320", "r322" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Purchased price per shares", "verboseLabel": "Shares Issued, Price Per Share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Ending Balance", "periodStartLabel": "Shares, Outstanding, Beginning Balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r108", "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r52", "r74", "r75", "r76", "r124", "r125", "r126", "r128", "r133", "r135", "r146", "r192", "r286", "r291", "r326", "r327", "r328", "r356", "r357", "r416", "r425", "r426", "r427", "r428", "r429", "r430", "r531", "r532", "r533", "r583" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r124", "r125", "r126", "r146", "r476" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://agapeatp.com/role/ScheduleOfEffectiveIncomeTaxRateDetailsParenthetical", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": { "auth_ref": [ "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Company share forfeiture" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r24", "r25", "r291" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock issued during period acquisitions, shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r24", "r25", "r286", "r291" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Issuance of common stock shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r52", "r286", "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock issued during period, value, acquisitions" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r24", "r25", "r286", "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r323" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Forfeiture of common stock" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r25", "r30", "r31", "r116", "r187", "r191", "r423", "r459" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Net deficit", "totalLabel": "TOTAL AGAPE CORPORATION STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r75", "r116", "r124", "r125", "r126", "r128", "r133", "r191", "r192", "r291", "r326", "r327", "r328", "r356", "r357", "r385", "r386", "r406", "r416", "r423", "r425", "r426", "r430", "r532", "r533", "r583" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "TOTAL EQUITY" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r114", "r273", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r431", "r461" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r431", "r461" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r431", "r461" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r431", "r461" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r460", "r463" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOWS INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCutsAndJobsActOf2017OtherTaxEffectDescription": { "auth_ref": [ "r64", "r73" ], "lang": { "en-us": { "role": { "documentation": "Description of other income tax effect related to application of Tax Cuts and Jobs Act that are reclassified from accumulated other comprehensive income to retained earnings.", "label": "Tax rate description" } } }, "localname": "TaxCutsAndJobsActOf2017OtherTaxEffectDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income tax payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TimeDeposits": { "auth_ref": [ "r497", "r507" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of time deposit liabilities, including certificates of deposit.", "label": "Time deposits" } } }, "localname": "TimeDeposits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r181", "r182", "r183", "r184", "r186", "r189" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "verboseLabel": "Accounts receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradingActivitiesGainLossByTypeTable": { "auth_ref": [ "r414", "r415" ], "lang": { "en-us": { "role": { "documentation": "Schedule of gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance by statement location, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit).", "label": "Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table]" } } }, "localname": "TradingActivitiesGainLossByTypeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TradingActivityByTypeAxis": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by type of trading activity.", "label": "Trading Activity [Axis]" } } }, "localname": "TradingActivityByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TradingActivityByTypeDomain": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit)." } } }, "localname": "TradingActivityByTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradingActivityGainsAndLossesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Trading Activity, Gains and Losses, Net [Line Items]" } } }, "localname": "TradingActivityGainsAndLossesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/BusinessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk or Uncertainty, Nature [Axis]" } } }, "localname": "UnusualRiskOrUncertaintyByNatureAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyImpact": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes the potential impact of the occurrence of the defined risk or adverse resolution of an uncertainty on the entity's financial statements, including a range of potential loss if reasonably estimable.", "label": "COVID-19 impact description" } } }, "localname": "UnusualRiskOrUncertaintyImpact", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "localname": "UnusualRiskOrUncertaintyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r147", "r148", "r149", "r150", "r156", "r157", "r158" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableIncomeInterestRateMember": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Trading in derivative and nonderivative instrument that provides fluctuating return in form of periodic payment of interest based on movement of benchmark rate and return of principal at maturity.", "label": "Variable Income Interest Rate [Member]" } } }, "localname": "VariableIncomeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.", "label": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)" } } }, "localname": "VariableInterestEntityDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/VariableInterestEntityVie" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "verboseLabel": "Basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r159": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r188": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r224": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r236": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r309": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "http://asc.fasb.org/topic&trid=2122478" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121825205&loc=d3e27249-109313" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r369": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r383": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "184", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5634876-113961" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r433": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r455": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r463": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.12)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r563": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r564": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r565": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r566": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r567": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r568": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r569": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r571": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r572": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r573": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r574": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r575": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r576": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r577": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r578": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r579": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r581": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r582": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL116659650-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659663-227067" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" } }, "version": "2.1" } ZIP 118 0001493152-22-007862-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-007862-xbrl.zip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�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